
<html lang="en"     class="pb-page"  data-request-id="85246a9c-4f53-4ee6-ace1-98a77a07766a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-10;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.8b00246;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation" /></meta><meta name="dc.Creator" content="Brian&#xA;T.  O’Neill" /></meta><meta name="dc.Creator" content="Elizabeth M.  Beck" /></meta><meta name="dc.Creator" content="Christopher R.  Butler" /></meta><meta name="dc.Creator" content="Charles E.  Nolan" /></meta><meta name="dc.Creator" content="Cathleen  Gonzales" /></meta><meta name="dc.Creator" content="Lei  Zhang" /></meta><meta name="dc.Creator" content="Shawn D.  Doran" /></meta><meta name="dc.Creator" content="Kimberly  Lapham" /></meta><meta name="dc.Creator" content="Leanne M.  Buzon" /></meta><meta name="dc.Creator" content="Jason K.  Dutra" /></meta><meta name="dc.Creator" content="Gabriela  Barreiro" /></meta><meta name="dc.Creator" content="Xinjun  Hou" /></meta><meta name="dc.Creator" content="Luis A.  Martinez-Alsina" /></meta><meta name="dc.Creator" content="Bruce N.  Rogers" /></meta><meta name="dc.Creator" content="Anabella  Villalobos" /></meta><meta name="dc.Creator" content="John C.  Murray" /></meta><meta name="dc.Creator" content="Kevin  Ogilvie" /></meta><meta name="dc.Creator" content="Erik A.  LaChapelle" /></meta><meta name="dc.Creator" content="Cheng  Chang" /></meta><meta name="dc.Creator" content="Lorraine F.  Lanyon" /></meta><meta name="dc.Creator" content="Claire M.  Steppan" /></meta><meta name="dc.Creator" content="Ashley  Robshaw" /></meta><meta name="dc.Creator" content="Katherine  Hales" /></meta><meta name="dc.Creator" content="Germaine G.  Boucher" /></meta><meta name="dc.Creator" content="Karamjeet  Pandher" /></meta><meta name="dc.Creator" content="Christopher  Houle" /></meta><meta name="dc.Creator" content="Claude W.  Ambroise" /></meta><meta name="dc.Creator" content="David  Karanian" /></meta><meta name="dc.Creator" content="David  Riddell" /></meta><meta name="dc.Creator" content="Kelly R.  Bales" /></meta><meta name="dc.Creator" content="Michael A.  Brodney" /></meta><meta name="dc.Description" content="A major challenge in the development of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease is the alignment of potency, drug-like propert..." /></meta><meta name="Description" content="A major challenge in the development of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease is the alignment of potency, drug-like propert..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 3, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00246" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00246" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00246" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00246" /></link>
        
    
    

<title>Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00246" /></meta><meta property="og:title" content="Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0023.jpeg" /></meta><meta property="og:description" content="A major challenge in the development of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease is the alignment of potency, drug-like properties, and selectivity over related aspartyl proteases such as Cathepsin D (CatD) and BACE2. The potential liabilities of inhibiting BACE2 chronically have only recently begun to emerge as BACE2 impacts the processing of the premelanosome protein (PMEL17) and disrupts melanosome morphology resulting in a depigmentation phenotype. Herein, we describe the identification of clinical candidate PF-06751979 (64), which displays excellent brain penetration, potent in vivo efficacy, and broad selectivity over related aspartyl proteases including BACE2. Chronic dosing of 64 for up to 9 months in dog did not reveal any observation of hair coat color (pigmentation) changes and suggests a key differentiator over current BACE1 inhibitors that are nonselective against BACE2 in later stage clinical development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00246"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00246">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00246&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00246&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00246&amp;href=/doi/10.1021/acs.jmedchem.8b00246" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4476-4504</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00114" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00255" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Brian T. O’Neill</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian T. O’Neill</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian%0AT.++O%E2%80%99Neill">Brian T. O’Neill</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1928-4803" title="Orcid link">http://orcid.org/0000-0002-1928-4803</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elizabeth M. Beck</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elizabeth M. Beck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+M.++Beck">Elizabeth M. Beck</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher R. Butler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher R. Butler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+R.++Butler">Christopher R. Butler</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9387-5011" title="Orcid link">http://orcid.org/0000-0002-9387-5011</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Charles E. Nolan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Charles E. Nolan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Charles+E.++Nolan">Charles E. Nolan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cathleen Gonzales</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cathleen Gonzales</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cathleen++Gonzales">Cathleen Gonzales</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lei Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lei Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Zhang">Lei Zhang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8118-1402" title="Orcid link">http://orcid.org/0000-0001-8118-1402</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shawn D. Doran</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shawn D. Doran</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shawn+D.++Doran">Shawn D. Doran</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kimberly Lapham</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kimberly Lapham</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly++Lapham">Kimberly Lapham</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Leanne M. Buzon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leanne M. Buzon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leanne+M.++Buzon">Leanne M. Buzon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jason K. Dutra</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jason K. Dutra</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jason+K.++Dutra">Jason K. Dutra</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gabriela Barreiro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gabriela Barreiro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gabriela++Barreiro">Gabriela Barreiro</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xinjun Hou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xinjun Hou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xinjun++Hou">Xinjun Hou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Luis A. Martinez-Alsina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luis A. Martinez-Alsina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luis+A.++Martinez-Alsina">Luis A. Martinez-Alsina</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bruce N. Rogers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bruce N. Rogers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+N.++Rogers">Bruce N. Rogers</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anabella Villalobos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anabella Villalobos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anabella++Villalobos">Anabella Villalobos</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John C. Murray</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John C. Murray</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+C.++Murray">John C. Murray</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin Ogilvie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin Ogilvie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Ogilvie">Kevin Ogilvie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Erik A. LaChapelle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Erik A. LaChapelle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Erik+A.++LaChapelle">Erik A. LaChapelle</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cheng Chang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cheng Chang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Chang">Cheng Chang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lorraine F. Lanyon</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lorraine F. Lanyon</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, Primary Pharmacology, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lorraine+F.++Lanyon">Lorraine F. Lanyon</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claire M. Steppan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claire M. Steppan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, Primary Pharmacology, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claire+M.++Steppan">Claire M. Steppan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ashley Robshaw</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ashley Robshaw</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ashley++Robshaw">Ashley Robshaw</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katherine Hales</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katherine Hales</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katherine++Hales">Katherine Hales</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Germaine G. Boucher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Germaine G. Boucher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Germaine+G.++Boucher">Germaine G. Boucher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karamjeet Pandher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karamjeet Pandher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karamjeet++Pandher">Karamjeet Pandher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher Houle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher Houle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Houle">Christopher Houle</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claude W. Ambroise</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claude W. Ambroise</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claude+W.++Ambroise">Claude W. Ambroise</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Karanian</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Karanian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Karanian">David Karanian</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David Riddell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Riddell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Riddell">David Riddell</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kelly R. Bales</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kelly R. Bales</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Internal Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kelly+R.++Bales">Kelly R. Bales</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Michael A. Brodney</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael A. Brodney</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicine Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#8fe2e6ece7eeeae3a1eea1edfde0ebe1eaf6cfe7e0fbe2eee6e3a1ece0e2"><span class="__cf_email__" data-cfemail="335e5a505b52565f1d521d51415c575d564a735b5c475e525a5f1d505c5e">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Brodney">Michael A. Brodney</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7592-4097" title="Orcid link">http://orcid.org/0000-0001-7592-4097</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00246&amp;href=/doi/10.1021%2Facs.jmedchem.8b00246" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4476–4504</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 3, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 February 2018</li><li><span class="item_label"><b>Published</b> online</span>3 April 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 May 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00246" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00246</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4476%26pageCount%3D29%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBrian%250AT.%2BO%25E2%2580%2599Neill%252C%2BElizabeth%2BM.%2BBeck%252C%2BChristopher%2BR.%2BButler%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D10%26contentID%3Dacs.jmedchem.8b00246%26title%3DDesign%2Band%2BSynthesis%2Bof%2BClinical%2BCandidate%2BPF-06751979%253A%2BA%2BPotent%252C%2BBrain%2BPenetrant%252C%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B1%2B%2528BACE1%2529%2BInhibitor%2BLacking%2BHypopigmentation%26numPages%3D29%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4504%26publicationDate%3DMay%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00246"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2929</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00246" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Clinical Candidate PF-06751979: A Potent, Brain Penetrant, β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Lacking Hypopigmentation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Brian\nT.&quot;,&quot;last_name&quot;:&quot;O’Neill&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;M. Beck&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;R. Butler&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;E. Nolan&quot;},{&quot;first_name&quot;:&quot;Cathleen&quot;,&quot;last_name&quot;:&quot;Gonzales&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Shawn&quot;,&quot;last_name&quot;:&quot;D. Doran&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;Lapham&quot;},{&quot;first_name&quot;:&quot;Leanne&quot;,&quot;last_name&quot;:&quot;M. Buzon&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;K. Dutra&quot;},{&quot;first_name&quot;:&quot;Gabriela&quot;,&quot;last_name&quot;:&quot;Barreiro&quot;},{&quot;first_name&quot;:&quot;Xinjun&quot;,&quot;last_name&quot;:&quot;Hou&quot;},{&quot;first_name&quot;:&quot;Luis&quot;,&quot;last_name&quot;:&quot;A. Martinez-Alsina&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;N. Rogers&quot;},{&quot;first_name&quot;:&quot;Anabella&quot;,&quot;last_name&quot;:&quot;Villalobos&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;C. Murray&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Ogilvie&quot;},{&quot;first_name&quot;:&quot;Erik&quot;,&quot;last_name&quot;:&quot;A. LaChapelle&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Lorraine&quot;,&quot;last_name&quot;:&quot;F. Lanyon&quot;},{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;M. Steppan&quot;},{&quot;first_name&quot;:&quot;Ashley&quot;,&quot;last_name&quot;:&quot;Robshaw&quot;},{&quot;first_name&quot;:&quot;Katherine&quot;,&quot;last_name&quot;:&quot;Hales&quot;},{&quot;first_name&quot;:&quot;Germaine&quot;,&quot;last_name&quot;:&quot;G. Boucher&quot;},{&quot;first_name&quot;:&quot;Karamjeet&quot;,&quot;last_name&quot;:&quot;Pandher&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Houle&quot;},{&quot;first_name&quot;:&quot;Claude&quot;,&quot;last_name&quot;:&quot;W. Ambroise&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Karanian&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Riddell&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;R. Bales&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Brodney&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;4476-4504&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00246&quot;},&quot;abstract&quot;:&quot;A major challenge in the development of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease is the alignment of potency, drug-like properties, and selectivity over related aspartyl proteases such as Cathepsin D (CatD) and BACE2. The potential liabilities of inhibiting BACE2 chronically have only recently begun to emerge as BACE2 impacts the processing of the premelanosome protein (PMEL17) and disrupts melanosome morphology resulting in a depigmentation phenotype. Herein, we describe the identification of clinical candidate PF-06751979 (64), which displays excellent brain penetration, potent in vivo efficacy, and broad selectivity over related aspartyl proteases including BACE2. Chronic dosing of 64 for up to 9 months in dog did not reveal any observation of hair coat color (pigmentation) changes and suggests a key differentiator over current BACE1 inhibitors that are nonselective against BACE2 in later stage clinical development.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00246&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00246" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00246&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00246" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00246&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00246" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00246&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00246&amp;href=/doi/10.1021/acs.jmedchem.8b00246" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00246" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00246" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00246%26sid%3Dliteratum%253Aachs%26pmid%3D29613789%26genre%3Darticle%26aulast%3DO%25E2%2580%2599Neill%26date%3D2018%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BClinical%2BCandidate%2BPF-06751979%253A%2BA%2BPotent%252C%2BBrain%2BPenetrant%252C%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B1%2B%2528BACE1%2529%2BInhibitor%2BLacking%2BHypopigmentation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D10%26spage%3D4476%26epage%3D4504%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=291251" title="Sodium">Sodium</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/jmcmar.2018.61.issue-10/20180524/jmcmar.2018.61.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A major challenge in the development of β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer’s disease is the alignment of potency, drug-like properties, and selectivity over related aspartyl proteases such as Cathepsin D (CatD) and BACE2. The potential liabilities of inhibiting BACE2 chronically have only recently begun to emerge as BACE2 impacts the processing of the premelanosome protein (PMEL17) and disrupts melanosome morphology resulting in a depigmentation phenotype. Herein, we describe the identification of clinical candidate PF-06751979 (<b>64</b>), which displays excellent brain penetration, potent in vivo efficacy, and broad selectivity over related aspartyl proteases including BACE2. Chronic dosing of <b>64</b> for up to 9 months in dog did not reveal any observation of hair coat color (pigmentation) changes and suggests a key differentiator over current BACE1 inhibitors that are nonselective against BACE2 in later stage clinical development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72515" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72515" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) pathology is characterized by the presence of extracellular plaques in the hippocampal and cortical regions of the brain, accompanied by intraneuronal neurofibrillary tangles and extensive neuronal loss. Proteolytic cleavage of the amyloid precursor protein (APP) by β-site amyloid precursor protein cleaving enzyme 1 (BACE1), a member of the aspartyl protease family of enzymes, takes place within the endosome at low pH, generating a soluble N-terminal ectodomain of APP (sAPPβ) and C-terminal fragment (C99).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Subsequent cleavage of the membrane-bound C99 fragment by γ-secretase liberates the various amyloid-β (Aβ) peptide species, of which Aβ<sub>40</sub> and Aβ<sub>42</sub> are the predominant forms.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> A number of mutations in APP near the BACE1 cleavage site have been reported that either increase Aβ generation and are associated with early onset AD or decrease Aβ generation and protect against late-onset AD.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Therefore, limiting the generation of Aβ through inhibition of BACE1 is an attractive approach for the treatment of AD and is being intensely pursued by the pharmaceutical industry.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a></div><div class="NLM_p">Despite the considerable efforts to understand the impact of inhibiting BACE1, the physiological consequences of inhibiting BACE2 has only recently begun to emerge. The expression pattern of BACE2 is very low in brain and much greater in peripheral tissues.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Identifying and understanding the role of BACE2 substrates and their inhibition is important from an off-target perspective. Recently identified BACE2 substrates include transmembrane protein 27 (TMEM27) and the pigment cell-specific melanocyte protein (PMEL17). In the case of TMEM27, which is robustly expressed in pancreatic β-cells, inhibition of BACE2 may actually increase β-cell mass and improve glucose tolerance in conditions of insulin resistance.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, disruption of PMEL17 processing in pigment cells, due to BACE2 knockdown, has profound effects on the formation of physiologically important, nonpathologial amyloid fibers necessary for proper sequestration of melanin and ultrastuctural integrity of melanosomes.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> Genetic mutation of BACE2 in zebrafish through zinc finger nuclease-mediated genome editing generates a melanocyte migration phenotype, while failing to generate any semblance of a hypomyelination phenotype seen with BACE1 silencing.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Insights into the mechanism of this melanocyte migration phenotype comes from PMEL knockdown studies in zebrafish retinal pigment epithelium, demonstrating a failure of cylindrical melanosomes to form, which consequently prevents the movement of melanosomes into apical processes.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In addition, BACE2 KO mice display a hypopigmented phenotype,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and several nonselective BACE1/2 inhibitors such as AZD3293 (<b>5</b>), NB-360 (<b>6</b>), and SCH1682496 have shown fur and skin pigment loss in mice or dog following chronic dosing regimens.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14−16)</a></div><div class="NLM_p">In recent years, several small molecule BACE1 inhibitors including MK-8931 (<b>2</b>), AZD3293 (<b>5</b>), E2609, CNP-520, and JNJ-54861911 have advanced into late stage clinical trials (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> This new class of amidine based inhibitors possesses excellent BACE1 potency, adequate central nervous system (CNS) penetration, and robust lowering of Aβ in the cerebral spinal fluid (CSF) of humans and overcame ocular toxicity associated with earlier development candidates such as compound <b>1</b> likely due to the off-target inhibition of CatD.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> However, the current cohort of clinical development candidates appear to inhibit both BACE1 and BACE2 to a similar degree. This lack of selectivity is consistent with additional inhibitors reported in the literature such as LY-2886721 (<b>4</b>), Merck (<b>3</b>), and NB-360 (<b>6</b>).<a onclick="showRef(event, 'ref15 ref21 ref22 ref44'); return false;" href="javascript:void(0);" class="ref ref15 ref21 ref22 ref44">(15,21,22,44)</a> Despite the lack of selectivity over BACE2, we are unaware of any potential safety concerns emerging thus far in late stage clinical trials for the current cohort of Phase 3 molecules. For instance, the dosing of healthy human volunteers for 14-day duration with AZD3293, a nonselective BACE1 inhibitor, showed no signs of hypopigmentation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative overview of BACE1 inhibitors and selectivity over BACE2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The rational design of BACE1 inhibitors with an improved balance of potency, CNS penetration, and reduced safety liabilities has been a major focus within medicinal chemistry groups across the pharmaceutical industry. Balancing the compound attributes has been a direct result of optimizing the underlying physicochemical properties (p<i>K</i><sub>a</sub>, MW, logD, and hydrogen bond donors) and removing undesired structural motifs to increase the probability for compound survival.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> As BACE1 inhibition typically requires a basic amine for interaction with the catalytic aspartic acids, the optimization of the amidine p<i>K</i><sub>a</sub> has been critical in reducing P-gp mediated efflux and driving central pharmacodynamic responses.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24−27)</a> In addition to reducing efflux, a lower p<i>K</i><sub>a</sub> has been associated with reduced safety liabilities such as inhibition of the IKs channel (hERG) and reduction in potential drug–drug interactions (DDIs).<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a></div><div class="NLM_p">A common strategy to reduce p<i>K</i><sub>a</sub> has been modification of the amidine functionality by strategic placement of an electron withdrawing group such as fluorine (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> For example, we recently disclosed a novel series of thioamidine-containing BACE1 inhibitors that possesses excellent overall properties such as high CNS penetration (<i>C</i><sub>ub</sub>/<i>C</i><sub>up</sub> = 1), low clearance, reduced hERG inhibition, and low projected DDI.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> A key design element of the series was strategic incorporation of a p<i>K</i><sub>a</sub> lowering group adjacent to the thioamidine moiety (compound <b>7</b> to <b>8</b>). The addition of fluorine reduced the p<i>K</i><sub>a</sub> from 7.7 to 7.0, resulting in reduced inhibition of hERG from an IC<sub>50</sub> of 2.1 to 10.1 μM. Janssen and Novartis have described a related strategy for a series of 1,4-oxazine-derived inhibitors that suffered from poor CNS penetration due to high transporter efflux, hERG inhibition, and a weak pharmacodynamics response in brain, as exemplified by compound <b>9</b>. Tuning the p<i>K</i><sub>a</sub> of the amidine with a trifluoromethyl group (compound <b>10</b>) reduced the p<i>K</i><sub>a</sub> from 9.2 to 7.8 with a corresponding decrease in P-gp mediated efflux and an increase in brain penetration.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> A similar strategy was taken by F. Hoffman-La Roche,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> wherein the modification of the amidine p<i>K</i><sub>a</sub> by incorporation of the fluoro group resulted in a well-balanced analog with robust central lowering of Aβ due to increased exposure in brain (compound <b>12</b> vs <b>11</b>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Impact of reduced p<i>K</i><sub>a</sub> on key properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite the advances in aligning properties with potency, efforts in designing BACE1 inhibitors with selectivity over BACE2 have been minimal to date. A notable exception was the incorporation of unique substituents into the S3 pocket that take advantage of greater flexibility in the 10 s loop for BACE1 over BACE2 as reported by F. Hoffman-La Roche.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In this article, we describe efforts to modulate the basic p<i>K</i><sub>a</sub> of the thioamidine moiety (represented by <b>13</b>) through modification of the P1 substituent while simultaneously obtaining selectivity over BACE2 by modification of the inhibitor in the P3 and flap regions of BACE1 (represented by <b>14</b>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). We had previously described a stereospecific incorporation of electron withdrawing fluoro or trifluoromethyl groups on the thioamidine backbone core that also reduced the p<i>K</i><sub>a</sub> of this functionality but that required lengthy complex synthesis and failed to deliver molecules with improved selectivity over BACE2.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The present synthesis and characterization of thiazole containing inhibitors (<b>14</b>) has resulted in the identification of compound <b>64</b>, a clinical candidate with an excellent balance of BACE1 potency, CNS penetration, robust central Aβ lowering, long predicted human half-life, and selectivity over BACE2 as determined by in vitro binding, cellular/tissue pigmentation models, and long-term safety studies.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design strategy for modulating p<i>K</i><sub>a</sub> and selectivity over BACE2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00486" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00486" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We previously described a strategy to add aryl and heteroaryl substituents by straightforward Lewis acid catalyzed anion addition to isoxazoline template <b>15</b> followed by elaboration to the thioamidines <b>40</b>–<b>47</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The chirality of the isoxazoline <b>15</b> originates from commercial propylene oxide or a commercial homoallylic alcohol (<i>S</i>)-pent-4-en-2-ol that controls the creation of two additional chiral centers. The compact ring structure contributes to the high selectivity of the anion addition to the convex face. Following addition, the isoxazoline ring <b>16</b>–<b>23</b> can be reductively cleaved to amino-alcohols <b>24</b>–<b>31</b> and the thioamidine ring formed by addition of an acylisothiocyanate followed by ring closure to thioamides <b>32</b>–<b>39</b>. Deprotection in basic methanol provided the desired analogs <b>40</b>–<b>47</b> that were assessed for potency, p<i>K</i><sub>a</sub>, and physical properties.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Aryl or Heteroaryl Containing Thioamidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ArX, 2.5 M <i>n</i>-BuLi in hexane, BF<sub>3</sub>-Et<sub>2</sub>O, toluene/THF (10:1 v/v), −70 °C then add 1<b>5</b> in toluene/THF (10:1 v/v), 25–68%; (b) H<sub>2</sub>, Raney nickel, ethanol or IPA/THF, 50 °C; (c) 2 equiv of BzNCS, ethyl acetate, r.t. to 90 °C (no isolation of thiourea intermediate); (d) BzNCS, ethyl acetate, r.t., 2.5 h (isolate thiourea), then BzNCS, ethyl acetate, 90 °C, 26–66%; (e) DBU, methanol, 70 °C, 15–74%.</p></p></figure><div class="NLM_p">In addition, we prepared an array of analogs bearing various P1 moieties in a parallel medicinal chemistry fashion illustrated in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Starting with a diverse set of amino alcohols <b>48</b>, which were prepared using the procedure described above, the desired analogs <b>50</b> were obtained in two distinct steps followed by high throughput purification (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The success rate for this parallel effort was 89% (40/45). The sum total of these efforts led us to the thiazole series with the desired p<i>K</i><sub>a</sub> and physical property profile.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Array Chemistry To Generate P1 Aryl Groups<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EtO<sub>2</sub>CN═C═S/THF then Scavenging Resin; (b) MeTHF/H<sub>2</sub>O/TFA, 60 °C, 1 h; (c) 120 °C, 4 h; (d) high throughput purification.</p></p></figure><div class="NLM_p">In order to fully evaluate the SAR of the thiazole containing series, we desired a robust procedure to prepare the thiazole bromide <b>54</b>, which could serve as a viable intermediate for exploration of the P3 subpocket (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Selective C-2 halogen metal exchange of 2,4-dibromothiazole followed by addition to <b>15</b> provided compound <b>51</b>, which was poised for elaboration into the P3 region. Alternatively, addition of the anion from halogen metal exchange of 2-bromothiazole (or reductive removal of the previously mentioned C-4 bromide) afforded a substrate that could be metalated at C-5 directed by the proximal sulfur. Due to the presence of the bromide, an alternative method was required for selective cleavage of the N–O bond. Reduction with a Mo(0) hexacarbonyl complex followed by a reductive workup afforded the amino alcohol <b>52</b> without loss of the bromide. Addition of benzoyl isothiocyanate formed the thiourea <b>53</b>, which upon activation of the alcohol with Ghosez’s reagent<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> yielded the key thioamidine intermediate <b>54</b>.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Bromo-thiazole <b>54</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,4-dibromo-thiazole, 2.5 M <i>n</i>-BuLi in hexane, BF<sub>3</sub>-Et<sub>2</sub>O, toluene/THF (10:1 v/v), −70 °C then add 1<b>5</b> in toluene/THF (10:1 v/v), 1 h, 85%; (b) Mo(CO)<sub>6</sub>, CH<sub>3</sub>CN, H<sub>2</sub>O, NaBH<sub>4</sub>, 70 °C, 1 h, 95%; (c) benzoyl isothiocyante, CH<sub>2</sub>Cl<sub>2</sub>, rt, 24 h, 66%; (d) Ghosez’s reagent, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h, 77%.</p></p></figure><div class="NLM_p">The elaboration of the bromide <b>54</b> into the key thiazole-amides <b>56</b>–<b>68</b> and <b>70</b>–<b>71</b> is shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The bromide was transformed to an amine and eventually to amides <b>55</b> by one of several routes described below. Our initial protocol involved a copper-catalyzed azide addition in the presence of ascorbic acid that conveniently reduced the azide <i>in situ</i> to an amine. Acylation of the amine yielded the desired amides <b>55</b>, which readily deprotected in basic methanol to afford thioamidines <b>56</b>–<b>68</b>. Amides <b>55</b> were also available via direct palladium catalyzed amidation. For target <b>69</b>, the bromide of <b>54</b> was removed via zinc reduction, and a new anion was then formed at C-5 with butyl lithium. The anion was then quenched with CO<sub>2</sub> to give the acid, which by suitable manipulation was converted to a series of amides <b>69</b>. Deprotection afforded the C-5 amides <b>70</b> and <b>71</b> in good yield.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Elaboration of Bromide <b>54</b> into Amide Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine, NaN<sub>3</sub>, H<sub>2</sub>O, sodium-<span class="smallcaps smallerCapital">l</span>-ascorbate rt then CuI, 70 °C, 2 h, 47%; (b) HATU, R-CO<sub>2</sub>H, DMF, rt, 1 h, or 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxide, pyridine or Et<sub>3</sub>N, rt, 12–24 h; (c) ArC(O)NH<sub>2</sub>, Pd<sub>2</sub>dba<sub>3</sub>, <i>t</i>BuBrettPhos, LiO-<i>t</i>-Bu, 2-MeBuOH, 95 °C, 1 h, 61%; (d) methoxyl-amine, HCl, pyridine, 50 °C, 16 h, or DBU, methanol, 70 °C; (e) Zn dust, THF, aq NaOH, 40 °C, 16 h, 86%; (f) <i>n</i>-BuLi, THF, CO<sub>2</sub>, −78 °C, 1 h, 95%; (g) HATU, R-NH<sub>2</sub>, DMF; (h) MeNH<sub>2</sub>, EtOH, rt, 2–4 h.</p></p></figure><div class="NLM_p">A synthesis of <b>64</b> on intermediate scale (25 g) is illustrated in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. The Buchwald coupling conditions arose from the need to replace the azide coupling on scale and provided a mild, selective deprotection with HCl. Amide formation with <b>72</b> was easily accomplished through coupling with a variety of agents such as HATU or T<sub>3</sub>P. The final debenzoylation of <b>73</b> was delicate due to interference from the thioamidine. This was achieved in high yield using basic methanol.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>64</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,4-dimethoxy benzyl amine, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>t</i>-BuONa, <i>t</i>-BuXPhos, 70 °C, 1 h then HCl, H<sub>2</sub>O, rt, 1 h, 70%; (c) HATU, iPrNEt<sub>2</sub>, CH<sub>3</sub>CN, 5-(difluoromethoxy)picolinic acid, rt, 4 h, 81%; (d) DBU, methanol, 70 °C, 1.5 h, 55%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11834" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11834" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our primary strategy to modulate the basic p<i>K</i><sub>a</sub> of the amidine was accomplished by a systematic exploration of the P1 region (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Our goal was to identify those aromatic substituents or heteroaryl replacements that inherently reduced p<i>K</i><sub>a</sub> to an optimal range of 6.5–7, an optimal range to balance BACE1 potency with overall alignment of properties. This strategy would obviate the need to fluorinate the core and reduce synthetic complexity. In previous SAR, we had optimized the fluorination pattern on the P1 substituent for BACE1 potency, and the optimal substitution pattern was the 2,4-difluoro analog <b>40</b>, which had a basic p<i>K</i><sub>a</sub> of 8.1.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> As anticipated, removal of the fluorines produced analog <b>42</b> with weaker BACE1 potency in a fluorescent polarization (FP) assay and a higher p<i>K</i><sub>a</sub> (8.8). Attempts to further reduce the p<i>K</i><sub>a</sub> with an ortho-substituted aryl group (<b>41</b> or <b>43</b>) resulted in a similar potency and p<i>K</i><sub>a</sub> relative to unsubstituted phenyl analog <b>42</b>. We next investigated installation of a 2-pyridyl group <b>(44</b>) in P1 and were surprised that the p<i>K</i><sub>a</sub> increased to 8.6 relative to analog <b>40</b>. Further modification to five-membered ring heteroaryls such as thiophenes <b>45</b> or <b>46</b> resulted in reasonable BACE1 potency, but only the 2-thienyl analog <b>46</b> reduced the p<i>K</i><sub>a</sub> to the desired range. This raised the possibility that a thiazole in P1 would further reduce the p<i>K</i><sub>a</sub> of the amidine due to the greater electron withdrawing nature relative to thiophene. We were gratified to find that thiazole <b>47</b> resulted in a BACE1 inhibitor with a p<i>K</i><sub>a</sub> of 7 and displayed reasonable cellular activity (IC<sub>50</sub> = 2.05 μM), low P-gp mediated efflux, high passive permeability, and low clearance from human liver microsomes. Despite the drop in potency for thiazole <b>47</b>, we anticipated that appropriate substitution on the thiazole ring would make favorable interactions with protein residues to improve potency without increasing p<i>K</i><sub>a</sub>. Across the P1 variations prepared in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, each analog displayed weak activity against CatD and the hERG channel.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Modification of the P1 Aryl Group</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0015.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0016.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values obtained from BACE1 Fluorescent Polarization (FP) Assay.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values obtained from CatD FP Assay.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> values obtained from BACE1 Whole-Cell Assay (WCA).</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of a test compound at 2 μM across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">RRCK-MDCK cells used to evaluate passive permeability.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Hepatic clearance predicted from in vitro human microsomal stability study.</p></div></div><div></div></div><div class="NLM_p">A key strategy to improve potency of thiazole <b>47</b> was installation of an aryl amide moiety to engage the backbone carbonyl of Gly230, while simultaneously placing an aryl substituent into the lipophilic S3 pocket. To guide the optimal placement of the amide group, we modeled thiazole <b>47</b> using a cocrystal structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CLM">5CLM</a>) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a,b). Because of a wider bond angle (150° vs 131°) induced by the sulfur atom in the thiazole ring, the vector off the 5-position of the thiazole is not ideal for aligning the amide functionality within the P1–P3 region of the protein (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a). However, the 4-position of the thiazole afforded a more favorable angle for amide introduction (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b). Structural optimizations of the two proposed phenyl amides demonstrated that 5-substituted phenyl amide would not make the key hydrogen bond (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C), yet the 4-substituted phenyl amide would occupy the S3 pocket nicely and make the desired hydrogen bond interaction to Gly230 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>d).</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Molecular modeling of thiazole regioisomers. Vectors reach the S3 pocket from 4- or 5-position of thiazole <b>40</b> aligned in cocrystal structure (thin gray, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CLM">5CLM</a>). (a,b) Initial vector of 4- or 5-substitutions. (c,d) modeled phenyl amides reaching S3 pockets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We also evaluated the conformational energy profile of the thiazole orientation of thiazole <b>47</b> to assess the potential energy penalty as different substitutions were introduced into P3. The torsion of amidine and thiazole bond was subjected to a conformational analysis using TetraChem with B3LYP/6-31G** in gas phase.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> We noticed that the <i>trans</i>-conformation (corresponding to <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a) is at the lowest energy potential well, whereas the <i>cis</i>-conformation (corresponding to <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b) is only at a slightly higher energy state (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), giving us assurance that any conformational penalty of 4- vs 5-substituted thiazoles would be tolerated without a significant loss of potency.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Energy confirmations of thiazole <b>47</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Since the conformational energies for thiazole <b>47</b> were relatively comparable, we modeled four variations of aryl-amide linkers (<b>74</b>–<b>77</b>) to assess and rank-order their potential binding to BACE1 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Structure minimization using a variant of MM-GB/SA calculations (PLIERS<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a>) showed that 4-pheny amide <b>76</b> and 5-phenyl reversed amide <b>75</b> bound preferably based on intermolecular energy, desolvation, and ligand strain energy components (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). An important consideration is the angle between the bicyclic core and the amide group on the thiazole ring. The requirement to reverse the amide confirmation from <b>74</b> to <b>75</b> allowed for the optimization of the amide vector to P3 and alignment of a hydrogen bond between Gly230 and the amide.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A,B) Aryl-amide linkers designed to reach S3 pocket with potential to make H-bond to Gly230 backbone carbonyl.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As the amido-thiazoles <b>75</b> and <b>76</b> both appeared to satisfy the key parameters for binding, synthesis, and profiling of analogs, <b>70</b>–<b>71</b> and <b>56</b>–<b>57</b> were initiated, which contained a methoxy group for additional potency (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). For each case, molecular modeling suggested that a meta- or para-substituted aryl group was optimal for BACE1 activity. We were gratified to find that both analogs <b>56</b> and <b>70</b> showed considerable binding and cellular potency improvement relative to the parent thiazole <b>47</b> while maintaining a similar p<i>K</i><sub>a</sub> (6.8 and 6.5, respectively). Both analogs exhibited low clearance in human liver microsomes and high passive permeability. Unfortunately, the increase in hydrogen bond donor (HBD) count and molecular weight increased the P-gp mediated efflux liability. Modification of the P3 aryl ring to a pyridine ring has been previously demonstrated to reduce P-gp mediated efflux due to the potential for an intramolecular hydrogen bond between the amide NH with nitrogen of the pyridine ring.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In an attempt to understand the impact of the pyridine ring on efflux and lower logD, we designed and profiled analogs <b>71</b> and <b>57</b>. For each matched molecular pair, the modification from phenyl to pyridine improved potency, lowered P-gp mediated efflux, and reduced hERG binding without negatively impacting clearance in human microsomes relative to the phenyl analogs <b>56</b> and <b>70</b>. Unfortunately, cross-species plasma instability with 5-amido-substituted thiazoles <b>70</b> and <b>71</b> precluded further evaluation for efficacy or safety due to rapid turnover in rodent plasma. Fortunately, thiazole-amides <b>56</b> and <b>57</b> were stable in cross species plasma stability assays.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Profile for Aryl-Amides <b>52</b>–<b>55</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0018.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0019.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values obtained from BACE1 FP Assay.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values obtained from CatD FP Assay.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> values obtained from BACE1 Whole-Cell Assay (WCA).</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of a test compound at 2 μM across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">RRCK-MDCK cells used to evaluate passive permeability.</p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">Hepatic clearance predicted from in vitro human microsomal stability study.</p></div></div><div></div></div><div class="NLM_p">With the 4-amido substituent on the thiazole ring providing a vector to probe potency and selectivity by filling the P3 pocket, we profiled a range of six-membered ring heteroaryl groups such as pyridines and pyrazines containing a substituent in the 5-position (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). In each case, the regiochemistry of the heteroaryl ring placed a nitrogen atom ortho to the carbonyl of the amide as this was previously reported to both lock the confirmation of the amide and reduce P-gp mediated efflux. With suitable binding assays in place, pyridine <b>58</b> gave comparable potency and selectivity over CatD to the methoxy analog <b>56</b> while maintaining the low clearance, plasma stability, and low P-pg efflux ratio (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). As further potency improvements were needed, we modified the fluoro substituent to a variety of analogs (<b>60</b>–<b>64</b>). We were gratified to identify chloro, cyano, and difluoromethoxy substituents improved potency in binding and whole cell (IC<sub>50</sub> < 10 nM) BACE1 assays relative to fluoro analog <b>58</b>. In all cases, clearance was reduced, and the compounds showed high passive permeability. A second strategy to improve potency was incorporation of an <i>ortho</i>-methyl group resulting in analogs <b>59</b> and <b>65</b>. Substituted pyrazines (<b>66</b>–<b>67</b>) were well tolerated along with a five-membered ring in P3 such as pyrazole <b>68</b>. Using BACE1 and BACE2 FP assays, compounds <b>60</b>, <b>62</b>, <b>64</b>, and <b>67</b> displayed the highest levels of selectivity over BACE2 of 5.6-, 10-, 6.4-, and 5-fold, respectively. The improved selectivity with larger substituents in the P3 region may be explained by the greater flexibility in this region of the protein relative to the rigid confirmation observed in BACE2. Unfortunately, poor plasma stability was observed with compounds <b>60</b> and <b>66</b>–<b>68</b>, which precluded further development.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Profile for <b>58</b>–<b>68</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0020.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0021.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values obtained from BACE1 FP Assay.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values obtained from CatD FP Assay.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> values obtained from BACE1 Whole-Cell Assay (WCA).</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of a test compound at 2 μM across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">RRCK-MDCK cells used to evaluate passive permeability.</p></div><div class="footnote" id="t3fn6"><sup><sup>f</sup></sup><p class="last">Hepatic clearance predicted from in vitro human microsomal stability study. ND = not determined.</p></div></div><div></div></div><div class="NLM_p">A select group of compounds (<b>61</b>, <b>64</b>, <b>65</b>, 67) displayed an excellent alignment of properties and potency and were predicted to have good brain penetration due to the low P-gp mediated efflux as measured in the Borst Cell Line. However, in vivo neuropharmacokinetics (neuroPK) in mouse suggested that all four analogs were brain impaired with C<sub>ub</sub>/C<sub>up</sub> values ranging from 0.06 to 0.10 (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). To build a more comprehensive understanding of the transporters limiting brain penetration in rodent, we incorporated a higher expressing P-gp assay from the National Institutes of Health (NIH) along with a breast cancer resistant protein (BCRP) assay, an additional transporter highly expressed at the blood–brain barrier. These analogs now displayed a range of P-gp and BCRP-mediated efflux, which helped to explain the apparent in vitro to in vivo disconnect. Since the expression of P-gp is highest in rodents and lower in NHP and humans, we anticipated that NHP neuroPK would more accurately reflect brain penetration in humans.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In contrast to P-gp, BCRP expression in rodents is lower than NHP and unlikely to contribute to differences in brain penetration when comparing mouse to NHP. To this end, brain penetration studies in NHP were conducted and resulted in much improved <i>C</i><sub>ub</sub>/<i>C</i><sub>up</sub> values ranging from 0.28 to 0.62 and CSF/<i>C</i><sub>up</sub> ranging from 0.39 to 0.76.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Mouse vs NHP NeuroPK</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0022.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Unbound brain to unbound plasma and CSF to unbound plasma area under the curve (AUC) ratios in mice and nonhuman primates.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of a test compound at 2 μM across contiguous monolayers from MDR1- or BCRP-transfected MDCK cells.</p></div></div><div></div></div><div class="NLM_p">The in vitro and in vivo PK properties for compounds (<b>61</b>, <b>64</b>, and <b>65</b>) are shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. All three compounds were characterized by low in vitro clearance in rat, dog, and human microsomal systems. As expected based on the low in vitro clearance, compounds <b>61</b>, <b>64</b>, and <b>65</b> all exhibited low in vivo clearance in both rats and dogs. All three analogs were predicted to have a long half-life in human (>12 h).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro and in Vivo PK Properties of Representative Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK properties</th><th class="colsep0 rowsep0" align="center"><b>64</b></th><th class="colsep0 rowsep0" align="center"><b>61</b></th><th class="colsep0 rowsep0" align="center"><b>65</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vitro <i>h</i>-Cl<sub>h</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left"><8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vitro <i>r</i>-Cl<sub>h</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><25</td><td class="colsep0 rowsep0" align="left"><25</td><td class="colsep0 rowsep0" align="left"><25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vitro <i>d</i>-Cl<sub>h</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"><18</td><td class="colsep0 rowsep0" align="left"><18</td><td class="colsep0 rowsep0" align="left"><18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat CL (mL/min/kg)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog CL (mL/min/kg)<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">5.5</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat bioavailability (%)<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog bioavailability (%)<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">60</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Hepatic clearance predicted from in vitro human microsomal stability study.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Hepatic clearance predicted from in vitro rat microsomal stability study.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Hepatic clearance predicted from in vitro dog microsomal stability study.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Rat plasma clearance determined following a single intravenous bolus dose of 1 mg/kg.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">Dog plasma clearance determined following a single intravenous bolus dose of 1 mg/kg.</p></div><div class="footnote" id="t5fn6"><sup><sup>f</sup></sup><p class="last">Rat bioavailability determined following a single oral dose of either 3 or 5 mg/kg.</p></div><div class="footnote" id="t5fn7"><sup><sup>g</sup></sup><p class="last">Dog bioavailability determined following a single oral dose of either 1 or 3 mg/kg.</p></div></div></div><div class="NLM_p">Several compounds satisfied our criteria for advancement, but only compound <b>64</b> combined excellent potency, modest selectivity (∼5.6-fold) over BACE2, weak hERG inhibition, stability in plasma, and high predicted brain penetration. To understand the <i>in vivo</i> potency of compound <b>64</b>, we assessed the compound against a panel of Aβ end points in brain, CSF, and plasma in 129/sve mice and dog. The exposure was also measured in these biological compartments in order to understand PK/PD and predict efficacious concentrations (<i>C</i><sub>eff</sub>). For mouse studies, we used sensitive immunoassays to measure Aβx-42 in brain homogenates, as well as Aβx-40 in CSF (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,B). Acutely, robust lowering of brain Aβ42 persisted in a dose- and time-dependent manner with maximum inhibition of 56%, peaking at 5 to 7 h postdose. The 80 mg/kg dose did not produce any further reduction beyond the 50 mg/kg dose, but did demonstrate a delayed return to baseline at 14 h. Acute administration of <b>64</b> yielded a robust dose-responsive and time-dependent reduction of CSF Aβx-40 with peak inhibition at 3 h of >77%. To determine if the reduction in brain and CSF Aβ was maintained during sustained exposure to <b>64</b>, a 5 day subchronic study was executed, dosing once daily by subcutaneous (SC) administration (10 or 50 mg/kg/day). Brain and CSF samples were collected on day 5, following the last dose. Compound <b>64</b> produced a dose-responsive and time-dependent inhibition of Aβ42 in mouse brain. At the 50 mg/kg/day dose, maximal brain lowering was 63% at 7 to 9 h (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf" class="ext-link">Figure S1</a>). Administration of <b>64</b> (10 or 50 mg/kg/day for 5 days) produced a dose-responsive and time-dependent inhibition of Aβx-40 in mouse CSF resulting in 77% inhibition of CSF at 3 h post-final 50 mg/kg dose.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0007.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compound <b>64</b> on brain and CSF amyloid-beta following administration in mouse and dog. (A) Compound <b>64</b> (10, 50, or 80 mg/kg) and vehicle were administered subcutaneously to male 129/sve mice. Brain Aβx-42 was assessed at 1, 3, 5, 7, 9, and 14 h postdose. Data are expressed as the mean of % of vehicle of <i>n</i> = 5 animals per group ± SEM; ****<i>p</i> < 0.0001, ***<i>p</i> < 0.001, **<i>p</i> < 0.01, *<i>p</i> < 0.05. (B) Compound <b>64</b> (10, 50, or 80 mg/kg) and vehicle were administered subcutaneously to male 129/sve mice. CSF Aβx-40 was assessed at 1, 3, 5, 7, 9, and 14 h postdose. Data are expressed as the mean of % of vehicle of <i>n</i> = 5 animals per group ± SEM; ****<i>p</i> < 0.0001, ***<i>p</i> < 0.001, **<i>p</i> < 0.01. All values for the 50 mg/kg dose at 3 h were below BLQ, which is defined as <23% of vehicle. All values for the 80 mg/kg dose groups at 3, 5, 7, and 9 h where BLQ is defined as <36.3% of vehicle. BLQ data points were interpolated from the standard curve and are represented in the graph. (C) Male 129/sve mice were dosed subcutaneously once a day for 5 days with <b>64</b> (10 or 50 mg/kg/day) or vehicle. CSF Aβx-40 was assessed at 1, 3, 5, 7, 9, and 14 h after the last dose. Data are expressed as the mean percent of vehicle of <i>n</i> = 5 animals per group ± SEM; ****<i>p</i> < 0.0001, ***<i>p</i> < 0.001, **<i>p</i> < 0.01, *<i>p</i> < 0.05. (D) Time course data for the effect of <b>64</b> on CSF Aβx-42 levels in dog. Compound <b>64</b> was orally dosed at 1 or 3 mg/kg at time = 0 h. Data are the mean ± SEM, <i>n</i> = 3 per group; *<i>p</i> < 0.05 for the 1 mg/kg group, <sup>†</sup><i>p</i> < 0.05 for the 3 mg/kg group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Using cisterna magna cannulated Beagle dogs, the Aβx-42 lowering by <b>64</b> was evaluated in serial CSF samples collected over a 72 h period postdose following oral doses of 1 or 3 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D). The results for each analyte measured in the CSF over a time course of 72 h are expressed as absolute levels in picograms per milliliter. Following administration of <b>64</b>, the 3 mg/kg dose showed a long-lasting reduction in CSF levels of Aβx-42, with a maximum decrease of 74% versus baseline at 11 h post-dose.</div><div class="NLM_p">Our first goal was to establish a link between BACE2 inhibition in vitro and accumulation of full length PMEL17 in primary melonocytes. To this end, we assessed two nonselective BACE1 inhibitors (<b>3</b> and <b>4</b>) in primary human melanocytes from darkly pigmented donors after overnight incubation with a dose response of inhibitor from 10 μM to 1 nM. Accumulation of full length PMEL17 is apparent for both compounds (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf" class="ext-link">Figure S2</a>), consistent with inhibition of PMEL17 processing.</div><div class="NLM_p">Furthermore, we were concerned that the measurements in the standard fluorescent polarization (FP) assays, which utilize an artificial substrate, truncated enzyme, and a nonphysiological relevant pH (4.5), may not accurately reflect the selectivity for BACE1 over BACE2 in a native environment. Due to these limitations, we established BACE1 and BACE2 binding assays using full length human recombinant enzymes overexpressed in HEK293 cells where inhibition is determined by competition binding in cell paste at physiological pH (6.0). <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> compares the selectivity for literature molecules <b>3</b> and <b>4</b> relative to thiazoles <b>61</b>, <b>64</b>, and <b>65</b>. All inhibitors have excellent potency at BACE1 in binding or FP assay formats along with cellular activity looking at production of sAPPβ in H4 cells. Remarkably, thiazole <b>64</b> showed improved selectivity over BACE2 in binding (27-fold) relative to the literature examples and across multiple chemical series in our BACE1 program (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf" class="ext-link">Figure S3</a>). We hypothesized that the improved selectivity over BACE2 was due to subtle nonbinding interactions in BACE1 in the P3 and flap region of the enzyme that were less tolerated in BACE2.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Selectivity Profile for Analogs <b>3</b>, <b>4</b>, <b>61</b>, <b>64</b>, and <b>65</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col><col align="left" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">BACE1 binding (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">BACE2 binding (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">B2/B1 binding ratio</th><th class="colsep0 rowsep0" align="center" char=".">BACE1 FP (nM)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">BACE2 FP (nM)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">sAPPβ (nM)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">3D skin model (nM)<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left" char=".">6.4</td><td class="colsep0 rowsep0" align="left" char=".">3.3</td><td class="colsep0 rowsep0" align="left" char=".">0.5</td><td class="colsep0 rowsep0" align="left" char="."><2.2</td><td class="colsep0 rowsep0" align="left" char=".">4.5</td><td class="colsep0 rowsep0" align="left" char="."><0.54</td><td class="colsep0 rowsep0" align="left" char=".">2.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left" char=".">25.7</td><td class="colsep0 rowsep0" align="left" char=".">17.8</td><td class="colsep0 rowsep0" align="left" char=".">0.7</td><td class="colsep0 rowsep0" align="left" char=".">42.0</td><td class="colsep0 rowsep0" align="left" char=".">42.9</td><td class="colsep0 rowsep0" align="left" char=".">38.4</td><td class="colsep0 rowsep0" align="left" char=".">38.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left" char=".">8.2</td><td class="colsep0 rowsep0" align="left" char=".">20</td><td class="colsep0 rowsep0" align="left" char=".">2.4</td><td class="colsep0 rowsep0" align="left" char=".">29.1</td><td class="colsep0 rowsep0" align="left" char=".">21.6</td><td class="colsep0 rowsep0" align="left" char=".">4</td><td class="colsep0 rowsep0" align="left" char=".">234</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left" char=".">7.3</td><td class="colsep0 rowsep0" align="left" char=".">194</td><td class="colsep0 rowsep0" align="left" char=".">26.6</td><td class="colsep0 rowsep0" align="left" char=".">36.9</td><td class="colsep0 rowsep0" align="left" char=".">238</td><td class="colsep0 rowsep0" align="left" char=".">5</td><td class="colsep0 rowsep0" align="left" char=".">2860</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left" char=".">8.7</td><td class="colsep0 rowsep0" align="left" char=".">57</td><td class="colsep0 rowsep0" align="left" char=".">6.5</td><td class="colsep0 rowsep0" align="left" char=".">22.8</td><td class="colsep0 rowsep0" align="left" char=".">70.5</td><td class="colsep0 rowsep0" align="left" char=".">3</td><td class="colsep0 rowsep0" align="left" char=".">372</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values obtained from BACE1 or BACE2 binding assay.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> values obtained from BACE1 or BACE2 FP assay.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> values obtained from whole cell assay measuring sAPPβ.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">Spectrophotometric quantitation (L value) showing full dose response curves of the 3D skin model surface pigmentation using a hand-held Minolta CR-700D spectrophotometer following 9 days of treatment with compounds indicated. The change in L value compared to DMSO control was plotted against a dose response of compound in duplicate using a four-parameter curve fit with variable slope. The concentration showing a change in L value of 2 points (delta 2) was used to rank order compounds.</p></div></div></div><div class="NLM_p">In order to further understand and refine the apparent cell-free selectivity of thiazole <b>64</b>, we sought a cellular assay providing a more physiologically relevant end-point of pigmentation changes. Reconstituted human epidermis models are increasingly being used to evaluate potential therapeutics.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> To this end, we utilized a three-dimensional (3D) reconstructed skin model.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> This model uses melanocytes from African American donors that are devoid of pigmentation at the start of treatment. Following 9 days in culture, untreated melanocytes will demonstrate surface pigmentation, therefore providing a model in which BACE inhibitors could be compared with regard to their inhibitory effects on pigmentation. The surface pigmentation was quantified spectrophotometrically using a hand-held Minolta CR-700D spectrophotometer, generating an L value, which is an objective measure of skin pigmentation. Loss of pigmentation is accompanied by an increase in L value. The concentration accompanying a change in L value of 2.0 was used to rank order compounds. Dose response curves for <b>3</b>, <b>4</b>, and <b>64</b> are shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A. Thiazole <b>39</b> is clearly more selective in the reconstructed skin model with an L value of 2.86 μM relative to nonselective literature compound <b>3</b> or <b>4</b> as well as closely related analogs <b>61</b> and <b>65</b> (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0008.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Human 3D skin model surface pigmentation following 9 days in culture; images and L value quantitation and representative EM. (A) Spectrophotometric quantitation (L value) showing full dose response curves of the melanocytes surface pigmentation using a hand-held Minolta CR-700D spectrophotometer following 9 days of treatment with the compounds indicated. The change in L value compared to DMSO control was plotted against a dose response of compound in duplicate using a four-parameter curve fit with variable slope. The concentration showing a change in L value of 2 points (delta 2) was used to rank order compounds. The plotted delta L data is a compilation of 2–5 separate full dose response experiments. The dotted line designates the concentration of compound required for a change in L value of 2 units. (B) Representative transmission electron microscopic images (4000×) of melanocytes demonstrating a qualitative reduction in number of melanosomes in the 100 nM compound <b>3</b> and 161 nM compound <b>4</b> melanocytes from 3D skin model as compared with DMSO control. Inset images demonstrate alteration in melanosome morphology characterized by irregular shape and indistinct borders in the BACE inhibitor treated groups as compared with control. Bar equals one micron.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to validate the degree in surface pigmentation change of the melanocytes with a structural change in melanosomes as has been reported with BACE2 depletion,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> the ultrastructure of the treated melanocytes was examined by electron microscopy for <b>3</b> and <b>4</b> relative to control (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>B). This blind evaluation demonstrated altered melanosome morphology as well as a qualitative reduction in number of melanosomes in groups treated with a nonselective BACE inhibitor (positive control) albeit at relatively high concentrations of 100 and 161 nM, respectively. These ultrastructural changes in melanosomes were reflected in the higher L value scores in these groups, indicative of reduced surface pigmentation.</div><div class="NLM_p">In order to translate the in vitro binding and phenotypic cellular assays to coat color changes in vivo, pigmented C57BL/6J mice were selected for chronic dosing studies. Initially we sought to reproduce findings of hypopigmentation changes with extended dosing of SCH1682496 as reported, where loss of fur pigmentation occurred following 16 days of dosing with 100 mg/kg (BID).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Upon repeat of this study design, we observed a similar hypopigmentation phenotype with the changes in ventral fur having a heterogeneous and random pattern making quantification difficult. This was mostly likely due to the regional differences in phases of hair growth known to occur in mice. In order to have a more homogeneous pigmenation response, we sought to synchronize hair growth with depilation prior to the start of dosing. In a time-course in control mice, a three-week time frame was sufficient to observe hair regrowth equivalent to predepilation conditions (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf" class="ext-link">Figure S4</a>). To this end, we treated mice for 3 weeks using <b>3</b> and <b>4</b> in a dose-reponsive manner achieving projected <i>C</i><sub>avg</sub> of 7–144 nM for <b>3</b> and 103–5190 nM for <b>4</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf" class="ext-link">Figure S6</a>). Relative to control and low dose groups, the higher doses of the nonselective BACE inhibitors produced a homogeneous change in fur pigmentation (lighter color) at multiples of the BACE2 binding IC<sub>50</sub> unbound in plasma (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A,B; <a href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf" class="ext-link">Figure S6</a>).</div><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0009.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effect of chronic dosing at multiples of the BACE2 binding IC<sub>50</sub> on pigmentation in C57BL/6J mice after synchronization of fur growth. (A) Representative images from chronic dosing of compound <b>3</b> at observed plasma exposures of 2-, 14-, and 48-fold of the BACE2 IC<sub>50</sub>. (B) Representative images from chronic dosing of compound <b>4</b> at observed plasma exposures of 6-, 54-, and 291-fold of the BACE2 IC<sub>50</sub> (C) Representative images from chronic dosing of compound <b>64</b> and <b>3</b> at comparable projected Aβ lowering in human.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to compare selectivity across different BACE inhibitors, we sought to achieve a free plasma exposure on average relative to their projected efficacy as measured by Aβ lowering in brain (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C). Using the above chronic dosing paradigm, we compared compound <b>64</b> to <b>3</b> at concentrations targeting a projected 50% Aβ lowering in brain. The actual observed <i>C</i><sub>avg</sub> (unbound plasma) exposure was 31 and 42 nM for compound <b>64</b> and compound <b>3</b>, respectively, which projected an Aβ lowering in human CSF of 55% and 40%, respectively (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf" class="ext-link">Figure S6</a>). The lack of a pigmentation change in the <b>64</b>-treated mice is consistent with the improved selectivity indicated by both the binding and the 3D skin model cellular assays.</div><div class="NLM_p">Ultrastructural evaluation of follicular epithelial melanosomes from depigmentated areas of skin in these chronic mouse studies (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf" class="ext-link">Figure S7</a>) demonstrated similar morphological alterations as those noted in BACE inhibitor treated melanosomes in the 3D skin model preparation (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, insets). BACE inhibitor treatment in both the in vitro (3D skin model) and in vivo systems (mouse) resulted in melanosomes with irregular shape and indistinct borders as compared with controls indicating that the 3D skin model system was accurately recapitulating an in vivo effect despite the differences in species and melanosome localization. This in vitro to in vivo correlation helped validate the 3D skin model system and provided confidence in its use for screening BACE inhibitor compounds and potentially for predicting the likelihood of BACE inhibitor induced skin depigmentation in humans. With clear indicators of an improved selectivity profile, compound <b>64</b> was advanced into nonclinical toxicology studies. Dog toxicology studies that included daily cage side clinical observations and weekly detailed clinical observations showed no evidence of hair coat color (pigmentation) change. The dog studies included dosing <b>64</b> for up to 9 months at 26 mg/kg/day and achieved robust systemic exposure (<i>C</i><sub>avg</sub> = 6791 ng/mL total; 2326 nM unbound) that was approximately 10-fold above the BACE2 IC<sub>50</sub>. This lack of pigmentation effect in the chronic (9 month) dog study validated the selectivity over BACE2 in large animal species and further implicated the relationship to avoid potential hypopigmentation. The lack of hypopigmentation in dog after treatment with <b>64</b> is a potential differentiator compared to <b>AZD3293</b>, which showed reversible hypopigmentation in dog.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Furthermore, dosing of MK-8931 did not show hypopigmentation in chronic NHP studies, which suggests that species differences may impact the translatability of these findings to human.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p last">In conclusion, a novel series of selective, brain permeable, small molecule inhibitors of BACE1 were identified for the treatment of AD. By installing a thiazole group in P1, the amidine p<i>K</i><sub>a</sub> was reduced to an optimal range while minimizing synthetic complexity. Optimization of the heteroaryl group off of the amido-thiazole resulted in compounds with an excellent balance of potency and properties. To further understand the selectivity of the lead compounds, we incorporated a 3D skin model and utilized electron microscopy to understand the impact of BACE2 inhibition on melanogenesis. To build a translation to an <i>in vivo</i> outcome, a unique depilation study design to understand the coat color changes in mice was implemented. Compound <b>64</b> emerged as a clinical candidate with excellent potency, overall alignment of properties including selectivity over BACE2, and a lack of hypopigmentation change in dog after 9 months of dosing, which suggest a key differentiator over existing unselective BACE1 inhibitors. However, the safety and tolerability data from longer duration clinical trials with the current cohort of BACE1 inhibitors will establish the impact of chronic inhibition of BACE2. Recently, compound <b>64</b> recently completed phase 1 clinical trials and demonstrated potent- and dose-dependent Aβ lowering in human CSF.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83870" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83870" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vivo Experiments</h3><div class="NLM_p last">All procedures were carried out in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (1985), under approval of an Institutional Animal Care and Use Committee (IACUC).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Acute Treatment in Mice</h3><div class="NLM_p last">Male 129/sve wild-type mice (20–25 g) were in a nonfasted state prior to subcutaneous dosing with vehicle or compound <b>64</b> using a dosing volume of 10 mL/kg in 5:5:90 DMSO/Cremophor/saline vehicle. The mice (<i>n</i> = 5 per group) were then sacrificed at 1, 3, 5, 7, 14, 20, and 30 h postdose. Following cardiac puncture into ethylenediaminetetraacetic acid (EDTA)-containing tubes, whole blood samples (0.5–1.0 mL) were collected, and plasma was separated by centrifugation (1500 × <i>g</i> for 10 min at 4 °C). The generated plasma was distributed into separate tubes on wet ice for exposure measurements (50 μL) and Aβ analysis (remainder). CSF samples (8–12 μL) were obtained by cisterna magna puncture using a sterile 25 gauge needle and collected with a P-20 Eppendorff pipet. CSF samples were distributed into separate tubes on dry ice for exposure measurements (3 μL) and Aβ analysis (remainder). Whole brain was removed and divided for exposure measurements (cerebellum) and Aβ analysis (left and right hemispheres), weighed, and frozen on dry ice. Prior to the assay, all samples were stored at −80 °C.</div></div><div id="sec101" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Measurement of Rodent Amyloid-β</h3><div class="NLM_p">Frozen mouse hemibrains were homogenized (10% w/v) in 5 M guanidine HCl, using a Qiagen TissueLyser. Each sample was homogenized with a 5 mm stainless steel bead, four times, at a shaking rate of 24 times/s for 90 s, then incubated at 25 °C for 3 h and ultracentrifuged at 125,000 × <i>g</i> for 1 h at 4 °C. The resulting supernatant was removed and stored in a 96-well polypropylene deep well plate at −80 °C. Using solid-phase extraction using Waters Oasis reversed-phase HLB 96-well column plates (60 mg), the Aβ peptides were further purified. Column eluants in 98% MeOH and 2% NH<sub>4</sub>OH from 500 to 800 μL of original brain supernatant were evaporated to complete dryness and stored at −80 °C until assay. For plasma analysis, 140–175 μL of mouse plasma was treated 1:1 with 5 M guanidine HCl and incubated overnight with rotation at 4 °C. The entire volume was then purified through solid-phase extraction as indicated above.</div><div class="NLM_p">Samples were analyzed using a dissociation-enhanced lanthanide fluorescent immunoassay (DELFIA) platform enzyme-linked immunosorbent assay (ELISA). Configuration of the antibodies used in determining the level of Aβx-40 and Aβx-42 utilizes a common detect antibody (4G8) in combination with specific C-terminal antibodies for the 40 and 42 cleavage sites. For the Aβx-40 assay, a 384-well black Nunc Maxisorp plate was coated with 15 μL/well (4 μg/mL) capture antibody (Rinat 1219) in 0.1 M sodium bicarbonate coating buffer, pH 8.2. For the Aβx-42 assay, 15 μL/well (8 μg/mL) capture antibody (Rinat 10G3) was used. The plates were sealed and incubated at 4 °C overnight. Plates were washed with phosphate-buffered saline containing 0.05% Tween-20 (PBS-T) and blocked with 75 μL of blocking buffer (1% BSA in PBS-T) for 2 h at 25 °C.</div><div class="NLM_p last">After the plates had been washed with PBS-T, rodent Aβx-40 (California Peptide) or Aβx-42 (California Peptide) standard was serially diluted in blocking buffer, and 15 μL was applied to the plate in quadruplicate. Dried brain samples were reconstituted in 120 μL of blocking buffer, which corresponds to a 4.16- to 6.67-fold concentration. Then 15 μL of undiluted brain sample was added to the Aβx-42 assay plate in triplicate, or 15 μL of a 1:2 diluted brain sample was added to the Aβx-40 assay plate in triplicate. Dried plasma samples were reconstituted in 40 μL of blocking buffer, which corresponds to a 3.5- to 4.38-fold concentration, and 15 μL was added to the Aβx-40 assay plate in duplicate. CSF samples were diluted 1:8 in blocking buffer, and 15 μL was added to the Aβx-40 assay plate in duplicate. The plates containing the sample or standards were incubated for 2 h at 25 °C. The plates were washed with PBS-T, and 15 μL of detect antibody (4G8-Biotin, Covance) and 200 ng/mL in blocking buffer were added to each well, and incubation was carried out for 2 h at 25 °C. The plates were then washed with PBS-T, and 15 μL of europium-labeled streptavidin (PerkinElmer) and 50 ng/mL in blocking buffer were added for a 1 h incubation in the dark at 25 °C. The plates were washed with PBS-T, and 15 μL of PerkinElmer Enhancement solution was added to each well with 20 min incubation at RT. Plates were read on an EnVision plate reader using DELFIA time-resolved fluorimetry (Exc = 340/Em = 615), and samples were extrapolated against a standard curve using four-parameter logistics.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Human Melanocyte Cultures</h3><div class="NLM_p last">Human primary melanocytes from darkly pigmented neonatal foreskin (HEMn-DP) were obtained from Cascade Biologics (Portland, Oregon), cultured in Medium 254 (cat# M-254–500) supplemented with Human Melanocyte Growth Supplement (HMGS, Cat#S-002–5) in the absence of antibiotics and antimycotics at 37 °C under 5% CO<sub>2</sub>. All experiments used melanocytes that had been passaged <8 times and were plated at 1,000,000 per well in a six-well plate. After the initial plating, attached cells were treated with various concentrations (10 μM to 1 nM) of compounds prepared from DMSO stocks that also had a known range of BACE2 selectivity. The final DMSO concentration was 0.1%, and DMSO alone served as the control. Following 24 h of treatment, the media was removed, and the cells were rinsed once with PBS prior to being harvested using a cell scraper into 0.5 mL Eppendorf tubes using 75 μL of lysis buffer (1% Triton-X-100 in PBS or RIPA containing protease/phosphatase inhibitors + benzonase nuclease). Samples were incubated with shaking for 30 min at 4 °C and centrifuged at 5000 rpm for 10 min, and supernatants and pellets were frozen at −80 °C for Western blot analysis.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Western Blot Analysis</h3><div class="NLM_p last">Cell lysates were prepared in NuPAGE LDS buffer, heated at 80 °C for 5 min, and proteins were then separated by gel electrophoresis using the NuPAGE Novex 4–12% Bis-Tris gel system. Proteins were then transferred onto a nitrocellulose membrane using the iBlot Dry Blotting system. All the reagents were purchased from ThermoFisher Scientific. The nitrocellulose membranes were then probed with a Rabbit anti-PMEL antibody (Abcam ab137078) or a Mouse anti-PMEL HMB45 (Abcam ab787) and visualized using the corresponding IRDye antispecies antibody (LI-COR). The membrane was then scanned using the LI-COR Odyssey.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Human BACE1 and BACE2 Enzymatic Activity Using a Fluorescence Polarization Assay</h3><div class="NLM_p last">Both BACE1 and BACE2 enzymatic activity was measured with the aid of an optimized synthetic peptide substrate biotin-GLTNIKTEEISEISYEVEFR-C[Oregon green]KK-OH. Upon cleavage of the peptide substrate, a decrease in fluorescence polarization was measured. Compounds were diluted by half log in 100% DMSO 11 times with a top concentration of 10 mM in a 384-well polypropylene plate. The 100% DMSO dose response curve was then added to a 384-well black assay plate as 0.150 μL per well. The final working top concentration was 0.1 mM, and the DMSO concentration was 1%. A volume of 7.5 μL of BACE substrate was then added in assay buffer (100 mM sodium acetate, pH to 4.5 with glacial acetic acid, 0.001% Tween 20). The background wells in column 1 of the 384-well assay plate received 7.5 μL of assay buffer. The reaction was started with the addition of 7.5 μL of BACE1 or BACE2 enzyme in assay buffer to all wells except the background wells in column 1. The final concentration of peptide substrate was 150 nM, and the final concentration of BACE1 and BACE2 enzyme was 0.15 and 2.5 nM, respectively. The assay plate was sealed and incubated at 37 °C for 3 or 1 h (BACE1 or BACE2, respectively). After incubation, 15 μL of stop solution (1.5 μM streptavidin in Dulbecco’s phosphate buffered saline) was added to all wells, and the plate was read on the Envision Plate Reader (PerkinElmer, No. 2103) optimized to read fluorescence polarization on the millipolarization scale. Percent effect values for each concentration of compound were calculated based on fluorescence polarization (FP) readings in the 100% effect control wells containing no enzyme and the 0% effect control wells containing no compound. Curve-fitting analysis utilizing concentrations and percent effect values for a given compound was plotted, and the concentration for 50% effect (IC<sub>50</sub>) was determined using a sigmoidal four-parameter fit algorithm.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Soluble Amyloid Precursor Protein Beta (sAPPβ) Cellular Assay for BACE1 Activity</h3><div class="NLM_p">The inhibitory activity of compounds against the BACE1 enzyme is measured in a human neuroglioma cell line. The neuroglioma cell line, H4, was stably transfected with wild type amyloid precursor protein (APP), which is the substrate for BACE1 enzyme. Upon cleavage by BACE1, a soluble portion of the amyloid precursor protein is released into the cell media, which is then measured by an enzyme-linked immunosorbent assay (ELISA). Compounds were solubilized in 100% DMSO to a concentration of 30 mM and diluted by half log in 100% DMSO 11 times for a final top concentration of 30 μM and DMSO concentration of 1%.</div><div class="NLM_p">The neuroglioma cell line H4 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS) and 200 mM glutamax. Cells were plated overnight in tissue culture treated Falcon 384-well plates at a cell density of 4500 cells/well in 50 μL of media. The next day, media was removed, and cells were washed once with phosphate buffered saline, after which 25 μL of media was placed in all wells, followed by the addition of the diluted compound dose response curve. The highest concentration tested was 30 μM with 1% DMSO. Cells serving as the background controls received 30 μM of a proprietary compound. Compounds were allowed to incubate with cells overnight in a 37 °C incubator. Concurrently, 384-well black Nunc Maxisorp plates were also incubated overnight at 4 °C with 10 μL of 4 μg/mL Aβ antibody available from Pierce (OMA1–03132) in coating buffer (0.1 M sodium bicarbonate, pH 8.8 to 9.0).</div><div class="NLM_p last">The next day, the coated plates were washed three times with PBS containing 0.05% Tween 20 (PBST), blocked with 1% bovine serum albumin (BSA) in PBST for 1 h, and then washed three times with PBST. After which, 10 μL of media from the treated cells was then transferred to the washed plates and incubated for 1 h, followed by washing three times. Next, 10 μL of a 1:1000 dilution of sAPPβ antibody (Signet SIG-39138), which is specific for the soluble fragment cleaved N-terminus to the beta secretase cleavage site of amyloid precursor protein, was added and incubated for 1 h. The plates were washed three times and then incubated with 10 μL of a 1:1000 dilution of antirabbit, HRP-tagged antibody from GE Healthcare. Plates were washed one last time, and then 30 μL of chemiluminescent substrate (Pierce 73069) was added to the wells. Signal was then read on an EnVision plate reader using standard luminescent settings. The percent (%) effect at each concentration of compound was calculated based on and relative to the amount of sAPPβ total produced by the positive and negative control wells contained within each assay plate. The positive control wells contained a saturating concentration of a proprietary control compound that produced a maximal level of sAPPβ inhibition. Intrinsic activity values for each compound were calculated relative to the maximal % effect produced by this control compound. The negative control wells did not contain any compound, but rather DMSO alone, and the response to DMSO was used to set the baseline (0%) response in the assay. The concentrations and % effect values for each compound were plotted using a four-parameter logistic dose response equation, and the concentration that inhibited 50% (IC<sub>50</sub>) was calculated. The IC<sub>50</sub> for a control compound was evaluated in each experiment as a quality control measure. If the end point value was within 3-fold of the expected value, then the experiment was deemed acceptable.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> BACE1 and BACE2 Radioligand Binding Assays</h3><div class="NLM_p">The overexpression of human full length BACE1 was completed by transient transfection of HEK-293 cells with the BamMam expression system (invitrogen A24223) followed by zeocin selection and single cell cloning by limiting dilution of the stable transfectant. The resultant clonal HEK293 stable cell line expressing human FL BACE1 was scaled up for production of crude BACE1 cell membrane used for the BACE1 radioligand binding assay. The overexpression of human full length BACE2 was completed by HEK293 cell transfection with human BACE2 (Myc-DDK-tagged) vector (Origene RC204860) using lipofectamine LTX transfection system (Life Technology #15338100). A stable cell batch was generated by maintaining these cells under Geneticin selection. The resultant clonal HEK293 stable cell line expressing human FL BACE2 was scaled up for production of crude BACE2 cell membrane used for the BACE2 radioligand binding assay. Crude cell membrane homogenates were prepared by homogenizing each cell paste at 8 or 24 mg/mL (BACE1 and BACE2, respectively) in 50 mM Tris buffer (pH = 7.4) containing 2 mM magnesium chloride on ice for 10 s at setting 5 with a Polytron. Aliquots prepared on ice were frozen at −80 °C for daily use.</div><div class="NLM_p last">Parallel scintillation proximity assays (SPA) were utilized to quantitate the degree of BACE1 and BACE2 binding by compounds with a radioligand equipotent for BACE1 and BACE2 (<sup>3</sup>H-PF-6475886, 25 nM). Briefly, the reaction mixture in 50 mM sodium acetate buffer (pH = 6.0) contained 10 nM 3<i>H</i>-ligand, 20 or 440 μg of cell paste (BACE1 or BACE2, respectively), 66 μg of SPA bead (PEI-WGA bead, PerkinElmer RPNQ0003), and test compound with a final dimethyl sulfoxide (DMSO) concentration of 1.8% in a final volume of 27.5 μL. Compounds that were solubilized in 100% DMSO were added as a 500 nL spot to the Corning 384-well SPA plates using a noncontact acoustic dispenser, and the nonspecific binding was defined by 10 μM <b>10</b> (equipotent for BACE1 and BACE2, 27 nM).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Binding was carried out at room temperature for 30 min after which time the SPA plates were centrifuged and read on a TriLux Microbeta reader to determine the number of counts bound. The percent (%) effect at each concentration of compound was calculated compared to vehicle, and the IC<sub>50</sub> of binding was determined with a four-parameter logistic dose response equation.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Phenotypic Pigmentation Assay in Human 3D Reconstructed Skin</h3><div class="NLM_p">Sealed 24-well plates containing individual inserts of the MelanoDerm MEL-300 tissues and medium were purchased from MatTek Corporation and stored unopened at 4 °C for 24 h. On the day that experiments began, the samples were removed from 4 °C for 1 h and allowed to equilibrate at room temperature before being transferred into six-well plates under sterile conditions. Prewarmed maintenance medium was pipetted into each well and placed into a humidified 37 °C, 5% CO<sub>2</sub> incubator for 1 h prior to applying compounds. Following the 1 h incubation, the media contained within the six-well plate was removed by aspiration, and a culture stand (no MEL-STND) was placed into each well of the six-well plate. Prewarmed 5.0 mL of maintenance media containing a final concentration of compound (100 μM to 0.1 nM) was added. The final DMSO concentration is 0.1%, which was added to each well. The cell culture insert containing the MelanoDerm is placed on top of the culture stand such that the media level touches the bottom of the inset, while the surface of the MelanoDerm remains dry. Air bubbles that are trapped underneath the cell culture insert are released by tilting the inset with sterile forceps. The six-well plates were then returned to the incubator for a period of 9 days. Medium was changed every 48–60 h with the appropriate final concentration of each treatment compound. Care was taken to aspirate all of the media from the well to ensure that exactly 5 mL was delivered for the medium replacement. As controls, 0.1% DMSO was used to represent ZPE. The HPE for the assay was not determined since the degree of pigmentation loss (increasing L*) varied depending on compound and often did not demonstrate an upper asymptote.</div><div class="NLM_p">After 9 days, each MelanoDerm was removed from media and washed twice with 0.9 mL of PBS, ensuring that the surface of the MelanoDerm remained dry. The insert was blotted on sterile gauze, and the sides of the inset were cleaned with sterile cotton-tipped applicators. AMinolta CR700d spectrophotometer was used to quantitate the level of reflected light represented by the L*a*b*color model system, developed by the Commission Internationale d’Eclairage, which was used to objectively describe all colors visible to the human eye. The spectrophotometer was equipped with a retrofitted mask aperture of 1.25 cm, enabling the MelanoDerm insert to fit within the reading window of the spectrophotometer where illumination of the surface of the MelanoDerm with a pulsed xenon arc lamp was recorded. The instrument was calibrated for both zero and white calibration. The zero calibration was performed by holding the black side of the White Calibration Cap (CM-A177), provided with the instrument, to the mask aperture. The white calibration was performed with the White Calibration Cap locked on to the instrument, with the White Calibration Plate facing the mask aperture. After the MelanoDerm insert was rinsed with PBS and dried, it was placed on a Konica Minolta CR-A43 Calibration Plate, which provided a consistent background and even platform during the reading process. The MelanoDerm insert was then inserted into the mask aperture of the spectrophotometer and measured using Spectra-Magic NX Software. Each MelanoDerm was measured three times with no intervening wait time, and measurements were autoaveraged. Readings of L* value (brightness spectrum from black to white), a* (spectrum from red to green), and b* (spectrum from blue to yellow) were taken, as well as absorbance at 470 nm. L* values have been previously reported to demonstrate the greatest sensitivity to differences in human facial pigmentation, so this value was used for all quantitation.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p last">Raw L* values were converted to delta L* by subtracting the DMSO background control L* value from each sample L* value. The delta L* values were plotted in Graph Pad Prism using a log of agonist versus variable response with a four-parameter nonlinear regression curve fit. The concentration of any given compound required to give a change in L* value of 2.0 was interpolated from the generated curve.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> In Vivo Hypopigmentation Studies</h3><div class="NLM_p">All procedures were carried out in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (1985), under approval of an Institutional Animal Care and Use Committee (IACUC). C57BL6 pigmented mice obtained from Jackson Laboratories were used for all studies. In order to assess oral pharmacokinetic feasibility for chronic dosing studies, mice were acutely dosed via oral gavage with test compound suspended in methylcellulose 0.5% (w/v)/98.5% water/1% Tween 80. Blood was collected by cardiac puncture from separate mice at 1, 4, 12, and 24 h after dosing in order to obtain the free plasma Cave (AUC ng·h/mL). Whole blood samples (0.5–1.0 mL) were collected by cardiac puncture into EDTA-containing tubes, and plasma was separated by centrifugation (1500 × <i>g</i> for 10 min at 4 °C). The generated plasma was distributed into separate tubes on wet ice for exposure measurements (25 μL).</div><div class="NLM_p">Only compounds that could achieve free plasma concentrations at adequate exposure multiples above the BACE2 IC<sub>50</sub> were selected for chronic dosing. In most cases, adequate exposure was obtained with BID dosing. Twenty-four hours prior to the first dose, all mice in the study were depilated with Nair (Church and Dwight Co., Inc.) in order to synchronize hair growth and provide a more homogeneous hypopigmentation response. Briefly, mice were anesthetized with 2% isoflurane in oxygen, and all hair removal took place under a hood. Rectangular regions of hair on the ventral surface, from the hind legs to the front legs, and on the dorsal surface on the back rear of the mouse were first removed using an electric razor (Norelco G390, Philips) immediately followed by depilation. Occasional skin lesions were monitored and treated by veterinary care with topical treatment of chlorohexidine and dermal gel.</div><div class="NLM_p">At weekly time points after initiation of dosing, photographic images were taken under standardized lighting conditions of the initially depilated ventral and dorsal surface areas. A white-light LED floodlight source (30 W, IP66, Zitrades) placed atop a white photobox was used as an illumination source. A Canon PowerShot SX20 IS digital camera was subsequently placed at the same distance on the photobox with identical camera settings applied for all photographic sessions (white balanced, ISO400). A CameraTrax 24ColorCard (2 × 3 with White Balance) was additionally placed within the photobox followed by anesthetized mice centrally positioned for ventral and dorsal surface area capture. The Minolta CR700d spectrophotometer was also used to provide a more quantitative measurement of hair pigmentation. Measurements were taken from the same region of each mouse in the initial depilated area with care taken to avoid any occasional lesions or pre-existing pigmentation patches. The same spectrophotometer and mask aperture of 1.25 cm described above were used to measure mouse hair pigmentation by placing the aperture directly in contact with the mouse to avoid interfering external light. For all photography and spectrophotometric readings, mice were anesthetized with 2% isoflurane in oxygen in order to obtain stable high quality images.</div><div class="NLM_p last">Mice were dosed chronically until the desired phenotypic response was obtained, at which point necropsy was performed at 4 h post-last dose in order to compare with the 4 h time point assessed in the initial oral PK study. Whole blood samples (0.5–1.0 mL) were collected by cardiac puncture into EDTA-containing tubes, and plasma was separated by centrifugation (1500 × <i>g</i> for 10 min at 4 °C). The generated plasma was distributed into separate tubes on wet ice for exposure measurements (25 μL). Skin samples were taken from both ventral and dorsal surfaces of the mouse and fixed in cold 4% paraformaldehyde for histological evaluation.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Histological Processing and Sectioning</h3><div class="NLM_p last">Skin sections and MelanoDerm cultures were processed in an automated tissue processor, embedded in paraffin, sectioned at 5 μm, and stained with hematoxylin and eosin (H&E).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Transmission Electron Microscopy for MelanoDerm EM Methods</h3><div class="NLM_p last">MelanoDerm cultures following the standard 9 day treatment were assessed spectrophotometrically as described and fixed in cold 4% paraformaldehyde for processing. The nylon membrane was carefully removed from the wells and then bisected. One half was processed for standard paraffin embedment and H&E staining and the other half was processed for TEM as follows. The MelanoDerms were further trimmed and put into EM fixative (2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M phosphate buffer) and fixed for at least 24 h at 4 °C. Following fixation, MelanoDerms were transferred to 0.1 M phosphate buffer, rinsed, and post fixed in 1% OsO<sub>4</sub> for 2 h at 4 °C. Following osmication, samples were rinsed in DI water followed by dehydration through a graded alcohol series and transition through propylene oxide. They were infiltrated in an increasing resin to propylene oxide mixture followed by a change to pure resin prior to embedding. Thick sections were cut on a Leica UCT ultramicrotome and stained with Toluidine Blue. Blocks were trimmed for areas of interest, and thin sections were picked up on 200 mesh copper palladium grids. These were contrast stained with uranyl acetate and lead citrate prior to evaluation using a Hitachi H-7100 transmission electron microscope. Ten cells per treatment per MelanoDerm were photographed at 4000× using a digital CCD camera system (Advanced Microscopy Techniques, Danvers, MA). Photos were blinded with respect to treatment and evaluated by a veterinary pathologist.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Transmission Electron Microscopy for Mouse Skin EM Methods</h3><div class="NLM_p last">Skin samples were received in 4% methanol free paraformaldehyde. Sections from the ventral and dorsal surfaces were trimmed; one set for standard paraffin embedment and H&E staining and a second set for TEM evaluation. Skin samples were processed for TEM as described above. Thick Toluidine Blue stained sections were evaluated, and those containing optimally oriented deep follicular epithelium were further trimmed, thin sectioned, contrast stained, and examined using a Hitachi H-7100 transmission electron microscope. Images were captured using a digital CCD camera system (Advanced Microscopy Techniques, Danvers, MA) and evaluated by a veterinary pathologist.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Neuropharmacokinetic Studies in Male CD-1 Mice</h3><div class="NLM_p last">The in-life and bioanalytical portions of these studies were conducted at BioDuro, Pharmaceutical Product Development Inc. (Beijing, China). Male CD-1 mice were obtained from PUMC, China. Mice received a 10 mg/kg subcutaneous (sc) dose of compounds <b>61</b>, <b>64</b>, <b>65</b>, or <b>67</b>. The doses were prepared in 5% DMSO/95% (0.5% methylcellulose) and delivered in a volume of 5 mL/kg. Animals were sacrificed in a CO<sub>2</sub> chamber. Blood, brain, and CSF samples were collected at 1, 4, and 7 h postdosing. Plasma was isolated after centrifugation. The plasma, brain, and CSF samples were stored at −80 °C prior to analysis.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Measurement of Fraction Unbound in Brain</h3><div class="NLM_p last">The unbound fraction of each compound was determined in brain tissue homogenate using a 96-well equilibrium dialysis method as described by Kalvass et al.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> with the following exceptions. Brain homogenates were prepared from freshly harvested rat brains following dilution with a 4-fold volume of phosphate buffer, and spiked with 1 μM compound. The homogenates were dialyzed against an equal volume (150 μL) of phosphate buffer at 37 °C for 6 h. After the incubation, equal volumes (50 μL) of brain homogenate and buffer samples were collected and mixed with 50 μL of buffer or control homogenate, respectively, for preparation of mixed matrix samples. All samples were then precipitated with internal standard in acetonitrile (200 μL), vortexed, and centrifuged. Supernatants were analyzed using an LC–MS/MS assay. A dilution factor of 5 was applied to the calculation of brain fraction unbound.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Generic Liquid Chromatography Tandem Mass Spectrometry (LC–MS/MS) Assay for Exposure Measurements in Plasma, Brain, and CSF</h3><div class="NLM_p last">Plasma, brain, and CSF were collected as described above and frozen at −80 °C until analysis by LC–MS/MS. Standard curves were prepared in respective matrixes via serial dilution at a concentration of 1.0–2000 ng/mL (plasma and CSF) or 0.5–2000 ng/g (brain). For plasma, a 50 μL aliquot of sample was precipitated with 500 μL of MTBE containing an internal standard. Samples were vortexed for 1 min, then centrifuged at 3000 rpm for 10 min. The supernatant was transferred to a 96-well plate. Frozen brain tissue was weighed and an isopropanol/water (60:40) volume equivalent to four times the mass was added before homogenization in a bead beater (BioSpec Products Inc., Bartlesville, OK). A 50 μL aliquot of sample was precipitated with 500 μL of MTBE containing an internal standard. Samples were vortexed for 1 min, then centrifuged at 3000 rpm for 10 min. The supernatant was transferred to a 96-well plate. For CSF, a 50 μL aliquot of sample was precipitated with 500 μL of MTBE containing an internal standard. Samples were vortexed for 1 min, then centrifuged at 3000 rpm for 10 min. The supernatant (300 μL) was transferred to a 96-well plate. LC–MS/MS analysis was carried out using a high-performance liquid chromatography system consisting of tertiary Shimadzu LC20AD pumps (Shimadzu Scientific Instruments, Columbia, MD) with a CTC PAL autosampler (Leap Technologies, Carrboro, NC) interfaced to an API 4000 LC–MS/MS quadrupole tandem mass spectrometer (AB Sciex Inc., Ontario, Canada). The mobile phase consisted of solvent A (water with 0.1% formic acid) and solvent B (acetonitrile with 0.1% formic acid). The gradient was as follows: solvent B was held at 5% for 0.4 min, linearly ramped from 5% to 95% in 0.5 min, held at 90% for 0.6 min, and then stepped to 5% over 0.01 min. The mass spectrometer was operated using positive electrospray ionization. All raw data was processed using Analyst Software ver. 1.4.2 (AB Sciex Inc., Ontario, Canada).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> hERG Patch Clamp Assay</h3><div class="NLM_p last">All testing was carried out in CHO cells transfected with the hERG gene, purchased from Millipore (PrecisION hERG-CHO Recombinant Cell Line CYL3038). The cell line was grown in DMEM/F-12, GlutaMAX with 10% fetal bovine serum, 1% penicillin–streptomycin, 1% genticin, and 1% of 1 M HEPES buffer solution and maintained at approximately 37 °C in a humidified atmosphere containing 5% carbon dioxide. The cells were passaged every 3–5 days based on confluency. On the day of the experiment, 50–80% confluent cells were harvested from a 175 cm<sup>2</sup> culture flask using Detachin. After 10 min of exposure to Detachin at 37 °C, the cells were centrifuged for 1 min at 1000 rpm. The supernatant was removed, and the cell pellet was reconstituted in 5–8 mL of serum-free media with 2.5% of 1 M HEPES, placed on the Qstirrer, and allowed to recover. After a ∼30 min recovery period, experiments were initiated.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> hERG Potassium Channel Current Recordings</h3><div class="NLM_p">hERG current was elicited and recorded using the automated Qpatch HT system.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The suspended cells in the Qstirrer were transferred to 48 individual recording chambers on a Qplate 48 containing extracellular recording saline composed of (in mM) 132 NaCl, 4 KCl, 1.8 CaCl<sub>2</sub>, 1.2 MgCl<sub>2</sub>, 10 HEPES, and 11.1 glucose and were adjusted to pH 7.35 ± 0.1 with NaOH. The intracellular recording saline was composed of (in mM) 70 KF, 60 KCl, 15 NaCl, 5 EGTA, and 5 HEPES and was adjusted to pH 7.2 ± 0.1 with KOH. Membrane currents were recorded at room temperature.</div><div class="NLM_p last">hERG current was elicited from a holding potential of −80 mV with a voltage step to +30 mV for 1 s, followed by a ramp back to −80 mV at 0.55 mV/ms. Test pulses were delivered at a frequency of 0.25 Hz. Up to four different concentrations were studied for each cell, each exposure lasting 5 min or until steady-state effects were observed. In a separate set of experiments, full concentration–response relationships were determined for the positive control, cisapride, and an IC<sub>50</sub> was reported for this study.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Chemistry General Methods</h3><div class="NLM_p last">Solvents and reagents were of reagent grade and were used as supplied by the manufacturer. All reactions were run under a N<sub>2</sub> atmosphere. Organic extracts were routinely dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. Concentration refers to rotary evaporation under reduced pressure. Chromatography refers to flash chromatography using disposable RediSepRf 4 to 120 g silica columns, Biotage disposable columns on a CombiFlash Companion, or Biotage Horizon automatic purification system. Microwave reactions were carried out in a SmithCreator microwave reactor from Personal Chemistry. Purification by mass-triggered HPLC was carried out using Waters XTerra PrepMS C18 columns, 5 μm, 30 × 100 mm. Compounds were presalted as TFA salts and diluted with 1 mL of dimethyl sulfoxide. Samples were purified by mass-triggered collection using a mobile phase of 0.1% trifluoroacetic acid in water and acetonitrile, with a gradient of 100% aqueous to 100% acetonitrile over 10 min at a flow rate of 20 mL/min. All target compounds were analyzed using ultra high performance liquid chromatography/ultraviolet/evaporative light scattering detection coupled to time-of-flight mass spectrometry (UHPLC/UV/ELSD/TOFMS). LC–MS analyses were performed on a Waters Acquity UPLC–MS system with a Waters Aquity HSS T3, 1.7 μm C18 column (50 mm × 2.1 mm). UPLC conditions: mobile phase A = 0.1% formic acid in water (v/v), mobile phase B = 0.1% formic acid in acetonitrile; flow rate = 1.25 mL/min; compounds were eluted with a gradient of 5% B/A to 95% B/A for 1.1 min. All tested compounds were found to be >95% pure by UHPLC/UV/ELSD/TOFMS.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> UHPLC/MS Analysis</h3><div class="NLM_p last">The UHPLC was performed on a Waters ACQUITY UHPLC system (Waters, Milford, MA), which was equipped with a binary solvent delivery manager, column manager, and sample manager coupled to ELSD and UV detectors (Waters, Milford, MA). Detection was performed on a Waters LCT premier XE mass spectrometer (Waters, Milford, MA). The instrument was fitted with an Acquity BEH (Bridged Ethane Hybrid) C18 column (30 mm × 2.1 mm, 1.7 μm particle size, Waters, Milford, MA) operated at 60 °C.</div></div><div id="sec100" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Syntheses</h3><div class="NLM_p">See <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> for method of preparation, structure, and physicochemical data of <b>58</b>–<b>60</b>, <b>62</b>, <b>66</b>, and <b>68</b>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Method of Preparation, Structure, and Physicochemical Data for Examples <b>58</b>–<b>60</b>, <b>62</b>, <b>66</b>, and <b>68</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0017.gif" alt="" id="gr100" /></img><div></div></div><div id="sec4_19_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (3<i>aR</i>,5<i>S</i>)-5-Methyl-3,3<i>a</i>,4,5-tetrahydro-7<i>H</i>-pyrano[3,4-<i>c</i>][1,2]oxazole (<b>15</b>)</h4><div class="NLM_p"><i>Step 1.</i> To a suspension of sodium hydride (60% in mineral oil, 13.9 g, 0.348 mol) in tetrahydrofuran (350 mL) was added a solution of (<i>S</i>)-pent-4-en-2-ol (10.0 g, 0.116 mol) in tetrahydrofuran (50 mL) at 0 °C. The reaction was warmed to room temperature and stirred for 30 min, whereupon 2-bromo-1,1-diethoxyethane (68.6 g, 0.348 mol) was added, and the reaction mixture was heated to reflux for 18 h. The reaction mixture was then cooled to 0 °C, quenched with water (50 mL), and partitioned between ethyl acetate (300 mL) and water (200 mL). The organic layer was washed with saturated aqueous sodium chloride solution (2 × 100 mL), dried, and concentrated in vacuo. Silica gel chromatography (eluent: 30:1 petroleum ether/ethyl acetate) provided the product as a yellow oil. Yield: 17.4 g, 86.0 mmol, 74%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>), δ 5.76–5.85 (m, 1H), 5.02–5.09 (m, 2H), 4.58–4.60 (m, 1H), 3.66–3.74 (m, 2H), 3.43–3.61 (m, 5H), 2.29–2.36 (m, 1H), 2.13–2.20 (m, 1H), 1.21 (t, <i>J</i> = 7.2 Hz, 6H), 1.14 (d, <i>J</i> = 6.4 Hz, 3H).</div><div class="NLM_p"><i>Step 2.</i> To a solution of (4<i>S</i>)-4-(2,2-diethoxyethoxy)pent-1-ene (17.4 g, 86.0 mmol) in tetrahydrofuran (100 mL) was added aqueous hydrochloric acid (2 M, 51.0 mL, 0.102 mol), and the reaction mixture was heated to 75 °C for 1 h. After removal of solvent in vacuo, ethanol (100 mL) and water (20 mL) were added, followed by sodium acetate (35.17 g, 0.43 mol) and hydroxylamine hydrochloride (17.9 g, 0.257 mol). The reaction mixture was stirred at 60 °C for 18 h, whereupon it was concentrated in vacuo; the residue was then partitioned between water and dichloromethane. The aqueous layer was extracted with dichloromethane (3 × 200 mL), and the combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure. Silica gel chromatography (eluent: 10:1 petroleum ether/ethyl acetate) provided the product as a yellow oil, which was used without further purification in the subsequent step. Yield: 8.6 g, 60 mmol, 70%.</div><div class="NLM_p last"><i>Step 3.</i> To a solution of (1<i>E</i>)-<i>N</i>-hydroxy-2-[(2<i>S</i>)-pent-4-en-2-yloxy]ethanimine (8.6 g, 60 mmol) and triethylamine (0.455 g, 4.50 mmol) in dichloromethane (150 mL) at room temperature was slowly added an aqueous solution of sodium hypochlorite (6%, 90 mL), at a rate that maintained the internal reaction temperature between 20 and 25 °C. After completion of the addition, the organic layer was dried, filtered, and concentrated <i>in vacuo.</i> Silica gel chromatography (eluent: 10:1 petroleum ether/ethyl acetate) provided the product as a yellow oil. Yield: 5.70 g, 40.4 mmol, 67%. LCMS <i>m</i>/<i>z</i> 142.1 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>), δ 4.68 (d, <i>J</i> = 13.2 Hz, 1H), 4.59 (dd, <i>J</i> = 10, 8 Hz, 1H), 4.18 (d, <i>J</i> = 13.2 Hz, 1H), 3.76 (dd, <i>J</i> = 12, 8 Hz, 1H), 3.59–3.66 (m, 1H), 3.39–3.50 (m, 1H), 2.14–2.19 (m, 1H). 1.42–1.51 (m, 1H), 1.25 (d, <i>J</i> =6 Hz, 3H).</div></div><div id="sec4_19_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-8<i>a</i>-(2,4-Difluorophenyl)-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>40</b>)</h4><div class="NLM_p"><i>Step 1:</i> Prepared in similar fashion as <b>18</b> but utilized 2,4-difluoro-1-iodobenzene (5.28 g, 22 mmol), BF<sub>3</sub>·Et<sub>2</sub>O (3.12g, 22 mmol), <i>n</i>-BuLi (8.8 mL, 2.5 M in hexane, 22 mmol), <b>15</b> (1.55 g, 11 mmol), and 10/1 (v/v) toluene/THF (70 mL total) to afford (3<i>aR</i>,5<i>S</i>,7<i>aS</i>)-7<i>a</i>-(2,4-difluorophenyl)-5-methylhexahydro-1<i>H</i>-pyrano[3,4-<i>c</i>]isoxazole (<b>16</b>) (2.24g, 80% yield) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92 (td, <i>J</i> = 6.9, 9.0, 9.0 Hz, 1H), 6.88 (dddd, <i>J</i> = 0.9, 2.5, 8.0, 8.8 Hz, 1H), 6.79 (ddd, <i>J</i> = 2.5, 8.6, 11.3 Hz, 1H), 6.30 (s, 1H), 4.10 (dd, <i>J</i> = 1.9, 12.6 Hz, 1H), 3.79 (d, <i>J</i> = 12.7 Hz, 1H), 3.75–3.66 (m, 2H), 3.53 (dd, <i>J</i> = 5.0, 7.1 Hz, 1H), 3.06 (dddd, <i>J</i> = 1.5, 4.9, 6.4, 11.5 Hz, 1H), 1.90–1.80 (m, 1H), 1.51–1.38 (m, 1H), 1.26 (d, <i>J</i> = 6.2 Hz, 3H).</div><div class="NLM_p"><i>Step 2:</i> To a solution of <b>16</b> (2.6 g, 10.2 mmol) in acetonitrile/water (90 mL/6 mL) was added molybdenum hexacarbonyl (2.96 g, 11.2 mmol) in one portion at room temperature. The mixture was refluxed for 30 min and cooled down, then sodium borohydride (388 mg, 10.2 mmol) was added slowly. The reaction was refluxed for 2 h, then the mixture was concentrated. Ethyl acetate (30 mL) was added to the residue then filtered. The filtrate was washed with brine (100 mL × 4). The organic phase was dried and concentrated. The residue was purified by flash column chromatography (gradient: 10% to 50% ethyl acetate in petroleum ether) to afford ((2<i>S</i>,4<i>R</i>,5<i>S</i>)-5-amino-5-(2,4-difluorophenyl)-2-methyltetrahydro-2<i>H</i>-pyran-4-yl)methanol (<b>24</b>) (2 g, 76% yield) as a yellow oil. LCMS <i>m</i>/<i>z</i> 403.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.64 (td, <i>J</i> = 6.4, 8.9, 9.0 Hz, 1H), 6.99–6.89 (m, 1H), 6.81 (ddd, <i>J</i> = 2.6, 8.6, 12.6 Hz, 1H), 4.18 (dd, <i>J</i> = 2.5, 11.3 Hz, 1H), 3.70 (dtt, <i>J</i> = 3.0, 3.0, 6.0, 6.0, 12.1 Hz, 1H), 3.52 (dd, <i>J</i> = 2.6, 11.4 Hz, 1H), 3.37–3.29 (m, 2H), 2.25 (dq, <i>J</i> = 2.7, 2.8, 2.8, 12.8 Hz, 1H), 1.98–1.84 (m, 1H), 1.68 (ddd, <i>J</i> = 2.6, 4.3, 14.2 Hz, 1H), 1.32 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p"><i>Step 3:</i> Prepared in similar fashion as <b>35</b> but utilized <b>24</b> (450 mg, 1.75 mmol), benzoyl isothiocyanate (0.99 g, 6.12 mmol), and ethyl acetate (20 mL). After stirring at room temperature for 2 h, the reaction was then stirred at 90 °C for 16 h. The reaction was cooled to room temperature and left standing overnight, which gave way to a white precipitate. The heterogeneous mixture was concentrated to ∼3 mL, and the solid was filtered. The solid was recrystallized twice from ethyl acetate (∼10 mL) then lyophilized to afford <i>N</i>-((4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-8<i>a</i>-(2,4-difluorophenyl)-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>32</b>) (290 mg, 41.2%) as a white solid. LCMS <i>m</i>/<i>z</i> 403.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.26 (br s, 1H), 8.23 (d, 2H), 7.54–7.34 (m, 4H), 6.96–6.82 (m, 2H), 4.13 (d, 1H), 3.84–3.69 (m, 2H), 3.19–3.06 (m, 1H), 2.99 (dd, 1H), 2.62 (dd, 1H), 2.00–1.84 (m, 1H), 1.68–1.60 (m, 1H), 1.28 (d, 3H).</div><div class="NLM_p last"><i>Step 4:</i> To a stirring solution of <b>32</b> (304 mg, 0.775 mmol) in methanol (18.9 mL) was added DBU (96.8 mg, 0.604 mmol). The reaction was stirred at 80 °C overnight, cooled to room temperature, concentrated in vacuo, and then partitioned between ethyl acetate and saturated aqueous sodium bicarbonate solution. The aqueous layer was washed with ethyl acetate, and then the combined organic extracts were washed with water followed by brine solution. The organic extract was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to afford the crude material, which was purified by flash column chromatography (silica gel, 100% ethyl acetate isocratic) to afford (4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-8<i>a</i>-(2,4-difluorophenyl)-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>40</b>) (188 mg, 83.4%) as a white solid. LCMS <i>m</i>/<i>z</i> 299.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.39–7.30 (m, 1H), 7.01–6.92 (m, 2H), 4.08 (dd, <i>J</i> = 2.3, 11.1 Hz, 1H), 3.74 (dqd, <i>J</i> = 2.3, 6.1, 6.1, 6.1, 12.2 Hz, 1H), 3.65 (d, <i>J</i> = 11.1 Hz, 1H), 2.94–2.82 (m, 2H), 2.70–2.62 (m, 1H), 1.76–1.65 (m, 1H), 1.54 (ddd, <i>J</i> = 2.4, 4.1, 13.2 Hz, 1H), 1.22 (d, <i>J</i> = 6.2 Hz, 3H). [α]<sub>D</sub><sup>28.5</sup> = −5.217° (<i>c</i> = 0.547, CH<sub>3</sub>OH).</div></div><div id="sec4_19_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-6-Methyl-8<i>a</i>-(2-(trifluoromethyl)phenyl)-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>41</b>)</h4><div class="NLM_p"><i>Step 1:</i> Prepared in similar fashion as <b>18</b> but utilized 1-iodo-2-(trifluoromethyl)benzene (2.89 g, 10.6 mmol, 1.2 equiv), BF<sub>3</sub>·Et<sub>2</sub>O (1.81 g, 1.6 mL, 12.8 mmol), <i>n</i>-BuLi (5.7 mL, 2.5 M in hexane, 14.2 mmol), <b>15</b> (1.5 g, 10.6 mmol), toluene (70 mL), and THF (7 mL) to afford two separate batches of (3<i>aR</i>,5<i>S</i>,7<i>aS</i>)-5-methyl-7<i>a</i>-(2-(trifluoromethyl)phenyl)hexahydro-1<i>H</i>-pyrano[3,4-<i>c</i>]isoxazole (<b>17</b>) as white oils after combining different flash column fractions. Combined yield: 62.1%. Batch 1 (293 mg, 99.01% purity by LCMS, 9.6% yield) LCMS <i>m</i>/<i>z</i> 287.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.46 (d, <i>J</i> = 8.2 Hz, 1H), 7.71 (d, <i>J</i> = 7.9 Hz, 1H), 7.57 (t, <i>J</i> = 7.7, 7.7 Hz, 1H), 7.42 (t, <i>J</i> = 7.6, 7.6 Hz, 1H), 6.45 (s, 1H), 4.13 (d, <i>J</i> = 12.8 Hz, 1H), 3.81–3.69 (m, 3H), 3.50 (dd, <i>J</i> = 7.1, 4.8 Hz, 1H), 3.22 (dt, <i>J</i> = 11.6, 5.8, 5.8 Hz, 1H), 1.87 (ddd, <i>J</i> = 14.2, 7.2, 2.1 Hz, 1H), 1.46 (dt, <i>J</i> = 14.2, 11.4, 11.4 Hz, 1H), 1.25 (d, <i>J</i> = 6.1 Hz, 3H). Batch 2 (1.60 g, 90.20% purity by LCMS, 52.5% yield) LCMS <i>m</i>/<i>z</i> 287.9 [M + H]<sup>+</sup>.</div><div class="NLM_p"><i>Step 2:</i> Prepared in similar fashion as <b>26</b> but utilized <b>7</b> (1.60g, 5.6 mmol), Raney nickel (817 mg, 13.9 mmol), isopropanol (40 mL), and THF (40 mL) to afford ((2<i>S</i>,4<i>R</i>,5<i>S</i>)-5-amino-2-methyl-5-(2-(trifluoromethyl)phenyl)tetrahydro-2<i>H</i>-pyran-4-yl)methanol (<b>25</b>) (1.58g, 70% purity by LCMS) as a white oil that was advanced as-is without further purification. LCMS <i>m</i>/<i>z</i> 289.9 [M + H]<sup>+</sup>.</div><div class="NLM_p"><i>Step 3:</i> Prepared in similar fashion as <b>35</b> but utilized <b>25</b> (1.58 g, 5.46 mmol), benzoyl isothiocyanate (1.96 g, 12.01 mmol), and ethyl acetate (120 mL). After benzoyl isothiocyanate addition, the reaction was stirred at room temperature for 2 h rather than 1.5 h before heating to 90 °C for 20 h. Flash column chromatography (40 g of silica gel, 0% to 35% ethyl acetate in petroleum ether) afforded a white oil (1.2 g), which was diluted in methanol (30 mL) and stirred for 30 min. Two crops of white solids were filtered to afford <i>N</i>-((4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-6-methyl-8<i>a</i>-(2-(trifluoromethyl)phenyl)-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>33</b>) (620 mg, 26.1% yield). LCMS <i>m</i>/<i>z</i> 434.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 50 °C) δ 12.18 (br s, 1H), 8.23 (s, 2H), 7.85 (d, <i>J</i> = 7.9 Hz, 1H), 7.75 (br s, 1H), 7.60 (t, <i>J</i> = 7.5, 7.5 Hz, 1H), 7.52–7.40 (m, 4H), 4.38–3.54 (m, 3H), 3.26 (s, 1H), 3.10 (d, <i>J</i> = 9.9 Hz, 1H), 2.62 (dd, <i>J</i> = 2.6, 12.7 Hz, 1H), 1.94 (q, <i>J</i> = 11.8, 12.0, 12.0 Hz, 1H), 1.70–1.61 (m, 1H), 1.30 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p last"><i>Step 4:</i> To a stirring solution <b>33</b> (500 mg, 1.15 mmol) in methanol (25 mL) was added DBU (263 mg, 1.73 mmol). The reaction was stirred at 70 °C for 16 h, cooled to room temperature, concentrated in vacuo, and subjected to preparative reverse-phase HPLC (column, DuraShell C18 150 × 25 mm × 5 μm; gradient, 34% to 54% acetonitrile in aqueous 0.05% (v/v) ammonia hydroxide over 10 min then hold 2 min; flow rate, 30 mL/min). Product fractions were lyophilized then repurified by preparative reverse-phase HPLC (column, Phenomenex Gemini C18 250 × 50 mm × 10 μm; gradient, 13% to 33% acetonitrile in 0.225% aqueous formic acid over 10 min then hold 2 min; flow rate, 30 mL/min). Lyophilization afforded the mono formic acid salt of (4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-6-methyl-8<i>a</i>-(2-(trifluoromethyl)phenyl)-4,4<i>a</i>,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>41</b>) (66 mg, 15%) as a white solid. LCMS <i>m</i>/<i>z</i> 330.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.59 (s, 1H, formic acid), 7.89–7.77 (m, 2H), 7.70–7.61 (m, 1H), 7.47 (t, <i>J</i> = 7.7, 7.7 Hz, 1H), 4.11–3.97 (m, 1H), 3.83–3.70 (m, 1H), 3.42–3.27 (m, 1H), 3.14–3.03 (m, 1H), 2.67 (dd, <i>J</i> = 2.8, 12.7 Hz, 1H), 1.79 (q, <i>J</i> = 11.6, 11.9, 11.9 Hz, 1H), 1.66–1.57 (m, 1H), 1.31 (d, <i>J</i> = 6.1 Hz, 3H). [α]<sub>D</sub><sup>28.8</sup> = −116.8° (<i>c</i> =0.518, CH<sub>3</sub>OH).</div></div><div id="sec4_19_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-6-Methyl-8<i>a</i>-phenyl-4,4<i>a</i>,5,6,8,8<i>a</i>-Hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>42</b>)</h4><div class="NLM_p"><i>Step 1:</i> To a colorless solution of iodobenzene (2.25 g, 11.1 mmol, 1.2 equiv) in toluene (80 mL) was added BF<sub>3</sub>·Et<sub>2</sub>O (1.57 g, 1.39 mL, 11.1 mmol) at −65 °C, followed by slowly addition of <i>n</i>-BuLi (4.94 mL, 2.5 M in hexane, 12.3 mmol, 1.34 equiv). After stirring for 10 min, a solution of <b>15</b> (1.30 g, 9.21 mmol, 1 equiv) in THF (8 mL) was added dropwise at −65 °C. The resulting colorless solution was stirred for another 50 min at the same temperature. TLC (petroleum ether/ethyl acetate 2:1, <i>R</i><sub>f</sub> ≈ 0.6, stained by KMnO<sub>4</sub>) indicated most of the starting material was consumed, and a new less polar spot was shown. The mixture was quenched with saturated aqueous NH<sub>4</sub>Cl (80 mL), and the temperature quickly warmed up to −10 °C. After warming to room temperature, the mixture was diluted with ethyl acetate (50 mL), partitioned, and separated. The aqueous layer was extracted with ethyl acetate (80 mL × 2). The combined organic layers were washed with brine (30 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Flash column chromatography (silica gel, 0 → 15% ethyl acetate in petroleum ether gradient) of the crude material afforded (3<i>aR</i>,5<i>S</i>,7<i>aS</i>)-5-methyl-7<i>a</i>-phenylhexahydro-1<i>H</i>-pyrano[3,4-<i>c</i>]isoxazole (<b>18</b>) (1.30 g, 64.4%) as a white solid. LCMS <i>m</i>/<i>z</i> 219.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.59 (d, <i>J</i> = 7.7 Hz, 2H), 7.32 (t, <i>J</i> = 7.6, 7.6 Hz, 2H), 7.26–7.20 (m, 1H), 6.24 (s, 1H), 3.84 (d, <i>J</i> = 12.9 Hz, 1H), 3.75 (d, <i>J</i> = 12.9 Hz, 1H), 3.62 (t, <i>J</i> = 7.9, 7.9 Hz, 2H), 3.48 (dd, <i>J</i> = 7.0, 4.8 Hz, 1H), 2.92–2.81 (m, 1H), 1.81 (ddd, <i>J</i> = 14.2, 6.8, 2.1 Hz, 1H), 1.43 (dt, <i>J</i> = 14.3, 11.7, 11.7 Hz, 1H), 1.24 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p"><i>Step 2:</i> Raney nickel (0.603g, 13.7 mmol) was added to a solution of <b>18</b> (1.2 g, 5.472 mmol, 1 equiv) in isopropanol (20 mL) and THF (20 mL) at room temperature while under Ar. The resulting black mixture was degassed three times with hydrogen and stirred at 50 °C under a hydrogen balloon (∼15 psi) for 2 h. TLC (petroleum ether/ethyl acetate 2:1, <i>R</i><sub>f</sub> ≈ 0.03, UV) showed the starting material was consumed completely. The mixture was cooled to room temperature and filtered through a Celite pad. The filter cake was washed with ethyl acetate (40 mL). The combined filtrates were concentrated in vacuo to afford ((2<i>S</i>,4<i>R</i>,5<i>S</i>)-5-amino-2-methyl-5-phenyltetrahydro-2<i>H</i>-pyran-4-yl)methanol (<b>26</b>) (1.32 g) as a crude yellow oil that was advanced as-is without further purification.</div><div class="NLM_p"><i>Step 3:</i> Benzoyl isothiocyanate (2.14 g, 13.1 mmol) was added in one portion to a stirring solution of <b>26</b> (1.32 g, 5.965 mmol) in ethyl acetate (30 mL) at room temperature. The resulting yellow solution was stirred at room temperature for 20 h then at 90 °C for an additional 20 h. The reaction mixture was filtered, the filter cake was washed with ethyl acetate (10 mL), and the solid was dried in vacuo to afford <i>N</i>-((4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-6-methyl-8<i>a</i>-phenyl-4,4<i>a</i>,5,6,8,8a<i>-</i>hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>34</b>) (1.28 g, 58.6% yield) as a yellow solid. LCMS <i>m</i>/<i>z</i> 366.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.13 (br s, 1H), 8.29–8.22 (m, 2H), 7.53–7.30 (m, 8H), 3.83–3.72 (m, 3H), 3.02 (dd, <i>J</i> = 12.6, 4.1 Hz, 1H), 2.80–2.72 (m, 1H), 2.53 (dd, <i>J</i> = 12.7, 2.9 Hz, 1H), 2.04–1.92 (m, 1H), 1.66 (ddd, <i>J</i> = 13.7, 4.3, 2.3 Hz, 1H), 1.30 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p last"><i>Step 4:</i> DBU (218 mg, 1.43 mmol) was added to a solution of <b>34</b> (350 mg, 0.955 mmol) in methanol (15 mL) at room temperature. The reaction was stirred at 70 °C for 16 h and concentrated in vacuo, then the crude material was purified by preparative reverse-phase HPLC (column, DuraShell 150 × 25 mm × 5 μm; gradient, 24% to 44% acetonitrile in aqueous 0.05% (v/v) ammonia hydroxide over 10 min then hold 2 min; flow rate, 30 mL/min). After concentration and lyophilization, compound <b>42</b> (184 mg, 73.4% yield) was obtained as a white solid. LCMS <i>m</i>/<i>z</i> 262.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.37–7.29 (m, 4H), 7.27–7.21 (m, 1H), 4.54 (s, 2H), 3.85 (d, <i>J</i> = 11.2 Hz, 1H), 3.77–3.67 (m, 2H), 2.98 (dd, <i>J</i> = 4.1, 12.0 Hz, 1H), 2.49 (dd, <i>J</i> = 2.7, 12.1 Hz, 1H), 2.44 (dt, <i>J</i> = 3.5, 3.5, 12.2 Hz, 1H), 1.80 (q, <i>J</i> = 12.0, 12.3, 12.3 Hz, 1H), 1.48 (ddd, <i>J</i> = 2.4, 3.8, 13.2 Hz, 1H), 1.29 (d, <i>J</i> = 6.1 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 151.00, 143.35, 128.62, 127.07, 126.53, 79.24, 73.76, 58.75, 33.47, 32.01, 28.86, 21.85. [α]<sub>D</sub><sup>28.8</sup> = +0.844° (<i>c</i> 0.533, CH<sub>3</sub>OH). For 2D-NMR experiments (HSQC, NOESY), see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf" class="ext-link">Table S1</a>.</div></div><div id="sec4_19_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-8<i>a</i>-(2-Methoxyphenyl)-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>43</b>)</h4><div class="NLM_p"><i>Step 1:</i> Prepared in similar fashion as <b>18</b> but utilized 2-bromoanisole (2.38 g, 12.8 mmol), BF<sub>3</sub>·Et<sub>2</sub>O (1.81 g, 1.6 mL, 12.8 mmol), <i>n</i>-BuLi (5.7 mL, 2.5 M in hexane, 14.2 mmol), <b>15</b> (1.5 g, 10.6 mmol), toluene (80 mL), and THF (8 mL) to afford (3<i>aR</i>,5<i>S</i>,7<i>aS</i>)-7<i>a</i>-(2-methoxyphenyl)-5-methylhexahydro-1<i>H</i>-pyrano[3,4-<i>c</i>]isoxazole (<b>19</b>) (718 mg, 27.1% yield) as a colorless gum. LCMS <i>m</i>/<i>z</i> 249.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.81 (d, <i>J</i> = 7.6 Hz, 1H), 7.19–7.13 (m, 1H), 6.88 (t, <i>J</i> = 7.5, 7.5 Hz, 1H), 6.78 (d, <i>J</i> = 8.2 Hz, 1H), 6.21 (s, 1H), 4.27 (d, <i>J</i> = 12.4 Hz, 1H), 3.77 (s, 3H), 3.69–3.55 (m, 2H), 3.53 (d, <i>J</i> = 6.9 Hz, 1H), 3.44–3.38 (m, 1H), 3.22 (ddd, <i>J</i> = 11.8, 7.0, 4.9 Hz, 1H), 1.71 (ddd, <i>J</i> = 14.0, 7.0, 2.0 Hz, 1H), 1.32 (dt, <i>J</i> = 14.1, 11.5, 11.5 Hz, 1H), 1.14 (d, <i>J</i> = 6.2 Hz, 3H).</div><div class="NLM_p"><i>Step 2:</i> Prepared in similar fashion as <b>26</b> but utilized <b>19</b> (250 mg, 1 mmol), Raney nickel (147 mg, 2.51 mmol), isopropanol (10 mL), and THF (10 mL) to afford ((2<i>S</i>,4<i>R</i>,5<i>S</i>)-5-amino-5-(2-methoxyphenyl)-2-methyltetrahydro-2<i>H</i>-pyran-4-yl)methanol (<b>27</b>) (245 mg, 97.9% yield) as a yellow oil that was advanced as-is. LCMS <i>m</i>/<i>z</i> 252.0 [M + H]<sup>+</sup>.</div><div class="NLM_p"><i>Step 3:</i> Benzoyl isothiocyanate (525 mg, 3.22 mmol) was added in one portion to a stirring solution <b>27</b> (245 mg, 0.975 mmol) in ethyl acetate (15 mL) at room temperature. The resulting yellow solution was stirred at room temperature for 1.5 h, then at 90 °C for an additional 20 h. The reaction mixture was concentrated, and the crude was purified by flash column chromatography (silica gel, 10 → 30% ethyl acetate in petroleum ether) to afford 345 mg of yellow solid, which was triturated with petroleum ether/ethyl acetate (6 mL, 5:1) to yield <i>N</i>-((4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-8<i>a</i>-(2-methoxyphenyl)-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>35</b>) (174 mg, 45% yield) as a white solid after filtration. LCMS <i>m</i>/<i>z</i> 396.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 50 °C) δ 12.05 (br s, 1H), 8.27 (d, 2H), 7.51–7.35 (m, 4H), 7.31 (td, 1H), 6.99 (t, 1H), 6.95 (d, 1H), 4.38 (d, 1H), 3.88 (s, 3H), 3.81–3.68 (m, 2H), 3.55 (d, 1H), 3.11–2.94 (m, 1H), 2.53 (dd, 1H), 1.94 (d, 1H), 1.60 (ddd, 1H), 1.28 (d, 3H).</div><div class="NLM_p last"><i>Step 4:</i> DBU (20 μL, 20.4 mg, 0.127 mmol) was added to a stirring suspension of <b>35</b> (55 mg, 0.139 mmol) in methanol (2.0 mL). The initial heterogeneous mixture was heated to 70 °C, and the resulting solution was heated at that temperature for 16 h. The reaction mixture was cooled to room temperature, concentrated, dissolved in dichloromethane (10 mL), and washed with brine (2 × 5 mL). The aqueous layers were back-extracted with additional dichloromethane (5 mL), and the combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Preparative reverse-phase HPLC purification (column, XBridge C18 19 × 100 mm × 5 μm; A = water; B = acetonitrile; gradient, 95.0% water/5.0% acetonitrile linear to 5.0% water/95.0% acetonitrile in 8.5 min, hold at 0% water/100% acetonitrile to 10.0 min; flow rate, 25 mL/min) followed by lyophilization afforded (4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-8<i>a</i>-(2-methoxyphenyl)-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>43</b>) (29.6 mg, 72.9%) as a white solid. LCMS <i>m</i>/<i>z</i> 293.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ 7.28–7.20 (m, 2H), 7.01–6.97 (m, 1H), 6.92 (td, 1H), 4.83 (br s, 2H), 4.33 (d, 1H), 3.82 (s, 3H), 3.68 (dqd, 1H), 3.43 (d, 1H), 3.31 (dq, 1H), 2.74 (dd, 1H), 2.52 (dd, 1H), 1.62–1.51 (m, 1H), 1.45 (dd, 1H), 1.15 (d, 3H). [α]<sub>D</sub><sup>29.1</sup> = −50.4° (<i>c</i> 0.522, CH<sub>3</sub>OH).</div></div><div id="sec4_19_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-8<i>a</i>-(3-Fluoropyridin-2-yl)-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>44</b>)</h4><div class="NLM_p"><i>Step 1:</i> To a solution of 2-bromo-3-fluoropyridine (3.12g, 17.7 mmol) in toluene (80 mL) and THF (40 mL) was added <i>n</i>-BuLi (7.5 mL, 2.5 M in hexane, 19 mmol) dropwise at −70 °C. After stirring for 40 min, a solution of <b>15</b> (1 g, 7.084 mmol) in toluene (20 mL) and THF (10 mL) was added dropwise at −70 °C. The mixture was stirred for 60 min at the same temperature. TLC (petroleum ether/ethyl acetate 2:1, <i>R</i><sub>f</sub> ≈ 0.15, stained by KMnO<sub>4</sub>) showed the reaction was complete. The reaction solution was quenched with saturated aqueous NH<sub>4</sub>Cl (50 mL). The mixture was separated, and the aqueous layer was extracted with additional ethyl acetate (50 mL× 3). The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford the crude product (3.85 g, yellow oil). Flash column chromatography (silica gel; gradient, 0 to 60% ethyl acetate in petroleum ether) afforded (3<i>aR</i>,5<i>S</i>,7<i>aS</i>)-7<i>a</i>-(3-fluoropyridin-2-yl)-5-methylhexahydro-1<i>H</i>-pyrano[3,4-<i>c</i>]isoxazole (<b>20</b>) (1.15g, 68.1% yield) as a white solid. LCMS <i>m</i>/<i>z</i> 238.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.39 (d, <i>J</i> = 4.5 Hz, 1H), 7.41 (dd, <i>J</i> = 11.1, 8.3 Hz, 1H), 7.31–7.26 (m, 1H), 6.41 (s, 1H), 4.18 (s, 1H), 3.84 (d, <i>J</i> = 12.3 Hz, 1H), 3.65 (dt, <i>J</i> = 18.7, 6.2, 6.2 Hz, 4H), 1.88 (dd, <i>J</i> = 13.9, 6.8 Hz, 1H), 1.79–1.54 (m, 1H), 1.27 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p"><i>Step 2:</i> Prepared in similar fashion as <b>26</b> but utilized <b>20</b> (780 mg, 3.27 mmol), Raney nickel (576 mg, 9.82 mmol), isopropanol (20 mL), and THF (20 mL) to afford crude ((2<i>S</i>,4<i>R</i>,5<i>S</i>)-5-amino-5-(3-fluoropyridin-2-yl)-2-methyltetrahydro-2<i>H</i>-pyran-4-yl)methanol (<b>20</b>) (780 mg) as a white oil that was advanced as-is without further purification.</div><div class="NLM_p"><i>Step 3:</i> Prepared in similar fashion as <b>35</b> but utilized <b>20</b> (0.78 g, 3.25 mmol), benzoyl isothiocyanate (1.32 g, 8.12 mmol), and ethyl acetate (30 mL). After stirring at room temperature for 1.5 h, the reaction was then stirred at 90 °C for 16 h. Flash column chromatography (12g silica gel, 10% to 100% ethyl acetate in petroleum ether) of the crude material afforded <i>N</i>-((4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-8<i>a</i>-(3-fluoropyridin-2-yl)-6-methyl-4,4<i>a</i>,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>28</b>) (560 mg, 44.7% yield) as a yellow solid. LCMS <i>m</i>/<i>z</i> 385.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.45 (br s, 1H), 8.40 (dt, <i>J</i> = 4.4, 1.4, 1.4 Hz, 1H), 8.23 (dd, <i>J</i> = 8.3, 1.3 Hz, 2H), 7.49–7.36 (m, 4H), 7.31 (dt, <i>J</i> = 8.3, 3.9, 3.9 Hz, 1H), 4.18 (d, <i>J</i> = 12.1 Hz, 1H), 3.76–3.65 (m, 2H), 3.52 (dd, <i>J</i> = 12.8, 4.3 Hz, 1H), 3.44 (dq, <i>J</i> = 11.3, 4.2, 4.1, 4.1 Hz, 1H), 2.64 (dd, <i>J</i> = 12.8, 2.6 Hz, 1H), 1.98 (q, <i>J</i> = 12.9, 12.9, 12.8 Hz, 1H), 1.66 (ddd, <i>J</i> = 13.5, 4.2, 2.3 Hz, 1H), 1.28 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p last"><i>Step 4:</i> To a stirring solution <b>28</b> (480 mg, 1.25 mmol) in methanol (10 mL) was added DBU (190 mg, 1.25 mmol). The reaction was stirred at 70 °C for 16 h, cooled to room temperature, and concentrated in vacuo, then purified by flash column chromatography (silica gel; gradient, 0 → 10% methanol in dichloromethane) to afford (4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-8<i>a</i>-(3-fluoropyridin-2-yl)-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>36</b>) (105 mg, white solid, contaminated with DBU). The solid was suspended in water (10 mL), stirred for 1 h, filtered, and lyophilized to afford pure (<b>36</b>) (52 mg, 14.8% yield) as a white solid. LCMS <i>m</i>/<i>z</i> 281.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 4.0 Hz, 1H), 7.41–7.29 (m, 1H), 7.20 (dt, <i>J</i> = 3.8, 3.8, 7.8 Hz, 1H), 4.38 (br s, 2H), 4.16 (d, <i>J</i> = 11.0 Hz, 1H), 3.76 (d, <i>J</i> = 11.0 Hz, 1H), 3.72–3.61 (m, 1H), 3.39 (dd, <i>J</i> = 4.6, 12.3 Hz, 1H), 3.09–2.96 (m, 1H), 2.66–2.56 (m, 1H), 1.77 (q, <i>J</i> = 12.5, 12.6, 12.6 Hz, 1H), 1.53–1.42 (m, 1H), 1.26 (d, <i>J</i> = 6.1 Hz, 3H). [α]<sub>D</sub><sup>29.0</sup> = −19.0° (<i>c</i> 0.524, CH<sub>3</sub>OH).</div></div><div id="sec4_19_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-6-Methyl-8<i>a</i>-(thiophen-3-yl)-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>45</b>)</h4><div class="NLM_p"><i>Step 1:</i> To a solution of 3-bromothiophene (2.6 g, 15.9 mmol) in toluene (50 mL) and THF (5 mL) was added BF<sub>3</sub>·Et<sub>2</sub>O (2.11 g, 14.9 mmol) at −70 °C, followed by slow addition of <i>n</i>-BuLi (2.5 M in hexane, 5.12 mL, 12.8 mmol). After stirring for 30 min, a solution of <b>15</b> (1.5 g, 10.6 mmol) in toluene (10 mL) and THF (1 mL) was added dropwise at −78 °C. The mixture was stirred for 60 min at the same temperature. TLC (petroleum ether/ethyl acetate = 3:1, <i>R</i><sub>f</sub>  ≈ 0.5, stained by I<sub>2</sub>) showed the reaction was complete. The reaction solution was quenched with saturated aqueous ammonium chloride (50 mL), and the temperature warmed up to 15 °C rapidly. The mixture was separated, and the aqueous layer was extracted with ethyl acetate (50 mL × 3). The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated. The crude product was purified by flash column chromatography (silica gel, 0 → 20% ethyl acetate in petroleum ether) to afford ∼90% pure product (1.25 g). This was combined with similarly enriched material from another reaction (same otherwise but 1/3 the scale; via 0.5 g of <b>15</b>) and repurified as above to afford pure (3<i>aR</i>,5<i>S</i>,7<i>aS</i>)-5-methyl-7<i>a</i>-(thiophen-3-yl)hexahydro-1<i>H</i>-pyrano[3,4-<i>c</i>]isoxazole (<b>21</b>) (1.12 g, 35.2% averaged yield) as an off-white solid. LCMS <i>m</i>/<i>z</i> 225.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.43 (d, <i>J</i> = 2.6 Hz, 1H), 7.30 (dd, <i>J</i> = 5.0, 3.0 Hz, 1H), 7.13 (d, <i>J</i> = 5.1 Hz, 1H), 6.29 (s, 1H), 3.93 (d, <i>J</i> = 12.9 Hz, 1H), 3.79 (d, <i>J</i> = 12.8 Hz, 1H), 2.81 (ddd, <i>J</i> = 11.5, 6.7, 4.6 Hz, 1H), 1.82 (ddd, <i>J</i> = 14.2, 6.7, 2.1 Hz, 1H), 1.44 (dt, <i>J</i> = 14.3, 11.6, 11.6 Hz, 1H), 1.26 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p"><i>Step 2:</i> Prepared in similar fashion as <b>26</b> but utilized <b>21</b> (550 mg, 2.44 mmol), Raney nickel (500 mg, 8.52 mmol), and ethanol (20 mL, in lieu of 1:1 THF/isopropanol) to afford ((2<i>S</i>,4<i>R</i>,5<i>S</i>)-5-amino-2-methyl-5-(thiophen-3-yl)tetrahydro-2<i>H</i>-pyran-4-yl)methanol (<b>29</b>) (550 mg) as a colorless oil that was advanced as-is without further purification.</div><div class="NLM_p"><i>Step 3:</i> Prepared in similar fashion as <b>35</b> but utilized <b>29</b> (550 mg, 2.42 mmol), benzoyl isothiocyanate (1 g, 6.1 mmol), and ethyl acetate (20 mL). After stirring at room temperature for 1.5 h, the reaction was then stirred at 90 °C for 16 h. Two identical flash column chromatographies (12 g silica gel; gradient, 5% to 30% ethyl acetate in petroleum ether) afforded <i>N</i>-((4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-6-methyl-8<i>a</i>-(thiophen-3-yl)-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>29</b>) (240 mg, 66.6% yield) as an off-white solid. LCMS <i>m</i>/<i>z</i> 372.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.40 (br s, 1H), 8.22 (d, <i>J</i> = 6.6 Hz, 2H), 7.51–7.38 (m, 4H), 7.25–7.23 (m, 1H), 6.98 (dd, <i>J</i> = 5.1, 1.5 Hz, 1H), 3.87 (d, <i>J</i> = 12.4 Hz, 1H), 3.82–3.69 (m, 2H), 3.14 (dd, <i>J</i> = 12.4, 3.9 Hz, 1H), 2.66–2.52 (m, 2H), 2.03–1.90 (m, 1H), 1.68–1.61 (m, 1H), 1.29 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p last"><i>Step 4:</i> To a stirring solution of <b>29</b> (170 mg, 0.456 mmol) in methanol (10 mL) was added DBU (69.5 mg, 0.456 mmol). The reaction was stirred at 70 °C for 16 h, cooled to room temperature, concentrated in vacuo, then subjected to preparative reverse-phase HPLC (column, DuraShell C18 150 × 25 mm × 5 μm; gradient, 24% to 44% acetonitrile in aqueous 0.05% (v/v) ammonium hydroxide over 10 min then hold 2 min; flow rate, 30 mL/min). Product fractions were lyophilized to afford (4<i>aR</i>,6<i>S</i>,8<i>aS</i>)-6-methyl-8<i>a</i>-(thiophen-3-yl)-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>45</b>) (58 mg, 47.4% yield) as a white solid. LCMS <i>m</i>/<i>z</i> 268.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30 (dd, <i>J</i> = 3.1, 5.0 Hz, 1H), 7.08 (dd, <i>J</i> = 1.3, 3.1 Hz, 1H), 6.96 (dd, <i>J</i> = 1.3, 5.1 Hz, 1H), 4.43 (br s, 2H), 3.88 (d, <i>J</i> = 11.2 Hz, 1H), 3.76–3.64 (m, 2H), 3.07 (dd, <i>J</i> = 4.1, 12.1 Hz, 1H), 2.52 (dd, <i>J</i> = 2.8, 12.2 Hz, 1H), 2.33–2.25 (m, 1H), 1.83–1.71 (m, 1H), 1.46 (ddd, <i>J</i> = 2.2, 4.0, 13.3 Hz, 1H), 1.27 (d, <i>J</i> = 6.2 Hz, 3H). [α]<sub>D</sub><sup>29.0</sup> = +46.0° (<i>c</i> 0.524, CH<sub>3</sub>OH).</div></div><div id="sec4_19_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-6-Methyl-8<i>a</i>-(thiophen-2-yl)-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>46</b>)</h4><div class="NLM_p"><i>Step 1:</i> Prepared in similar fashion to <b>18</b> but utilized 2-bromothiophene (1.91 g, 11.7 mmol), BF<sub>3</sub>·Et<sub>2</sub>O (1.7 g, 1.5 mL, 12 mmol), <i>n</i>-BuLi (2.5 M in hexane, 5.1 mL, 12.8 mmol), <b>15</b> (1.5 g, 10.6 mmol), toluene (80 mL), and THF (8 mL) at −70 °C rather than at −65 °C. Purification of the crude compound by flash column chromatography (silica gel, 0 to 25% ethyl acetate in petroleum ether) afforded an off-white solid (1.78 g), which was dissolved in ethyl acetate (30 mL), concentrated to ∼10 mL, causing a precipitate, then filtered to obtain pure (3<i>aR</i>,5<i>S</i>,7<i>aR</i>)-5-methyl-7a-(thiophen-2-yl)hexahydro-1<i>H</i>-pyrano[3,4-<i>c</i>]isoxazole (<b>22</b>) (995 mg, 41.6% yield) as a white solid. LCMS <i>m</i>/<i>z</i> 225.7 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.22 (d, <i>J</i> = 5.0 Hz, 1H), 7.03 (dd, <i>J</i> = 3.6, 1.1 Hz, 1H), 6.99 (dd, <i>J</i> = 5.0, 3.6 Hz, 1H), 6.37 (s, 1H), 3.99 (d, <i>J</i> = 12.8 Hz, 1H), 3.84–3.69 (m, 3H), 3.64 (dqd, <i>J</i> = 12.1, 6.2, 6.1, 6.1, 2.1 Hz, 1H), 2.89 (ddd, <i>J</i> = 11.5, 6.7, 4.6 Hz, 1H), 1.84 (ddd, <i>J</i> = 14.2, 6.8, 2.1 Hz, 1H), 1.45 (dt, <i>J</i> = 14.2, 11.6, 11.6 Hz, 1H), 1.26 (d, <i>J</i> = 6.2 Hz, 3H). Concentration of the mother liquor afforded additional <b>22</b> as a pale yellow solid (780 mg, 32.6% yield) of slightly lower purity by <sup>1</sup>H-NMR as compared to the precipitated batch. Combined yield is 74.2%.</div><div class="NLM_p"><i>Step 2:</i> Prepared in similar fashion as <b>26</b> but utilized <b>22</b> (780 mg, 3.46 mmol), Raney nickel (508 mg, 8.66 mmol), isopropanol (10 mL), and THF (10 mL) to afford ((2<i>S</i>,4<i>R</i>,5<i>R</i>)-5-amino-2-methyl-5-(thiophen-2-yl)tetrahydro-2<i>H</i>-pyran-4-yl)methanol (<b>30</b>) (740 mg, 94% yield) as a yellow oil that was advanced as-is without further purification. LCMS <i>m</i>/<i>z</i> 227.8 [M + H]<sup>+</sup></div><div class="NLM_p"><i>Step 3:</i> Prepared in similar fashion as <b>35</b> but utilized <b>30</b> (700 mg, 2.35 mmol), benzoyl isothiocyanate (1.34 g, 8.22 mmol, 3.3 equiv), and ethyl acetate (25 mL). Two sequential flash column chromatographies (Gradient, 0% to 12–13% ethyl acetate in petroleum ether) afforded <i>N</i>-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-6-methyl-8<i>a</i>-(thiophen-2-yl)-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>38</b>) (390 mg, 44.6%) as a white solid. LCMS <i>m</i>/<i>z</i> 372.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.28 (br s, 1H), 8.19 (d, <i>J</i> = 7.6 Hz, 2H), 7.50 (t, <i>J</i> = 7.2, 7.2 Hz, 1H), 7.43 (t, <i>J</i> = 7.5, 7.5 Hz, 2H), 7.29 (d, <i>J</i> = 5.3 Hz, 1H), 7.04–6.97 (m, 2H), 3.95 (d, <i>J</i> = 12.2 Hz, 1H), 3.82–3.70 (m, 2H), 3.27 (dd, <i>J</i> = 12.9, 4.1 Hz, 1H), 2.57 (t, <i>J</i> = 10.8, 10.8 Hz, 2H), 1.94 (q, <i>J</i> = 12.5, 12.5, 12.5 Hz, 1H), 1.70–1.64 (m, 1H), 1.28 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p last"><i>Step 4:</i> To a stirring solution of <b>38</b> (175 mg, 0.470 mmol) in methanol (10 mL) was added DBU (107 mg, 0.705 mmol). The reaction was stirred at 70 °C for 16 h, concentrated in vacuo, dissolved in dichloromethane (20 mL), and washed with brine (2 × 15 mL). The aqueous layers were back-extracted with dichloromethane (30 mL), and the combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude residue was first purified by silica gel chromatography (gradient, 0 → 4% methanol in dichloromethane) then twice by preparative reverse-phase HPLC (column, Diamonsil C18 150 × 20 mm × 5 μm; gradient, 22% →42% acetonitrile in aqueous 0.05% (v/v) ammonia hydroxide over 10 min then hold 2 min; flow rate, 30 mL/min). Lyophilization afforded (4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-6-methyl-8<i>a</i>-(thiophen-2-yl)-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>46</b>) (53 mg, 42% yield). LCMS <i>m</i>/<i>z</i> 268.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.20 (dd, <i>J</i> = 1.1, 5.1 Hz, 1H), 6.98 (dd, <i>J</i> = 3.6, 5.1 Hz, 1H), 6.83 (dd, <i>J</i> = 1.1, 3.6 Hz, 1H), 4.46 (br s, 2H), 3.96 (d, <i>J</i> = 11.2 Hz, 1H), 3.75–3.64 (m, 2H), 3.24 (dd, <i>J</i> = 4.1, 12.2 Hz, 1H), 2.56 (dd, <i>J</i> = 2.8, 12.3 Hz, 1H), 2.37–2.28 (m, 1H), 1.84–1.73 (m, 1H), 1.49 (ddd, <i>J</i> = 2.3, 4.1, 13.4 Hz, 1H), 1.27 (d, <i>J</i> = 6.2 Hz, 3H). [α]<sub>D</sub><sup>29.1</sup> = +10.0° (<i>c</i> 0.549, CH<sub>3</sub>OH).</div></div><div id="sec4_19_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-6-Methyl-8<i>a</i>-(thiazol-2-yl)-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>47</b>)</h4><div class="NLM_p"><i>Step 1:</i> Prepared in similar fashion as <b>18</b>, but utilized 2-bromothiazole (2.09 g, 12.8 mmol), BF<sub>3</sub>·Et<sub>2</sub>O (1.81 g, 1.6 mL, 12.8 mmol), <i>n</i>-BuLi (5.7 mL, 2.5 M in hexane, 14.2 mmol), <b>15</b> (1.5 g, 10.6 mmol), toluene (80 mL), and THF (8 mL). Flash column chromatography (silica gel, 0 → 35% ethyl acetate in petroleum ether gradient) on the crude product afforded enriched (3<i>aR</i>,5<i>S</i>,7<i>aR</i>)-5-methyl-7<i>a</i>-(thiazol-2-yl)hexahydro-1<i>H</i>-pyrano[3,4-<i>c</i>]isoxazole (<b>23</b>) (630 mg) as a yellow solid. This solid was triturated with petroleum ether/ethyl acetate (5:1, 6 mL) to afford pure <b>23</b> (456 mg, 19% yield, 100% purity by LCMS) as a white solid. LCMS <i>m</i>/<i>z</i> 226.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.75 (d, <i>J</i> = 3.2 Hz, 1H), 7.29 (d, <i>J</i> = 3.3 Hz, 1H), 6.45 (s, 1H), 3.97 (d, <i>J</i> = 3.1 Hz, 2H), 3.75–3.62 (m, 3H), 3.36 (dt, <i>J</i> = 12.1, 5.5, 5.5 Hz, 1H), 1.25 (d, <i>J</i> = 6.0 Hz, 3H), 4.03–3.91 (m, 2H), 1.88 (ddd, <i>J</i> = 13.8, 6.6, 1.8 Hz, 1H), 1.50–1.35 (m, 1H). Note: Concentration of the mother liquor afforded additional <b>23</b> (153 mg, 6% yield, 94% purity by LCMS) as a pale yellow solid. Combined yield: 25%.</div><div class="NLM_p"><i>Step 2:</i> Prepared in similar fashion as <b>26</b> but utilized <b>23</b> (187 mg, 0.826 mmol), Raney nickel (121 mg, 2.07 mmol), isopropanol (10 mL), and THF (10 mL) to afford ((2<i>S</i>,4<i>R</i>,5<i>R</i>)-5-amino-2-methyl-5-(thiazol-2-yl)tetrahydro-2<i>H</i>-pyran-4-yl)methanol (<b>31</b>) (169 mg) as a yellow oil that was advanced as-is without further purification.</div><div class="NLM_p"><i>Step 3:</i> Prepared in similar fashion as <b>35</b> but utilized <b>31</b> (169 mg, 0.740 mmol), benzoyl isothiocyanate (399 mg, 2.44 mmol), and ethyl acetate (15 mL). Flash column chromatography (20 g silica gel, 10% to 70% ethyl acetate in petroleum ether) of the crude sample afforded 378 mg of a yellow oil that was resubjected to an additional flash column chromatography (12 g silica gel, 30% to 50% ethyl acetate in petroleum ether). Two separate batches of <i>N</i>-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-6-methyl-8<i>a</i>-(thiazol-2-yl)-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (<b>39</b>) were isolated after combining different flash column fractions. Combined yield: 160 mg, 57.9%. Batch 1 (60 mg, 21.7% yield, pale yellow solid after lyophilization, 98.9% purity by LCMS). LCMS <i>m</i>/<i>z</i> 373.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, 50 °C) δ 11.52 (s, 1H), 8.23–8.06 (m, 2H), 7.56–7.48 (m, 1H), 7.48–7.40 (m, 2H), 7.32 (d, <i>J</i> = 3.2 Hz, 1H), 4.03–3.92 (m, 2H), 3.78 (dq, <i>J</i> = 2.3, 6.1, 6.1, 6.1, 12.3 Hz, 1H), 3.20–3.07 (m, 2H), 2.59 (dd, <i>J</i> = 1.8, 12.4 Hz, 1H), 1.91 (d, <i>J</i> = 12.4 Hz, 1H), 1.70–1.62 (m, 1H), 1.29 (d, <i>J</i> = 6.1 Hz, 3H). Batch 2 (100 mg, 36.2% yield, pale yellow oil, 89.2% purity by LCMS). LCMS <i>m</i>/<i>z</i> 373.8 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 4:</i> To a stirring mixture of <b>39</b> (100 mg, 0.668 mmol) in methanol (10 mL) was added DBU (61.1 mg, 0.268 mmol). The reaction was stirred at 70 °C for 16 h and concentrated in vacuo. Then the residue was dissolved in dichloromethane (20 mL) and washed with brine (2 × 15 mL). The aqueous layers were back-extracted with dichloromethane (30 mL), and the combined organic extracts (∼50 mL) were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification of the crude residue by preparative reverse-phase HPLC (column, Diamonsil C18 150 × 20 mm × 5 μm; gradient, 12% to 32% acetonitrile in aqueous 0.05% (v/v) ammonia hydroxide over 10 min then hold 2 min; flow rate, 30 mL/min) followed by concentration and lyophilization of the product fractions afforded (4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-6-methyl-8<i>a</i>-(thiazol-2-yl)-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>47</b>) (47 mg, 65% yield). LCMS <i>m</i>/<i>z</i> 269.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.77 (d, <i>J</i> = 3.2 Hz, 1H), 7.26 (d, <i>J</i> = 2.6 Hz, 1H), 4.71 (s, 2H), 3.95 (d, <i>J</i> = 11.1 Hz, 1H), 3.87 (d, <i>J</i> = 11.1 Hz, 1H), 3.75 (tdd, <i>J</i> = 12.3, 10.6, 6.0, 3.1 Hz, 1H), 3.12 (dd, <i>J</i> = 12.5, 3.9 Hz, 1H), 2.90 (dq, <i>J</i> = 11.3, 3.5, 3.5, 3.2 Hz, 1H), 2.58 (dd, <i>J</i> = 12.5, 2.5 Hz, 1H), 1.80 (q, <i>J</i> = 12.8, 12.8, 12.7 Hz, 1H), 1.54 (dt, <i>J</i> = 13.5, 3.7, 3.7 Hz, 1H), 1.28 (d, <i>J</i> = 6.1 Hz, 3H). [α]<sub>D</sub><sup>29.1</sup> = −32.7° (<i>c</i> 0.554, CH<sub>3</sub>OH).</div></div><div id="sec4_19_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(2-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-Amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl)thiazol-4-yl)-4-methoxybenzamide (<b>56</b>)</h4><div class="NLM_p"><i>Step 1.</i> To a solution of 4-methoxybenzoic acid (62.0 mg, 0.405 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (0.080 mL, 0.463 mmol) in DMF (3 mL, 0.1 M) was added <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate (HATU, 97%, 154 mg, 0.405 mmol) in one portion at 15 °C. The resulting mixture was stirred for 30 min, followed by addition of <b>72</b> (150 mg, 0386 mmol) in one portion. The resulting mixture was stirred at RT over 16 h. The reaction mixture was then partitioned between ethyl acetate (10 mL) and water (10 mL). The aqueous layer was extracted twice with ethyl acetate, and the combined organic layers were washed with saturated aqueous sodium chloride solution (50 mL), dried over sodium sulfate, filtered, and concentrated in vacuo. Silica gel chromatography (gradient, 10% to 40% ethyl acetate in petroleum ether) afforded the product <i>N</i>-(2-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-benzamido-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl)thiazol-4-yl)-4-methoxybenzamide as a solid. Yield: 110 mg, 0.210 mmol, 55%. LCMS <i>m</i>/<i>z</i> 523.1, M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.65 (s, 1H), 8.10 (d, <i>J</i> = 7.6 Hz, 2H), 8.01 (s, 1H), 7.92–7.85 (m, 2H), 7.73 (s, 1H), 7.58–7.50 (m, 1H), 7.46 (dd, <i>J</i> = 8.2, 6.7 Hz, 2H), 7.01–6.95 (m, 2H), 3.88 (s, 3H), 3.81–3.69 (m, 1H), 3.17 (dd, <i>J</i> = 13.0, 4.0 Hz, 1H), 2.95 (m, 2H), 2.59 (dd, <i>J</i> = 12.9, 2.8 Hz, 1H), 1.90 (q, <i>J</i> = 12.6 Hz, 1H), 1.71–1.62 (m, 2H), 1.33–1.27 (d, 3H).</div><div class="NLM_p last"><i>Step 2.</i> To an EtOH solution (10 mL) of <i>N</i>-(2-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-benzamido-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl)thiazol-4-yl)-4-methoxybenzamide (110 mg, 0.210 mmol) at rt was added pyridine (anhydrous, 1.66 g, 21 mmol, 100 equiv) and methoxyamine hydrochloride (176 mg, 2.10 mmol, 10 equiv). The resulting solution was heated to 35 °C until complete consumption of the starting material. The reaction mixture was then concentrated under reduced pressure and purified by preparative HPLC purification (column, DuraShell 150 × 25 mm × 5 μm; mobile phase, from 28% MeCN in H<sub>2</sub>O (0.05% ammonia) to 48% MeCN in H<sub>2</sub>O (0.05% ammonia); gradient time. 10 min; 100% B; hold time, 2 min; flow rate, 30 mL/min). The eluents were concentrated and lyophilized to afford compound <b>56</b> (75 mg, 0.179 mmol, 85%). LCMS <i>m</i>/<i>z</i> 418.9 M<sup>+</sup>. [α]<sub>D</sub><sup>23</sup> = −89.1 (<i>c</i> 0.63, MeOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.60 (s, 1H), 7.88 (dd, <i>J</i> = 9.5, 2.8 Hz, 2H), 7.68 (s, 1H), 7.07–6.91 (m, 2H), 4.87–4.50 (b, 2H), 4.06–3.77 (m, 5H), 3.74 (m, 1H), 3.16 (dd, <i>J</i> = 12.5, 4.3 Hz, 1H), 2.76 (d, <i>J</i> = 12.3 Hz, 1H), 2.66–2.52 (m, 1H), 1.81 (q, <i>J</i> = 12.9 Hz, 1H), 1.54 (d, <i>J</i> = 13.9 Hz, 1H), 1.29 (d, <i>J</i> = 7.8 Hz, 3H).</div></div><div id="sec4_19_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(2-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-Amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl)thiazol-4-yl)-5-methoxypicolinamide (<b>57</b>)</h4><div class="NLM_p"><i>Step 1.</i> To a solution of 4-methoxybenzoic acid (62.0 mg, 0.405 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (0.080 mL, 0.463 mmol) in DMF (3 mL, 0.1 M) was added <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate (HATU, 97%, 154 mg, 0.405 mmol) in one portion at 15 °C. The resulting mixture was stirred for 30 min, followed by addition of <b>72</b> (150 mg, 0386 mmol) in one portion. The resulting mixture was stirred at rt over 32 h. The reaction mixture was then partitioned between ethyl acetate (10 mL) and water (10 mL). The aqueous layer was extracted twice with ethyl acetate, and the combined organic layers were washed with saturated aqueous sodium chloride solution (50 mL), dried over sodium sulfate, filtered, and concentrated in vacuo. Silica gel chromatography (gradient, 10% to 40% ethyl acetate in petroleum ether) afforded the product as a solid. Yield: 150 mg, 0.286 mmol, 85%. LCMS <i>m</i>/<i>z</i> 524.1, M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 10.43 (s, 1H), 8.28 (d, <i>J</i> = 2.8 Hz, 1H), 8.23 (d, <i>J</i> = 8.6 Hz, 1H), 8.12 (m, 2H), 7.75 (s, 1H), 7.54 (m, 1H), 7.46 (m, 2H), 7.35 (dd, <i>J</i> = 8.7, 2.8 Hz, 1H), 3.96 (m, 5H), 3.78 (m, 1H), 3.19 (dd, <i>J</i> = 13.0, 4.1 Hz, 1H), 3.10–3.00 (m, 1H), 2.61 (dd, <i>J</i> = 13.0, 2.8 Hz, 1H), 1.91 (m, 1H), 1.67 (m, 1H), 1.30 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p last"><i>Step 2.</i> To an EtOH solution (10 mL) of <i>N</i>-(2-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-benzamido-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl)thiazol-4-yl)-5-methoxypicolinamide (150 mg, 0.286 mmol) at rt was added pyridine (anhydrous, 2.27 g, 28.6 mmol) and methoxyamine hydrochloride (239 mg, 2.86 mmol). The resulting solution was heated to 35 °C until complete consumption of starting material. The reaction mixture was then concentrated under reduced pressure and purified by preparative HPLC purification (Column: DuraShell 150 × 25 mm × 5 μm; mobile phase: from 28% MeCN in H<sub>2</sub>O (0.05% ammonia) to 48% MeCN in H<sub>2</sub>O (0.05% ammonia); gradient time, 10 min; 100% B; hold time, 2 min; flow rate, 30 mL/min). The eluents were concentrated and lyophilized to afford compound <b>57</b> (7 mg, 0.017 mmol, 6%). LCMS <i>m</i>/<i>z</i> 441.9, M + Na. [α]<sub>D</sub><sup>22</sup> = −107.1 (<i>c</i> 0.32, MeOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 10.39 (s, 1H), 8.27 (d, <i>J</i> = 2.8 Hz, 1H), 8.23 (d, <i>J</i> = 8.7 Hz, 1H), 7.68 (s, 1H), 7.34 (dd, <i>J</i> = 8.7, 2.9 Hz, 1H), 4.58 (b, 2H), 3.94 (s, 4H), 3.87 (d, <i>J</i> = 11.1 Hz, 1H), 3.80–3.67 (m, 1H), 3.18 (dd, <i>J</i> = 12.5, 4.0 Hz, 1H), 2.84 (dd, <i>J</i> = 12.9, 3.6 Hz, 1H), 2.64–2.53 (m, 1H), 1.80 (m, 1H), 1.57–1.48 (m, 1H), 1.29 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_19_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-{2-[(4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-Amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl]-1,3-thiazol-4-yl}-5-chloropyridine-2-carboxamide (<b>61</b>)</h4><div class="NLM_p"><i>Step 1.</i> Synthesis of <i>N</i>-{2-[(4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-(benzoylamino)-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl]-1,3-thiazol-4-yl}-5-chloropyridine-2-carboxamide. To a solution of 5-chloropyridine-2-carboxylic acid (38.9 mg, 0.247 mmol) in DMF (2 mL) was added DIPEA (133 mg, 1.03 mmol) at rt, followed by addition of HATU (235 mg, 0.618 mmol). The resulting orange solution was stirred for 30 min at rt. Then <b>72</b> (80 mg, 0.21 mmol) in DMF (3 mL) was added via syringe, and the mixture was stirred at rt for 2 h. LCMS showed that the reaction was done. The mixture was poured into ice-water (50 mL) and extracted with EA (20 mL × 2). The combined organic layers were washed with water (20 mL × 2) and brine (20 mL × 2), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give crude product as yellow oil. The crude product was purified by prep. TLC (pet ether/EtOAc 2:1). The product was obtained as a colorless oil and used directly in the next transformation. Yield: 80 mg, 0.15 mmol, 71%. LCMS <i>m</i>/<i>z</i> 527.9 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 2.</i> Methoxylamine hydrochloride (94.9 mg, 1.14 mmol) and pyridine (899 mg, 11.4 mmol) were added to a solution of the above thioamide (60 mg, 0.11 mmol) in ethanol (5 mL), and the reaction mixture was heated at reflux for 72 h. Volatiles were removed under reduced pressure, and the residue was purified by reversed phase HPLC (column, Phenomenex Gemini C18, 8 μm; mobile phase A, aqueous ammonia, pH 10; mobile phase B, acetonitrile; gradient, 45% to 65% B) to afford the product as a white solid. Yield: 12.7 mg, 30.0 μmol, 27%. LCMS <i>m</i>/<i>z</i> 423.8 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.40 (br s, 1H), 8.58 (d, <i>J</i> = 2.3 Hz, 1H), 8.24 (d, <i>J</i> = 8.3 Hz, 1H), 7.90 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.73 (s, 1H), 4.5–4.8 (br s, 2H), 3.92 (AB quartet, <i>J</i><sub>AB</sub> = 11.1 Hz, Δν<sub>AB</sub> = 40.2 Hz, 2H), 3.71–3.80 (m, 1H), 3.18 (dd, <i>J</i> = 12.6, 4.2 Hz, 1H), 2.81–2.89 (m, 1H), 2.60 (dd, <i>J</i> = 12, 3 Hz, 1H), 1.75–1.87 (m, 1H), 1.51–1.59 (m, 1H), 1.30 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Shift 173.4, 160.9, 153.8, 147.31, 147.29, 146.8, 137.4, 135.6, 123.4, 103.5, 78.6, 73.5, 60.0, 33.1, 30.7, 29.1, 21.6</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Crystalline Compound <b>61</b>, Hydrochloride Salt</h4><div class="NLM_p last">A sample of compound <b>61</b> (15 mg, 0.035 mmol) was dissolved in ethanol (5 mL) at 60 °C. Concentrated hydrochloric acid (5.9 μL, 0.0708 mmol) was added, and the slurry was allowed to slowly cool to room temperature with stirring. The resulting crystals were collected via filtration to afford the product as a white solid, which was crystalline by powder X-ray diffraction analysis. Yield: 14.7 mg, 0.0319 mmol, 91%. LCMS <i>m</i>/<i>z</i> 424.3, 426.3 [M + H]<sup>+</sup>. [α]<sub>D</sub><sup>22</sup> = −83.4 (<i>c</i> 0.75, DMSO). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.71 (dd, <i>J</i> = 2.4, 0.7 Hz, 1H), 8.22 (dd, half of ABX pattern, <i>J</i> = 8.4, 0.7 Hz, 1H), 8.09 (dd, half of ABX pattern, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.90 (s, 1H), 4.06 (s, 2H), 3.82–3.92 (m, 1H), 3.19–3.26 (m, 2H), 2.97–3.04 (m, 1H), 1.83 (ddd, <i>J</i> = 14, 4, 2.5 Hz, 1H), 1.62 (ddd, <i>J</i> = 14, 11.5, 11.5 Hz, 1H), 1.29 (d, <i>J</i> = 6.2 Hz, 3H).</div></div><div id="sec4_20_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-{2-[(4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-Amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl]-1,3-thiazol-4-yl}-5-cyanopyridine-2-carboxamide (<b>63</b>)</h4><div class="NLM_p"><i>Step 1.</i> To a solution of 5-cyanopyridine-2-carboxylic acid (236 mg, 1.54 mmol) in DMF (4 mL) was added HATU (1.47 g, 3.86 mmol) at rt, followed by addition of DIPEA (832 mg, 6.43 mmol). The resulting solution was stirred for 30 min at rt. Then a solution of <b>72</b> (500 mg, 1.29 mmol) in DMF (6 mL) was added via syringe, and the mixture was stirred at rt for 1 h. LCMS showed the reaction was done. The mixture was poured into ice-water (100 mL) and extracted with EA (100 mL × 2). The combined organic layers were washed with water (50 mL × 2), brine (50 mL × 2), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give crude product as yellow oil. The crude product was purified by prep. TLC (pet ether/EtOAC 2:1). The product was obtained as a yellow oil and was directly in the next transformation. Yield: 300 mg, 0.58 mmol, 45%. LCMS <i>m</i>/<i>z</i> 519.1 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><i>Step 2.</i> Methoxylamine hydrochloride (483 mg, 5.78 mmol) and pyridine (4.58 g, 57.9 mmol) were added to a solution of the above thioamide (300 mg, 0.58 mmol) in ethanol (4 mL), and the reaction mixture was stirred at 50 °C for 16 h. After removal of solvent under reduced pressure, the residue was purified via reversed phase HPLC (column, Kromasil Eternity XT C18, 10 μm; mobile phase A, aqueous ammonia, pH 10; mobile phase B, acetonitrile; gradient, 22% to 42% B) to afford the product as a white solid. Yield: 69 mg, 0.17 mmol, 29%. LCMS <i>m</i>/<i>z</i> 414.8 [M + H]<sup>+</sup>. [α]<sub>D</sub><sup>22</sup> = −142 (<i>c</i> 0.29, acetonitrile). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.44 (br s, 1H), 8.90–8.94 (m, 1H), 8.43 (br d, <i>J</i> = 8.3 Hz, 1H), 8.22 (dd, <i>J</i> = 8, 2 Hz, 1H), 7.77 (s, 1H), 4.5–4.9 (br s, 2H), 3.92 (AB quartet, <i>J</i><sub>AB</sub> = 11 Hz, Δν<sub>AB</sub> = 44 Hz, 2H), 3.70–3.80 (m, 1H), 3.17 (dd, <i>J</i> = 12, 4 Hz, 1H), 2.81–2.89 (m, 1H), 2.61 (dd, <i>J</i> = 13, 3 Hz, 1H), 1.75–1.87 (m, 1H), 1.52–1.60 (m, 1H), 1.30 (d, <i>J</i> = 6.2 Hz, 3H).</div></div><div id="sec4_20_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-{2-[(4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-Amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)yl]-1,3-thiazol-4-yl}-5-(difluoromethoxy)pyridine-2-carboxamide (<b>64</b>)</h4><div class="NLM_p"><i>Step 1.</i> Potassium carbonate (45.1 g, 326 mmol) was added to a solution of methyl 5-hydroxypyridine-2-carboxylate (20 g, 130 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (500 mL), and the reaction mixture was stirred at room temperature for 0.5 h. Sodium chloro(difluoro)acetate (63.7 g, 418 mmol) was introduced, and the resulting mixture was heated at 100 °C for 5 h, whereupon it was partitioned between saturated aqueous sodium chloride solution (300 mL) and ethyl acetate (300 mL). The aqueous layer was extracted with ethyl acetate (3 × 200 mL), and the combined organic layers were washed with saturated aqueous sodium chloride solution (2 × 200 mL), dried, filtered, and concentrated in vacuo. Silica gel chromatography (eluent, 5:1 petroleum ether/ethyl acetate) afforded the product as a pale yellow oil. Yield: 17 g, 84 mmol, 65%. LCMS <i>m</i>/<i>z</i> 204.1 [M + H<sup>+</sup>]; GCMS <i>m</i>/<i>z</i> 203 (M<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, CDCl3) δ 8.56 (s, 1H), 8.17 (d, <i>J</i> = 8.7 Hz, 1H), 7.59 (br d, <i>J</i> = 8.7 Hz, 1H), 6.64 (t, JHF = 71.9 Hz, 1H), 4.00 (s, 3H).</div><div class="NLM_p"><i>Step 2.</i> A solution of methyl 5-(difluoromethoxy)pyridine-2-carboxylate (17 g, 84 mmol) in tetrahydrofuran (100 mL) and water (50 mL) was cooled to 0 °C and treated with lithium hydroxide (6.0 g, 250 mmol). After the reaction mixture had stirred at room temperature for 2 h, it was acidified to a pH of 3 with 1 M aqueous hydrochloric acid. The aqueous layer was extracted with ethyl acetate (3 × 100 mL), and the combined organic layers were washed with saturated aqueous sodium chloride solution (100 mL), dried, filtered, and concentrated under reduced pressure to provide the product as a white solid. Yield: 13 g, 69 mmol, 82%. LCMS <i>m</i>/<i>z</i> 189.8 [M + H]+. <sup>1</sup>H NMR (400 MHz, CDCl3) δ 8.52 (d, <i>J</i> = 2.4 Hz, 1H), 8.29 (d, <i>J</i> = 8.5 Hz, 1H), 7.73 (dd, <i>J</i> = 8.6, 2.4 Hz, 1H), 6.68 (t, <i>J</i><sub><i>HF</i></sub> = 71.5 Hz, 1H).</div><div class="NLM_p"><i>Step 3.</i> To a solution of <b>72</b> (350 mg, 0.901 mmol) and 5-(difluoromethoxy)pyridine-2-carboxylic acid (204 mg, 1.08 mmol) in acetonitrile (9 mL) was added <i>N</i>,<i>N</i>-diisopropylethylamine (0.314 mL, 1.80 mmol), followed by <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate (HATU, 97%, 424 mg, 1.08 mmol). After the reaction mixture had stirred for 4 h, it was partitioned between ethyl acetate (10 mL) and water (10 mL). The aqueous layer was extracted twice with ethyl acetate, and the combined organic layers were washed with saturated aqueous sodium chloride solution (50 mL), dried over sodium sulfate, filtered, and concentrated in vacuo. Silica gel chromatography (gradient, 0% to 80% ethyl acetate in heptane) afforded the product as a solid. Yield: 410 mg, 0.733 mmol, 81%. LCMS <i>m</i>/<i>z</i> 560.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.45 (s, 1H), 8.33 (d, <i>J</i> = 8.59 Hz, 1H), 8.14 (d, <i>J</i> = 7.41 Hz, 2H), 7.79 (s, 1H), 7.70 (dd, <i>J</i> = 2.34, 8.59 Hz, 1H), 7.45–7.60 (m, 3H), 6.48–6.89 (m, 1H), 3.94–4.06 (m, 2H), 3.80 (dd, <i>J</i> = 6.05, 9.17 Hz, 1H), 3.21 (dd, <i>J</i> = 3.90, 12.88 Hz, 1H), 3.01–3.11 (m, 1H), 2.63 (dd, <i>J</i> = 2.73, 12.88 Hz, 1H), 1.92 (q, <i>J</i> = 12.62 Hz, 1H), 1.65–1.75 (m, 1H), 1.32 (d, <i>J</i> = 6.24 Hz, 3H).</div><div class="NLM_p last"><i>Step 4.</i> A solution of <b>73</b> (390 mg, 0.762 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 95%, 132 μL, 0.838 mmol) in methanol (15 mL) was heated at 70 °C for 90 min. After removal of solvent in vacuo, the residue was purified via silica gel chromatography (gradient, 0% to 8% methanol in dichloromethane) to provide the product <b>64</b> as a solid. Yield: 191 mg, 0.419 mmol, 55%. [α]<sub>D</sub><sup>22</sup> = −102.82 (<i>c</i> 1.3, CHCl<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 456.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.40 (br s, 1H), 8.48 (br dd, <i>J</i> = 2.7, 0.6 Hz, 1H), 8.31 (dd, <i>J</i> = 8.6, 0.6 Hz, 1H), 7.72 (s, 1H), 7.68 (ddt, <i>J</i> = 8.6, 2.7, 0.7 Hz, 1H), 6.65 (t, <i>J</i><sub>HF</sub> = 72.0 Hz, 1H), 3.93 (AB quartet, downfield doublet is broadened, <i>J</i>AB = 11.2 Hz, ΔνAB = 45.8 Hz, 2H), 3.75 (dqd, <i>J</i> = 11.2, 6.1, 2.3 Hz, 1H), 3.19 (dd, <i>J</i> = 12.6, 4.0 Hz, 1H), 2.83–2.90 (m, 1H), 2.61 (dd, <i>J</i> = 12.6, 2.8 Hz, 1H), 1.81 (ddd, <i>J</i> = 13.2, 12.9, 11.4 Hz, 1H), 1.56 (ddd, <i>J</i> = 13.4, 4.2, 2.3 Hz, 1H), 1.30 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Crystalline Compound <b>64</b>, Hydrochloride Salt</h4><div class="NLM_p">A sample of compound <b>64</b> (224 mg, 0.492 mmol) was dissolved in ethyl acetate (1 mL) at 60 °C. Hydrogen chloride (2 M in diethyl ether, 0.49 mL, 0.98 mmol) was added, and the slurry was allowed to cool to room temperature with stirring. Solvents were removed in vacuo, and the residue was dissolved in hot ethanol. The resulting solution was allowed to cool to room temperature and stand for 3 days; single crystals were observed, one of which was subjected to the X-ray crystal structure determination described below. This confirmed the indicated stereochemistry of the hydrochloride salt of <b>64</b>. The ethanol was blown down to a minimum, and the solid was collected via filtration. This sample was crystalline by powder X-ray diffraction analysis. Yield: 200 mg, 0.41 mmol, 83%. LCMS <i>m</i>/<i>z</i> 457.1 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.41 (s, 1H), 8.49 (d, <i>J</i> = 2.34 Hz, 1H), 8.33 (d, <i>J</i> = 8.59 Hz, 1H), 7.74 (s, 1H), 7.69 (dd, <i>J</i> = 2.34, 8.59 Hz, 1H), 6.46–6.88 (m, 1H), 3.96–4.03 (m, 1H), 3.85–3.92 (m, 1H), 3.71–3.82 (m, 1H), 3.20 (dd, <i>J</i> = 3.90, 12.88 Hz, 1H), 2.83–2.93 (m, 1H), 2.62 (dd, <i>J</i> = 2.54, 12.68 Hz, 1H), 1.76–1.90 (m, 1H), 1.53–1.61 (m, 1H), 1.31 (d, <i>J</i> = 6.24 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 173.3, 160.8, 153.8, 149.6, 146.8, 146.1, 140.3, 127.9, 123.6, 115.0, 103.3, 78.6, 73.4, 60.0, 33.1, 30.7, 29.0, 21.6</div><div class="NLM_p last">The procedure above was repeated as follows: 10.6 g (1 equiv, 23.3 mmol) of <b>1</b> was dissolved in ethanol (0.1 M, 115 mL) at 65 °C. Once the material was dissolved, concentrated HCl (2 equiv, 3.9 mL, 12 M) was added. The slurry was stirred at room temperature for 2 h. The crystals were collected by vacuum filtration. A single crystal X-ray analysis of <b>64</b>·HCl was obtained (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf" class="ext-link">Figure S9</a>).</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Direct Amide Coupling in the Preparation of Compound <b>64</b></h4><div class="NLM_p"><i>Step 1.</i> To a suspension of 5-(difluoromethoxy)picolinic acid (1 g, 5.29 mmol) in dichloromethane (10 mL) was added oxalyl chloride (944 mg, 7.93 mmol) and a catalytic amount of dimethylformamide in room temperature. After the addition, the reaction was stirred at 30 °C for 2 h. The reaction was concentrated in vacuo. The residue was taken up in dry dichloromethane (10 mL), and ammonia gas was bubbled through at −20 °C for 5 min followed by stirring for 30 min at room temperature. The reaction mixture was diluted with water (20 mL) and extracted with dichloromethane (20 mL). The organic layer was concentrated in vacuo to give the desired product, which was triturated with 10 mL of diethyl ether to give product as a white solid (667 mg, 66.9%). LCMS <i>m</i>/<i>z</i> 189.0 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 5.77 (br. s., 1 H) 6.61 (t, <i>J</i> = 71.80 Hz, 1 H) 7.62 (dd, <i>J</i> = 8.53, 2.51 Hz, 1 H) 7.73 (br. s., 1 H) 8.25 (d, <i>J</i> = 8.53 Hz, 1 H) 8.43 (d, <i>J</i> = 2.51 Hz, 1 H).</div><div class="NLM_p last"><i>Step 2.</i> To a vial charged with tris(dibenzylideneacetone)dipalladium(0) (5.5 mg, 0.006 mmol), 2-(di-<i>tert</i>-butylphosphino)-2′,4′,6′-triisopropyl-3,6-dimethoxy-1,1′-biphenyl (8.2 mg, 0.017 mmol), and lithium <i>tert</i>-butoxide (22.3 mg, 0.278 mmol) was added 2-methyl-2-butanol (0.3 mL, degassed). The vial was purged with nitrogen and heated at 95 °C for 3 min. Compound <b>54</b>, <i>N</i>-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-8<i>a</i>-(4-bromothiazol-2-yl)-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (50 mg, 0.11 mmol), and 5-(difluoromethoxy)picolinamide (25 mg 0.133 mmol) in 2:1 mixture of 2-methyl-2-butanol and 1,4-dioxane (0.15 mL, degassed) was added and stirred at 95 °C for 1 h. Solvent was removed, and residue was purified via silica gel chromatography (heptane/EtOAc 0–50% gradient) to give product as a white solid (38 mg, 61%). LCMS <i>m</i>/<i>z</i> 560.0 [M + H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 1.30 (d, <i>J</i> = 6.24 Hz, 3 H), 1.68 (ddd, <i>J</i> = 13.46, 3.90, 2.15 Hz, 1 H), 1.83–2.00 (m, 1 H), 2.61 (dd, <i>J</i> = 13.27, 2.73 Hz, 1 H), 3.04 (dd, <i>J</i> = 12.49, 2.73 Hz, 1 H), 3.19 (dd, <i>J</i> = 13.07, 4.10 Hz, 1 H), 3.72–3.85 (m, 1 H), 3.91–4.03 (m, 2 H), 6.66 (t, <i>J</i> = 7.81, 1 H), 7.42–7.50 (m, 2 H), 7.50–7.57 (m, 1 H), 7.68 (dd, <i>J</i> = 8.59, 2.73 Hz, 1 H), 7.78 (s, 1 H), 8.12 (br. s., 2 H), 8.32 (d, <i>J</i> = 8.59 Hz, 1 H), 8.48 (d, <i>J</i> = 2.34 Hz, 1 H) 10.43 (s, 1 H).</div></div><div id="sec4_22_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-{2-[(4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-Amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl]-1,3-thiazol-4-yl}-5-(difluoromethoxy)-3-methylpyridine-2-carboxamide (<b>65</b>)</h4><div class="NLM_p"><i>Step 1.</i> A mixture of 3-methylpyridine-2-carbonitrile (128 g, 1.08 mol) and tetrabutylammonium nitrate (363 g, 1.19 mol) in <i>tert</i>-butyl methyl ether (1.3 L) was cooled to 4 °C. Trifluoroacetic anhydride (171 mL, 1.21 mol) was added, and the reaction mixture was allowed to stir at room temperature for 60 h. It was then adjusted to a pH of approximately 7 by the addition of 20% aqueous sodium hydroxide solution and extracted with dichloromethane (3 × 1 L). The combined organic layers were dried, filtered, and concentrated in vacuo; purification via silica gel chromatography (gradient, 0% to 10% ethyl acetate in petroleum ether) afforded 3-methyl-5-nitropyridine-2-carbonitrile as a yellow solid. Yield: 70 g, 0.43 mmol, 40%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.31–9.36 (m, 1H), 8.47–8.52 (m, 1H), 2.74 (s, 3H).</div><div class="NLM_p"><i>Step 2.</i> To a solution of 3-methyl-5-nitropyridine-2-carbonitrile (40.0 g, 245 mmol) in ethanol (630 mL) and water (70 mL) was added calcium chloride (13.6 g, 123 mmol), followed by iron powder (123 g, 2.20 mol), and the reaction mixture was stirred overnight at room temperature. After filtration of the reaction mixture, the filtrate was concentrated in vacuo, and the residue was purified by chromatography on silica gel (gradient, 10% to 50% ethyl acetate in petroleum ether). 5-Amino-3-methylpyridine-2-carbonitrile was obtained as a yellow solid. Yield: 20.0 g, 150 mmol, 61%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.94 (d, <i>J</i> = 2.5 Hz, 1H), 6.81 (d, <i>J</i> = 2.5 Hz, 1H), 4.07–4.19 (br s, 2H), 2.45 (s, 3H).</div><div class="NLM_p"><i>Step 3.</i> Sodium nitrite (1.6 M aqueous solution containing 10.3 g of sodium nitrite, 149 mmol) was slowly added to a 0 °C solution of 5-amino-3-methylpyridine-2-carbonitrile (18.0 g, 135 mmol) in water (243 mL) and concentrated sulfuric acid (67.5 mL). The reaction mixture was warmed to room temperature and then stirred at 100 °C for 3 h, whereupon it was cooled and extracted with ethyl acetate (3 × 75 mL). The combined organic layers were washed with water (2 × 75 mL) and with saturated aqueous sodium chloride solution (2 × 75 mL), dried, filtered, and concentrated under reduced pressure to afford 5-hydroxy-3-methylpyridine-2-carbonitrile as a yellow solid. Yield: 16 g, 120 mmol, 89%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.07 (br s, 1H), 8.08 (d, <i>J</i> = 2.6 Hz, 1H), 7.20 (d, <i>J</i> = 2.3 Hz, 1H), 2.40 (s, 3H).</div><div class="NLM_p"><i>Step 4.</i> A mixture of 5-hydroxy-3-methylpyridine-2-carbonitrile (5.70 g, 42.5 mmol), sodium chlorodifluoroacetate (13.0 g, 85.3 mmol), and potassium carbonate (17.6 g, 127 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (175 mL) was stirred for 30 min at 100 °C. The reaction mixture was then diluted with ethyl acetate (400 mL) and sequentially washed with saturated aqueous ammonium chloride solution (3 × 200 mL) and saturated aqueous sodium chloride solution (3 × 200 mL). The combined aqueous layers were extracted with ethyl acetate (200 mL), and the combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. Silica gel chromatography (gradient, 5% to 15% ethyl acetate in petroleum ether) provided 5-(difluoromethoxy)-3-methylpyridine-2-carbonitrile as a colorless oil. Yield: 3.9 g, 21 mmol, 49%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.39 (br d, <i>J</i> = 2.1 Hz, 1H), 7.43–7.47 (m, 1H), 6.64 (t, <i>J</i><sub>HF</sub> = 71.5 Hz, 1H), 2.59 (s, 3H).</div><div class="NLM_p"><i>Step 5.</i> Aqueous sodium hydroxide solution (1 M, 124 mL, 124 mmol) was added to a solution of 5-(difluoromethoxy)-3-methylpyridine-2-carbonitrile (7.60 g, 41.3 mmol) in ethanol (200 mL), and the reaction mixture was stirred for 16 h at 70 °C. It was then diluted with <i>tert</i>-butyl methyl ether (200 mL) and extracted with water (2 × 100 mL). The combined aqueous layers were washed with <i>tert</i>-butyl methyl ether (100 mL), acidified to pH 2 with 1 M aqueous hydrochloric acid, and extracted with <i>tert</i>-butyl methyl ether (2 × 200 mL). The combined organic extracts were dried over sodium sulfate, filtered, and concentrated in vacuo to afford 5-(difluoromethoxy)-3-methylpyridine-2-carboxylic acid as a white solid. Yield: 6.6 g, 32 mmol, 77%. LCMS <i>m</i>/<i>z</i> 203.7 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.32 (br d, <i>J</i> = 2.1 Hz, 1H), 7.58–7.62 (m, 1H), 7.06 (t, <i>J</i><sub>HF</sub> = 72.7 Hz, 1H), 2.64 (s, 3H).</div><div class="NLM_p"><i>Step 6.</i> A flask charged with tris(dibenzylideneacetone)dipalladium(0) (0.35g, 0.39 mmol), di-<i>tert</i>-butyl[2′,4′,6′-tri(propan-2-yl)biphenyl-2-yl]phosphane (0.49 g, 1.16 mmol), and sodium <i>tert</i>-butoxide (1.86 g,19.4 mmol) was purged twice with nitrogen. 1,4-Dioxane (15 mL) was added, and the reaction mixture was heated at 85 °C (internal reaction temperature) for 5 min, whereupon a solution of <b>72</b> (3.5 g, 7.74 mmol) and 1-(2,4-dimethoxyphenyl)methanamine (1.98 mL, 13.2 mmol) in 1,4-dioxane (14 mL) was concurrently added via syringe. After the addition had been completed, stirring was continued for 15 min at 85 °C (internal reaction temperature); the reaction mixture was then removed from the oil bath and quickly cooled to room temperature via immersion in a water bath. Diatomaceous earth and water (60 mL) were added, and the mixture was filtered through a pad of diatomaceous earth. The pad was washed with dichloromethane (3 × 30 mL). The organic layer of the combined filtrates was washed with water (3 × 30 mL) until the pH of the resulting aqueous layer was found to be neutral. The organic layer was then washed sequentially with an aqueous solution of citric acid (5%, 2 × 50 mL), saturated aqueous sodium bicarbonate solution (2 × 30 mL), and saturated aqueous sodium chloride solution (50 mL), dried over sodium sulfate, and filtered. The filtrate was adsorbed onto silica gel and chromatographed [gradient, 10% to 100% (5% triethylamine in ethyl acetate) in heptane]; the orange solid obtained from chromatography was triturated with diethyl ether (10 mL) to afford <i>N</i>-[(4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-8<i>a</i>-{4-[(2,4-dimethoxybenzyl)amino]-1,3-thiazol-2-yl}-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide as a white solid (1.78 g). The filtrate from the trituration was concentrated in vacuo, and the residue was triturated with diethyl ether (5 mL) to provide additional product as a brown solid (1.15 g). Combined yield: 2.93 g, 5.44 mmol, 70%. LCMS <i>m</i>/<i>z</i> 539.2 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.04–8.27 (br s, 2H), 7.39–7.58 (m, 3H), 7.20 (d, <i>J</i> = 8.3 Hz, 1H), 6.48 (d, half of AB quartet, <i>J</i> = 2.4 Hz, 1H), 6.44 (dd, half of ABX pattern, <i>J</i> = 8.3, 2.4 Hz, 1H), 5.74 (s, 1H), 4.21 (br s, 2H), 3.94 (br s, 2H), 3.84 (s, 3H), 3.81 (s, 3H), 3.7–3.8 (m, 1H), 3.23 (dd, <i>J</i> = 13, 4 Hz, 1H), 2.95–3.06 (m, 1H), 2.52–2.62 (m, 1H), 1.80–1.95 (m, 1H), 1.6–1.69 (m, 1H, assumed; partially obscured by water peak), 1.28 (d, <i>J</i> = 6.0 Hz, 3H).</div><div class="NLM_p"><i>Step 7.</i> 2,4,6-Tripropyl-1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxide (50% solution by weight in ethyl acetate, 8.84 mL, 14.8 mmol) was added to a mixture of 5-(difluoromethoxy)-3-methylpyridine-2-carboxylic acid (1.21 g, 5.96 mmol) and triethylamine (2.06 mL, 14.8 mmol) in ethyl acetate (8 mL), and the reaction mixture was heated at 65 °C for 20 min. Amine <b>37</b> (2.0 g, 3.71 mmol) was introduced, and stirring was continued at 65 °C for 1 h. The reaction mixture was then cooled to room temperature and diluted with ethyl acetate (10 mL); the resulting solution was washed sequentially with water (2 × 15 mL), saturated aqueous sodium bicarbonate solution (25 mL), and saturated aqueous sodium chloride solution (25 mL), dried over sodium sulfate, filtered, and concentrated under reduced pressure. The resulting solid was dissolved in dichloromethane (150 mL) and treated with trifluoroacetic acid (14 mL); the reaction mixture was allowed to stir at room temperature for 16 h, whereupon it was basified to pH 8 with saturated aqueous sodium bicarbonate solution (100 mL). The aqueous layer was extracted with dichloromethane (2 × 25 mL), and the combined organic layers were washed with saturated aqueous sodium chloride solution (100 mL), dried over sodium sulfate, filtered, and concentrated in vacuo. The residue was purified using chromatography on silica gel (gradient, 0% to 5% methanol in dichloromethane) to afford a solid (2.4 g), which was triturated with ethyl acetate (10 mL) to provide the product as a white solid (2.13 g). By <sup>1</sup>H NMR analysis, this material contained ethyl acetate. Yield, corrected for solvent: 1.93 g, 3.36 mmol, 91%. LCMS <i>m/</i>z 574.2 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.62 (s, 1H), 8.34 (br d, <i>J</i> = 2.6 Hz, 1H), 8.00–8.26 (v br s, 2H), 7.75 (s, 1H), 7.51–7.58 (m, 1H), 7.41–7.51 (m, 3H), 6.64 (t, <i>J</i><sub>HF</sub> = 72.1 Hz, 1H), 3.93–4.02 (m, 2H), 3.74–3.84 (m, 1H), 3.20 (br dd, <i>J</i> = 13, 4 Hz, 1H), 3.00–3.10 (m, 1H), 2.84 (s, 3H), 2.61 (br dd, <i>J</i> = 13, 2.6 Hz, 1H), 1.84–1.98 (m, 1H), 1.64–1.72 (m, 1H), 1.31 (d, <i>J</i> = 6.1 Hz, 3H).</div><div class="NLM_p last"><i>Step 8.</i> A solution of the above thioamide (2.10 g, 3.66 mmol) in xylenes (11 mL) was placed in a pressure tube and treated with SiliCycle, SiliaMetS diamine (7.0 g, 11.0 mmol); the tube was sealed and stirred at room temperature for 5 min before being placed in a 135 °C oil bath. After stirring for 16 h, the reaction mixture was cooled to room temperature over 20 min. Dichloromethane (5 mL) was added, and the mixture was filtered through diatomaceous earth, followed by rinsing of the filter pad with dichloromethane (3 × 10 mL). Concentration of the combined filtrates under reduced pressure provided a clear oil, which was seeded with a crystal of the product. The mixture immediately became heterogeneous, and the solid was collected via filtration, washed with toluene (2 × 5 mL), and stirred in diethyl ether (10 mL) for 30 min. Filtration and washing of the collected solid with cold diethyl ether (2 × 10 mL) afforded the product as a white solid (1.28 g). The combined filtrates were concentrated in vacuo, and the residue was filtered; the isolated solid was stirred with diethyl ether (5 mL) for 30 min, then filtered and washed with cold diethyl ether (2 × 10 mL). This provided additional product as an off-white solid (0.33 g). Combined yield: 1.61 g, 3.43 mmol, 94%. [α]<sub>D</sub><sup>22</sup> = −102.27 (<i>c</i> 0.555, CHCl<sub>3</sub>). LCMS <i>m</i>/<i>z</i> 470.5 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.57 (br s, 1H), 8.32 (br d, <i>J</i> = 2 Hz, 1H), 7.68 (s, 1H), 7.42 (br d, <i>J</i> = 2 Hz, 1H), 6.63 (t, <i>J</i><sub>HF</sub> = 72.2 Hz, 1H), 4.51–4.59 (br s, 2H), 3.91 (AB quartet, <i>J</i><sub>AB</sub> = 11.0 Hz, Δν<sub>AB</sub> = 32.5 Hz, 2H), 3.70–3.80 (m, 1H), 3.18 (dd, <i>J</i> = 12.5, 4.0 Hz, 1H), 2.84 (s, 3H), 2.80–2.88 (m, 1H), 2.59 (dd, <i>J</i> = 12.6, 2.8 Hz, 1H), 1.75–1.86 (m, 1H), 1.54 (ddd, <i>J</i> = 13, 4, 2 Hz, 1H), 1.29 (d, <i>J</i> = 6.2 Hz, 3H).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Crystalline Compound <b>65</b></h4><div class="NLM_p last">A sample of compound <b>65</b> (94.0 mg, 0.200 mmol) was mixed with propan-2-yl acetate (1.0 mL) and heated to 55 °C. The fine suspension was stirred at 55 to 60 °C for 2 h, then allowed to cool to room temperature and stir for 1 h. Filtration, followed by washing of the filter cake with propan-2-yl acetate, provided <b>65</b> as an off-white solid. This material was crystalline by powder X-ray diffraction analysis. Yield: 60 mg, 0.13 mmol, 64%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.81 (s, 1H), 8.42 (d, <i>J</i> = 2.2 Hz, 1H), 7.72 (d, <i>J</i> = 2 Hz, 1H), 7.62 (s, 1H), 7.44 (t, <i>J</i><sub>HF</sub> = 73.0 Hz, 1H), 6.25 (br s, 2H), 3.68 (s, 2H), 3.57–3.66 (m, 1H), 2.85–2.94 (m, 1H), 2.60–2.70 (m, 5H), 1.49–1.66 (m, 2H), 1.14 (d, <i>J</i> = 6.0 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 173.1, 162.3, 153.7, 148.9, 147.3, 143.2, 138.1, 137.3, 130.9, 115.0, 102.6, 78.7, 73.5, 60.0, 33.1, 30.7, 29.1, 21.6, 20.8</div></div><div id="sec4_23_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-{2-[(4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-Amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl]-1,3-thiazol-4-yl}-5-(difluoromethoxy)pyrazine-2-carboxamide (<b>67</b>)</h4><div class="NLM_p"><i>Step 1.</i> To a solution of methyl 5-hydroxypyrazine-2-carboxylate (9.25 g, 60.0 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (120 mL) were added potassium carbonate (24.8 g, 179 mmol) and sodium chloro(difluoro)acetate (18.3 g, 120 mmol). The mixture was heated to 100 °C for 15 min, whereupon it was filtered, and the filter cake was washed with ethyl acetate (2 × 50 mL). The combined filtrates were poured into saturated aqueous ammonium chloride solution (200 mL) and extracted with ethyl acetate (3 × 200 mL); the combined organic layers were washed sequentially with saturated aqueous sodium bicarbonate solution (2 × 300 mL) and with saturated aqueous sodium chloride solution (2 × 300 mL), dried, filtered, and concentrated in vacuo. Chromatography on silica gel (gradient, 0% to 15% ethyl acetate in petroleum ether) afforded methyl 5-(difluoromethoxy)pyrazine-2-carboxylate as a yellow solid. Yield: 1.7 g, 8.3 mmol, 14%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.92 (d, <i>J</i> = 1.2 Hz, 1H), 8.47 (d, <i>J</i> = 1.2 Hz, 1H), 7.49 (t, <i>J</i><sub>HF</sub> = 71.3 Hz, 1H), 4.04 (s, 3H).</div><div class="NLM_p"><i>Step 2.</i> Aqueous sodium hydroxide solution (5 M, 4.10 mL, 20.5 mmol) was added to a solution of methyl 5-(difluoromethoxy)pyrazine-2-carboxylate (2.10 g, 10.3 mmol) in tetrahydrofuran (25 mL) and water (12 mL). The reaction mixture was stirred at room temperature for 5 min, whereupon it was treated with aqueous hydrochloric acid (2 M, 11 mL). The mixture was extracted with ethyl acetate (2 × 150 mL), and the combined organic layers were washed with saturated aqueous sodium chloride solution (2 × 100 mL), dried, filtered, and concentrated under reduced pressure to provide 5-(difluoromethoxy)pyrazine-2-carboxylic acid as a yellow solid. Yield: 1.8 g, 9.5 mmol, 92%. LCMS <i>m</i>/<i>z</i> 189.0 [M – H<sup>+</sup>]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.05 (d, <i>J</i> = 1.3 Hz, 1H), 8.43 (d, <i>J</i> = 1.4 Hz, 1H), 7.52 (t, <i>J</i><sub>HF</sub> = 71.0 Hz, 1H).</div><div class="NLM_p"><i>Step 3.</i> Amine <b>72</b> (5.0 g, 13.0 mmol, 1 equiv), 5-(difluoromethoxy)pyrazine-2-carboxylic acid (2.52 g, 13.3 mmol, 1.03 equiv), and ethyl acetate (25.7 mL, 0.5 M) were added to a round-bottom flask. To this solution was added triethylamine (7.16 mL, 51.5 mmol, 4 equiv). This solution was cooled to 0 °C followed by the slow addition of 50% T<sub>3</sub>P in DMF (18.8 mL, 32.2 mmol, 2.5 equiv). After 5 min, the reaction was warmed to rt and stirred for 1 h. The reaction was then diluted with DCM and quenched with 1 N HCl. The layers were stirred and separated. The organic layer was then washed with sat. aqueous bicarbonate, and the aqueous layer was back extracted with DCM (3×). The combined organic layers were concentrated to 1/4 the volume, then diluted with isopropyl alcohol. The solution was heated to 80 °C to get precipitate back into solution. The solution was then cooled to 0 °C and stirred for 30 min. The mixture was filtered and washed with cold isopropyl alcohol. <i>N</i>-{2-[(4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-(Benzoylamino)-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl]-1,3-thiazol-4-yl}-5-(difluoromethoxy)-pyrazine-2-carboxamide was isolated as a solid. Yield: 3.8 g, 8.45 mmol, 65%. LCMS <i>m</i>/<i>z</i> 561.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.12 (s, 1H), 9.06 (d, <i>J</i> = 1.37 Hz, 1H), 8.35 (d, <i>J</i> = 1.17 Hz, 1H), 7.99–8.20 (m, 2H), 7.77 (s, 1H), 7.31–7.71 (m, 4H), 3.89–4.02 (m, 2H), 3.70–3.81 (m, 1H), 3.16 (dd, <i>J</i> = 3.72, 12.91 Hz, 1H), 2.93–3.05 (m, 1H), 2.60 (dd, <i>J</i> = 2.64, 13.01 Hz, 1H), 1.82–1.96 (m, 1H), 1.62–1.71 (m, 1H), 1.29 (d, <i>J</i> = 6.06 Hz, 3H).</div><div class="NLM_p last"><i>Step 4.</i> Pyridine (0.96 mL, 12 mmol) and methoxylamine hydrochloride (96.9 mg, 1.16 mmol) were added to a solution of <i>N</i>-{2-[(4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-(benzoylamino)-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl]-1,3-thiazol-4-yl}-5-(difluoromethoxy)pyrazine-2-carboxamide (65 mg, 0.12 mmol) in ethanol (1.2 mL). The reaction mixture was stirred at 50 °C for 5 h, whereupon it was cooled to room temperature and concentrated in vacuo. The residue was diluted with dichloromethane and washed sequentially with aqueous sodium bicarbonate solution (3 times), with water, and with saturated aqueous sodium chloride solution. After being dried over sodium sulfate and filtered, the solution was concentrated under reduced pressure and purified via silica gel chromatography (gradient, 0% to 4% methanol in dichloromethane) to provide the product as a solid. Yield: 41 mg, 90 μmol, 75%. LCMS <i>m</i>/<i>z</i> 457.1 [M + H]<sup>+</sup>. [α]<sub>D</sub><sup>20</sup> = −55.5 (<i>c</i> 0.765, CH<sub>2</sub>Cl<sub>2</sub>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.09 (br s, 1H), 9.06 (d, <i>J</i> = 1.3 Hz, 1H), 8.34 (d, <i>J</i> = 1.3 Hz, 1H), 7.71 (s, 1H), 7.51 (t, <i>J</i><sub>HF</sub> = 71.4 Hz, 1H), 3.89 (AB quartet, <i>J</i><sub>AB</sub> = 11.1 Hz, Δν<sub>AB</sub> = 4 0.8 Hz, 2H), 3.73 (dqd, <i>J</i> = 11.2, 6.1, 2.2 Hz, 1H), 3.16 (dd, <i>J</i> = 12.5, 4.0 Hz, 1H), 2.77–2.84 (m, 1H), 2.58 (dd, <i>J</i> = 12.5, 2.8 Hz, 1H), 1.80 (ddd, <i>J</i> = 13.1, 12.9, 11.4 Hz, 1H), 1.53 (ddd, <i>J</i> = 13.4, 4.2, 2.3 Hz, 1H), 1.28 (d, <i>J</i> = 6.1 Hz, 3H). <sup>13</sup>C NMR (151 MHz, CD<sub>3</sub>OD) δ 168.8, 160.9, 147.7, 141.25, 141.19, 140.4, 133.5, 114.3, 103.9, 100.0, 74.5, 73.4, 59.8, 33.6, 31.9, 28.1, 20.2.</div></div><div id="sec4_23_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-{2-[(4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-Amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl]-1,3-thiazol-4-yl}amides via <i>N</i>-Acylation of <b>37</b> Followed by Selective Hydrolysis</h4><div class="NLM_p"><i>Method A.</i> A solution of <b>72</b> (25.2 mg, 64.9 μmol) in ethyl acetate (0.5 mL) was added to the appropriate carboxylic acid (78 μmol). 2,4,6-Tripropyl-1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxide (50% weight solution in ethyl acetate, 0.26 mL, 0.13 mmol) and pyridine (21 μL, 0.26 mmol) were added, and the reaction mixture was shaken at room temperature for 16 h. It was then partitioned between water (1.5 mL) and ethyl acetate (2.4 mL) with vortexing. The organic layer was passed through a solid-phase extraction cartridge (6 mL) charged with sodium sulfate (∼1 g); this extraction procedure was repeated twice. The combined eluents were concentrated in vacuo, dissolved in ethanol (0.75 mL), treated with hydrazine monohydrate (51 μL, 1.0 mmol) and shaken at room temperature for 6 h. After removal of solvent in vacuo, the product was purified via reversed phase HPLC using one of the following methods: (1) column, Waters XBridge C18, 5 μm; mobile phase A, 0.03% ammonium hydroxide in water (v/v); mobile phase B, 0.03% ammonium hydroxide in acetonitrile (v/v); gradient: [5% or 10%] to 100% B. (2) Column, Waters Sunfire C18, 5 μm; mobile phase A, 0.05% trifluoroacetic acid in water (v/v); mobile phase B, 0.05% trifluoroacetic acid in acetonitrile (v/v); gradient, 5% to 100% B.</div><div class="NLM_p last"><i>Method B</i>. A solution of <b>72</b> (46.6 mg, 0.120 mmol) in ethyl acetate (1.5 mL) was added to the appropriate carboxylic acid (0.12 mmol), and the mixture was cooled in a dry ice box. Triethylamine (70 μL, 0.50 mmol) and 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxide (50% weight solution in ethyl acetate, 0.14 mL, 0.24 mmol) were added, and the reaction mixture was allowed to warm to ambient temperature, then shaken at room temperature for 3 to 6 h. It was then partitioned between half-saturated aqueous sodium bicarbonate solution (1.5 mL) and ethyl acetate (2.4 mL) with vortexing. The organic layer was passed through a solid-phase extraction cartridge (6 mL) charged with sodium sulfate (∼1 g); this extraction procedure was repeated twice. The combined eluents were concentrated in vacuo, dissolved in ethanol (0.5 mL), treated with a solution of methylamine in ethanol (33% by weight, 0.5 mL, 4 mmol), and shaken at room temperature for 3 h. After removal of solvent in vacuo, the product was purified via reversed phase HPLC (column, Waters XBridge C18, 5 μm; mobile phase A, 0.03% ammonium hydroxide in water (v/v); mobile phase B, 0.03% ammonium hydroxide in acetonitrile (v/v); gradient, 5% to [40% or 100%] B).</div></div><div id="sec4_23_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-Amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl)-<i>N</i>-(3-methoxyphenyl)thiazole-5-carboxamide (<b>70</b>)</h4><div class="NLM_p"><i>Step 1.</i> To a stirring mixture of 2-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-benzamido-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl)thiazole-5-carboxylic acid (92 mg, 0.22 mmol) and <i>m</i>-anisidine (137 mg, 1.11 mmol) in ethyl acetate (4 mL) was added trimethylamine (0.135 mL, 0.969 mmol) followed by T<sub>3</sub>P (0.285 mL, 0.479 mmol, 50 wt % solution in ethyl acetate). The resulting solution was stirred cold for 0.5 h then allowed to warm to rt overnight as the cooling bath expired. The reaction was diluted with saturated aqueous sodium bicarbonate solution (7.5 mL) and extracted with ethyl acetate (3 × 10 mL). The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to give a crude residue. Purification via flash column chromatography (silica gel; gradient, 0 to 100% ethyl acetate in heptanes) afforded 2-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-benzamido-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl)-<i>N</i>-(3-methoxyphenyl)thiazole-5-carboxamide (98 mg, 85% yield) as a solid. LCMS <i>m</i>/<i>z</i> 523.3 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.29 (s, 1H), 8.05 (br s., 2H), 7.61 (s, 1H), 7.55–7.60 (m, <i>J</i> = 7.20, 7.20 Hz, 1H), 7.46–7.52 (m, <i>J</i> = 7.50, 7.50 Hz, 2H), 7.32 (t, <i>J</i> = 2.25 Hz, 1H), 7.22–7.26 (m, 1H), 7.06 (dd, <i>J</i> = 1.96, 8.02 Hz, 1H), 6.72 (dd, <i>J</i> = 2.45, 8.31 Hz, 1H), 3.97–4.02 (m, 1H), 3.90–3.96 (m, 1H), 3.81 (s, 3H), 3.78 (ddd, <i>J</i> = 1.96, 6.21, 11.20 Hz, 1H), 3.10–3.16 (m, 1H), 3.04–3.10 (m, 1H), 2.63 (dd, <i>J</i> = 2.35, 12.91 Hz, 1H), 1.82–1.94 (m, 1H), 1.65–1.71 (m, 1H), 1.30 (d, <i>J</i> = 0.26 Hz, 3H).</div><div class="NLM_p last"><i>Step 2.</i> Methylamine (2 mL, 16 mmol, 33 wt % solution in ethanol) was added to a stirring solution of the above thioamide (94 mg, 0.18 mmol) in absolute ethanol (1.5 mL). The reaction was stirred at room temperature for 3.5 h, concentrated in vacuo, and purified via flash column chromatography (silica gel; gradient, 30 → 100% ethyl acetate in heptanes) to afford 2-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl)-<i>N</i>-(3-methoxyphenyl)thiazole-5-carboxamide (<b>70</b>) (71 mg, 94% yield) as a solid. LCMS <i>m</i>/<i>z</i> 419.4 [M + H]<sup>+</sup>. [α]<sub>D</sub><sup>22</sup> = +36.1 (<i>c</i> 0.63, CH<sub>3</sub>OH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.25 (s, 1H), 7.58 (s, 1H), 7.32 (t, <i>J</i> = 2.2, 2.2 Hz, 1H), 7.23 (t, <i>J</i> = 8.2, 8.2 Hz, 1H), 7.03 (ddd, <i>J</i> = 0.8, 2.0, 8.0 Hz, 1H), 6.70 (ddd, <i>J</i> = 0.8, 2.5, 8.3 Hz, 1H), 4.71 (br s, 2H), 3.95 (d, <i>J</i> = 11.0 Hz, 1H), 3.85 (d, <i>J</i> = 11.0 Hz, 1H), 3.81 (s, 3H), 3.73 (dqd, <i>J</i> = 2.1, 6.0, 6.1, 6.1, 12.2 Hz, 1H), 3.13 (dd, <i>J</i> = 4.0, 12.6 Hz, 1H), 2.89 (ddq, <i>J</i> = 2.0, 2.0, 2.9, 4.0, 11.0 Hz, 1H), 2.61 (dd, <i>J</i> = 2.8, 12.6 Hz, 1H), 1.80 (td, <i>J</i> = 11.4, 12.9, 13.0 Hz, 1H), 1.55 (ddd, <i>J</i> = 2.4, 4.2, 13.4 Hz, 1H), 1.28 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_23_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-amino-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl)-<i>N</i>-(6-methoxypyridin-2-yl)thiazole-5-carboxamide (<b>71</b>)</h4><div class="NLM_p"><i>Step 1.</i> Sodium hydroxide (35 mL, 1 M) was added to a suspension of compound <b>54</b> (3.02 g, 6.68 mmol) and zinc dust (2400 mg) in THF (35 mL). The mixture was stirred at 40 °C for 16 h, then at 50 °C for 2.5 h prior to allowing the mixture to cool back to room temperature. The suspension was filtered over Celite. The Celite was washed with THF. The combined filtrates were washed with brine (50 mL) and separated. The aqueous phase was extracted with ethyl acetate (2 × 50 mL). The pooled organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to a colorless foam that was purified by flash column chromatography [gradient, 0 to 100% ethyl acetate in heptane] to afford the title compound as a white solid (2.15 g, 5.76 mmol, 86%). LCMS <i>m</i>/<i>z</i> 374.4 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.00–8.40 (br m, 2 H) 7.85 (d, <i>J</i> = 3.12 Hz, 1H) 7.44–7.62 (m, 3H) 7.35 (d, <i>J</i> = 2.73 Hz, 1H) 3.99 (br. s., 2H) 3.74–3.91 (m, 1H) 3.09–3.21 (m, 2H) 2.63 (d, <i>J</i> = 11.32 Hz, 1H) 1.86–2.00 (m, 1H) 1.69 (d, <i>J</i> = 13.27 Hz, 1H) 1.32 (d, <i>J</i> = 5.85 Hz, 3H).</div><div class="NLM_p"><i>Step 2.</i><i>n</i>-Butyllithium (394 μL, 2.5 M in hexanes) was added dropwise to a preargon-sparged solution of <i>N</i>-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-6-methyl-8<i>a</i>-(thiazol-2-yl)-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide (153 mg, 0.41 mmol) in tetrahydrofuran (10 mL) at −78 °C. The mixture was stirred cold for 1 h prior to bubbling carbon dioxide through the mixture for 10 min. After stirring this mixture at −78 °C for 1 h, argon was bubbled through the mixture for 5 min. Sodium hydroxide was added (20 mL, 0.25 M), and the mixture was removed from the dry ice bath and allowed to warm to near room temperature. The mixture was extracted with dichloromethane (2 × 15 mL). The aqueous phase was brought to an approximate pH of 2 by the addition of 1 M hydrochloric acid and extracted with ethyl actetate (3 × 25 mL). The pooled ethyl acetate layers were dried over sodium sulfate, filtered, and concentrated in vacuo to afford the title compound as a yellow-white solid (162 mg, 0.39 mmol, 95%). LCMS <i>m</i>/<i>z</i> 418.1 (M + H). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.39 (s, 1H) 8.06 (d, <i>J</i> = 7.41 Hz, 2H) 7.58–7.67 (m, 1H) 7.49–7.55 (m, 2H) 3.94–4.08 (m, 2H) 3.75–3.89 (m, 1H) 2.99–3.14 (m, 2H) 2.75 (d, <i>J</i> = 10.54 Hz, 1H) 1.73–1.83 (m, 2H) 1.29 (d, <i>J</i> = 6.24 Hz, 3H).</div><div class="NLM_p"><i>Step 3.</i><i>O</i>-(2-Oxo-1(2<i>H</i>)pyridyl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate (29 mg) was added to a mixture of 2-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-benzamido-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl)thiazole-5-carboxylic acid (41 mg, 0.098 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (34 μL) in DMF (2.5 mL). The mixture was stirred at RT for 45 min prior to the addition of 6-methoxypyridin-2-amine (48.7 mg in 0.3 mL of DMF). The mixture was stirred at rt for 1 h, then stirred at 45 °C for 16 h prior to the addition of more 6-methoxypyridin-2-amine (35 μL). This mixture was stirred at 45 °C for another 7 h prior to allowing to the solution to cool back to near room temperature. The mixture was diluted with saturated aqueous sodium bicarbonate (25 mL) and extracted with ethyl acetate (3 × 35 mL). The pooled ethyl acetate layers were dried over sodium sulfate, filtered, and concentrated in vacuo to an amber oil that was purified by flash column chromatography (gradient, 0 to 100% ethyl acetate in heptane) to afford the title compound as a white solid (23.6 mg, 0.045 mmol, 46%). LCMS <i>m</i>/<i>z</i> 524.1 (M + H). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.36 (s, 1H) 7.96–8.20 (br. m., 3H) 7.81 (d, <i>J</i> = 7.81 Hz, 1H) 7.65 (t, <i>J</i> = 8.00 Hz, 1H) 7.60 (d, <i>J</i> = 6.24 Hz, 1H) 7.49–7.56 (m, 2H) 6.57 (d, <i>J</i> = 8.20 Hz, 1H) 3.94–4.07 (m, 2H) 3.91 (s, 3H) 3.76–3.86 (m, 1H) 3.05–3.21 (m, 2H) 2.67 (d, <i>J</i> = 12.10 Hz, 1H) 1.83–1.98 (m, 1H) 1.72 (d, <i>J</i> = 14.05 Hz, 1H) 1.33 (d, <i>J</i> = 6.24 Hz, 3H).</div><div class="NLM_p last"><i>Step 4.</i> Methylamine (0.5 mL, 33% in ethanol) was added to a solution of 2-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-2-benzamido-6-methyl-4,4<i>a</i>,5,6-tetrahydropyrano[3,4-<i>d</i>][1,3]thiazin-8<i>a</i>(8<i>H</i>)-yl)-<i>N</i>-(6-methoxypyridin-2-yl)thiazole-5-carboxamide (23.5 mg, 0.045 mmol) in ethanol (0.5 mL) and stirred at room temperature. After stirring for 16 h, the mixture was concentrated in vacuo to a colorless oil that was purified by flash column chromatography (gradient: 25–100% ethyl acetate in heptane) to afford the title compound <b>71</b> as a white solid (14 mg, 0.033 mmol, 74%). LCMS <i>m</i>/<i>z</i> 420.1 (M + H). [α]<sub>D</sub><sup>22</sup> = +18.0 (<i>c</i> 0.76, MeOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.30 (s, 1H) 8.02 (br. s., 1H) 7.78 (d, <i>J</i> = 7.83 Hz, 1H) 7.62 (t, <i>J</i> = 7.92 Hz, 1H) 6.53 (d, <i>J</i> = 8.41 Hz, 1H) 3.96–4.03 (m, 1H) 3.84–3.90 (m, 4H) 3.69–3.78 (m, 1H) 3.14 (d, <i>J</i> = 12.62 Hz, 1H) 2.94 (d, <i>J</i> = 12.91 Hz, 1H) 2.64 (d, <i>J</i> = 12.91 Hz, 1H) 1.73–1.88 (m, 1H) 1.54–1.62 (m, 1H) 1.29 (d, <i>J</i> = 6.16 Hz, 3H).</div></div><div id="sec4_23_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-[(4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-8<i>a</i>-(4-Amino-1,3-thiazol-2-yl)-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (<b>72</b>)</h4><div class="NLM_p"><i>Step 1.</i> 2,4-Dibromo-1,3-thiazole (44.7 g, 184 mmol) was dissolved in a mixture of toluene and tetrahydrofuran (10:1, 900 mL) and cooled to −78 °C. To this solution was added boron trifluoride diethyl etherate (21.9 mL, 177 mmol), followed by dropwise addition of <i>n</i>-butyllithium (2.5 M solution in hexanes, 68.0 mL, 170 mmol), and the reaction mixture was stirred for 30 min. A solution of <b>15</b> (20 g, 140 mmol) in a mixture of toluene and tetrahydrofuran (10:1, 22 mL) was then added dropwise; the reaction temperature was maintained below −72 °C during the course of both additions. Stirring was continued for 1 h at −78 °C, whereupon the reaction was quenched via the addition of saturated aqueous ammonium chloride solution. The aqueous layer was extracted three times with ethyl acetate, and the combined organic layers were washed with water and with saturated aqueous sodium chloride solution, dried over sodium sulfate, filtered, and concentrated in vacuo. Silica gel chromatography (gradient, 0% to 100% ethyl acetate in heptane) afforded the product <b>51</b> as a tacky amber oil. Yield: 36.34 g, 119.1 mmol, 85%. LCMS <i>m</i>/<i>z</i> 305.0, 307.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.22 (s, 1H), 3.97 (AB quartet, upfield doublet is broadened, <i>J</i><sub>AB</sub> = 12.6 Hz, Δν<sub>AB</sub> = 13.4 Hz, 2H), 3.67–3.76 (m, 3H), 3.38 (br ddd, <i>J</i> = 11.8, 6.9, 4.6 Hz, 1H), 1.90 (ddd, <i>J</i> = 14.1, 6.9, 2.1 Hz, 1H), 1.42 (ddd, <i>J</i> = 14.1, 11.7, 11.7 Hz, 1H), 1.27 (d, <i>J</i> = 6.2 Hz, 3H).</div><div class="NLM_p"><i>Step 2.</i> Molybdenum hexacarbonyl (98%, 6.67 g, 24.8 mmol) was added to a solution of <b>51</b> (15.12 g, 49.54 mmol) in a mixture of acetonitrile (390 mL) and water (20 mL), and the reaction mixture was heated at reflux for 1 h. After cooling to room temperature, the reaction mixture was chilled in an ice bath, treated portionwise with sodium borohydride (7.50 g, 198 mmol), and allowed to stir at 0 °C for 1 h. The mixture was then filtered through a pad of diatomaceous earth, and the pad was washed three times with dichloromethane; the organic portion of the combined filtrate was washed with saturated aqueous sodium chloride solution, dried over sodium sulfate, filtered, and concentrated in vacuo. Methanol was added to the residue then removed via concentration under reduced pressure. This methanol treatment was repeated, and the resulting residue was dissolved in dichloromethane, washed twice with 1 M aqueous sodium hydroxide solution, washed once with saturated aqueous sodium chloride solution, and concentrated in vacuo, affording the product as a brown solid. Yield: 14.48 g, 47.13 mmol, 95%. LCMS <i>m</i>/<i>z</i> 307.0, 309.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.22 (s, 1H), 3.79 (d, half of AB quartet, <i>J</i> =11.5 Hz, 1H), 3.64–3.75 (m, 3H), 3.54 (dd, half of ABX pattern, <i>J</i> = 11.5, 4.1 Hz, 1H), 2.46–2.54 (m, 1H), 1.82–1.94 (m, 1H), 1.67–1.74 (m, 1H), 1.32 (d, <i>J</i> = 6.2 Hz, 3H).</div><div class="NLM_p"><i>Step 3.</i> Benzoyl isothiocyanate (6.92 g, 42.4 mmol) was added in a dropwise manner to a solution of <b>52</b> (14.48 g, 47.13 mmol) in dichloromethane (420 mL), and the reaction mixture was stirred at room temperature for 24 h. Volatiles were removed in vacuo, and the residue was purified via silica gel chromatography (gradient, 0% to 50% ethyl acetate in heptane), providing the product as a yellow solid. Yield: 14.7 g, 31.2 mmol, 66%. LCMS <i>m</i>/<i>z</i> 472.1 [M+H+]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.70 (br s, 1H), 8.93 (br s, 1H), 7.86–7.90 (m, 2H), 7.62–7.67 (m, 1H), 7.51–7.56 (m, 2H), 7.25 (s, 1H), 5.47 (d, <i>J</i> = 11.9 Hz, 1H), 3.91 (d, <i>J</i> = 12.0 Hz, 1H), 3.83 (d, <i>J</i> = 4.4 Hz, 2H), 3.74–3.81 (m, 1H), 2.44–2.52 (m, 1H), 1.80–1.87 (m, 2H), 1.33 (d, <i>J</i> = 6.2 Hz, 3H).</div><div class="NLM_p"><i>Step 4.</i> 1-Chloro-<i>N</i>,<i>N</i>,2-trimethylprop-1-en-1-amine (Ghosez’s reagent, 7.85 mL, 59.3 mmol) was added dropwise to a solution of <b>53</b> (9.30 g, 19.8 mmol) in dichloromethane (200 mL). After 1 h at room temperature, the reaction mixture was partitioned between dichloromethane and saturated aqueous sodium bicarbonate solution. The organic layer was washed with saturated aqueous sodium chloride solution, dried over sodium sulfate, filtered, and concentrated in vacuo. Silica gel chromatography (gradient, 0% to 100% ethyl acetate in heptane) provided the product as a solid. Yield: 6.90 g, 15.2 mmol, 77%. LCMS <i>m</i>/<i>z</i> 452.1, 454.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 13.69 (br s, 1H), 8.38–8.43 (m, 2H), 7.64–7.70 (m, 1H), 7.54–7.60 (m, 2H), 7.34 (s, 1H), 4.45 (d, <i>J</i> = 12.5 Hz, 1H), 3.93 (d, <i>J</i> = 12.5 Hz, 1H), 3.74–3.83 (m, 1H), 3.28–3.36 (m, 1H), 3.23 (dd, <i>J</i> = 13.5, 4.0 Hz, 1H), 2.77 (dd, <i>J</i> = 13.5, 2.8 Hz, 1H), 1.66–1.82 (m, 2H), 1.32 (d, <i>J</i> = 6.2 Hz, 3H).</div><div class="NLM_p"><i>Step 5.</i> Sodium <i>tert</i>-butoxide (19.6 g, 204 mmol), tris(dibenzylideneacetone)dipalladium(0) (3.74 g, 4.09 mmol), and di-<i>tert</i>-butyl[2′,4′,6′-tri(propan-2-yl)biphenyl-2-yl]phosphane (5.21 g, 12.3 mmol) were dissolved in degassed 1,4-dioxane (175 mL), and the reaction flask was purged with nitrogen and placed in an oil bath heated to 95 °C. Once the internal temperature reached 90 °C, a solution of 1-(2,4-dimethoxyphenyl)methanamine (20.9 mL, 139 mmol) and <b>54</b> (37.0 g, 81.8 mmol) in 1,4-dioxane (200 mL) was added over 1.5 min, and the reaction mixture was allowed to heat in a 95 °C oil bath for 13 min. The reaction vessel was then placed in an ice water bath to rapidly cool to 25 °C, and the reaction was filtered through Celite. The filter cake was washed with dichloromethane (500 mL), and the filtrate was concentrated in vacuo. The residue was diluted with dichloromethane (300 mL), and the solution cooled to 8 °C in an ice bath. Methanesulfonic acid (64 mL, 980 mmol) was added dropwise at such a rate to ensure the internal reaction temperature did not exceed 21 °C. After addition of the methanesulfonic acid, the reaction was stirred at 21 °C for 25 min. The reaction was then washed with aqueous hydrochloric acid (3 × 250 mL, 1 N). The combined aqueous was filtered through Celite, and the filter cake was washed with water (2 × 250 mL). The filtrate was cooled to 12 °C in an ice bath, and a mixture of 150 g ice in aqueous sodium hydroxide (360 mL, 5 N) was added with stirring at such a rate to prevent the internal reaction temperature from exceeding 21 °C (final pH = 10). The now heterogeneous aqueous mixture was saturated with solid sodium chloride, and the aqueous was washed with dichloromethane (4 × 400 mL). The combined organics were washed with aqueous citric acid (500 mL, 5% citric acid in water [w/v]) and brine (200 mL), then dried over anhydrous magnesium sulfate, filtered, and concentrated to provide title compound containing 16% residual solvent. Yield: 27.1 g, 69.6 mmol, 85.1% (69.6% yield corrected for residual solvent). LCMS <i>m</i>/<i>z</i> 389.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10–8.19 (br m, 2H), 7.49–7.55 (m, 1H), 7.42–7.48 (m, 2H), 5.94 (s, 1H), 3.95 (AB quartet, <i>J</i><sub>AB</sub> = 12.1 Hz, Δν<sub>AB</sub> = 6.2 Hz, 2H), 3.77 (dqd, <i>J</i> = 11.2, 6.1, 2.3 Hz, 1H), 3.22 (dd, <i>J</i> = 12.9, 4.1 Hz, 1H), 2.97–3.05 (m, 1H), 2.59 (dd, <i>J</i> = 12.9, 2.8 Hz, 1H), 1.83–1.95 (m, 1H), 1.65 (ddd, <i>J</i> = 13.7, 4.3, 2.4 Hz, 1H), 1.29 (d, <i>J</i> = 6.2 Hz, 3H).</div><div class="NLM_p last"><i>Alternative Step 5.</i> To an ethanol solution (35.0 mL, absolute) of <i>N</i>-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-8<i>a</i>-(4-bromothiazol-2-yl)-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide <b>54</b> (0.44 g, 0.97 mmol) was added <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine (0.17g, 1.20 mmol), followed by sodium azide (0.600g, 9.22 mmol) and a water solution (10.0 mL) of (+)-sodium-<span class="smallcaps smallerCapital">l</span>-ascorbate (0.092g, 0.46 mmol) The resulting solution was purged with nitrogen and vacuum (3×). Then the reaction mixture was stirred under nitrogen at rt for 15 min. Copper(I) iodide (0.087g, 0.46 mmol) was then added, and the resulting solution was heated to 70 °C with a nitrogen inlet for 2 h. The reaction mixture was then concentrated under reduced pressure and partitioned between ethyl acetate (50 mL) and hydrogen chloride (1 N, 2 aq., 100 mL). The resulting organic layer was separated, and the aqueous layer was again washed with ethyl acetate (1 × 50 mL). The aqueous layer was then basified to pH 9 with aq. sodium bicarbonate (250 mL). Organics were extracted with dichloromethane (3 × 100 mL), washed with brine (1 × 250 mL), dried over sodium sulfate, filtered, and concentrated under reduced pressure to yield <i>N</i>-((4<i>aR</i>,6<i>S</i>,8<i>aR</i>)-8<i>a</i>-(4-aminothiazol-2-yl)-6-methyl-4,4<i>a</i>,5,6,8,8<i>a</i>-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl)benzamide as an orange solid (0.177 g, 47% yield).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00246" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86422" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86422" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00246" class="ext-link">10.1021/acs.jmedchem.8b00246</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Effect of compound <b>64</b> on brain Aβ following 5 days of subchronic dosing; BACE2 inhibition causes accumulation of full length PMEL in primary human melanocytes; BACE1 and BACE2 binding curves; time course of fur regrowth in control C57Blk mice following depilation with Nair; dose response effect of <b>3</b> and <b>4</b> on pigmentation in C57Blk mice at 3 weeks post-depilation; projected <i>C</i><sub>avg</sub> concentration in mouse studies; mouse skin epithelial transmission electron microscopic images; 3D skin model delta L quantification for <b>61</b> and <b>65</b>; single crystal X-ray analysis of <b>64</b>-HCl (CCDC 1829109); representative <sup>1</sup>H NMR (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf">jm8b00246_si_001.pdf (4.4 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_002.csv">jm8b00246_si_002.csv (1.64 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00246" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Brodney</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7592-4097" title="Orcid link">http://orcid.org/0000-0001-7592-4097</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#caa7a3a9a2abafa6e4abe4a8b8a5aea4afb38aa2a5bea7aba3a6e4a9a5a7"><span class="__cf_email__" data-cfemail="86ebefe5eee7e3eaa8e7a8e4f4e9e2e8e3ffc6eee9f2ebe7efeaa8e5e9eb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian
T. O’Neill</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1928-4803" title="Orcid link">http://orcid.org/0000-0002-1928-4803</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth M. Beck</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher R. Butler</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9387-5011" title="Orcid link">http://orcid.org/0000-0002-9387-5011</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles E. Nolan</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cathleen Gonzales</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Zhang</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8118-1402" title="Orcid link">http://orcid.org/0000-0001-8118-1402</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shawn D. Doran</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly Lapham</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leanne M. Buzon</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason K. Dutra</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriela Barreiro</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinjun Hou</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luis A. Martinez-Alsina</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce N. Rogers</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anabella Villalobos</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John C. Murray</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Ogilvie</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erik A. LaChapelle</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Medicinal Chemistry, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Chang</span> - <span class="hlFld-Affiliation affiliation">Medicine
Design, Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lorraine F. Lanyon</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Primary Pharmacology, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire M. Steppan</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Primary Pharmacology, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ashley Robshaw</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katherine Hales</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Germaine G. Boucher</span> - <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karamjeet Pandher</span> - <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Houle</span> - <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claude W. Ambroise</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Karanian</span> - <span class="hlFld-Affiliation affiliation">Drug
Safety Research and Development, Pfizer
Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Riddell</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly R. Bales</span> - <span class="hlFld-Affiliation affiliation">Internal
Medicine, Pfizer Inc., Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d221e8046-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75121" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75121" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to thank Leslie Pustilnik, Stephen Noell, Shawn Hallowell, Carol Menard, and Eric Benvenuti for screening support, along with Katherine McGrath, Theresa Dickinson, and Tracy Brown Phillips for reagent production. Peter Mikochik contributed experiments for the optimization of the Buchwald coupling of bromide <b>54</b>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-secretase</p></td></tr><tr><td class="NLM_term">DDI</td><td class="NLM_def"><p class="first last">drug–drug interaction</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid-β</p></td></tr><tr><td class="NLM_term">sAPPβ</td><td class="NLM_def"><p class="first last">N-terminal ectodomain of APP</p></td></tr><tr><td class="NLM_term">C99</td><td class="NLM_def"><p class="first last">C-terminal fragment</p></td></tr><tr><td class="NLM_term">CatD</td><td class="NLM_def"><p class="first last">cathepsin D</p></td></tr><tr><td class="NLM_term">WCA</td><td class="NLM_def"><p class="first last">whole cell assay</p></td></tr><tr><td class="NLM_term">CFA</td><td class="NLM_def"><p class="first last">cell free assay</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">TMEM27</td><td class="NLM_def"><p class="first last">transmembrane protein 27</p></td></tr><tr><td class="NLM_term">PMEL17</td><td class="NLM_def"><p class="first last">pigment cell-specific melanocyte protein</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">hydrogen bond donor</p></td></tr><tr><td class="NLM_term">NIH</td><td class="NLM_def"><p class="first last">National Institutes of Health</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistant protein</p></td></tr><tr><td class="NLM_term">BLQ</td><td class="NLM_def"><p class="first last">below limit of quantitation</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">hour</p></td></tr><tr><td class="NLM_term">mg/kg</td><td class="NLM_def"><p class="first last">milligram per kilogram</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">3D</td><td class="NLM_def"><p class="first last">three-dimensional</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">DELFIA</td><td class="NLM_def"><p class="first last">dissociation-enhanced lanthanide fluorescent immunoassay</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">platform enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">THP</td><td class="NLM_def"><p class="first last">tetrahydropyran</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25103" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25103" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span> <span> </span><span class="NLM_article-title">The β-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">12787</span>– <span class="NLM_lpage">12794</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3657-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1523%2FJNEUROSCI.3657-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=19828790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12787-12794&issue=41&author=R.+Vassarauthor=D.+M.+Kovacsauthor=R.+Yanauthor=P.+C.+Wong&title=The+%CE%B2-secretase+enzyme+BACE+in+health+and+Alzheimer%E2%80%99s+disease%3A+regulation%2C+cell+biology%2C+function%2C+and+therapeutic+potential&doi=10.1523%2FJNEUROSCI.3657-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential</span></div><div class="casAuthors">Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12787-12794</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder.  The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation.  Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ prodn. in AD.  Since its discovery 10 years ago, much has been learned about BACE.  This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiol. functions in sodium current, synaptic transmission, myelination, and schizophrenia.  The therapeutic potential of BACE will also be considered.  This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGn8h_x-7_bVg90H21EOLACvtfcHk0lgTTWa97FA3jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP&md5=a462ad002cf3801570725719d71647c6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3657-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3657-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DThe%2520%25CE%25B2-secretase%2520enzyme%2520BACE%2520in%2520health%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520regulation%252C%2520cell%2520biology%252C%2520function%252C%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26issue%3D41%26spage%3D12787%26epage%3D12794%26doi%3D10.1523%2FJNEUROSCI.3657-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marks, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, M. J.</span></span> <span> </span><span class="NLM_article-title">BACE and γ-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1007/s11064-009-0054-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1007%2Fs11064-009-0054-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=19760173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=181-210&issue=2&author=N.+Marksauthor=M.+J.+Berg&title=BACE+and+%CE%B3-secretase+characterization+and+their+sorting+as+therapeutic+targets+to+reduce+amyloidogenesis&doi=10.1007%2Fs11064-009-0054-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">BACE and γ-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis</span></div><div class="casAuthors">Marks, Neville; Berg, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-210</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Secretases are enzymes that process amyloid precursor protein (APP), a prototypic type-1 membrane protein.  This has led directly to discovery of novel aspartic proteases (β-secretase or BACE), a tetramer complex, γ-secretase (γ-SC) contg. presenilins, nicastrin, aph-1 and pen-2, and a new role for metalloprotease(s) of the ADAM family as α-secretases.  Recent advances in defining pathways that mediate endosomal/lysosomal/autophagic/exosomal trafficking now provide targets for new drugs to attenuate abnormal prodn. of fibril-forming products characteristic of Alzheimer's disease (AD).  A key to success includes not only characterization of relevant secretases, but mechanisms for sorting and transport of key metabolites to abnormal vesicles or sites for assembly of fibrils.  New developments highlighted here include an important role for an 'early recycling endosome' coated in a retromer complex contg. lipoprotein receptor LRP-II (SorLA) for switching APP to a non-amyloidogenic pathway for α-secretase processing, or to shuttle APP to a 'late endosome compartment' to form Aβ or AICD.  LRP11 (SorLA) is of particular importance since it decreases in sporadic AD whose etiol. is otherwise unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptFxOS-WJwAbVg90H21EOLACvtfcHk0ljrHpLfOmUKlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentLnJ&md5=312eb981ae39671456e316bf050166dc</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs11064-009-0054-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-009-0054-1%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DN.%26aulast%3DBerg%26aufirst%3DM.%2BJ.%26atitle%3DBACE%2520and%2520%25CE%25B3-secretase%2520characterization%2520and%2520their%2520sorting%2520as%2520therapeutic%2520targets%2520to%2520reduce%2520amyloidogenesis%26jtitle%3DNeurochem.%2520Res.%26date%3D2010%26volume%3D35%26issue%3D2%26spage%3D181%26epage%3D210%26doi%3D10.1007%2Fs11064-009-0054-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckman, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostaszewski, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. George Hyslop, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younkin, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid β-protein</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1006/nbdi.1998.0183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1006%2Fnbdi.1998.0183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=9746908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlenurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1998&pages=107-116&issue=2&author=M.+Citronauthor=C.+B.+Eckmanauthor=T.+S.+Diehlauthor=C.+Corcoranauthor=B.+L.+Ostaszewskiauthor=W.+Xiaauthor=G.+Levesqueauthor=P.+St.+George+Hyslopauthor=S.+G.+Younkinauthor=D.+J.+Selkoe&title=Additive+effects+of+PS1+and+APP+mutations+on+secretion+of+the+42-residue+amyloid+%CE%B2-protein&doi=10.1006%2Fnbdi.1998.0183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid β-protein</span></div><div class="casAuthors">Citron, Martin; Eckman, Christopher B.; Diehl, Thekla S.; Corcoran, Chris; Ostaszewski, Beth L.; Xia, Weiming; Levesque, Georges; St. George Hyslop, Peter; Younkin, Steven G.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-116</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Humans harboring missense mutations in the presenilin 1 (PS1) gene undergo progressive cerebral deposition of the 42-residue amyloid β-protein (Aβ42) at an early age and develop severe Alzheimer's disease.  Aβ42 is selectively elevated in the conditioned media of cells expressing mutant but not wild-type PS1, indicating that presenilin mutations alter APP processing.  Here we analyze the effects of various PS1 mutant constructs on the cellular prodn. of Aβ42.  A construct expressing only the PS1 N-terminal endoproteolytic fragment with the mutation Y115H causes no significant increase in Aβ42, whereas a full-length PS1 construct with the same mutation does.  This result suggests that the pathogenic effect of mutant presenilins is produced by the full-length mol. even though only a minor proportion of total PS1 occurs as holoprotein in tissues and cell lines.  We demonstrate that the effects of two different PS1 mutations are additive when engineered into the same PS1 mol.  Therefore, two mutations alter γ-secretase processing of APP more than one and the PS1 mutations described to date do not cause the max. possible PS1-mediated rise in Aβ42.  When a PS1 mutation was expressed in cells carrying the APPv7171 mutation, Aβ42 rose dramatically to become the predominant secreted Aβ species, an observation of interest for transgenic modeling of AD.  Our results are consistent with the hypothesis that presenilin is a major regulator of the proteolytic processing of APP by γ-secretases.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ck6RE7yz9LVg90H21EOLACvtfcHk0ljrHpLfOmUKlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlenurg%253D&md5=afd0de91ae36a1981ce9644f876ee1c1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.1998.0183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.1998.0183%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DEckman%26aufirst%3DC.%2BB.%26aulast%3DDiehl%26aufirst%3DT.%2BS.%26aulast%3DCorcoran%26aufirst%3DC.%26aulast%3DOstaszewski%26aufirst%3DB.%2BL.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DLevesque%26aufirst%3DG.%26aulast%3DSt.%2BGeorge%2BHyslop%26aufirst%3DP.%26aulast%3DYounkin%26aufirst%3DS.%2BG.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAdditive%2520effects%2520of%2520PS1%2520and%2520APP%2520mutations%2520on%2520secretion%2520of%2520the%252042-residue%2520amyloid%2520%25CE%25B2-protein%26jtitle%3DNeurobiol.%2520Dis.%26date%3D1998%26volume%3D5%26issue%3D2%26spage%3D107%26epage%3D116%26doi%3D10.1006%2Fnbdi.1998.0183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaedal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulem, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudbjartsson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhangale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenlocher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsdottir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreassen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joensson, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palotie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsteinsdottir, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, K.</span></span> <span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span>. <i>Nature (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span> (<span class="NLM_issue">7409</span>),  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&issue=7409&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Joenssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0litHyDS8MT2uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJoensson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2012%26volume%3D488%26issue%3D7409%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allsop, D.</span></span> <span> </span><span class="NLM_article-title">Amyloid deposition as the central event in the etiology of Alzheimer’s disease</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1016/0165-6147(91)90609-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1016%2F0165-6147%2891%2990609-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1763432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383-388&issue=10&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+deposition+as+the+central+event+in+the+etiology+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2F0165-6147%2891%2990609-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid deposition as the central event in the etiology of Alzheimer's disease</span></div><div class="casAuthors">Hardy, John; Allsop, David</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">383-8</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A review with 50 refs. of pathol. and etiol. of Alzheimer's disease; the function of β-amyloid precursor protein and the mechanism of formation of cerebrovascular amyloid peptide β/A4; and the progression of the disease from amyloid formation to neurofibrillary tangles and cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRPqP0OKB5rVg90H21EOLACvtfcHk0litHyDS8MT2uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D&md5=7756055cd27bec2821c9926267a93872</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2891%2990609-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252891%252990609-V%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520deposition%2520as%2520the%2520central%2520event%2520in%2520the%2520etiology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26issue%3D10%26spage%3D383%26epage%3D388%26doi%3D10.1016%2F0165-6147%2891%2990609-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minogue, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala Frigerio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadeeva, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasco, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">The APP family of proteins: similarities and differences</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1042/BST0350416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1042%2FBST0350416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=17371289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Wrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=416-420&issue=2&author=D.+M.+Walshauthor=A.+M.+Minogueauthor=C.+Sala+Frigerioauthor=J.+V.+Fadeevaauthor=W.+Wascoauthor=D.+J.+Selkoe&title=The+APP+family+of+proteins%3A+similarities+and+differences&doi=10.1042%2FBST0350416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The APP family of proteins: similarities and differences</span></div><div class="casAuthors">Walsh, D. M.; Minogue, A. M.; Sala Frigerio, C.; Fadeeva, J. V.; Wasco, W.; Selkoe, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">416-420</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Overwhelming evidence indicates that the Aβ (amyloid β-peptide) plays a crit. role in the pathogenesis of Alzheimer's disease.  Aβ is derived from the APP (amyloid precursor protein) by the action of two aspartyl proteases (β- and γ-secretases) that are leading candidates for therapeutic intervention.  APP is a member of a multigene family that includes APLP1 (amyloid precursor-like protein 1) and APLP2.  Both APLPs are processed in a manner analogous to APP, with all three proteins subject to ectodomain shedding and subsequent cleavage by γ-secretase.  Careful study of the APP family of proteins has already revealed important insights about APP.  Here, we will review how knowledge of the similarities and differences between APP and the APLPs may prove useful for the development of novel disease-modifying therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgIFSCWiOS3bVg90H21EOLACvtfcHk0litHyDS8MT2uA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Wrtb8%253D&md5=30c7dcfea77c0bc2b2dae85d4a2d4d90</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2FBST0350416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0350416%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DMinogue%26aufirst%3DA.%2BM.%26aulast%3DSala%2BFrigerio%26aufirst%3DC.%26aulast%3DFadeeva%26aufirst%3DJ.%2BV.%26aulast%3DWasco%26aufirst%3DW.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520APP%2520family%2520of%2520proteins%253A%2520similarities%2520and%2520differences%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2007%26volume%3D35%26issue%3D2%26spage%3D416%26epage%3D420%26doi%3D10.1042%2FBST0350416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu-Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeloff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Expression analysis of BACE2 in brain and peripheral tissues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span> (<span class="NLM_issue">27</span>),  <span class="NLM_fpage">20647</span>– <span class="NLM_lpage">20651</span>, <span class="refDoi"> DOI: 10.1074/jbc.M002688200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1074%2Fjbc.M002688200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=20647-20651&issue=27&author=B.+D.+Bennettauthor=S.+Babu-Khanauthor=R.+Loeloffauthor=J.+C.+Louisauthor=E.+Curranauthor=M.+Citronauthor=R.+Vassar&title=Expression+analysis+of+BACE2+in+brain+and+peripheral+tissues&doi=10.1074%2Fjbc.M002688200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M002688200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M002688200%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DExpression%2520analysis%2520of%2520BACE2%2520in%2520brain%2520and%2520peripheral%2520tissues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26issue%3D27%26spage%3D20647%26epage%3D20651%26doi%3D10.1074%2Fjbc.M002688200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esterhazy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuetzer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechsteiner, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doebeli, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prummer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieske, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marselli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr-Conte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebersold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliorini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, M.</span></span> <span> </span><span class="NLM_article-title">Bace2 Is a β cell-enriched protease that regulates pancreatic β cell function and mass</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2011.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1016%2Fj.cmet.2011.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=21907142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=365-377&issue=3&author=D.+Esterhazyauthor=I.+Stuetzerauthor=H.+Wangauthor=M.+P.+Rechsteinerauthor=J.+Beauchampauthor=H.+Doebeliauthor=H.+Hilpertauthor=H.+Matileauthor=M.+Prummerauthor=A.+Schmidtauthor=N.+Lieskeauthor=B.+Boehmauthor=L.+Marselliauthor=D.+Boscoauthor=J.+Kerr-Conteauthor=R.+Aebersoldauthor=G.+A.+Spinasauthor=H.+Mochauthor=C.+Miglioriniauthor=M.+Stoffel&title=Bace2+Is+a+%CE%B2+cell-enriched+protease+that+regulates+pancreatic+%CE%B2+cell+function+and+mass&doi=10.1016%2Fj.cmet.2011.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass</span></div><div class="casAuthors">Esterhazy, Daria; Stuetzer, Ina; Wang, Haiyan; Rechsteiner, Markus P.; Beauchamp, Jeremy; Doebeli, Heinz; Hilpert, Hans; Matile, Hugues; Prummer, Michael; Schmidt, Alexander; Lieske, Nora; Boehm, Bernhard; Marselli, Lorella; Bosco, Domenico; Kerr-Conte, Julie; Aebersold, Ruedi; Spinas, Giatgen Andreia; Moch, Holger; Migliorini, Cristiano; Stoffel, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Decreased β cell mass and function are hallmarks of type 2 diabetes.  Here we identified, through a siRNA screen, beta site amyloid precursor protein cleaving enzyme 2 (Bace2) as the sheddase of the proproliferative plasma membrane protein Tmem27 in murine and human β cells.  Mice with functionally inactive Bace2 and insulin-resistant mice treated with a newly identified Bace2 inhibitor both display augmented β cell mass and improved control of glucose homeostasis due to increased insulin levels.  These results implicate Bace2 in the control of β cell maintenance and provide a rational strategy to inhibit this protease for the expansion of functional pancreatic β cell mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNmw-BllVxx7Vg90H21EOLACvtfcHk0lg3Mo-GXR5Mag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM&md5=489e20b2d997eb0cbaff195819e35d64</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DEsterhazy%26aufirst%3DD.%26aulast%3DStuetzer%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRechsteiner%26aufirst%3DM.%2BP.%26aulast%3DBeauchamp%26aufirst%3DJ.%26aulast%3DDoebeli%26aufirst%3DH.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DPrummer%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DLieske%26aufirst%3DN.%26aulast%3DBoehm%26aufirst%3DB.%26aulast%3DMarselli%26aufirst%3DL.%26aulast%3DBosco%26aufirst%3DD.%26aulast%3DKerr-Conte%26aufirst%3DJ.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSpinas%26aufirst%3DG.%2BA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DMigliorini%26aufirst%3DC.%26aulast%3DStoffel%26aufirst%3DM.%26atitle%3DBace2%2520Is%2520a%2520%25CE%25B2%2520cell-enriched%2520protease%2520that%2520regulates%2520pancreatic%2520%25CE%25B2%2520cell%2520function%2520and%2520mass%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D14%26issue%3D3%26spage%3D365%26epage%3D377%26doi%3D10.1016%2Fj.cmet.2011.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koulov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alory-Jost, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balch, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span> <span> </span><span class="NLM_article-title">Functional amyloid formation within mammalian tissue</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">e6</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.0040006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1371%2Fjournal.pbio.0040006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=16300414" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=e6&issue=1&author=D.+M.+Fowlerauthor=A.+V.+Koulovauthor=C.+Alory-Jostauthor=M.+S.+Marksauthor=W.+E.+Balchauthor=J.+W.+Kelly&title=Functional+amyloid+formation+within+mammalian+tissue&doi=10.1371%2Fjournal.pbio.0040006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.0040006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.0040006%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DD.%2BM.%26aulast%3DKoulov%26aufirst%3DA.%2BV.%26aulast%3DAlory-Jost%26aufirst%3DC.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DBalch%26aufirst%3DW.%2BE.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DFunctional%2520amyloid%2520formation%2520within%2520mammalian%2520tissue%26jtitle%3DPLoS%2520Biol.%26date%3D2006%26volume%3D4%26issue%3D1%26spage%3De6%26doi%3D10.1371%2Fjournal.pbio.0040006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stayrook, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmon, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shorter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span> <span> </span><span class="NLM_article-title">N-terminal domains elicit formation of functional Pmel17 amyloid fibrils</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">35543</span>– <span class="NLM_lpage">35555</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.047449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1074%2Fjbc.M109.047449" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=35543-35555&issue=51&author=B.+Wattauthor=G.+van+Nielauthor=D.+M.+Fowlerauthor=I.+Hurbainauthor=K.+C.+Lukauthor=S.+E.+Stayrookauthor=M.+A.+Lemmonauthor=G.+Raposoauthor=J.+Shorterauthor=J.+W.+Kellyauthor=M.+S.+Marks&title=N-terminal+domains+elicit+formation+of+functional+Pmel17+amyloid+fibrils&doi=10.1074%2Fjbc.M109.047449"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.047449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.047449%26sid%3Dliteratum%253Aachs%26aulast%3DWatt%26aufirst%3DB.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26aulast%3DFowler%26aufirst%3DD.%2BM.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DStayrook%26aufirst%3DS.%2BE.%26aulast%3DLemmon%26aufirst%3DM.%2BA.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3DShorter%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26atitle%3DN-terminal%2520domains%2520elicit%2520formation%2520of%2520functional%2520Pmel17%2520amyloid%2520fibrils%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26issue%3D51%26spage%3D35543%26epage%3D35555%26doi%3D10.1074%2Fjbc.M109.047449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serneels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fort, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span> <span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">10658</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&issue=26&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D26%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Bebber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruscha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span> <span> </span><span class="NLM_article-title">Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1111/jnc.12198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1111%2Fjnc.12198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=23406323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWqs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2013&pages=471-481&issue=4&author=F.+van%0ABebberauthor=A.+Hruschaauthor=M.+Willemauthor=B.+Schmidauthor=C.+Haass&title=Loss+of+Bace2+in+zebrafish+affects+melanocyte+migration+and+is+distinct+from+Bace1+knock+out+phenotypes&doi=10.1111%2Fjnc.12198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes</span></div><div class="casAuthors">van Bebber, Frauke; Hruscha, Alexander; Willem, Michael; Schmid, Bettina; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">3&4</span>),
    <span class="NLM_cas:pages">471-481</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Alzheimer's disease is the most frequent dementia.  Pathol., Alzheimer's disease is characterized by the accumulation of senile plaques composed of amyloid β-peptide (Aβ).  Two proteases, β- and γ-secretase proteolytically generate Aβ from its precursor, the β-amyloid precursor protein (APP).  Inhibition of β-secretase, also referred to as beta-site APP cleaving enzyme (BACE1) or γ-secretase is therefore of prime interest for the development of amyloid-lowering drugs.  To assess the in vivo function of zebrafish Bace1 (zBace1), we generated zBace1 knock out fish by zinc finger nuclease-mediated genome editing.  Bace1 mutants (bace1-/-) are hypomyelinated in the PNS while the CNS is not affected.  Moreover, the no. of mechanosensory neuromasts is elevated in bace1-/-.  Mutations in zebrafish Bace2 (zBace2) revealed a distinct melanocyte migration phenotype, which is not obsd. in bace1-/-.  Double homozygous bace1-/-;bace2-/- fish do not enhance the single mutant phenotypes indicating non-redundant distinct physiol. functions.  Single homozygous bace1 mutants as well as double homozygous bace1 and bace2 mutants are viable and fertile suggesting that Bace1 is a promising drug target without major side effects.  The identification of a specific bace2 -/- assocd. phenotype further allows improving selective Bace1 inhibitors and to distinguish between Bace 1 and Bace 2 inhibition in vivo.  Inhibition of BACE1 protease activity has therapeutic importance for Alzheimer's disease.  Anal. of BACE1 and BACE2 knock-out zebrafish revealed that they exhibit distinct phenotypes.  Bace1 mutants display hypomyelination in the PNS and supernumerary neuromasts while in bace2 mutants the shape and migration of melanocytes is affected.  These phenotypes are not further enhanced in the viable double mutants.  Our data suggest that blocking BACE1 activity is a safe therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6hPBx6BmbmLVg90H21EOLACvtfcHk0lhEvQVaktZO2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWqs7bL&md5=9a8f81383e56f96dfa821c98182a739f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12198%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BBebber%26aufirst%3DF.%26aulast%3DHruscha%26aufirst%3DA.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DB.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DLoss%2520of%2520Bace2%2520in%2520zebrafish%2520affects%2520melanocyte%2520migration%2520and%2520is%2520distinct%2520from%2520Bace1%2520knock%2520out%2520phenotypes%26jtitle%3DJ.%2520Neurochem.%26date%3D2013%26volume%3D127%26issue%3D4%26spage%3D471%26epage%3D481%26doi%3D10.1111%2Fjnc.12198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgoyne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seabra, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futter, C. E.</span></span> <span> </span><span class="NLM_article-title">Regulation of melanosome number, shape and movement in the zebrafish retinal pigment epithelium by OA1 and PMEL</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1400</span>– <span class="NLM_lpage">1407</span>, <span class="refDoi"> DOI: 10.1242/jcs.164400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1242%2Fjcs.164400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=25690007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosV2ltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2015&pages=1400-1407&issue=7&author=T.+Burgoyneauthor=M.+N.+O%E2%80%99Connorauthor=M.+C.+Seabraauthor=D.+F.+Cutlerauthor=C.+E.+Futter&title=Regulation+of+melanosome+number%2C+shape+and+movement+in+the+zebrafish+retinal+pigment+epithelium+by+OA1+and+PMEL&doi=10.1242%2Fjcs.164400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of melanosome number, shape and movement in the zebrafish retinal pigment epithelium by OA1 and PMEL</span></div><div class="casAuthors">Burgoyne, Thomas; O'Connor, Marie N.; Seabra, Miguel C.; Cutler, Daniel F.; Futter, Clare E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1400-1407</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Anal. of melanosome biogenesis in the retinal pigment epithelium (RPE) is challenging because it occurs predominantly in a short embryonic time window.  Here, we show that the zebrafish provides an ideal model system for studying this process because in the RPE the timing of melanosome biogenesis facilitates mol. manipulation using morpholinos.  Morpholino-mediated knockdown of OA1 (also known as GPR143), mutations in the human homolog of which cause the most common form of human ocular albinism, induces a major redn. in melanosome no., recapitulating a key feature of the mammalian disease where reduced melanosome nos. precede macromelanosome formation.  We further show that PMEL, a key component of mammalian melanosome biogenesis, is required for the generation of cylindrical melanosomes in zebrafish, which in turn is required for melanosome movement into the apical processes and maintenance of photoreceptor integrity.  Spherical and cylindrical melanosomes contg. similar melanin vols. co-exist in the cell body but only cylindrical melanosomes enter the apical processes.  Taken together, our findings indicate that melanosome no. and shape are independently regulated and that melanosome shape controls a function in the RPE that depends on localization in the apical processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW8AE6Al4h4rVg90H21EOLACvtfcHk0lhEvQVaktZO2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosV2ltL8%253D&md5=461278b06690ee6fe2a7363203a105fc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1242%2Fjcs.164400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.164400%26sid%3Dliteratum%253Aachs%26aulast%3DBurgoyne%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BN.%26aulast%3DSeabra%26aufirst%3DM.%2BC.%26aulast%3DCutler%26aufirst%3DD.%2BF.%26aulast%3DFutter%26aufirst%3DC.%2BE.%26atitle%3DRegulation%2520of%2520melanosome%2520number%252C%2520shape%2520and%2520movement%2520in%2520the%2520zebrafish%2520retinal%2520pigment%2520epithelium%2520by%2520OA1%2520and%2520PMEL%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2015%26volume%3D128%26issue%3D7%26spage%3D1400%26epage%3D1407%26doi%3D10.1242%2Fjcs.164400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attalla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soderberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budd Haeberlein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingersoll, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. W.</span></span> <span> </span><span class="NLM_article-title">Reversible and species-specific depigmentation effects of AZD3293, a BACE inhibitor for the treatment of Alzheimer’s Disease, are related to BACE2 inhibition and confined to epidermis and hair</span>. <i>Journal of Prevention of Alzheimer’s Disease</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=29199322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A280%3ADC%252BC1M3ntlKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=202-218&issue=4&author=G.+Cebersauthor=T.+Lejeuneauthor=B.+Attallaauthor=M.+Soderbergauthor=R.+C.+Alexanderauthor=S.+Budd+Haeberleinauthor=A.+R.+Kuglerauthor=E.+W.+Ingersollauthor=S.+Platzauthor=C.+W.+Scott&title=Reversible+and+species-specific+depigmentation+effects+of+AZD3293%2C+a+BACE+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+Disease%2C+are+related+to+BACE2+inhibition+and+confined+to+epidermis+and+hair"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible and Species-Specific Depigmentation Effects of AZD3293, a BACE Inhibitor for the Treatment of Alzheimer's Disease, Are Related to BACE2 Inhibition and Confined to Epidermis and Hair</span></div><div class="casAuthors">Cebers G; Lejeune T; Attalla B; Soderberg M; Alexander R C; Budd Haeberlein S; Kugler A R; Ingersoll E W; Platz S; Scott C W</div><div class="citationInfo"><span class="NLM_cas:title">The journal of prevention of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">202-218</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  AZD3293 (also known as LY3314814) is a novel, potent, non-selective BACE1/BACE2 inhibitor currently in Phase 3 clinical development for the treatment of Alzheimer's disease.  OBJECTIVES:  The purpose of these studies was to characterize the effects, putative mechanism, and reversibility of hypopigmentation following treatment with AZD3293 in pigmented Long-Evans rats, Beagle dogs, human cell cultures, and humans.  DESIGN:  Nonclinical studies were conducted in Long-Evans pigmented rats, and both young and older Beagle dogs using a variety of oral dose levels of AZD3293 or AZD3839 (BACE inhibition reference compound; used in older dogs only) for dosing durations of 13 to 26 weeks.  In vitro studies of normal human epidermal melanocytes and reconstituted human epidermis were also conducted.  Skin biopsy data from a multiple-dose Phase 1 clinical study of AZD3293 (NCT01795339) are also reported.  SETTING:  Nonclinical in vivo and in vitro studies were conducted in laboratory settings in the US, Canada, and France; the multiple dose clinical study was conducted in a specialized inpatient setting in the US.  PARTICIPANTS:  Beagle dogs: 13-week study N=36 young (8-10 mo) animals; 39-week study N=64 young animals; and a second 13-week study N=32 older (30-32 mo) animals.  Long-Evans rats: N=68 animals.  Multiple-dose clinical study: only data for subjects enrolled in Part 2 of this study are included in this report (N=16).  INTERVENTIONS:  AZD3293 was the primary intervention used in these studies.  AZD3839, a relatively BACE1-selective reference inhibitor compound was used in one group in the 13 week study in older Beagle dogs and one in vitro assessment.  Finally, AZ1340, another relatively BACE1-selective reference inhibitor compound was used only in one in vitro assessment.  MEASUREMENTS:  Measurements for the nonclinical studies in dogs and rats included macroscopic observation and assessment of skin biopsies via histopathology, immunochemistry, and electron microscopy.  Measurements for the in vitro studies included melanocyte premelanosome protein (PMEL) processing, cytotoxicity, melanin synthesis, Pmel17 labeling, and melanocyte dendricity.  Measurements in the clinical study included scoring of melanin content in skin biopsies taken before and after dosing with AZD3293 over 14 days at dose levels up to 150 mg.  RESULTS:  Depigmentation in rats and dogs was limited to skin, hair, and mucosa with no effects on other pigmented tissues.  At a cellular level depigmentation was observed within a week of treatment, whereas the appearance of depigmentation in skin and hair did not become apparent until, at earliest, 4 weeks of treatment.  The depigmentation effects were reversible, not associated with degenerative or inflammatory changes, and were dose- and species-dependent in severity.  Full recovery of melanization was observed at the microscopic (cellular) level and at least partial recovery was seen in the macroscopic appearance of animals by the end of the 12-week recovery period in both rats and dogs.  Interestingly, no changes in melanin production or melanocyte morphology were seen in human primary melanocytes or reconstituted human epidermis in vitro.  Finally, there were no changes in melanization level in skin biopsies following 12 days of daily AZD3293 treatment at doses of AZD3293 up to 150 mg/day in human subjects.  CONCLUSIONS:  AZD3293, a novel, potent, non-selective BACE1/BACE2 inhibitor is in development as a potentially disease-modifying treatment for Alzheimer's disease.  Chronic nonclinical studies in Beagle dogs and pigmented rats showed macroscopic and microscopic hypopigmentation effects of AZD3293 that were limited to skin, hair, and mucosa.  These effects were shown to be reversible in both species.  Analysis of data from nonclinical and in vitro studies suggests that hypopigmentation is caused by BACE2 inhibition resulting in accumulation of a premelanosome protein fragment, which interrupts the normal production of melanin.  No macroscopic or microscopic reports of hypopigmentation were observed in a Phase 1 clinical study following 13 doses of AZD3293 over 14 days at dose levels up to 150 mg/day.  These data suggest that hypopigmentation is species-specific and humans appear to be least sensitive to the depigmentation effect caused by BACE2 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnMZvqjWSFT7t7lRqEFUJVfW6udTcc2ebj-pDB7UcM67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3ntlKisw%253D%253D&md5=8eaa57d7d8e3bb8bfad9244ffb5ae16a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DLejeune%26aufirst%3DT.%26aulast%3DAttalla%26aufirst%3DB.%26aulast%3DSoderberg%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DBudd%2BHaeberlein%26aufirst%3DS.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DIngersoll%26aufirst%3DE.%2BW.%26aulast%3DPlatz%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DC.%2BW.%26atitle%3DReversible%2520and%2520species-specific%2520depigmentation%2520effects%2520of%2520AZD3293%252C%2520a%2520BACE%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%252C%2520are%2520related%2520to%2520BACE2%2520inhibition%2520and%2520confined%2520to%2520epidermis%2520and%2520hair%26jtitle%3DJournal%2520of%2520Prevention%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26date%3D2016%26volume%3D3%26issue%3D4%26spage%3D202%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span> <span> </span><span class="NLM_article-title">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-beta and neuroinflammation in APP transgenic mice</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">44</span>, <span class="refDoi"> DOI: 10.1186/s13024-015-0033-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1186%2Fs13024-015-0033-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=26336937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=44&author=U.+Neumannauthor=H.+Rueegerauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=R.+M.+Lueoendauthor=M.+Tintelnot-Blomleyauthor=G.+Laueauthor=K.+Beltzauthor=B.+Voggauthor=P.+Schmidauthor=W.+Frieauffauthor=D.+R.+Shimshekauthor=M.+Staufenbielauthor=L.+H.+Jacobson&title=A+novel+BACE+inhibitor+NB-360+shows+a+superior+pharmacological+profile+and+robust+reduction+of+amyloid-beta+and+neuroinflammation+in+APP+transgenic+mice&doi=10.1186%2Fs13024-015-0033-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice</span></div><div class="casAuthors">Neumann, Ulf; Rueeger, Heinrich; Machauer, Rainer; Veenstra, Siem Jacob; Lueoend, Rainer M.; Tintelnot-Blomley, Marina; Laue, Grit; Beltz, Karen; Vogg, Barbara; Schmid, Peter; Frieauff, Wilfried; Shimshek, Derya R.; Staufenbiel, Matthias; Jacobson, Laura H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44/1-44/15</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease (AD) is the most common form of dementia, the no. of affected individuals is rising, with significant impacts for healthcare systems.  Current symptomatic treatments delay, but do not halt, disease progression.  Genetic evidence points to aggregation and deposition of amyloid-β (Aβ) in the brain being causal for the neurodegeneration and dementia typical of AD.  Approaches to target Aβ via inhibition of γ-secretase or passive antibody therapy have not yet resulted in substantial clin. benefits.  Inhibition of BACE1 (β-secretase) has proven a challenging concept, but recent BACE1inhibitors can enter the brain sufficiently well to lower Aβ.  However, failures with the first clin. BACE1 inhibitors have highlighted the need to generate compds. with appropriate efficacy and safety profiles, since long treatment periods are expected to be necessary in humans.  Results: Treatment with NB-360, a potent and brain penetrable BACE-1 inhibitor can completely block the progression of Aβ deposition in the brains of APP transgenic mice, a model for amyloid pathol.  We furthermore show that almost complete redn. of Aβ was achieved also in rats and in dogs, suggesting that these findings are translational across species and can be extrapolated to humans.  Amyloid pathol. may be an initial step in a complex pathol. cascade; therefore we investigated the effect of BACE-1 inhibition on neuroinflammation, a prominent downstream feature of the disease.  NB-360 stopped accumulation of activated inflammatory cells in the brains of APP transgenic mice.  Upon chronic treatment of APP transgenic mice, patches of gray hairs appeared.  Conclusions: In a rapidly developing field, the data on NB-360 broaden the chem. space and expand knowledge on the properties that are needed to make a BACE-1 inhibitor potent and safe enough for long-term use in patients.  Due to its excellent brain penetration, reasonable oral doses of NB-360 were sufficient to completely block amyloid-β deposition in an APP transgenic mouse model.  Data across species suggest similar treatment effects can possibly be achieved in humans.  The reduced neuroinflammation upon amyloid redn. by NB-360 treatment supports the notion that targeting amyloid-β pathol. can have beneficial downstream effects on the progression of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJLgu8zl8_LVg90H21EOLACvtfcHk0ljKG_db_DogdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D&md5=728407859709d7de57d68bfdc374fe85</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1186%2Fs13024-015-0033-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-015-0033-8%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DLueoend%26aufirst%3DR.%2BM.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DLaue%26aufirst%3DG.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26atitle%3DA%2520novel%2520BACE%2520inhibitor%2520NB-360%2520shows%2520a%2520superior%2520pharmacological%2520profile%2520and%2520robust%2520reduction%2520of%2520amyloid-beta%2520and%2520neuroinflammation%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DMol.%2520Neurodegener.%26date%3D2015%26volume%3D10%26spage%3D44%26doi%3D10.1186%2Fs13024-015-0033-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovsepian, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez-Llorca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt Elvang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volbracht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, C. K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herms, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">729</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2014.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1016%2Fj.biopsych.2014.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=25599931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2015&pages=729-739&issue=8&author=S.+Filserauthor=S.+V.+Ovsepianauthor=M.+Masanaauthor=L.+Blazquez-Llorcaauthor=A.+Brandt+Elvangauthor=C.+Volbrachtauthor=M.+B.+Muellerauthor=C.+K.+E.+Jungauthor=J.+Herms&title=Pharmacological+inhibition+of+BACE1+impairs+synaptic+plasticity+and+cognitive+functions&doi=10.1016%2Fj.biopsych.2014.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Inhibition of BACE1 Impairs Synaptic Plasticity and Cognitive Functions</span></div><div class="casAuthors">Filser, Severin; Ovsepian, Saak V.; Masana, Merce; Blazquez-Llorca, Lidia; Brandt Elvang, Anders; Volbracht, Christiane; Mueller, Marianne B.; Jung, Christian K. E.; Herms, Jochen</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">729-739</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">BACE1 (beta site amyloid precursor protein cleaving enzyme 1) is the rate limiting protease in amyloid β prodn., hence a promising drug target for the treatment of Alzheimer's disease.  Inhibition of BACE1, as the major β-secretase in vivo with multiple substrates, however is likely to have mechanism-based adverse effects.  We explored the impact of long-term pharmacol. inhibition of BACE1 on dendritic spine dynamics, synaptic functions, and cognitive performance of adult mice.  Sandwich ELISA was used to assess Aβ40 levels in brain and plasma after oral administration of BACE1 inhibitors SCH1682496 or LY2811376.  In vivo two-photon microscopy of the somatosensory cortex was performed to monitor structural dynamics of dendritic spines while synaptic functions and plasticity were measured via electrophysiol. recordings of excitatory postsynaptic currents and hippocampal long-term potentiation in brain slices.  Finally, behavioral tests were performed to analyze the impact of pharmacol. inhibition of BACE1 on cognitive performance.  Dose-dependent decrease of Aβ40 levels in vivo confirmed suppression of BACE1 activity by both inhibitors.  Prolonged treatment caused a redn. in spine formation of layer V pyramidal neurons, which recovered after withdrawal of inhibitors.  Congruently, the rate of spontaneous and miniature excitatory postsynaptic currents in pyramidal neurons and hippocampal long-term potentiation were reduced in animals treated with BACE1 inhibitors.  These effects were not detected in Bace1-/- mice treated with SCH1682496, confirming BACE1 as the pharmacol. target.  Described structural and functional changes were assocd. with cognitive deficits as revealed in behavioral tests.  Our findings indicate important functions to BACE1 in structural and functional synaptic plasticity in the mature brain, with implications for cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBtdj8QyF3sLVg90H21EOLACvtfcHk0ljKG_db_DogdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKntLg%253D&md5=cfeed5a68833142e39074442dc343f42</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2014.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2014.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DFilser%26aufirst%3DS.%26aulast%3DOvsepian%26aufirst%3DS.%2BV.%26aulast%3DMasana%26aufirst%3DM.%26aulast%3DBlazquez-Llorca%26aufirst%3DL.%26aulast%3DBrandt%2BElvang%26aufirst%3DA.%26aulast%3DVolbracht%26aufirst%3DC.%26aulast%3DMueller%26aufirst%3DM.%2BB.%26aulast%3DJung%26aufirst%3DC.%2BK.%2BE.%26aulast%3DHerms%26aufirst%3DJ.%26atitle%3DPharmacological%2520inhibition%2520of%2520BACE1%2520impairs%2520synaptic%2520plasticity%2520and%2520cognitive%2520functions%26jtitle%3DBiol.%2520Psychiatry%26date%3D2015%26volume%3D77%26issue%3D8%26spage%3D729%26epage%3D739%26doi%3D10.1016%2Fj.biopsych.2014.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dockendorf, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijn, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palcza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troyer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M. S.</span></span> <span> </span><span class="NLM_article-title">The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">363</span>),  <span class="NLM_fpage">363ra150</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad9704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1126%2Fscitranslmed.aad9704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=27807285" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=363ra150&issue=363&author=M.+E.+Kennedyauthor=A.+W.+Stamfordauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+F.+Dockendorfauthor=M.+Eganauthor=L.+Ereshefskyauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=S.+Jheeauthor=H.+J.+Kleijnauthor=R.+Kuvelkarauthor=W.+Liauthor=B.+A.+Mattsonauthor=H.+Meiauthor=J.+Palczaauthor=J.+D.+Scottauthor=M.+Tanenauthor=M.+D.+Troyerauthor=J.+L.+Tsengauthor=J.+A.+Stoneauthor=E.+M.+Parkerauthor=M.+S.+Forman&title=The+BACE1+inhibitor+verubecestat+%28MK-8931%29+reduces+CNS+%CE%B2-amyloid+in+animal+models+and+in+Alzheimer%E2%80%99s+disease+patients&doi=10.1126%2Fscitranslmed.aad9704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9704%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DDockendorf%26aufirst%3DM.%2BF.%26aulast%3DEgan%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJhee%26aufirst%3DS.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMattson%26aufirst%3DB.%2BA.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DTroyer%26aufirst%3DM.%2BD.%26aulast%3DTseng%26aufirst%3DJ.%2BL.%26aulast%3DStone%26aufirst%3DJ.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DForman%26aufirst%3DM.%2BS.%26atitle%3DThe%2520BACE1%2520inhibitor%2520verubecestat%2520%2528MK-8931%2529%2520reduces%2520CNS%2520%25CE%25B2-amyloid%2520in%2520animal%2520models%2520and%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26issue%3D363%26spage%3D363ra150%26doi%3D10.1126%2Fscitranslmed.aad9704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cárdenas, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H. L.</span></span> <span> </span><span class="NLM_article-title">The design, development, and evaluation of BACE1 inhibitors for the treatment of Alzheimer’s Disease</span>. <i>Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1007/7355_2016_16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1007%2F7355_2016_16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=27-85&author=A.+K.+Ghoshauthor=E.+L.+C%C3%A1rdenasauthor=H.+L.+Osswald&title=The+design%2C+development%2C+and+evaluation+of+BACE1+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1007%2F7355_2016_16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2F7355_2016_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F7355_2016_16%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DC%25C3%25A1rdenas%26aufirst%3DE.%2BL.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DThe%2520design%252C%2520development%252C%2520and%2520evaluation%2520of%2520BACE1%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DTop.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D27%26epage%3D85%26doi%3D10.1007%2F7355_2016_16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBell, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span> <span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">16507</span>– <span class="NLM_lpage">16516</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&issue=46&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+S.+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lhIQtxg0J-wWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DLaBell%26aufirst%3DE.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26issue%3D46%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuhl, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanian, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroise, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brulet, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">am Ende, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judkins, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span> <span> </span><span class="NLM_article-title">Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13042</span>, <span class="refDoi"> DOI: 10.1038/ncomms13042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1038%2Fncomms13042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=27727204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GqtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13042&author=A.+M.+Zuhlauthor=C.+E.+Nolanauthor=M.+A.+Brodneyauthor=S.+Niessenauthor=K.+Atchisonauthor=C.+Houleauthor=D.+A.+Karanianauthor=C.+Ambroiseauthor=J.+W.+Bruletauthor=E.+M.+Beckauthor=S.+D.+Doranauthor=B.+T.+O%E2%80%99Neillauthor=C.+W.+am+Endeauthor=C.+Changauthor=K.+F.+Geogheganauthor=G.+M.+Westauthor=J.+C.+Judkinsauthor=X.+Houauthor=D.+R.+Riddellauthor=D.+S.+Johnson&title=Chemoproteomic+profiling+reveals+that+cathepsin+D+off-target+activity+drives+ocular+toxicity+of+%CE%B2-secretase+inhibitors&doi=10.1038%2Fncomms13042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors</span></div><div class="casAuthors">Zuhl, Andrea M.; Nolan, Charles E.; Brodney, Michael A.; Niessen, Sherry; Atchison, Kevin; Houle, Christopher; Karanian, David A.; Ambroise, Claude; Brulet, Jeffrey W.; Beck, Elizabeth M.; Doran, Shawn D.; O'Neill, Brian T.; am Ende, Christopher W.; Chang, Cheng; Geoghegan, Kieran F.; West, Graham M.; Judkins, Joshua C.; Hou, Xinjun; Riddell, David R.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13042</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of β-secretase BACE1 is considered one of the most promising approaches for treating Alzheimer's disease.  Several structurally distinct BACE1 inhibitors have been withdrawn from development after inducing ocular toxicity in animal models, but the target mediating this toxicity has not been identified.  Here we use a clickable photoaffinity probe to identify cathepsin D (CatD) as a principal off-target of BACE1 inhibitors in human cells.  We find that several BACE1 inhibitors blocked CatD activity in cells with much greater potency than that displayed in cell-free assays with purified protein.  Through a series of exploratory toxicol. studies, we show that quantifying CatD target engagement in cells with the probe is predictive of ocular toxicity in vivo.  Taken together, our findings designate off-target inhibition of CatD as a principal driver of ocular toxicity for BACE1 inhibitors and more generally underscore the power of chem. proteomics for discerning mechanisms of drug action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0-LulGVRdJLVg90H21EOLACvtfcHk0lgRyFBXD1HRpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GqtbbL&md5=5e2c31195f4f03babec561a5824ccb0d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fncomms13042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13042%26sid%3Dliteratum%253Aachs%26aulast%3DZuhl%26aufirst%3DA.%2BM.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DKaranian%26aufirst%3DD.%2BA.%26aulast%3DAmbroise%26aufirst%3DC.%26aulast%3DBrulet%26aufirst%3DJ.%2BW.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DWest%26aufirst%3DG.%2BM.%26aulast%3DJudkins%26aufirst%3DJ.%2BC.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DChemoproteomic%2520profiling%2520reveals%2520that%2520cathepsin%2520D%2520off-target%2520activity%2520drives%2520ocular%2520toxicity%2520of%2520%25CE%25B2-secretase%2520inhibitors%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13042%26doi%3D10.1038%2Fncomms13042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative Verubecestat (MK-8931)-a β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&issue=23&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+Verubecestat+%28MK-8931%29-a+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520Verubecestat%2520%2528MK-8931%2529-a%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D23%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borders, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brier, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickso, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevorkyan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komjathy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathe, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaught, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winneroski, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span> <span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1210</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4129-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1523%2FJNEUROSCI.4129-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=25609634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1199-1210&issue=3&author=P.+C.+Mayauthor=B.+A.+Willisauthor=S.+L.+Loweauthor=R.+A.+Deanauthor=S.+A.+Monkauthor=P.+J.+Cockeauthor=J.+E.+Audiaauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+A.+Brierauthor=D.+O.+Calligaroauthor=T.+A.+Dayauthor=L.+Ereshefskyauthor=J.+A.+Ericksoauthor=H.+Gevorkyanauthor=C.+R.+Gonzalesauthor=D.+E.+Jamesauthor=S.+S.+Jheeauthor=S.+F.+Komjathyauthor=L.+Liauthor=T.+D.+Lindstromauthor=B.+M.+Matheauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=G.+M.+Vaughtauthor=B.+M.+Watsonauthor=L.+L.+Winneroskiauthor=Z.+Yangauthor=D.+J.+Mergott&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+A%CE%B2+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.4129-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span></div><div class="casAuthors">May, Patrick C.; Willis, Brian A.; Lowe, Stephen L.; Dean, Robert A.; Monk, Scott A.; Cocke, Patrick J.; Audia, James E.; Boggs, Leonard N.; Borders, Anthony R.; Brier, Richard A.; Calligaro, David O.; Day, Theresa A.; Ereshefsky, Larry; Erickso, Jon A.; Gevorkyan, Hykop; Gonzales, Celedon R.; James, Douglas E.; Jhee, Stanford S.; Komjathy, Steven F.; Li, Linglin; Lindstrom, Terry D.; Mathe, Brian M.; Martenyi, Ferenc; Sheehan, Scott M.; Stout, Stephanie L.; Timm, David E.; Vaught, Grant M.; Watson, Brian M.; Winneroski, Leonard L.; Yang, Zhixiang; Mergott, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1199-1210, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).  Therefore, the development of potent and selective inhibitors of BACE1 has been a focus of many drug discovery efforts in academia and industry.  Herein, we report the nonclin. and early clin. development of LY2886721, a BACE1 active site inhibitor that reached phase 2 clin. trials in AD.  LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclin. animal models.  Similar potent and persistent amyloid β lowering was obsd. in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects.  Collectively, these data add support for BACE1 inhibition as an effective means of amyloid lowering and as an attractive target for potential disease modification therapy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDFLhcsiUDLVg90H21EOLACvtfcHk0lgPsTodUF7LVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D&md5=7e16cc00767a8af4da7dd17b6e40e8f5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4129-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4129-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DErickso%26aufirst%3DJ.%2BA.%26aulast%3DGevorkyan%26aufirst%3DH.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DJames%26aufirst%3DD.%2BE.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DKomjathy%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMathe%26aufirst%3DB.%2BM.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DVaught%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520A%25CE%25B2%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26issue%3D3%26spage%3D1199%26epage%3D1210%26doi%3D10.1523%2FJNEUROSCI.4129-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, M. D.</span></span> <span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mMitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1410</span>, <span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&issue=9&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mMitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+a+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mMitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520a%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26issue%3D9%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajapakse, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nantermet, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selnick, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrow, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGaughey, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katherine Holloway, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espeseth, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colussi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouthamel, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tugusheva, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span> <span> </span><span class="NLM_article-title">SAR of tertiary carbinamine derived BACE1 inhibitors: Role of aspartate ligand amine pK a in enzyme inhibition</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1885</span>– <span class="NLM_lpage">1889</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.01.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1016%2Fj.bmcl.2010.01.137" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1885-1889&issue=6&author=H.+A.+Rajapakseauthor=P.+G.+Nantermetauthor=H.+G.+Selnickauthor=J.+C.+Barrowauthor=G.+B.+McGaugheyauthor=S.+Munshiauthor=S.+R.+Lindsleyauthor=M.+B.+Youngauthor=P.+L.+Ngoauthor=M.+Katherine+Hollowayauthor=M.-T.+Laiauthor=A.+S.+Espesethauthor=X.-P.+Shiauthor=D.+Colussiauthor=B.+Pietrakauthor=M.-C.+Crouthamelauthor=K.+Tugushevaauthor=Q.+Huangauthor=M.+Xuauthor=A.+J.+Simonauthor=L.+Kuoauthor=D.+J.+Hazudaauthor=S.+Grahamauthor=J.+P.+Vacca&title=SAR+of+tertiary+carbinamine+derived+BACE1+inhibitors%3A+Role+of+aspartate+ligand+amine+pK+a+in+enzyme+inhibition&doi=10.1016%2Fj.bmcl.2010.01.137"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.137%26sid%3Dliteratum%253Aachs%26aulast%3DRajapakse%26aufirst%3DH.%2BA.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DLindsley%26aufirst%3DS.%2BR.%26aulast%3DYoung%26aufirst%3DM.%2BB.%26aulast%3DNgo%26aufirst%3DP.%2BL.%26aulast%3DKatherine%2BHolloway%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DShi%26aufirst%3DX.-P.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DCrouthamel%26aufirst%3DM.-C.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DSAR%2520of%2520tertiary%2520carbinamine%2520derived%2520BACE1%2520inhibitors%253A%2520Role%2520of%2520aspartate%2520ligand%2520amine%2520pK%2520a%2520in%2520enzyme%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D6%26spage%3D1885%26epage%3D1889%26doi%3D10.1016%2Fj.bmcl.2010.01.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gravenfors, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlstroem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlstroem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstroem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kieseritzky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slivo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjaell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroemberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, F.</span></span> <span> </span><span class="NLM_article-title">New aminoimidazoles as β-Secretase (BACE-1) inhibitors showing amyloid-β (Aβ) lowering in brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9297</span>– <span class="NLM_lpage">9311</span>, <span class="refDoi"> DOI: 10.1021/jm300991n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&issue=21&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T.+Ginmanauthor=S.+Karlstroemauthor=J.+Kihlstroemauthor=K.+Kolmodinauthor=J.+Lindstroemauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=C.+Slivoauthor=B.-M.+Swahnauthor=L.-L.+Olssonauthor=P.+Johanssonauthor=S.+Eketjaellauthor=J.+Faeltingauthor=F.+Jeppssonauthor=K.+Stroembergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-Secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28A%CE%B2%29+lowering+in+brain&doi=10.1021%2Fjm300991n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DKarlstroem%26aufirst%3DS.%26aulast%3DKihlstroem%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstroem%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketjaell%26aufirst%3DS.%26aulast%3DFaelting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStroemberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-Secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D21%26spage%3D9297%26epage%3D9311%26doi%3D10.1021%2Fjm300991n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span> <span> </span><span class="NLM_article-title">Structural modifications that alter the P-Glycoprotein efflux properties of compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4877</span>– <span class="NLM_lpage">4895</span>, <span class="refDoi"> DOI: 10.1021/jm201136z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&issue=11&author=S.+A.+Hitchcock&title=Structural+modifications+that+alter+the+P-Glycoprotein+efflux+properties+of+compounds&doi=10.1021%2Fjm201136z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span></div><div class="casAuthors">Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4877-4895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This perspective is focused on structural modifications and strategies that can be applied during compd. optimization in order to modulate the P-glycoprotein efflux properties of small mols. with a particular emphasis on implications for CNS penetration. The precise mol. interactions that confer P-glycoprotein efflux remain relatively poorly defined. The promiscuous nature of P-glycoprotein efflux renders the rational circumvention of efflux, while simultaneously optimizing compds. for eficacy, safety, and pharmacokinetic properties, an extremely challenging undertaking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_5RBtwgb-rVg90H21EOLACvtfcHk0lhj8vcMh66FBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D&md5=6c5dffbb11db6fa893ff3c50fe7778cc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-Glycoprotein%2520efflux%2520properties%2520of%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D11%26spage%3D4877%26epage%3D4895%26doi%3D10.1021%2Fjm201136z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann-Roder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span> <span> </span><span class="NLM_article-title">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1002%2Fcmdc.200700059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=17530727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1100-1115&issue=8&author=M.+Morgenthalerauthor=E.+Schweizerauthor=A.+Hoffmann-Roderauthor=F.+Beniniauthor=R.+E.+Martinauthor=G.+Jaeschkeauthor=B.+Wagnerauthor=H.+Fischerauthor=S.+Bendelsauthor=D.+Zimmerliauthor=J.+Schneiderauthor=F.+Diederichauthor=M.+Kansyauthor=K.+Muller&title=Predicting+and+tuning+physicochemical+properties+in+lead+optimization%3A+amine+basicities&doi=10.1002%2Fcmdc.200700059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span></div><div class="casAuthors">Morgenthaler, Martin; Schweizer, Eliane; Hoffmann-Roder, Anja; Benini, Fausta; Martin, Rainer E.; Jaeschke, Georg; Wagner, Bjorn; Fischer, Holger; Bendels, Stefanie; Zimmerli, Daniel; Schneider, Josef; Diederich, Francois; Kansy, Manfred; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1100-1115</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  This review describes simple and useful concepts for predicting and tuning the pKa values of basic amine centers, a crucial step in the optimization of phys. and ADME properties of many lead structures in drug-discovery research.  The article starts with a case study of tricyclic thrombin inhibitors featuring a tertiary amine center with pKa values that can be tuned over a wide range, from the usual value of around 10 to below 2 by (remote) neighboring functionalities commonly encountered in medicinal chem.  Next, the changes in pKa of acyclic and cyclic amines upon substitution by fluorine, oxygen, nitrogen, and sulfur functionalities, as well as carbonyl and carboxyl derivs. are systematically analyzed, leading to the derivation of simple rules for pKa prediction.  Electronic and stereoelectronic effects in cyclic amines are discussed, and the emerging computational methods for pKa predictions are briefly surveyed.  The rules for tuning amine basicities should not only be of interest in drug-discovery research, but also to the development of new crop-protection agents, new amine ligands for organometallic complexes, and in particular, to the growing field of amine-based organocatalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodsWRMtrxWPbVg90H21EOLACvtfcHk0lhj8vcMh66FBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D&md5=478b70744312c01d3a43cf435d9598de</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700059%26sid%3Dliteratum%253Aachs%26aulast%3DMorgenthaler%26aufirst%3DM.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DHoffmann-Roder%26aufirst%3DA.%26aulast%3DBenini%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DPredicting%2520and%2520tuning%2520physicochemical%2520properties%2520in%2520lead%2520optimization%253A%2520amine%2520basicities%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26issue%3D8%26spage%3D1100%26epage%3D1115%26doi%3D10.1002%2Fcmdc.200700059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ginman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmstroem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emond, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsblom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lake, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehgelmeble, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterky, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravenfors, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, F.</span></span> <span> </span><span class="NLM_article-title">Core refinement toward permeable β-Secretase (BACE-1) inhibitors with low hERG activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4181</span>– <span class="NLM_lpage">4205</span>, <span class="refDoi"> DOI: 10.1021/jm3011349</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3011349" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4181-4205&issue=11&author=T.+Ginmanauthor=J.+Viklundauthor=J.+Malmstroemauthor=J.+Blidauthor=R.+Emondauthor=R.+Forsblomauthor=A.+Johanssonauthor=A.+Kersauthor=F.+Lakeauthor=F.+Sehgelmebleauthor=K.+J.+Sterkyauthor=M.+Berghauthor=A.+Lindgrenauthor=P.+Johanssonauthor=F.+Jeppssonauthor=J.+Faeltingauthor=Y.+Gravenforsauthor=F.+Rahm&title=Core+refinement+toward+permeable+%CE%B2-Secretase+%28BACE-1%29+inhibitors+with+low+hERG+activity&doi=10.1021%2Fjm3011349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm3011349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3011349%26sid%3Dliteratum%253Aachs%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DMalmstroem%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DEmond%26aufirst%3DR.%26aulast%3DForsblom%26aufirst%3DR.%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DLake%26aufirst%3DF.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSterky%26aufirst%3DK.%2BJ.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DLindgren%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DFaelting%26aufirst%3DJ.%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DCore%2520refinement%2520toward%2520permeable%2520%25CE%25B2-Secretase%2520%2528BACE-1%2529%2520inhibitors%2520with%2520low%2520hERG%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D11%26spage%3D4181%26epage%3D4205%26doi%3D10.1021%2Fjm3011349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanguinetti, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tristani-Firouzi, M.</span></span> <span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span>. <i>Nature (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>440</i></span> (<span class="NLM_issue">7083</span>),  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1038/nature04710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&issue=7083&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia&doi=10.1038%2Fnature04710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0liIKRonMte_DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2006%26volume%3D440%26issue%3D7083%26spage%3D463%26epage%3D469%26doi%3D10.1038%2Fnature04710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krummenacher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozmen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergadano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochstrasser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David-Pierson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3980</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&issue=10&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D10%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundesmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaChapelle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikochik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakya, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3223</span>– <span class="NLM_lpage">3252</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3223-3252&issue=7&author=M.+A.+Brodneyauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=G.+Barreiroauthor=E.+F.+Johnsonauthor=D.+Riddellauthor=K.+Parrisauthor=C.+E.+Nolanauthor=Y.+Fanauthor=K.+Atchisonauthor=C.+Gonzalesauthor=A.+E.+Robshawauthor=S.+D.+Doranauthor=M.+W.+Bundesmannauthor=L.+Buzonauthor=J.+Dutraauthor=K.+Henegarauthor=E.+LaChapelleauthor=X.+Houauthor=B.+N.+Rogersauthor=J.+Panditauthor=R.+Liraauthor=L.+Martinez-Alsinaauthor=P.+Mikochikauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=L.+Priceauthor=S.+M.+Sakyaauthor=A.+Yuauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Utilizing+structures+of+CYP2D6+and+BACE1+complexes+to+reduce+risk+of+drug-drug+interactions+with+a+novel+series+of+centrally+efficacious+BACE1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DBuzon%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%26aulast%3DHenegar%26aufirst%3DK.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DMikochik%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DL.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DUtilizing%2520structures%2520of%2520CYP2D6%2520and%2520BACE1%2520complexes%2520to%2520reduce%2520risk%2520of%2520drug-drug%2520interactions%2520with%2520a%2520novel%2520series%2520of%2520centrally%2520efficacious%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D7%26spage%3D3223%26epage%3D3252%26doi%3D10.1021%2Facs.jmedchem.5b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">1,4-Oxazine β-Secretase 1 (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8216</span>– <span class="NLM_lpage">8235</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&issue=20&author=F.+J.+R.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Martinez-Lamencaauthor=M.+Van+Goolauthor=A.+Garcia-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-Secretase+1+%28BACE1%29+inhibitors%3A+from+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarcia-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-Secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D20%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosez, L.</span></span> <span> </span><span class="NLM_article-title">α-Chloroenamines. New reagents for organic synthesis</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">852</span>– <span class="NLM_lpage">853</span>, <span class="refDoi"> DOI: 10.1002/anie.197208522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1002%2Fanie.197208522" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1972&pages=852-853&issue=9&author=L.+Ghosez&title=%CE%B1-Chloroenamines.+New+reagents+for+organic+synthesis&doi=10.1002%2Fanie.197208522"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fanie.197208522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.197208522%26sid%3Dliteratum%253Aachs%26aulast%3DGhosez%26aufirst%3DL.%26atitle%3D%25CE%25B1-Chloroenamines.%2520New%2520reagents%2520for%2520organic%2520synthesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1972%26volume%3D11%26issue%3D9%26spage%3D852%26epage%3D853%26doi%3D10.1002%2Fanie.197208522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ufimtsev, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, T. J.</span></span> <span> </span><span class="NLM_article-title">Quantum chemistry on graphical processing units. 3. analytical energy gradients, geometry optimization, and first principles molecular dynamics</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2619</span>– <span class="NLM_lpage">2628</span>, <span class="refDoi"> DOI: 10.1021/ct9003004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct9003004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVelurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=2619-2628&issue=10&author=I.+S.+Ufimtsevauthor=T.+J.+Martinez&title=Quantum+chemistry+on+graphical+processing+units.+3.+analytical+energy+gradients%2C+geometry+optimization%2C+and+first+principles+molecular+dynamics&doi=10.1021%2Fct9003004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Quantum Chemistry on Graphical Processing Units. 3. Analytical Energy Gradients, Geometry Optimization, and First Principles Molecular Dynamics</span></div><div class="casAuthors">Ufimtsev, Ivan S.; Martinez, Todd J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2619-2628</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We demonstrate that a video gaming machine contg. two consumer graphical cards can outpace a state-of-the-art quad-core processor workstation by a factor of more than 180× in Hartree-Fock energy + gradient calcns.  Such performance makes it possible to run large scale Hartree-Fock and D. Functional Theory calcns., which typically require hundreds of traditional processor cores, on a single workstation.  Benchmark Born-Oppenheimer mol. dynamics simulations are performed on two mol. systems using the 3-21G basis set - a hydronium ion solvated by 30 waters (94 atoms, 405 basis functions) and an aspartic acid mol. solvated by 147 waters (457 atoms, 2014 basis functions).  Our GPU implementation can perform 27 ps/day and 0.7 ps/day of ab initio mol. dynamics simulation on a single desktop computer for these systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWznU7lqZh8LVg90H21EOLACvtfcHk0lhm_1ki78Shbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVelurvJ&md5=f4e320ac3479e4b566a6b8bdb9e5add8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fct9003004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct9003004%26sid%3Dliteratum%253Aachs%26aulast%3DUfimtsev%26aufirst%3DI.%2BS.%26aulast%3DMartinez%26aufirst%3DT.%2BJ.%26atitle%3DQuantum%2520chemistry%2520on%2520graphical%2520processing%2520units.%25203.%2520analytical%2520energy%2520gradients%252C%2520geometry%2520optimization%252C%2520and%2520first%2520principles%2520molecular%2520dynamics%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2009%26volume%3D5%26issue%3D10%26spage%3D2619%26epage%3D2628%26doi%3D10.1021%2Fct9003004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span> <i>MacroModel</i>, Schrödinger
Release 2017–4; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MacroModel%2C+Schr%C3%B6dinger%0ARelease+2017%E2%80%934%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMacroModel%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trapa, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span> <span> </span><span class="NLM_article-title">Insights from an integrated physiologically based pharmacokinetic model for brain penetration</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>105</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">971</span>, <span class="refDoi"> DOI: 10.1016/j.xphs.2015.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1016%2Fj.xphs.2015.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2016&pages=965-971&issue=2&author=P.+E.+Trapaauthor=E.+Belovaauthor=J.+L.+Lirasauthor=D.+O.+Scottauthor=S.+J.+Steyn&title=Insights+from+an+integrated+physiologically+based+pharmacokinetic+model+for+brain+penetration&doi=10.1016%2Fj.xphs.2015.12.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2015.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2015.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DTrapa%26aufirst%3DP.%2BE.%26aulast%3DBelova%26aufirst%3DE.%26aulast%3DLiras%26aufirst%3DJ.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26atitle%3DInsights%2520from%2520an%2520integrated%2520physiologically%2520based%2520pharmacokinetic%2520model%2520for%2520brain%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D105%26issue%3D2%26spage%3D965%26epage%3D971%26doi%3D10.1016%2Fj.xphs.2015.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Danilenko, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G. D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span> <span> </span><span class="NLM_article-title">In vitro skin models and their predictability in defining normal and disease biology, pharmacology, and toxicity</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1177/0192623316632074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1177%2F0192623316632074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=26940714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2qur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=555-563&issue=4&author=D.+M.+Danilenkoauthor=G.+D.+L.+Phillipsauthor=D.+Diaz&title=In+vitro+skin+models+and+their+predictability+in+defining+normal+and+disease+biology%2C+pharmacology%2C+and+toxicity&doi=10.1177%2F0192623316632074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro skin models and their predictability in defining normal and disease biology, pharmacology, and toxicity</span></div><div class="casAuthors">Danilenko, Dimitry M.; Phillips, Gail D. Lewis; Diaz, Dolores</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">555-563</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">In vitro skin model systems are increasingly being used both in the early evaluation of therapeutic drug candidates and in confirmatory mechanistic studies.  The most commonly used of these in vitro model systems are reconstituted human epidermis (RHE) models.  These RHE models consist solely of epidermal keratinocytes, which comes with some limitations but also with the advantage of focusing toxicol. and pharmacol. evaluation on keratinocytes alone.  RHE models can generally be implemented more quickly, easily, and reproducibly than in vivo models and can thus be used for high throughput compd. screening while potentially reducing the need for animal studies.  Histol. evaluation of RHE sections can be done quite easily, and the sections are very amenable to quantification via image anal., including automated anal.  RHE model systems can provide very valuable early indications of therapeutic candidate biol., pharmacol., and toxicity; and early results have demonstrated that RHE models have been quite predictive for in vivo pharmacol. and toxicol. effects on the skin, including clin. skin toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcv7KaXFHzyLVg90H21EOLACvtfcHk0lhm_1ki78Shbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2qur%252FP&md5=d92c01898512a6376621231d6dbc145e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1177%2F0192623316632074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623316632074%26sid%3Dliteratum%253Aachs%26aulast%3DDanilenko%26aufirst%3DD.%2BM.%26aulast%3DPhillips%26aufirst%3DG.%2BD.%2BL.%26aulast%3DDiaz%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520skin%2520models%2520and%2520their%2520predictability%2520in%2520defining%2520normal%2520and%2520disease%2520biology%252C%2520pharmacology%252C%2520and%2520toxicity%26jtitle%3DToxicol.%2520Pathol.%26date%3D2016%26volume%3D44%26issue%3D4%26spage%3D555%26epage%3D563%26doi%3D10.1177%2F0192623316632074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takekoshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osamura, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawana, S.</span></span> <span> </span><span class="NLM_article-title">Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model</span>. <i>J. Mol. Histol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1023/B:HIJO.0000023388.51625.6c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1023%2FB%3AHIJO.0000023388.51625.6c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=15328920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvFKrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2004&pages=157-165&issue=2&author=R.+Takeyamaauthor=S.+Takekoshiauthor=H.+Nagataauthor=R.+Y.+Osamuraauthor=S.+Kawana&title=Quercetin-induced+melanogenesis+in+a+reconstituted+three-dimensional+human+epidermal+model&doi=10.1023%2FB%3AHIJO.0000023388.51625.6c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model</span></div><div class="casAuthors">Takeyama, Reiko; Takekoshi, Susumu; Nagata, Hidetaka; Osamura, R. Yoshiyuki; Kawana, Seiji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Histology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-165</span>CODEN:
                <span class="NLM_cas:coden">JMHOAO</span>;
        ISSN:<span class="NLM_cas:issn">1567-2379</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">Quercetin (3,5,7,3',4'-pentahydroxyflavone) is one of the most abundant natural flavonoids.  It is present in various common vegetables and fruits.  In this report, we examd. the effect of quercetin on melanogenesis using a three-dimensional reconstituted human epidermal culture model, MelanoDerm, which is a new com.-available cultured human epidermis contg. functional melanocytes.  Treatment with 10 μM quercetin induced an increase of tyrosinase activity in cultured epidermis after 3-5 days in time-dependent manner.  In the quercetin-treated epidermis, furthermore, melanin content and tyrosinase expression were markedly increased, as shown by immunohistochem. after a 7-day culture period.  Ultrastructural studies clearly indicated an accumulation of mature melanosomes (stages III and IV) inside the basal layer of the cultured epidermis after the quercetin treatment.  In addn., the dendrites of melanocytes extended further towards the adjacent keratinocytes after quercetin treatment.  These results suggest that quercetin has an effect on maturation of melanosomes and that quercetin has the potential to induced melanogenesis in human epidermis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptdi8MRP_MsLVg90H21EOLACvtfcHk0lhgGJWzxIsxDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvFKrtLw%253D&md5=d08dc43ed8e62309966870349005dd92</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1023%2FB%3AHIJO.0000023388.51625.6c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253AHIJO.0000023388.51625.6c%26sid%3Dliteratum%253Aachs%26aulast%3DTakeyama%26aufirst%3DR.%26aulast%3DTakekoshi%26aufirst%3DS.%26aulast%3DNagata%26aufirst%3DH.%26aulast%3DOsamura%26aufirst%3DR.%2BY.%26aulast%3DKawana%26aufirst%3DS.%26atitle%3DQuercetin-induced%2520melanogenesis%2520in%2520a%2520reconstituted%2520three-dimensional%2520human%2520epidermal%2520model%26jtitle%3DJ.%2520Mol.%2520Histol.%26date%3D2004%26volume%3D35%26issue%3D2%26spage%3D157%26epage%3D165%26doi%3D10.1023%2FB%3AHIJO.0000023388.51625.6c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwat, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batzer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smuda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolbe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearing, V. J.</span></span> <span> </span><span class="NLM_article-title">The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>123</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">3102</span>– <span class="NLM_lpage">3111</span>, <span class="refDoi"> DOI: 10.1242/jcs.064774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1242%2Fjcs.064774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=20736300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGls7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2010&pages=3102-3111&issue=18&author=W.+Choiauthor=R.+Wolberauthor=W.+Gerwatauthor=T.+Mannauthor=J.+Batzerauthor=C.+Smudaauthor=H.+Liuauthor=L.+Kolbeauthor=V.+J.+Hearing&title=The+fibroblast-derived+paracrine+factor+neuregulin-1+has+a+novel+role+in+regulating+the+constitutive+color+and+melanocyte+function+in+human+skin&doi=10.1242%2Fjcs.064774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin</span></div><div class="casAuthors">Choi, Wonseon; Wolber, Rainer; Gerwat, Wolfram; Mann, Tobias; Batzer, Jan; Smuda, Christoph; Liu, Hongfang; Kolbe, Ludger; Hearing, Vincent J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3102-3111</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Interactions between melanocytes and neighboring cells in the skin are important in regulating skin color in humans.  We recently demonstrated that the less pigmented and thicker skin on the palms and soles is regulated by underlying fibroblasts in those areas, specifically via a secreted factor (DKK1) that modulates Wnt signaling.  In this study, we tested the hypothesis that dermal fibroblasts regulate the constitutive skin color of individuals ranging from very light to very dark.  We used microarray anal. to compare gene expression patterns in fibroblasts derived from lighter skin types compared to darker skin types, with a focus on secreted proteins.  We identified a no. of genes that differ dramatically in expression and, among the expressed proteins, neuregulin-1, which is secreted by fibroblasts derived from dark skin, effectively increases the pigmentation of melanocytes in tissue culture and in an artificial skin model and regulates their growth, suggesting that it is one of the major factors detg. human skin color.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprH4CJ0OpTXbVg90H21EOLACvtfcHk0lhgGJWzxIsxDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGls7zE&md5=428d53c9baec75a30d1df7eed4ed45e2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1242%2Fjcs.064774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.064774%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DWolber%26aufirst%3DR.%26aulast%3DGerwat%26aufirst%3DW.%26aulast%3DMann%26aufirst%3DT.%26aulast%3DBatzer%26aufirst%3DJ.%26aulast%3DSmuda%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DKolbe%26aufirst%3DL.%26aulast%3DHearing%26aufirst%3DV.%2BJ.%26atitle%3DThe%2520fibroblast-derived%2520paracrine%2520factor%2520neuregulin-1%2520has%2520a%2520novel%2520role%2520in%2520regulating%2520the%2520constitutive%2520color%2520and%2520melanocyte%2520function%2520in%2520human%2520skin%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2010%26volume%3D123%26issue%3D18%26spage%3D3102%26epage%3D3111%26doi%3D10.1242%2Fjcs.064774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wills, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tankisheva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckeridge, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span> <span> </span><span class="NLM_article-title">Saftey, tolerability, and pharmacokinetic and pharmacodynamic effects of PF-06751979, a potent and selective oral BACE1 inhibitor: results from phase1 single and multiple ascending dose studies in healthy young and older volunteers</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">P575</span>– <span class="NLM_lpage">P576</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2017.07.196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1016%2Fj.jalz.2017.07.196" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=P575-P576&issue=7&author=R.+Qiuauthor=R.+Liuauthor=P.+Heauthor=A.-M.+Willsauthor=E.+Tankishevaauthor=C.+Alveyauthor=C.+Buckeridgeauthor=M.+Bednarauthor=R.+C.+Alexanderauthor=D.+Chen&title=Saftey%2C+tolerability%2C+and+pharmacokinetic+and+pharmacodynamic+effects+of+PF-06751979%2C+a+potent+and+selective+oral+BACE1+inhibitor%3A+results+from+phase1+single+and+multiple+ascending+dose+studies+in+healthy+young+and+older+volunteers&doi=10.1016%2Fj.jalz.2017.07.196"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2017.07.196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2017.07.196%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DWills%26aufirst%3DA.-M.%26aulast%3DTankisheva%26aufirst%3DE.%26aulast%3DAlvey%26aufirst%3DC.%26aulast%3DBuckeridge%26aufirst%3DC.%26aulast%3DBednar%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DChen%26aufirst%3DD.%26atitle%3DSaftey%252C%2520tolerability%252C%2520and%2520pharmacokinetic%2520and%2520pharmacodynamic%2520effects%2520of%2520PF-06751979%252C%2520a%2520potent%2520and%2520selective%2520oral%2520BACE1%2520inhibitor%253A%2520results%2520from%2520phase1%2520single%2520and%2520multiple%2520ascending%2520dose%2520studies%2520in%2520healthy%2520young%2520and%2520older%2520volunteers%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2017%26volume%3D13%26issue%3D7%26spage%3DP575%26epage%3DP576%26doi%3D10.1016%2Fj.jalz.2017.07.196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osmanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viana, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meghpara, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edward, D. P.</span></span> <span> </span><span class="NLM_article-title">Objective measurement of periocular pigmentation</span>. <i>Photodermatol., Photoimmunol. Photomed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1111/j.1600-0781.2008.00377.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1111%2Fj.1600-0781.2008.00377.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=19000184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A280%3ADC%252BD1cjjt1Sgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2008&pages=285-90&issue=6&author=J.+A.+Leeauthor=S.+Osmanovicauthor=M.+A.+Vianaauthor=R.+Kapurauthor=B.+Meghparaauthor=D.+P.+Edward&title=Objective+measurement+of+periocular+pigmentation&doi=10.1111%2Fj.1600-0781.2008.00377.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Objective measurement of periocular pigmentation</span></div><div class="casAuthors">Lee Janet Agnes; Osmanovic Smajo; Viana Marlos A G; Kapur Rashmi; Meghpara Beeran; Edward Deepak P</div><div class="citationInfo"><span class="NLM_cas:title">Photodermatology, photoimmunology & photomedicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">285-90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To evaluate the Minolta CR-400 chromameter in objectively measuring periocular/facial pigmentation in subjects of different ethnicities.  METHODS:  The CR-400 was used to obtain skin color measurements from 75 African-American, Caucasian and Hispanic subjects in 16 facial and periocular locations.  Comparisons between ethnic and Fitzpatrick groups and instrument reliability were analyzed.  RESULTS:  Significant differences in L* were observed among all three ethnic groups, while values a* and b* were less sensitive to differences in pigmentation.  Comparison between Fitzpatrick groups again identified value L* as being the most sensitive, demonstrating significant differences between the more heavily pigmented groups.  The 16 facial locations measured were found to be statistically similar to each other, and the chromameter demonstrated excellent inter- and intra-instrument reliability.  CONCLUSIONS:  The Minolta CR-400 chromameter reliably measures facial pigmentation and can be useful for studies evaluating changes in skin pigmentation.  Value L* is the parameter that is most sensitive to differences between ethnic and Fitzpatrick groups.  Overlap between groups was observed, demonstrating that in future studies, each individual must serve as their own control when monitoring changes in pigmentation.  The similarity between all the locations tested demonstrates uniformity of facial pigmentation within an individual.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIBTA0A173CE2yPDyEFiigfW6udTcc2eaX38S04xwfZ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjjt1Sgtw%253D%253D&md5=e1a95a9bf9075660cc30fc56d6b3966e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0781.2008.00377.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0781.2008.00377.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DOsmanovic%26aufirst%3DS.%26aulast%3DViana%26aufirst%3DM.%2BA.%26aulast%3DKapur%26aufirst%3DR.%26aulast%3DMeghpara%26aufirst%3DB.%26aulast%3DEdward%26aufirst%3DD.%2BP.%26atitle%3DObjective%2520measurement%2520of%2520periocular%2520pigmentation%26jtitle%3DPhotodermatol.%252C%2520Photoimmunol.%2520Photomed.%26date%3D2008%26volume%3D24%26issue%3D6%26spage%3D285%26epage%3D90%26doi%3D10.1111%2Fj.1600-0781.2008.00377.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalvass, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollack, G. M.</span></span> <span> </span><span class="NLM_article-title">Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo P-glycoprotein efflux ratios</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">666</span>, <span class="refDoi"> DOI: 10.1124/dmd.106.012294</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1124%2Fdmd.106.012294" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=660-666&issue=4&author=J.+C.+Kalvassauthor=T.+S.+Maurerauthor=G.+M.+Pollack&title=Use+of+plasma+and+brain+unbound+fractions+to+assess+the+extent+of+brain+distribution+of+34+drugs%3A+comparison+of+unbound+concentration+ratios+to+in+vivo+P-glycoprotein+efflux+ratios&doi=10.1124%2Fdmd.106.012294"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.012294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.012294%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DPollack%26aufirst%3DG.%2BM.%26atitle%3DUse%2520of%2520plasma%2520and%2520brain%2520unbound%2520fractions%2520to%2520assess%2520the%2520extent%2520of%2520brain%2520distribution%2520of%252034%2520drugs%253A%2520comparison%2520of%2520unbound%2520concentration%2520ratios%2520to%2520in%2520vivo%2520P-glycoprotein%2520efflux%2520ratios%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26issue%3D4%26spage%3D660%26epage%3D666%26doi%3D10.1124%2Fdmd.106.012294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kutchinsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taboryski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vestergaard, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krzywkowski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungstrom, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helix, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bech, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willumsen, N. J.</span></span> <span> </span><span class="NLM_article-title">Characterization of potassium channel modulators with QPatch automated patch-clamp technology: system characteristics and performance</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">693</span>, <span class="refDoi"> DOI: 10.1089/154065803770381048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1089%2F154065803770381048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=685-693&issue=5&author=J.+Kutchinskyauthor=S.+Friisauthor=M.+Asmildauthor=R.+Taboryskiauthor=S.+Pedersenauthor=R.+K.+Vestergaardauthor=R.+B.+Jacobsenauthor=K.+Krzywkowskiauthor=R.+L.+Schroderauthor=T.+Ljungstromauthor=N.+Helixauthor=C.+B.+Sorensenauthor=M.+Bechauthor=N.+J.+Willumsen&title=Characterization+of+potassium+channel+modulators+with+QPatch+automated+patch-clamp+technology%3A+system+characteristics+and+performance&doi=10.1089%2F154065803770381048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1089%2F154065803770381048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F154065803770381048%26sid%3Dliteratum%253Aachs%26aulast%3DKutchinsky%26aufirst%3DJ.%26aulast%3DFriis%26aufirst%3DS.%26aulast%3DAsmild%26aufirst%3DM.%26aulast%3DTaboryski%26aufirst%3DR.%26aulast%3DPedersen%26aufirst%3DS.%26aulast%3DVestergaard%26aufirst%3DR.%2BK.%26aulast%3DJacobsen%26aufirst%3DR.%2BB.%26aulast%3DKrzywkowski%26aufirst%3DK.%26aulast%3DSchroder%26aufirst%3DR.%2BL.%26aulast%3DLjungstrom%26aufirst%3DT.%26aulast%3DHelix%26aufirst%3DN.%26aulast%3DSorensen%26aufirst%3DC.%2BB.%26aulast%3DBech%26aufirst%3DM.%26aulast%3DWillumsen%26aufirst%3DN.%2BJ.%26atitle%3DCharacterization%2520of%2520potassium%2520channel%2520modulators%2520with%2520QPatch%2520automated%2520patch-clamp%2520technology%253A%2520system%2520characteristics%2520and%2520performance%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2003%26volume%3D1%26issue%3D5%26spage%3D685%26epage%3D693%26doi%3D10.1089%2F154065803770381048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawiec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21917</span>, <span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21917&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+L.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0lh9p5QaX1vXmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BL.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21917%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">David L. McKinzie, Leonard L. Winneroski, Steven J. Green, Erik J. Hembre, Jon A. Erickson, Brian A. Willis, Scott A. Monk, Christopher D. Aluise, Thomas K. Baker, Jose E. Lopez, Jörg Hendle, James P. Beck, Richard A. Brier, Leonard N. Boggs, Anthony R. Borders, Patrick J. Cocke, Pablo Garcia-Losada, Stephen L. Lowe, Brian M. Mathes, Patrick C. May, Warren J. Porter, Stephanie L. Stout, David E. Timm, Brian M. Watson, Zhixiang Yang, <span class="NLM_string-name hlFld-ContribAuthor">Dustin J. Mergott</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8076-8100. <a href="https://doi.org/10.1021/acs.jmedchem.1c00489" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00489%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BEarly%252BClinical%252BDevelopment%252Bof%252BLY3202626%25252C%252Ba%252BLow-Dose%25252C%252BCNS-Penetrant%252BBACE%252BInhibitor%26aulast%3DMcKinzie%26aufirst%3DDavid%2BL.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D17032021%26date%3D03062021%26volume%3D64%26issue%3D12%26spage%3D8076%26epage%3D8100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bryan Li, Richard W. Barnhart, Amelie Dion, Steven Guinness, Alan Happe, Cheryl M. Hayward, Jeffrey Kohrt, Teresa Makowski, Mark Maloney, Jade D. Nelson, Asaad Nematalla, J. Christopher McWilliams, Zhihui Peng, Jeffrey Raggon, John Sagal, Gerald A. Weisenburger, Denghui Bao, Miguel Gonzalez, Jiangping Lu, Mark D. McLaws, Jian Tao, <span class="NLM_string-name hlFld-ContribAuthor">Baolin Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor—Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (6)
                                     , 1440-1453. <a href="https://doi.org/10.1021/acs.oprd.1c00126" title="DOI URL">https://doi.org/10.1021/acs.oprd.1c00126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.1c00126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.1c00126%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DProcess%252BDevelopment%252Bof%252Ba%252BSecond%252BGeneration%252B%2525CE%2525B2-Amyloid-Cleaving%252BEnzyme%252BInhibitor%2525E2%252580%252594Improving%252Bthe%252BRobustness%252Bof%252Ba%252BHalogen-Metal%252BExchange%252BUsing%252BContinuous%252BStirred-Tank%252BReactors%26aulast%3DLi%26aufirst%3DBryan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12042021%26date%3D24052021%26volume%3D25%26issue%3D6%26spage%3D1440%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kazuki Fujimoto, Shuhei Yoshida, Genta Tadano, Naoya Asada, Kouki Fuchino, Shinji Suzuki, Eriko Matsuoka, Takahiko Yamamoto, Shiho Yamamoto, Shigeru Ando, Naoki Kanegawa, Yutaka Tonomura, Hisanori Ito, Diederik Moechars, Frederik J. R. Rombouts, Harrie J. M. Gijsen, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Approaches to Improving Selectivity through Utilizing Explicit Water Molecules: Discovery of Selective β-Secretase (BACE1) Inhibitors over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3075-3085. <a href="https://doi.org/10.1021/acs.jmedchem.0c01858" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01858%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BApproaches%252Bto%252BImproving%252BSelectivity%252Bthrough%252BUtilizing%252BExplicit%252BWater%252BMolecules%25253A%252BDiscovery%252Bof%252BSelective%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitors%252Bover%252BBACE2%26aulast%3DFujimoto%26aufirst%3DKazuki%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26102020%26date%3D15032021%26volume%3D64%26issue%3D6%26spage%3D3075%26epage%3D3085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bryan Li, Gerald A. Weisenburger, <span class="NLM_string-name hlFld-ContribAuthor">J. Christopher McWilliams</span>. </span><span class="cited-content_cbyCitation_article-title">Practical Considerations and Examples in Adapting Amidations to Continuous Flow Processing in Early Development. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (10)
                                     , 2311-2318. <a href="https://doi.org/10.1021/acs.oprd.0c00112" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00112%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DPractical%252BConsiderations%252Band%252BExamples%252Bin%252BAdapting%252BAmidations%252Bto%252BContinuous%252BFlow%252BProcessing%252Bin%252BEarly%252BDevelopment%26aulast%3DLi%26aufirst%3DBryan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20032020%26date%3D11052020%26date%3D29042020%26volume%3D24%26issue%3D10%26spage%3D2311%26epage%3D2318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Liping H. Pettus, Matthew P. Bourbeau, Jodi Bradley, Michael D. Bartberger, Kui Chen, Dean Hickman, Michael Johnson, Qingyian Liu, James R. Manning, Adrian Nanez, Aaron C. Siegmund, Paul H. Wen, Douglas A. Whittington, Jennifer R. Allen, <span class="NLM_string-name hlFld-ContribAuthor">Stephen Wood</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of AM-6494: A Potent and Orally Efficacious β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor with in Vivo Selectivity over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2263-2281. <a href="https://doi.org/10.1021/acs.jmedchem.9b01034" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01034%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAM-6494%25253A%252BA%252BPotent%252Band%252BOrally%252BEfficacious%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitor%252Bwith%252Bin%252BVivo%252BSelectivity%252Bover%252BBACE2%26aulast%3DPettus%26aufirst%3DLiping%2BH.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D29062019%26date%3D18102019%26date%3D07102019%26volume%3D63%26issue%3D5%26spage%3D2263%26epage%3D2281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kazuki Fujimoto, Eriko Matsuoka, Naoya Asada, Genta Tadano, Takahiko Yamamoto, Kenji Nakahara, Kouki Fuchino, Hisanori Ito, Naoki Kanegawa, Diederik Moechars, Harrie J. M. Gijsen, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Selective β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: Targeting the Flap to Gain Selectivity over BACE2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 5080-5095. <a href="https://doi.org/10.1021/acs.jmedchem.9b00309" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00309%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BSelective%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE1%252529%252BInhibitors%25253A%252BTargeting%252Bthe%252BFlap%252Bto%252BGain%252BSelectivity%252Bover%252BBACE2%26aulast%3DFujimoto%26aufirst%3DKazuki%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D16022019%26date%3D13052019%26date%3D25042019%26volume%3D62%26issue%3D10%26spage%3D5080%26epage%3D5095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Britton</span>, <span class="hlFld-ContribAuthor ">Veronique  Gouverneur</span>, <span class="hlFld-ContribAuthor ">Jin-Hong  Lin</span>, <span class="hlFld-ContribAuthor ">Michael  Meanwell</span>, <span class="hlFld-ContribAuthor ">Chuanfa  Ni</span>, <span class="hlFld-ContribAuthor ">Gabriele  Pupo</span>, <span class="hlFld-ContribAuthor ">Ji-Chang  Xiao</span>, <span class="hlFld-ContribAuthor ">Jinbo  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Contemporary synthetic strategies in organofluorine chemistry. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Methods Primers</span><span> <strong>2021,</strong> <em>1 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s43586-021-00042-1" title="DOI URL">https://doi.org/10.1038/s43586-021-00042-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s43586-021-00042-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs43586-021-00042-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Methods%2520Primers%26atitle%3DContemporary%252Bsynthetic%252Bstrategies%252Bin%252Borganofluorine%252Bchemistry%26aulast%3DBritton%26aufirst%3DRobert%26date%3D2021%26date%3D2021%26volume%3D1%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alvaro  Miranda</span>, <span class="hlFld-ContribAuthor ">Enrique  Montiel</span>, <span class="hlFld-ContribAuthor ">Henning  Ulrich</span>, <span class="hlFld-ContribAuthor ">Cristian  Paz</span>, . </span><span class="cited-content_cbyCitation_article-title">Selective Secretase Targeting for Alzheimer’s Disease Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2021,</strong> <em>81 </em>
                                    (1)
                                     , 1-17. <a href="https://doi.org/10.3233/JAD-201027" title="DOI URL">https://doi.org/10.3233/JAD-201027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-201027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-201027%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DSelective%252BSecretase%252BTargeting%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%26aulast%3DMiranda%26aufirst%3DAlvaro%26date%3D2021%26volume%3D81%26issue%3D1%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>, <span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 25-52. <a href="https://doi.org/10.1080/13543776.2021.1832463" title="DOI URL">https://doi.org/10.1080/13543776.2021.1832463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1832463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1832463%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BBACE1%252Binhibitors%25253A%252Ba%252Bpatent%252Bliterature%252Breview%252B%2525282011%252Bto%252B2020%252529%26aulast%3DRombouts%26aufirst%3DFrederik%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D1%26spage%3D25%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer R.  Baker</span>, <span class="hlFld-ContribAuthor ">Adam  McCluskey</span>, <span class="hlFld-ContribAuthor ">Cecilia C.  Russell</span>. </span><span class="cited-content_cbyCitation_article-title">1,3-Thiazines and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00104-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00104-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00104-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00104-9%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C3-Thiazines%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DBaker%26aufirst%3DJennifer%2BR.%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elahe  Zarini-Gakiye</span>, <span class="hlFld-ContribAuthor ">Javad  Amini</span>, <span class="hlFld-ContribAuthor ">Nima  Sanadgol</span>, <span class="hlFld-ContribAuthor ">Gholamhassan  Vaezi</span>, <span class="hlFld-ContribAuthor ">Kazem  Parivar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Updates in the Alzheimer’s Disease Etiopathology and Possible Treatment Approaches: A Narrative Review of Current Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name">Current Molecular Pharmacology</span><span> <strong>2020,</strong> <em>13 </em>
                                    (4)
                                     , 273-294. <a href="https://doi.org/10.2174/1874467213666200422090135" title="DOI URL">https://doi.org/10.2174/1874467213666200422090135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1874467213666200422090135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1874467213666200422090135%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Molecular%2520Pharmacology%26atitle%3DRecent%252BUpdates%252Bin%252Bthe%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BEtiopathology%252Band%252BPossible%252BTreatment%252BApproaches%25253A%252BA%252BNarrative%252BReview%252Bof%252BCurrent%252BClinical%252BTrials%26aulast%3DZarini-Gakiye%26aufirst%3DElahe%26date%3D2020%26volume%3D13%26issue%3D4%26spage%3D273%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Xinyue  Liu</span>, <span class="hlFld-ContribAuthor ">Weiming  Xia</span>, <span class="hlFld-ContribAuthor ">Yingkai  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunyu  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Neuroscience</span><span> <strong>2020,</strong> <em>13 </em><a href="https://doi.org/10.3389/fnmol.2020.00137" title="DOI URL">https://doi.org/10.3389/fnmol.2020.00137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnmol.2020.00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnmol.2020.00137%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Neuroscience%26atitle%3DTargeting%252BAmyloidogenic%252BProcessing%252Bof%252BAPP%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DZhao%26aufirst%3DJing%26date%3D2020%26date%3D2020%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Frohn</span>, <span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">Aaron C.  Siegmund</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Qian</span>, <span class="hlFld-ContribAuthor ">Albert  Amegadzie</span>, <span class="hlFld-ContribAuthor ">Ning  Chen</span>, <span class="hlFld-ContribAuthor ">Helming  Tan</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Allen</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Bourbeau</span>. </span><span class="cited-content_cbyCitation_article-title">The development of a structurally distinct series of BACE1 inhibitors via the (Z)-fluoro-olefin amide bioisosteric replacement. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (14)
                                     , 127240. <a href="https://doi.org/10.1016/j.bmcl.2020.127240" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127240%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdevelopment%252Bof%252Ba%252Bstructurally%252Bdistinct%252Bseries%252Bof%252BBACE1%252Binhibitors%252Bvia%252Bthe%252B%252528Z%252529-fluoro-olefin%252Bamide%252Bbioisosteric%252Breplacement%26aulast%3DFrohn%26aufirst%3DMichael%26date%3D2020%26volume%3D30%26issue%3D14%26spage%3D127240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miren  Ettcheto</span>, <span class="hlFld-ContribAuthor ">Oriol  Busquets</span>, <span class="hlFld-ContribAuthor ">Triana  Espinosa-Jiménez</span>, <span class="hlFld-ContribAuthor ">Ester  Verdaguer</span>, <span class="hlFld-ContribAuthor ">Carme  Auladell</span>, <span class="hlFld-ContribAuthor ">Antoni  Camins</span>. </span><span class="cited-content_cbyCitation_article-title">A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2020,</strong> <em>26 </em>
                                    (12)
                                     , 1286-1299. <a href="https://doi.org/10.2174/1381612826666200211121416" title="DOI URL">https://doi.org/10.2174/1381612826666200211121416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612826666200211121416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612826666200211121416%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DA%252BChronological%252BReview%252Bof%252BPotential%252BDisease-Modifying%252BTherapeutic%252BStrategies%252Bfor%252BAlzheimer%252527s%252BDisease%26aulast%3DEttcheto%26aufirst%3DMiren%26date%3D2020%26volume%3D26%26issue%3D12%26spage%3D1286%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruolun  Qiu</span>, <span class="hlFld-ContribAuthor ">Jae Eun  Ahn</span>, <span class="hlFld-ContribAuthor ">Robert  Alexander</span>, <span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Ping  He</span>, <span class="hlFld-ContribAuthor ">Claire  Leurent</span>, <span class="hlFld-ContribAuthor ">Jessica  Mancuso</span>, <span class="hlFld-ContribAuthor ">Richard A.  Margolin</span>, <span class="hlFld-ContribAuthor ">Ekaterina  Tankisheva</span>, <span class="hlFld-ContribAuthor ">Danny  Chen</span>, . </span><span class="cited-content_cbyCitation_article-title">Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PF-06751979, a Potent and Selective Oral BACE1 Inhibitor: Results from Phase I Studies in Healthy Adults and Healthy Older Subjects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2019,</strong> <em>71 </em>
                                    (2)
                                     , 581-595. <a href="https://doi.org/10.3233/JAD-190228" title="DOI URL">https://doi.org/10.3233/JAD-190228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-190228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-190228%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DSafety%25252C%252BTolerability%25252C%252BPharmacokinetics%25252C%252Band%252BPharmacodynamic%252BEffects%252Bof%252BPF-06751979%25252C%252Ba%252BPotent%252Band%252BSelective%252BOral%252BBACE1%252BInhibitor%25253A%252BResults%252Bfrom%252BPhase%252BI%252BStudies%252Bin%252BHealthy%252BAdults%252Band%252BHealthy%252BOlder%252BSubjects%26aulast%3DQiu%26aufirst%3DRuolun%26date%3D2019%26volume%3D71%26issue%3D2%26spage%3D581%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Liu</span>, <span class="hlFld-ContribAuthor ">Bianca M.  Lauro</span>, <span class="hlFld-ContribAuthor ">Li  Ding</span>, <span class="hlFld-ContribAuthor ">Matteo  Rovere</span>, <span class="hlFld-ContribAuthor ">Michael S.  Wolfe</span>, <span class="hlFld-ContribAuthor ">Dennis J.  Selkoe</span>. </span><span class="cited-content_cbyCitation_article-title">Multiple BACE1 inhibitors abnormally increase the BACE1 protein level in neurons by prolonging its half-life. </span><span class="cited-content_cbyCitation_journal-name">Alzheimer's & Dementia</span><span> <strong>2019,</strong> <em>15 </em>
                                    (9)
                                     , 1183-1194. <a href="https://doi.org/10.1016/j.jalz.2019.06.3918" title="DOI URL">https://doi.org/10.1016/j.jalz.2019.06.3918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jalz.2019.06.3918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jalz.2019.06.3918%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520%2526%2520Dementia%26atitle%3DMultiple%252BBACE1%252Binhibitors%252Babnormally%252Bincrease%252Bthe%252BBACE1%252Bprotein%252Blevel%252Bin%252Bneurons%252Bby%252Bprolonging%252Bits%252Bhalf-life%26aulast%3DLiu%26aufirst%3DLei%26date%3D2019%26date%3D2019%26volume%3D15%26issue%3D9%26spage%3D1183%26epage%3D1194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehmet  Gümüş</span>, <span class="hlFld-ContribAuthor ">Mehmet  Yakan</span>, <span class="hlFld-ContribAuthor ">İrfan  Koca</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances of thiazole hybrids in biological applications. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (15)
                                     , 1979-1998. <a href="https://doi.org/10.4155/fmc-2018-0196" title="DOI URL">https://doi.org/10.4155/fmc-2018-0196</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0196%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bof%252Bthiazole%252Bhybrids%252Bin%252Bbiological%252Bapplications%26aulast%3DG%25C3%25BCm%25C3%25BC%25C5%259F%26aufirst%3DMehmet%26date%3D2019%26volume%3D11%26issue%3D15%26spage%3D1979%26epage%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Harrie J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (6)
                                     , 761-777. <a href="https://doi.org/10.1016/j.bmcl.2018.12.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252Bevolutions%252Bin%252Bthe%252BBACE1%252Binhibitor%252Bfield%252Bfrom%252B2014%252Bto%252B2018%26aulast%3DHsiao%26aufirst%3DChien-Chi%26date%3D2019%26volume%3D29%26issue%3D6%26spage%3D761%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative overview of BACE1 inhibitors and selectivity over BACE2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Impact of reduced p<i>K</i><sub>a</sub> on key properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design strategy for modulating p<i>K</i><sub>a</sub> and selectivity over BACE2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Aryl or Heteroaryl Containing Thioamidines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ArX, 2.5 M <i>n</i>-BuLi in hexane, BF<sub>3</sub>-Et<sub>2</sub>O, toluene/THF (10:1 v/v), −70 °C then add 1<b>5</b> in toluene/THF (10:1 v/v), 25–68%; (b) H<sub>2</sub>, Raney nickel, ethanol or IPA/THF, 50 °C; (c) 2 equiv of BzNCS, ethyl acetate, r.t. to 90 °C (no isolation of thiourea intermediate); (d) BzNCS, ethyl acetate, r.t., 2.5 h (isolate thiourea), then BzNCS, ethyl acetate, 90 °C, 26–66%; (e) DBU, methanol, 70 °C, 15–74%.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Array Chemistry To Generate P1 Aryl Groups<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EtO<sub>2</sub>CN═C═S/THF then Scavenging Resin; (b) MeTHF/H<sub>2</sub>O/TFA, 60 °C, 1 h; (c) 120 °C, 4 h; (d) high throughput purification.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Bromo-thiazole <b>54</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,4-dibromo-thiazole, 2.5 M <i>n</i>-BuLi in hexane, BF<sub>3</sub>-Et<sub>2</sub>O, toluene/THF (10:1 v/v), −70 °C then add 1<b>5</b> in toluene/THF (10:1 v/v), 1 h, 85%; (b) Mo(CO)<sub>6</sub>, CH<sub>3</sub>CN, H<sub>2</sub>O, NaBH<sub>4</sub>, 70 °C, 1 h, 95%; (c) benzoyl isothiocyante, CH<sub>2</sub>Cl<sub>2</sub>, rt, 24 h, 66%; (d) Ghosez’s reagent, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h, 77%.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Elaboration of Bromide <b>54</b> into Amide Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>trans</i>-<i>N</i>,<i>N</i>′-dimethylcyclohexane-1,2-diamine, NaN<sub>3</sub>, H<sub>2</sub>O, sodium-<span class="smallcaps smallerCapital">l</span>-ascorbate rt then CuI, 70 °C, 2 h, 47%; (b) HATU, R-CO<sub>2</sub>H, DMF, rt, 1 h, or 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxide, pyridine or Et<sub>3</sub>N, rt, 12–24 h; (c) ArC(O)NH<sub>2</sub>, Pd<sub>2</sub>dba<sub>3</sub>, <i>t</i>BuBrettPhos, LiO-<i>t</i>-Bu, 2-MeBuOH, 95 °C, 1 h, 61%; (d) methoxyl-amine, HCl, pyridine, 50 °C, 16 h, or DBU, methanol, 70 °C; (e) Zn dust, THF, aq NaOH, 40 °C, 16 h, 86%; (f) <i>n</i>-BuLi, THF, CO<sub>2</sub>, −78 °C, 1 h, 95%; (g) HATU, R-NH<sub>2</sub>, DMF; (h) MeNH<sub>2</sub>, EtOH, rt, 2–4 h.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>64</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 2,4-dimethoxy benzyl amine, Pd<sub>2</sub>(dba)<sub>3</sub>, <i>t</i>-BuONa, <i>t</i>-BuXPhos, 70 °C, 1 h then HCl, H<sub>2</sub>O, rt, 1 h, 70%; (c) HATU, iPrNEt<sub>2</sub>, CH<sub>3</sub>CN, 5-(difluoromethoxy)picolinic acid, rt, 4 h, 81%; (d) DBU, methanol, 70 °C, 1.5 h, 55%.</p></p></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Molecular modeling of thiazole regioisomers. Vectors reach the S3 pocket from 4- or 5-position of thiazole <b>40</b> aligned in cocrystal structure (thin gray, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CLM">5CLM</a>). (a,b) Initial vector of 4- or 5-substitutions. (c,d) modeled phenyl amides reaching S3 pockets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Energy confirmations of thiazole <b>47</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A,B) Aryl-amide linkers designed to reach S3 pocket with potential to make H-bond to Gly230 backbone carbonyl.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0007.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compound <b>64</b> on brain and CSF amyloid-beta following administration in mouse and dog. (A) Compound <b>64</b> (10, 50, or 80 mg/kg) and vehicle were administered subcutaneously to male 129/sve mice. Brain Aβx-42 was assessed at 1, 3, 5, 7, 9, and 14 h postdose. Data are expressed as the mean of % of vehicle of <i>n</i> = 5 animals per group ± SEM; ****<i>p</i> < 0.0001, ***<i>p</i> < 0.001, **<i>p</i> < 0.01, *<i>p</i> < 0.05. (B) Compound <b>64</b> (10, 50, or 80 mg/kg) and vehicle were administered subcutaneously to male 129/sve mice. CSF Aβx-40 was assessed at 1, 3, 5, 7, 9, and 14 h postdose. Data are expressed as the mean of % of vehicle of <i>n</i> = 5 animals per group ± SEM; ****<i>p</i> < 0.0001, ***<i>p</i> < 0.001, **<i>p</i> < 0.01. All values for the 50 mg/kg dose at 3 h were below BLQ, which is defined as <23% of vehicle. All values for the 80 mg/kg dose groups at 3, 5, 7, and 9 h where BLQ is defined as <36.3% of vehicle. BLQ data points were interpolated from the standard curve and are represented in the graph. (C) Male 129/sve mice were dosed subcutaneously once a day for 5 days with <b>64</b> (10 or 50 mg/kg/day) or vehicle. CSF Aβx-40 was assessed at 1, 3, 5, 7, 9, and 14 h after the last dose. Data are expressed as the mean percent of vehicle of <i>n</i> = 5 animals per group ± SEM; ****<i>p</i> < 0.0001, ***<i>p</i> < 0.001, **<i>p</i> < 0.01, *<i>p</i> < 0.05. (D) Time course data for the effect of <b>64</b> on CSF Aβx-42 levels in dog. Compound <b>64</b> was orally dosed at 1 or 3 mg/kg at time = 0 h. Data are the mean ± SEM, <i>n</i> = 3 per group; *<i>p</i> < 0.05 for the 1 mg/kg group, <sup>†</sup><i>p</i> < 0.05 for the 3 mg/kg group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0008.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Human 3D skin model surface pigmentation following 9 days in culture; images and L value quantitation and representative EM. (A) Spectrophotometric quantitation (L value) showing full dose response curves of the melanocytes surface pigmentation using a hand-held Minolta CR-700D spectrophotometer following 9 days of treatment with the compounds indicated. The change in L value compared to DMSO control was plotted against a dose response of compound in duplicate using a four-parameter curve fit with variable slope. The concentration showing a change in L value of 2 points (delta 2) was used to rank order compounds. The plotted delta L data is a compilation of 2–5 separate full dose response experiments. The dotted line designates the concentration of compound required for a change in L value of 2 units. (B) Representative transmission electron microscopic images (4000×) of melanocytes demonstrating a qualitative reduction in number of melanosomes in the 100 nM compound <b>3</b> and 161 nM compound <b>4</b> melanocytes from 3D skin model as compared with DMSO control. Inset images demonstrate alteration in melanosome morphology characterized by irregular shape and indistinct borders in the BACE inhibitor treated groups as compared with control. Bar equals one micron.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/medium/jm-2018-00246g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0009.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effect of chronic dosing at multiples of the BACE2 binding IC<sub>50</sub> on pigmentation in C57BL/6J mice after synchronization of fur growth. (A) Representative images from chronic dosing of compound <b>3</b> at observed plasma exposures of 2-, 14-, and 48-fold of the BACE2 IC<sub>50</sub>. (B) Representative images from chronic dosing of compound <b>4</b> at observed plasma exposures of 6-, 54-, and 291-fold of the BACE2 IC<sub>50</sub> (C) Representative images from chronic dosing of compound <b>64</b> and <b>3</b> at comparable projected Aβ lowering in human.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-10/acs.jmedchem.8b00246/20180517/images/large/jm-2018-00246g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00246&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i66">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82214" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82214" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span> <span> </span><span class="NLM_article-title">The β-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">12787</span>– <span class="NLM_lpage">12794</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3657-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1523%2FJNEUROSCI.3657-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=19828790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12787-12794&issue=41&author=R.+Vassarauthor=D.+M.+Kovacsauthor=R.+Yanauthor=P.+C.+Wong&title=The+%CE%B2-secretase+enzyme+BACE+in+health+and+Alzheimer%E2%80%99s+disease%3A+regulation%2C+cell+biology%2C+function%2C+and+therapeutic+potential&doi=10.1523%2FJNEUROSCI.3657-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential</span></div><div class="casAuthors">Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12787-12794</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder.  The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation.  Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ prodn. in AD.  Since its discovery 10 years ago, much has been learned about BACE.  This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiol. functions in sodium current, synaptic transmission, myelination, and schizophrenia.  The therapeutic potential of BACE will also be considered.  This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGn8h_x-7_bVg90H21EOLACvtfcHk0lgMGP15eu_Ohw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP&md5=a462ad002cf3801570725719d71647c6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3657-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3657-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DThe%2520%25CE%25B2-secretase%2520enzyme%2520BACE%2520in%2520health%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520regulation%252C%2520cell%2520biology%252C%2520function%252C%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26issue%3D41%26spage%3D12787%26epage%3D12794%26doi%3D10.1523%2FJNEUROSCI.3657-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marks, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, M. J.</span></span> <span> </span><span class="NLM_article-title">BACE and γ-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis</span>. <i>Neurochem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">181</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.1007/s11064-009-0054-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1007%2Fs11064-009-0054-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=19760173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=181-210&issue=2&author=N.+Marksauthor=M.+J.+Berg&title=BACE+and+%CE%B3-secretase+characterization+and+their+sorting+as+therapeutic+targets+to+reduce+amyloidogenesis&doi=10.1007%2Fs11064-009-0054-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">BACE and γ-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis</span></div><div class="casAuthors">Marks, Neville; Berg, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-210</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Secretases are enzymes that process amyloid precursor protein (APP), a prototypic type-1 membrane protein.  This has led directly to discovery of novel aspartic proteases (β-secretase or BACE), a tetramer complex, γ-secretase (γ-SC) contg. presenilins, nicastrin, aph-1 and pen-2, and a new role for metalloprotease(s) of the ADAM family as α-secretases.  Recent advances in defining pathways that mediate endosomal/lysosomal/autophagic/exosomal trafficking now provide targets for new drugs to attenuate abnormal prodn. of fibril-forming products characteristic of Alzheimer's disease (AD).  A key to success includes not only characterization of relevant secretases, but mechanisms for sorting and transport of key metabolites to abnormal vesicles or sites for assembly of fibrils.  New developments highlighted here include an important role for an 'early recycling endosome' coated in a retromer complex contg. lipoprotein receptor LRP-II (SorLA) for switching APP to a non-amyloidogenic pathway for α-secretase processing, or to shuttle APP to a 'late endosome compartment' to form Aβ or AICD.  LRP11 (SorLA) is of particular importance since it decreases in sporadic AD whose etiol. is otherwise unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptFxOS-WJwAbVg90H21EOLACvtfcHk0ljUnmWo7quHYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentLnJ&md5=312eb981ae39671456e316bf050166dc</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs11064-009-0054-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-009-0054-1%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DN.%26aulast%3DBerg%26aufirst%3DM.%2BJ.%26atitle%3DBACE%2520and%2520%25CE%25B3-secretase%2520characterization%2520and%2520their%2520sorting%2520as%2520therapeutic%2520targets%2520to%2520reduce%2520amyloidogenesis%26jtitle%3DNeurochem.%2520Res.%26date%3D2010%26volume%3D35%26issue%3D2%26spage%3D181%26epage%3D210%26doi%3D10.1007%2Fs11064-009-0054-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckman, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostaszewski, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St. George Hyslop, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younkin, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid β-protein</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">116</span>, <span class="refDoi"> DOI: 10.1006/nbdi.1998.0183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1006%2Fnbdi.1998.0183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=9746908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlenurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1998&pages=107-116&issue=2&author=M.+Citronauthor=C.+B.+Eckmanauthor=T.+S.+Diehlauthor=C.+Corcoranauthor=B.+L.+Ostaszewskiauthor=W.+Xiaauthor=G.+Levesqueauthor=P.+St.+George+Hyslopauthor=S.+G.+Younkinauthor=D.+J.+Selkoe&title=Additive+effects+of+PS1+and+APP+mutations+on+secretion+of+the+42-residue+amyloid+%CE%B2-protein&doi=10.1006%2Fnbdi.1998.0183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid β-protein</span></div><div class="casAuthors">Citron, Martin; Eckman, Christopher B.; Diehl, Thekla S.; Corcoran, Chris; Ostaszewski, Beth L.; Xia, Weiming; Levesque, Georges; St. George Hyslop, Peter; Younkin, Steven G.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-116</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Humans harboring missense mutations in the presenilin 1 (PS1) gene undergo progressive cerebral deposition of the 42-residue amyloid β-protein (Aβ42) at an early age and develop severe Alzheimer's disease.  Aβ42 is selectively elevated in the conditioned media of cells expressing mutant but not wild-type PS1, indicating that presenilin mutations alter APP processing.  Here we analyze the effects of various PS1 mutant constructs on the cellular prodn. of Aβ42.  A construct expressing only the PS1 N-terminal endoproteolytic fragment with the mutation Y115H causes no significant increase in Aβ42, whereas a full-length PS1 construct with the same mutation does.  This result suggests that the pathogenic effect of mutant presenilins is produced by the full-length mol. even though only a minor proportion of total PS1 occurs as holoprotein in tissues and cell lines.  We demonstrate that the effects of two different PS1 mutations are additive when engineered into the same PS1 mol.  Therefore, two mutations alter γ-secretase processing of APP more than one and the PS1 mutations described to date do not cause the max. possible PS1-mediated rise in Aβ42.  When a PS1 mutation was expressed in cells carrying the APPv7171 mutation, Aβ42 rose dramatically to become the predominant secreted Aβ species, an observation of interest for transgenic modeling of AD.  Our results are consistent with the hypothesis that presenilin is a major regulator of the proteolytic processing of APP by γ-secretases.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ck6RE7yz9LVg90H21EOLACvtfcHk0ljUnmWo7quHYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlenurg%253D&md5=afd0de91ae36a1981ce9644f876ee1c1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.1998.0183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.1998.0183%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DEckman%26aufirst%3DC.%2BB.%26aulast%3DDiehl%26aufirst%3DT.%2BS.%26aulast%3DCorcoran%26aufirst%3DC.%26aulast%3DOstaszewski%26aufirst%3DB.%2BL.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DLevesque%26aufirst%3DG.%26aulast%3DSt.%2BGeorge%2BHyslop%26aufirst%3DP.%26aulast%3DYounkin%26aufirst%3DS.%2BG.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DAdditive%2520effects%2520of%2520PS1%2520and%2520APP%2520mutations%2520on%2520secretion%2520of%2520the%252042-residue%2520amyloid%2520%25CE%25B2-protein%26jtitle%3DNeurobiol.%2520Dis.%26date%3D1998%26volume%3D5%26issue%3D2%26spage%3D107%26epage%3D116%26doi%3D10.1006%2Fnbdi.1998.0183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atwal, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snaedal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sulem, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudbjartsson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhangale, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huttenlocher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjornsdottir, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreassen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joensson, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palotie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrens, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnusson, O. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorsteinsdottir, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefansson, K.</span></span> <span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span>. <i>Nature (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>488</i></span> (<span class="NLM_issue">7409</span>),  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&issue=7409&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Joenssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0lh1QCLNIPN0fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJoensson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2012%26volume%3D488%26issue%3D7409%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allsop, D.</span></span> <span> </span><span class="NLM_article-title">Amyloid deposition as the central event in the etiology of Alzheimer’s disease</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1016/0165-6147(91)90609-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1016%2F0165-6147%2891%2990609-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1763432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383-388&issue=10&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+deposition+as+the+central+event+in+the+etiology+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2F0165-6147%2891%2990609-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid deposition as the central event in the etiology of Alzheimer's disease</span></div><div class="casAuthors">Hardy, John; Allsop, David</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">383-8</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    </div><div class="casAbstract">A review with 50 refs. of pathol. and etiol. of Alzheimer's disease; the function of β-amyloid precursor protein and the mechanism of formation of cerebrovascular amyloid peptide β/A4; and the progression of the disease from amyloid formation to neurofibrillary tangles and cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRPqP0OKB5rVg90H21EOLACvtfcHk0lh1QCLNIPN0fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmslKktr8%253D&md5=7756055cd27bec2821c9926267a93872</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0165-6147%2891%2990609-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-6147%252891%252990609-V%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520deposition%2520as%2520the%2520central%2520event%2520in%2520the%2520etiology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26issue%3D10%26spage%3D383%26epage%3D388%26doi%3D10.1016%2F0165-6147%2891%2990609-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minogue, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sala Frigerio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadeeva, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasco, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">The APP family of proteins: similarities and differences</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">416</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1042/BST0350416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1042%2FBST0350416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=17371289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjt1Wrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=416-420&issue=2&author=D.+M.+Walshauthor=A.+M.+Minogueauthor=C.+Sala+Frigerioauthor=J.+V.+Fadeevaauthor=W.+Wascoauthor=D.+J.+Selkoe&title=The+APP+family+of+proteins%3A+similarities+and+differences&doi=10.1042%2FBST0350416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The APP family of proteins: similarities and differences</span></div><div class="casAuthors">Walsh, D. M.; Minogue, A. M.; Sala Frigerio, C.; Fadeeva, J. V.; Wasco, W.; Selkoe, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">416-420</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Overwhelming evidence indicates that the Aβ (amyloid β-peptide) plays a crit. role in the pathogenesis of Alzheimer's disease.  Aβ is derived from the APP (amyloid precursor protein) by the action of two aspartyl proteases (β- and γ-secretases) that are leading candidates for therapeutic intervention.  APP is a member of a multigene family that includes APLP1 (amyloid precursor-like protein 1) and APLP2.  Both APLPs are processed in a manner analogous to APP, with all three proteins subject to ectodomain shedding and subsequent cleavage by γ-secretase.  Careful study of the APP family of proteins has already revealed important insights about APP.  Here, we will review how knowledge of the similarities and differences between APP and the APLPs may prove useful for the development of novel disease-modifying therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgIFSCWiOS3bVg90H21EOLACvtfcHk0lh1QCLNIPN0fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjt1Wrtb8%253D&md5=30c7dcfea77c0bc2b2dae85d4a2d4d90</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2FBST0350416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0350416%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DMinogue%26aufirst%3DA.%2BM.%26aulast%3DSala%2BFrigerio%26aufirst%3DC.%26aulast%3DFadeeva%26aufirst%3DJ.%2BV.%26aulast%3DWasco%26aufirst%3DW.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520APP%2520family%2520of%2520proteins%253A%2520similarities%2520and%2520differences%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2007%26volume%3D35%26issue%3D2%26spage%3D416%26epage%3D420%26doi%3D10.1042%2FBST0350416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu-Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeloff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span> <span> </span><span class="NLM_article-title">Expression analysis of BACE2 in brain and peripheral tissues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span> (<span class="NLM_issue">27</span>),  <span class="NLM_fpage">20647</span>– <span class="NLM_lpage">20651</span>, <span class="refDoi"> DOI: 10.1074/jbc.M002688200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1074%2Fjbc.M002688200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=20647-20651&issue=27&author=B.+D.+Bennettauthor=S.+Babu-Khanauthor=R.+Loeloffauthor=J.+C.+Louisauthor=E.+Curranauthor=M.+Citronauthor=R.+Vassar&title=Expression+analysis+of+BACE2+in+brain+and+peripheral+tissues&doi=10.1074%2Fjbc.M002688200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M002688200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M002688200%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DExpression%2520analysis%2520of%2520BACE2%2520in%2520brain%2520and%2520peripheral%2520tissues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26issue%3D27%26spage%3D20647%26epage%3D20651%26doi%3D10.1074%2Fjbc.M002688200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Esterhazy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuetzer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rechsteiner, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doebeli, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prummer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieske, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marselli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr-Conte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebersold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliorini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoffel, M.</span></span> <span> </span><span class="NLM_article-title">Bace2 Is a β cell-enriched protease that regulates pancreatic β cell function and mass</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">377</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2011.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1016%2Fj.cmet.2011.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=21907142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=365-377&issue=3&author=D.+Esterhazyauthor=I.+Stuetzerauthor=H.+Wangauthor=M.+P.+Rechsteinerauthor=J.+Beauchampauthor=H.+Doebeliauthor=H.+Hilpertauthor=H.+Matileauthor=M.+Prummerauthor=A.+Schmidtauthor=N.+Lieskeauthor=B.+Boehmauthor=L.+Marselliauthor=D.+Boscoauthor=J.+Kerr-Conteauthor=R.+Aebersoldauthor=G.+A.+Spinasauthor=H.+Mochauthor=C.+Miglioriniauthor=M.+Stoffel&title=Bace2+Is+a+%CE%B2+cell-enriched+protease+that+regulates+pancreatic+%CE%B2+cell+function+and+mass&doi=10.1016%2Fj.cmet.2011.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass</span></div><div class="casAuthors">Esterhazy, Daria; Stuetzer, Ina; Wang, Haiyan; Rechsteiner, Markus P.; Beauchamp, Jeremy; Doebeli, Heinz; Hilpert, Hans; Matile, Hugues; Prummer, Michael; Schmidt, Alexander; Lieske, Nora; Boehm, Bernhard; Marselli, Lorella; Bosco, Domenico; Kerr-Conte, Julie; Aebersold, Ruedi; Spinas, Giatgen Andreia; Moch, Holger; Migliorini, Cristiano; Stoffel, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Decreased β cell mass and function are hallmarks of type 2 diabetes.  Here we identified, through a siRNA screen, beta site amyloid precursor protein cleaving enzyme 2 (Bace2) as the sheddase of the proproliferative plasma membrane protein Tmem27 in murine and human β cells.  Mice with functionally inactive Bace2 and insulin-resistant mice treated with a newly identified Bace2 inhibitor both display augmented β cell mass and improved control of glucose homeostasis due to increased insulin levels.  These results implicate Bace2 in the control of β cell maintenance and provide a rational strategy to inhibit this protease for the expansion of functional pancreatic β cell mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNmw-BllVxx7Vg90H21EOLACvtfcHk0lgAg_JfjAOYnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM&md5=489e20b2d997eb0cbaff195819e35d64</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DEsterhazy%26aufirst%3DD.%26aulast%3DStuetzer%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRechsteiner%26aufirst%3DM.%2BP.%26aulast%3DBeauchamp%26aufirst%3DJ.%26aulast%3DDoebeli%26aufirst%3DH.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DPrummer%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DLieske%26aufirst%3DN.%26aulast%3DBoehm%26aufirst%3DB.%26aulast%3DMarselli%26aufirst%3DL.%26aulast%3DBosco%26aufirst%3DD.%26aulast%3DKerr-Conte%26aufirst%3DJ.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSpinas%26aufirst%3DG.%2BA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DMigliorini%26aufirst%3DC.%26aulast%3DStoffel%26aufirst%3DM.%26atitle%3DBace2%2520Is%2520a%2520%25CE%25B2%2520cell-enriched%2520protease%2520that%2520regulates%2520pancreatic%2520%25CE%25B2%2520cell%2520function%2520and%2520mass%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D14%26issue%3D3%26spage%3D365%26epage%3D377%26doi%3D10.1016%2Fj.cmet.2011.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koulov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alory-Jost, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balch, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span> <span> </span><span class="NLM_article-title">Functional amyloid formation within mammalian tissue</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">e6</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.0040006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1371%2Fjournal.pbio.0040006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=16300414" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=e6&issue=1&author=D.+M.+Fowlerauthor=A.+V.+Koulovauthor=C.+Alory-Jostauthor=M.+S.+Marksauthor=W.+E.+Balchauthor=J.+W.+Kelly&title=Functional+amyloid+formation+within+mammalian+tissue&doi=10.1371%2Fjournal.pbio.0040006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.0040006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.0040006%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DD.%2BM.%26aulast%3DKoulov%26aufirst%3DA.%2BV.%26aulast%3DAlory-Jost%26aufirst%3DC.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DBalch%26aufirst%3DW.%2BE.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DFunctional%2520amyloid%2520formation%2520within%2520mammalian%2520tissue%26jtitle%3DPLoS%2520Biol.%26date%3D2006%26volume%3D4%26issue%3D1%26spage%3De6%26doi%3D10.1371%2Fjournal.pbio.0040006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luk, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stayrook, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmon, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shorter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span> <span> </span><span class="NLM_article-title">N-terminal domains elicit formation of functional Pmel17 amyloid fibrils</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span> (<span class="NLM_issue">51</span>),  <span class="NLM_fpage">35543</span>– <span class="NLM_lpage">35555</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.047449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1074%2Fjbc.M109.047449" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=35543-35555&issue=51&author=B.+Wattauthor=G.+van+Nielauthor=D.+M.+Fowlerauthor=I.+Hurbainauthor=K.+C.+Lukauthor=S.+E.+Stayrookauthor=M.+A.+Lemmonauthor=G.+Raposoauthor=J.+Shorterauthor=J.+W.+Kellyauthor=M.+S.+Marks&title=N-terminal+domains+elicit+formation+of+functional+Pmel17+amyloid+fibrils&doi=10.1074%2Fjbc.M109.047449"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.047449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.047449%26sid%3Dliteratum%253Aachs%26aulast%3DWatt%26aufirst%3DB.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26aulast%3DFowler%26aufirst%3DD.%2BM.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DLuk%26aufirst%3DK.%2BC.%26aulast%3DStayrook%26aufirst%3DS.%2BE.%26aulast%3DLemmon%26aufirst%3DM.%2BA.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3DShorter%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26atitle%3DN-terminal%2520domains%2520elicit%2520formation%2520of%2520functional%2520Pmel17%2520amyloid%2520fibrils%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26issue%3D51%26spage%3D35543%26epage%3D35555%26doi%3D10.1074%2Fjbc.M109.047449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rochin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serneels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fort, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span> <span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">10658</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&issue=26&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D26%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Bebber, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruscha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span> <span> </span><span class="NLM_article-title">Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">471</span>– <span class="NLM_lpage">481</span>, <span class="refDoi"> DOI: 10.1111/jnc.12198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1111%2Fjnc.12198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=23406323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWqs7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2013&pages=471-481&issue=4&author=F.+van%0ABebberauthor=A.+Hruschaauthor=M.+Willemauthor=B.+Schmidauthor=C.+Haass&title=Loss+of+Bace2+in+zebrafish+affects+melanocyte+migration+and+is+distinct+from+Bace1+knock+out+phenotypes&doi=10.1111%2Fjnc.12198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of Bace2 in zebrafish affects melanocyte migration and is distinct from Bace1 knock out phenotypes</span></div><div class="casAuthors">van Bebber, Frauke; Hruscha, Alexander; Willem, Michael; Schmid, Bettina; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">3&4</span>),
    <span class="NLM_cas:pages">471-481</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Alzheimer's disease is the most frequent dementia.  Pathol., Alzheimer's disease is characterized by the accumulation of senile plaques composed of amyloid β-peptide (Aβ).  Two proteases, β- and γ-secretase proteolytically generate Aβ from its precursor, the β-amyloid precursor protein (APP).  Inhibition of β-secretase, also referred to as beta-site APP cleaving enzyme (BACE1) or γ-secretase is therefore of prime interest for the development of amyloid-lowering drugs.  To assess the in vivo function of zebrafish Bace1 (zBace1), we generated zBace1 knock out fish by zinc finger nuclease-mediated genome editing.  Bace1 mutants (bace1-/-) are hypomyelinated in the PNS while the CNS is not affected.  Moreover, the no. of mechanosensory neuromasts is elevated in bace1-/-.  Mutations in zebrafish Bace2 (zBace2) revealed a distinct melanocyte migration phenotype, which is not obsd. in bace1-/-.  Double homozygous bace1-/-;bace2-/- fish do not enhance the single mutant phenotypes indicating non-redundant distinct physiol. functions.  Single homozygous bace1 mutants as well as double homozygous bace1 and bace2 mutants are viable and fertile suggesting that Bace1 is a promising drug target without major side effects.  The identification of a specific bace2 -/- assocd. phenotype further allows improving selective Bace1 inhibitors and to distinguish between Bace 1 and Bace 2 inhibition in vivo.  Inhibition of BACE1 protease activity has therapeutic importance for Alzheimer's disease.  Anal. of BACE1 and BACE2 knock-out zebrafish revealed that they exhibit distinct phenotypes.  Bace1 mutants display hypomyelination in the PNS and supernumerary neuromasts while in bace2 mutants the shape and migration of melanocytes is affected.  These phenotypes are not further enhanced in the viable double mutants.  Our data suggest that blocking BACE1 activity is a safe therapeutic approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6hPBx6BmbmLVg90H21EOLACvtfcHk0lgAg_JfjAOYnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWqs7bL&md5=9a8f81383e56f96dfa821c98182a739f</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12198%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BBebber%26aufirst%3DF.%26aulast%3DHruscha%26aufirst%3DA.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DB.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DLoss%2520of%2520Bace2%2520in%2520zebrafish%2520affects%2520melanocyte%2520migration%2520and%2520is%2520distinct%2520from%2520Bace1%2520knock%2520out%2520phenotypes%26jtitle%3DJ.%2520Neurochem.%26date%3D2013%26volume%3D127%26issue%3D4%26spage%3D471%26epage%3D481%26doi%3D10.1111%2Fjnc.12198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burgoyne, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seabra, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Futter, C. E.</span></span> <span> </span><span class="NLM_article-title">Regulation of melanosome number, shape and movement in the zebrafish retinal pigment epithelium by OA1 and PMEL</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>128</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1400</span>– <span class="NLM_lpage">1407</span>, <span class="refDoi"> DOI: 10.1242/jcs.164400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1242%2Fjcs.164400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=25690007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosV2ltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2015&pages=1400-1407&issue=7&author=T.+Burgoyneauthor=M.+N.+O%E2%80%99Connorauthor=M.+C.+Seabraauthor=D.+F.+Cutlerauthor=C.+E.+Futter&title=Regulation+of+melanosome+number%2C+shape+and+movement+in+the+zebrafish+retinal+pigment+epithelium+by+OA1+and+PMEL&doi=10.1242%2Fjcs.164400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of melanosome number, shape and movement in the zebrafish retinal pigment epithelium by OA1 and PMEL</span></div><div class="casAuthors">Burgoyne, Thomas; O'Connor, Marie N.; Seabra, Miguel C.; Cutler, Daniel F.; Futter, Clare E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1400-1407</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Anal. of melanosome biogenesis in the retinal pigment epithelium (RPE) is challenging because it occurs predominantly in a short embryonic time window.  Here, we show that the zebrafish provides an ideal model system for studying this process because in the RPE the timing of melanosome biogenesis facilitates mol. manipulation using morpholinos.  Morpholino-mediated knockdown of OA1 (also known as GPR143), mutations in the human homolog of which cause the most common form of human ocular albinism, induces a major redn. in melanosome no., recapitulating a key feature of the mammalian disease where reduced melanosome nos. precede macromelanosome formation.  We further show that PMEL, a key component of mammalian melanosome biogenesis, is required for the generation of cylindrical melanosomes in zebrafish, which in turn is required for melanosome movement into the apical processes and maintenance of photoreceptor integrity.  Spherical and cylindrical melanosomes contg. similar melanin vols. co-exist in the cell body but only cylindrical melanosomes enter the apical processes.  Taken together, our findings indicate that melanosome no. and shape are independently regulated and that melanosome shape controls a function in the RPE that depends on localization in the apical processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW8AE6Al4h4rVg90H21EOLACvtfcHk0lhLrI11i8PWGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosV2ltL8%253D&md5=461278b06690ee6fe2a7363203a105fc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1242%2Fjcs.164400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.164400%26sid%3Dliteratum%253Aachs%26aulast%3DBurgoyne%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%2BN.%26aulast%3DSeabra%26aufirst%3DM.%2BC.%26aulast%3DCutler%26aufirst%3DD.%2BF.%26aulast%3DFutter%26aufirst%3DC.%2BE.%26atitle%3DRegulation%2520of%2520melanosome%2520number%252C%2520shape%2520and%2520movement%2520in%2520the%2520zebrafish%2520retinal%2520pigment%2520epithelium%2520by%2520OA1%2520and%2520PMEL%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2015%26volume%3D128%26issue%3D7%26spage%3D1400%26epage%3D1407%26doi%3D10.1242%2Fjcs.164400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attalla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soderberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budd Haeberlein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingersoll, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. W.</span></span> <span> </span><span class="NLM_article-title">Reversible and species-specific depigmentation effects of AZD3293, a BACE inhibitor for the treatment of Alzheimer’s Disease, are related to BACE2 inhibition and confined to epidermis and hair</span>. <i>Journal of Prevention of Alzheimer’s Disease</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=29199322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A280%3ADC%252BC1M3ntlKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=202-218&issue=4&author=G.+Cebersauthor=T.+Lejeuneauthor=B.+Attallaauthor=M.+Soderbergauthor=R.+C.+Alexanderauthor=S.+Budd+Haeberleinauthor=A.+R.+Kuglerauthor=E.+W.+Ingersollauthor=S.+Platzauthor=C.+W.+Scott&title=Reversible+and+species-specific+depigmentation+effects+of+AZD3293%2C+a+BACE+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+Disease%2C+are+related+to+BACE2+inhibition+and+confined+to+epidermis+and+hair"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Reversible and Species-Specific Depigmentation Effects of AZD3293, a BACE Inhibitor for the Treatment of Alzheimer's Disease, Are Related to BACE2 Inhibition and Confined to Epidermis and Hair</span></div><div class="casAuthors">Cebers G; Lejeune T; Attalla B; Soderberg M; Alexander R C; Budd Haeberlein S; Kugler A R; Ingersoll E W; Platz S; Scott C W</div><div class="citationInfo"><span class="NLM_cas:title">The journal of prevention of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">202-218</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  AZD3293 (also known as LY3314814) is a novel, potent, non-selective BACE1/BACE2 inhibitor currently in Phase 3 clinical development for the treatment of Alzheimer's disease.  OBJECTIVES:  The purpose of these studies was to characterize the effects, putative mechanism, and reversibility of hypopigmentation following treatment with AZD3293 in pigmented Long-Evans rats, Beagle dogs, human cell cultures, and humans.  DESIGN:  Nonclinical studies were conducted in Long-Evans pigmented rats, and both young and older Beagle dogs using a variety of oral dose levels of AZD3293 or AZD3839 (BACE inhibition reference compound; used in older dogs only) for dosing durations of 13 to 26 weeks.  In vitro studies of normal human epidermal melanocytes and reconstituted human epidermis were also conducted.  Skin biopsy data from a multiple-dose Phase 1 clinical study of AZD3293 (NCT01795339) are also reported.  SETTING:  Nonclinical in vivo and in vitro studies were conducted in laboratory settings in the US, Canada, and France; the multiple dose clinical study was conducted in a specialized inpatient setting in the US.  PARTICIPANTS:  Beagle dogs: 13-week study N=36 young (8-10 mo) animals; 39-week study N=64 young animals; and a second 13-week study N=32 older (30-32 mo) animals.  Long-Evans rats: N=68 animals.  Multiple-dose clinical study: only data for subjects enrolled in Part 2 of this study are included in this report (N=16).  INTERVENTIONS:  AZD3293 was the primary intervention used in these studies.  AZD3839, a relatively BACE1-selective reference inhibitor compound was used in one group in the 13 week study in older Beagle dogs and one in vitro assessment.  Finally, AZ1340, another relatively BACE1-selective reference inhibitor compound was used only in one in vitro assessment.  MEASUREMENTS:  Measurements for the nonclinical studies in dogs and rats included macroscopic observation and assessment of skin biopsies via histopathology, immunochemistry, and electron microscopy.  Measurements for the in vitro studies included melanocyte premelanosome protein (PMEL) processing, cytotoxicity, melanin synthesis, Pmel17 labeling, and melanocyte dendricity.  Measurements in the clinical study included scoring of melanin content in skin biopsies taken before and after dosing with AZD3293 over 14 days at dose levels up to 150 mg.  RESULTS:  Depigmentation in rats and dogs was limited to skin, hair, and mucosa with no effects on other pigmented tissues.  At a cellular level depigmentation was observed within a week of treatment, whereas the appearance of depigmentation in skin and hair did not become apparent until, at earliest, 4 weeks of treatment.  The depigmentation effects were reversible, not associated with degenerative or inflammatory changes, and were dose- and species-dependent in severity.  Full recovery of melanization was observed at the microscopic (cellular) level and at least partial recovery was seen in the macroscopic appearance of animals by the end of the 12-week recovery period in both rats and dogs.  Interestingly, no changes in melanin production or melanocyte morphology were seen in human primary melanocytes or reconstituted human epidermis in vitro.  Finally, there were no changes in melanization level in skin biopsies following 12 days of daily AZD3293 treatment at doses of AZD3293 up to 150 mg/day in human subjects.  CONCLUSIONS:  AZD3293, a novel, potent, non-selective BACE1/BACE2 inhibitor is in development as a potentially disease-modifying treatment for Alzheimer's disease.  Chronic nonclinical studies in Beagle dogs and pigmented rats showed macroscopic and microscopic hypopigmentation effects of AZD3293 that were limited to skin, hair, and mucosa.  These effects were shown to be reversible in both species.  Analysis of data from nonclinical and in vitro studies suggests that hypopigmentation is caused by BACE2 inhibition resulting in accumulation of a premelanosome protein fragment, which interrupts the normal production of melanin.  No macroscopic or microscopic reports of hypopigmentation were observed in a Phase 1 clinical study following 13 doses of AZD3293 over 14 days at dose levels up to 150 mg/day.  These data suggest that hypopigmentation is species-specific and humans appear to be least sensitive to the depigmentation effect caused by BACE2 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSnMZvqjWSFT7t7lRqEFUJVfW6udTcc2eZn8tu9EgE4X7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3ntlKisw%253D%253D&md5=8eaa57d7d8e3bb8bfad9244ffb5ae16a</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DLejeune%26aufirst%3DT.%26aulast%3DAttalla%26aufirst%3DB.%26aulast%3DSoderberg%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DBudd%2BHaeberlein%26aufirst%3DS.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DIngersoll%26aufirst%3DE.%2BW.%26aulast%3DPlatz%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DC.%2BW.%26atitle%3DReversible%2520and%2520species-specific%2520depigmentation%2520effects%2520of%2520AZD3293%252C%2520a%2520BACE%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%252C%2520are%2520related%2520to%2520BACE2%2520inhibition%2520and%2520confined%2520to%2520epidermis%2520and%2520hair%26jtitle%3DJournal%2520of%2520Prevention%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26date%3D2016%26volume%3D3%26issue%3D4%26spage%3D202%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veenstra, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lueoend, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tintelnot-Blomley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laue, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frieauff, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staufenbiel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span> <span> </span><span class="NLM_article-title">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-beta and neuroinflammation in APP transgenic mice</span>. <i>Mol. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">44</span>, <span class="refDoi"> DOI: 10.1186/s13024-015-0033-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1186%2Fs13024-015-0033-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=26336937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=44&author=U.+Neumannauthor=H.+Rueegerauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=R.+M.+Lueoendauthor=M.+Tintelnot-Blomleyauthor=G.+Laueauthor=K.+Beltzauthor=B.+Voggauthor=P.+Schmidauthor=W.+Frieauffauthor=D.+R.+Shimshekauthor=M.+Staufenbielauthor=L.+H.+Jacobson&title=A+novel+BACE+inhibitor+NB-360+shows+a+superior+pharmacological+profile+and+robust+reduction+of+amyloid-beta+and+neuroinflammation+in+APP+transgenic+mice&doi=10.1186%2Fs13024-015-0033-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice</span></div><div class="casAuthors">Neumann, Ulf; Rueeger, Heinrich; Machauer, Rainer; Veenstra, Siem Jacob; Lueoend, Rainer M.; Tintelnot-Blomley, Marina; Laue, Grit; Beltz, Karen; Vogg, Barbara; Schmid, Peter; Frieauff, Wilfried; Shimshek, Derya R.; Staufenbiel, Matthias; Jacobson, Laura H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44/1-44/15</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease (AD) is the most common form of dementia, the no. of affected individuals is rising, with significant impacts for healthcare systems.  Current symptomatic treatments delay, but do not halt, disease progression.  Genetic evidence points to aggregation and deposition of amyloid-β (Aβ) in the brain being causal for the neurodegeneration and dementia typical of AD.  Approaches to target Aβ via inhibition of γ-secretase or passive antibody therapy have not yet resulted in substantial clin. benefits.  Inhibition of BACE1 (β-secretase) has proven a challenging concept, but recent BACE1inhibitors can enter the brain sufficiently well to lower Aβ.  However, failures with the first clin. BACE1 inhibitors have highlighted the need to generate compds. with appropriate efficacy and safety profiles, since long treatment periods are expected to be necessary in humans.  Results: Treatment with NB-360, a potent and brain penetrable BACE-1 inhibitor can completely block the progression of Aβ deposition in the brains of APP transgenic mice, a model for amyloid pathol.  We furthermore show that almost complete redn. of Aβ was achieved also in rats and in dogs, suggesting that these findings are translational across species and can be extrapolated to humans.  Amyloid pathol. may be an initial step in a complex pathol. cascade; therefore we investigated the effect of BACE-1 inhibition on neuroinflammation, a prominent downstream feature of the disease.  NB-360 stopped accumulation of activated inflammatory cells in the brains of APP transgenic mice.  Upon chronic treatment of APP transgenic mice, patches of gray hairs appeared.  Conclusions: In a rapidly developing field, the data on NB-360 broaden the chem. space and expand knowledge on the properties that are needed to make a BACE-1 inhibitor potent and safe enough for long-term use in patients.  Due to its excellent brain penetration, reasonable oral doses of NB-360 were sufficient to completely block amyloid-β deposition in an APP transgenic mouse model.  Data across species suggest similar treatment effects can possibly be achieved in humans.  The reduced neuroinflammation upon amyloid redn. by NB-360 treatment supports the notion that targeting amyloid-β pathol. can have beneficial downstream effects on the progression of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJLgu8zl8_LVg90H21EOLACvtfcHk0lgaj9WMSZSJww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D&md5=728407859709d7de57d68bfdc374fe85</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1186%2Fs13024-015-0033-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-015-0033-8%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DLueoend%26aufirst%3DR.%2BM.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DLaue%26aufirst%3DG.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26atitle%3DA%2520novel%2520BACE%2520inhibitor%2520NB-360%2520shows%2520a%2520superior%2520pharmacological%2520profile%2520and%2520robust%2520reduction%2520of%2520amyloid-beta%2520and%2520neuroinflammation%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DMol.%2520Neurodegener.%26date%3D2015%26volume%3D10%26spage%3D44%26doi%3D10.1186%2Fs13024-015-0033-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovsepian, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez-Llorca, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt Elvang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volbracht, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, C. K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herms, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">729</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2014.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1016%2Fj.biopsych.2014.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=25599931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2015&pages=729-739&issue=8&author=S.+Filserauthor=S.+V.+Ovsepianauthor=M.+Masanaauthor=L.+Blazquez-Llorcaauthor=A.+Brandt+Elvangauthor=C.+Volbrachtauthor=M.+B.+Muellerauthor=C.+K.+E.+Jungauthor=J.+Herms&title=Pharmacological+inhibition+of+BACE1+impairs+synaptic+plasticity+and+cognitive+functions&doi=10.1016%2Fj.biopsych.2014.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Inhibition of BACE1 Impairs Synaptic Plasticity and Cognitive Functions</span></div><div class="casAuthors">Filser, Severin; Ovsepian, Saak V.; Masana, Merce; Blazquez-Llorca, Lidia; Brandt Elvang, Anders; Volbracht, Christiane; Mueller, Marianne B.; Jung, Christian K. E.; Herms, Jochen</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">729-739</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">BACE1 (beta site amyloid precursor protein cleaving enzyme 1) is the rate limiting protease in amyloid β prodn., hence a promising drug target for the treatment of Alzheimer's disease.  Inhibition of BACE1, as the major β-secretase in vivo with multiple substrates, however is likely to have mechanism-based adverse effects.  We explored the impact of long-term pharmacol. inhibition of BACE1 on dendritic spine dynamics, synaptic functions, and cognitive performance of adult mice.  Sandwich ELISA was used to assess Aβ40 levels in brain and plasma after oral administration of BACE1 inhibitors SCH1682496 or LY2811376.  In vivo two-photon microscopy of the somatosensory cortex was performed to monitor structural dynamics of dendritic spines while synaptic functions and plasticity were measured via electrophysiol. recordings of excitatory postsynaptic currents and hippocampal long-term potentiation in brain slices.  Finally, behavioral tests were performed to analyze the impact of pharmacol. inhibition of BACE1 on cognitive performance.  Dose-dependent decrease of Aβ40 levels in vivo confirmed suppression of BACE1 activity by both inhibitors.  Prolonged treatment caused a redn. in spine formation of layer V pyramidal neurons, which recovered after withdrawal of inhibitors.  Congruently, the rate of spontaneous and miniature excitatory postsynaptic currents in pyramidal neurons and hippocampal long-term potentiation were reduced in animals treated with BACE1 inhibitors.  These effects were not detected in Bace1-/- mice treated with SCH1682496, confirming BACE1 as the pharmacol. target.  Described structural and functional changes were assocd. with cognitive deficits as revealed in behavioral tests.  Our findings indicate important functions to BACE1 in structural and functional synaptic plasticity in the mature brain, with implications for cognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBtdj8QyF3sLVg90H21EOLACvtfcHk0lgaj9WMSZSJww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKntLg%253D&md5=cfeed5a68833142e39074442dc343f42</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2014.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2014.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DFilser%26aufirst%3DS.%26aulast%3DOvsepian%26aufirst%3DS.%2BV.%26aulast%3DMasana%26aufirst%3DM.%26aulast%3DBlazquez-Llorca%26aufirst%3DL.%26aulast%3DBrandt%2BElvang%26aufirst%3DA.%26aulast%3DVolbracht%26aufirst%3DC.%26aulast%3DMueller%26aufirst%3DM.%2BB.%26aulast%3DJung%26aufirst%3DC.%2BK.%2BE.%26aulast%3DHerms%26aufirst%3DJ.%26atitle%3DPharmacological%2520inhibition%2520of%2520BACE1%2520impairs%2520synaptic%2520plasticity%2520and%2520cognitive%2520functions%26jtitle%3DBiol.%2520Psychiatry%26date%3D2015%26volume%3D77%26issue%3D8%26spage%3D729%26epage%3D739%26doi%3D10.1016%2Fj.biopsych.2014.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dockendorf, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleijn, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palcza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troyer, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M. S.</span></span> <span> </span><span class="NLM_article-title">The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">363</span>),  <span class="NLM_fpage">363ra150</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aad9704</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1126%2Fscitranslmed.aad9704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=27807285" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=363ra150&issue=363&author=M.+E.+Kennedyauthor=A.+W.+Stamfordauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+F.+Dockendorfauthor=M.+Eganauthor=L.+Ereshefskyauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=S.+Jheeauthor=H.+J.+Kleijnauthor=R.+Kuvelkarauthor=W.+Liauthor=B.+A.+Mattsonauthor=H.+Meiauthor=J.+Palczaauthor=J.+D.+Scottauthor=M.+Tanenauthor=M.+D.+Troyerauthor=J.+L.+Tsengauthor=J.+A.+Stoneauthor=E.+M.+Parkerauthor=M.+S.+Forman&title=The+BACE1+inhibitor+verubecestat+%28MK-8931%29+reduces+CNS+%CE%B2-amyloid+in+animal+models+and+in+Alzheimer%E2%80%99s+disease+patients&doi=10.1126%2Fscitranslmed.aad9704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9704%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DDockendorf%26aufirst%3DM.%2BF.%26aulast%3DEgan%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJhee%26aufirst%3DS.%26aulast%3DKleijn%26aufirst%3DH.%2BJ.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DMattson%26aufirst%3DB.%2BA.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DPalcza%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DTanen%26aufirst%3DM.%26aulast%3DTroyer%26aufirst%3DM.%2BD.%26aulast%3DTseng%26aufirst%3DJ.%2BL.%26aulast%3DStone%26aufirst%3DJ.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DForman%26aufirst%3DM.%2BS.%26atitle%3DThe%2520BACE1%2520inhibitor%2520verubecestat%2520%2528MK-8931%2529%2520reduces%2520CNS%2520%25CE%25B2-amyloid%2520in%2520animal%2520models%2520and%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26issue%3D363%26spage%3D363ra150%26doi%3D10.1126%2Fscitranslmed.aad9704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cárdenas, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osswald, H. L.</span></span> <span> </span><span class="NLM_article-title">The design, development, and evaluation of BACE1 inhibitors for the treatment of Alzheimer’s Disease</span>. <i>Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1007/7355_2016_16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1007%2F7355_2016_16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=27-85&author=A.+K.+Ghoshauthor=E.+L.+C%C3%A1rdenasauthor=H.+L.+Osswald&title=The+design%2C+development%2C+and+evaluation+of+BACE1+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1007%2F7355_2016_16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2F7355_2016_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F7355_2016_16%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DC%25C3%25A1rdenas%26aufirst%3DE.%2BL.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DThe%2520design%252C%2520development%252C%2520and%2520evaluation%2520of%2520BACE1%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DTop.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D27%26epage%3D85%26doi%3D10.1007%2F7355_2016_16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBell, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span> <span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">16507</span>– <span class="NLM_lpage">16516</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&issue=46&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+S.+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lgfnLbB222D_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DLaBell%26aufirst%3DE.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26issue%3D46%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuhl, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karanian, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroise, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brulet, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">am Ende, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judkins, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. S.</span></span> <span> </span><span class="NLM_article-title">Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13042</span>, <span class="refDoi"> DOI: 10.1038/ncomms13042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1038%2Fncomms13042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=27727204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GqtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13042&author=A.+M.+Zuhlauthor=C.+E.+Nolanauthor=M.+A.+Brodneyauthor=S.+Niessenauthor=K.+Atchisonauthor=C.+Houleauthor=D.+A.+Karanianauthor=C.+Ambroiseauthor=J.+W.+Bruletauthor=E.+M.+Beckauthor=S.+D.+Doranauthor=B.+T.+O%E2%80%99Neillauthor=C.+W.+am+Endeauthor=C.+Changauthor=K.+F.+Geogheganauthor=G.+M.+Westauthor=J.+C.+Judkinsauthor=X.+Houauthor=D.+R.+Riddellauthor=D.+S.+Johnson&title=Chemoproteomic+profiling+reveals+that+cathepsin+D+off-target+activity+drives+ocular+toxicity+of+%CE%B2-secretase+inhibitors&doi=10.1038%2Fncomms13042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors</span></div><div class="casAuthors">Zuhl, Andrea M.; Nolan, Charles E.; Brodney, Michael A.; Niessen, Sherry; Atchison, Kevin; Houle, Christopher; Karanian, David A.; Ambroise, Claude; Brulet, Jeffrey W.; Beck, Elizabeth M.; Doran, Shawn D.; O'Neill, Brian T.; am Ende, Christopher W.; Chang, Cheng; Geoghegan, Kieran F.; West, Graham M.; Judkins, Joshua C.; Hou, Xinjun; Riddell, David R.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13042</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of β-secretase BACE1 is considered one of the most promising approaches for treating Alzheimer's disease.  Several structurally distinct BACE1 inhibitors have been withdrawn from development after inducing ocular toxicity in animal models, but the target mediating this toxicity has not been identified.  Here we use a clickable photoaffinity probe to identify cathepsin D (CatD) as a principal off-target of BACE1 inhibitors in human cells.  We find that several BACE1 inhibitors blocked CatD activity in cells with much greater potency than that displayed in cell-free assays with purified protein.  Through a series of exploratory toxicol. studies, we show that quantifying CatD target engagement in cells with the probe is predictive of ocular toxicity in vivo.  Taken together, our findings designate off-target inhibition of CatD as a principal driver of ocular toxicity for BACE1 inhibitors and more generally underscore the power of chem. proteomics for discerning mechanisms of drug action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0-LulGVRdJLVg90H21EOLACvtfcHk0lgfnLbB222D_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GqtbbL&md5=5e2c31195f4f03babec561a5824ccb0d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fncomms13042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13042%26sid%3Dliteratum%253Aachs%26aulast%3DZuhl%26aufirst%3DA.%2BM.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DHoule%26aufirst%3DC.%26aulast%3DKaranian%26aufirst%3DD.%2BA.%26aulast%3DAmbroise%26aufirst%3DC.%26aulast%3DBrulet%26aufirst%3DJ.%2BW.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DWest%26aufirst%3DG.%2BM.%26aulast%3DJudkins%26aufirst%3DJ.%2BC.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DChemoproteomic%2520profiling%2520reveals%2520that%2520cathepsin%2520D%2520off-target%2520activity%2520drives%2520ocular%2520toxicity%2520of%2520%25CE%25B2-secretase%2520inhibitors%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13042%26doi%3D10.1038%2Fncomms13042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative Verubecestat (MK-8931)-a β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&issue=23&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+Verubecestat+%28MK-8931%29-a+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520Verubecestat%2520%2528MK-8931%2529-a%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D23%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willis, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borders, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brier, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickso, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevorkyan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komjathy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathe, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaught, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winneroski, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span> <span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1210</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.4129-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1523%2FJNEUROSCI.4129-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=25609634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1199-1210&issue=3&author=P.+C.+Mayauthor=B.+A.+Willisauthor=S.+L.+Loweauthor=R.+A.+Deanauthor=S.+A.+Monkauthor=P.+J.+Cockeauthor=J.+E.+Audiaauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+A.+Brierauthor=D.+O.+Calligaroauthor=T.+A.+Dayauthor=L.+Ereshefskyauthor=J.+A.+Ericksoauthor=H.+Gevorkyanauthor=C.+R.+Gonzalesauthor=D.+E.+Jamesauthor=S.+S.+Jheeauthor=S.+F.+Komjathyauthor=L.+Liauthor=T.+D.+Lindstromauthor=B.+M.+Matheauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=G.+M.+Vaughtauthor=B.+M.+Watsonauthor=L.+L.+Winneroskiauthor=Z.+Yangauthor=D.+J.+Mergott&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+A%CE%B2+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.4129-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span></div><div class="casAuthors">May, Patrick C.; Willis, Brian A.; Lowe, Stephen L.; Dean, Robert A.; Monk, Scott A.; Cocke, Patrick J.; Audia, James E.; Boggs, Leonard N.; Borders, Anthony R.; Brier, Richard A.; Calligaro, David O.; Day, Theresa A.; Ereshefsky, Larry; Erickso, Jon A.; Gevorkyan, Hykop; Gonzales, Celedon R.; James, Douglas E.; Jhee, Stanford S.; Komjathy, Steven F.; Li, Linglin; Lindstrom, Terry D.; Mathe, Brian M.; Martenyi, Ferenc; Sheehan, Scott M.; Stout, Stephanie L.; Timm, David E.; Vaught, Grant M.; Watson, Brian M.; Winneroski, Leonard L.; Yang, Zhixiang; Mergott, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1199-1210, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).  Therefore, the development of potent and selective inhibitors of BACE1 has been a focus of many drug discovery efforts in academia and industry.  Herein, we report the nonclin. and early clin. development of LY2886721, a BACE1 active site inhibitor that reached phase 2 clin. trials in AD.  LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclin. animal models.  Similar potent and persistent amyloid β lowering was obsd. in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects.  Collectively, these data add support for BACE1 inhibition as an effective means of amyloid lowering and as an attractive target for potential disease modification therapy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDFLhcsiUDLVg90H21EOLACvtfcHk0lgo3l02hWYZpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D&md5=7e16cc00767a8af4da7dd17b6e40e8f5</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4129-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4129-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DErickso%26aufirst%3DJ.%2BA.%26aulast%3DGevorkyan%26aufirst%3DH.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DJames%26aufirst%3DD.%2BE.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DKomjathy%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMathe%26aufirst%3DB.%2BM.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DVaught%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520A%25CE%25B2%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26issue%3D3%26spage%3D1199%26epage%3D1210%26doi%3D10.1523%2FJNEUROSCI.4129-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, M. D.</span></span> <span> </span><span class="NLM_article-title">Structural alert/reactive metabolite concept as applied in medicinal chemistry to mMitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1345</span>– <span class="NLM_lpage">1410</span>, <span class="refDoi"> DOI: 10.1021/tx200168d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx200168d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=1345-1410&issue=9&author=A.+F.+Stepanauthor=D.+P.+Walkerauthor=J.+Baumanauthor=D.+A.+Priceauthor=T.+A.+Baillieauthor=A.+S.+Kalgutkarauthor=M.+D.+Aleo&title=Structural+alert%2Freactive+metabolite+concept+as+applied+in+medicinal+chemistry+to+mMitigate+the+risk+of+idiosyncratic+drug+toxicity%3A+a+perspective+based+on+the+critical+examination+of+trends+in+the+top+200+drugs+marketed+in+the+United+States&doi=10.1021%2Ftx200168d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Ftx200168d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx200168d%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBaillie%26aufirst%3DT.%2BA.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DStructural%2520alert%252Freactive%2520metabolite%2520concept%2520as%2520applied%2520in%2520medicinal%2520chemistry%2520to%2520mMitigate%2520the%2520risk%2520of%2520idiosyncratic%2520drug%2520toxicity%253A%2520a%2520perspective%2520based%2520on%2520the%2520critical%2520examination%2520of%2520trends%2520in%2520the%2520top%2520200%2520drugs%2520marketed%2520in%2520the%2520United%2520States%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2011%26volume%3D24%26issue%3D9%26spage%3D1345%26epage%3D1410%26doi%3D10.1021%2Ftx200168d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rajapakse, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nantermet, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selnick, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrow, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGaughey, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katherine Holloway, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espeseth, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colussi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouthamel, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tugusheva, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span> <span> </span><span class="NLM_article-title">SAR of tertiary carbinamine derived BACE1 inhibitors: Role of aspartate ligand amine pK a in enzyme inhibition</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1885</span>– <span class="NLM_lpage">1889</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.01.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1016%2Fj.bmcl.2010.01.137" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1885-1889&issue=6&author=H.+A.+Rajapakseauthor=P.+G.+Nantermetauthor=H.+G.+Selnickauthor=J.+C.+Barrowauthor=G.+B.+McGaugheyauthor=S.+Munshiauthor=S.+R.+Lindsleyauthor=M.+B.+Youngauthor=P.+L.+Ngoauthor=M.+Katherine+Hollowayauthor=M.-T.+Laiauthor=A.+S.+Espesethauthor=X.-P.+Shiauthor=D.+Colussiauthor=B.+Pietrakauthor=M.-C.+Crouthamelauthor=K.+Tugushevaauthor=Q.+Huangauthor=M.+Xuauthor=A.+J.+Simonauthor=L.+Kuoauthor=D.+J.+Hazudaauthor=S.+Grahamauthor=J.+P.+Vacca&title=SAR+of+tertiary+carbinamine+derived+BACE1+inhibitors%3A+Role+of+aspartate+ligand+amine+pK+a+in+enzyme+inhibition&doi=10.1016%2Fj.bmcl.2010.01.137"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.01.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.01.137%26sid%3Dliteratum%253Aachs%26aulast%3DRajapakse%26aufirst%3DH.%2BA.%26aulast%3DNantermet%26aufirst%3DP.%2BG.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DLindsley%26aufirst%3DS.%2BR.%26aulast%3DYoung%26aufirst%3DM.%2BB.%26aulast%3DNgo%26aufirst%3DP.%2BL.%26aulast%3DKatherine%2BHolloway%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DShi%26aufirst%3DX.-P.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DCrouthamel%26aufirst%3DM.-C.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DKuo%26aufirst%3DL.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DSAR%2520of%2520tertiary%2520carbinamine%2520derived%2520BACE1%2520inhibitors%253A%2520Role%2520of%2520aspartate%2520ligand%2520amine%2520pK%2520a%2520in%2520enzyme%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D6%26spage%3D1885%26epage%3D1889%26doi%3D10.1016%2Fj.bmcl.2010.01.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gravenfors, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlstroem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlstroem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolmodin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstroem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kieseritzky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slivo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swahn, B.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eketjaell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroemberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, F.</span></span> <span> </span><span class="NLM_article-title">New aminoimidazoles as β-Secretase (BACE-1) inhibitors showing amyloid-β (Aβ) lowering in brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9297</span>– <span class="NLM_lpage">9311</span>, <span class="refDoi"> DOI: 10.1021/jm300991n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300991n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9297-9311&issue=21&author=Y.+Gravenforsauthor=J.+Viklundauthor=J.+Blidauthor=T.+Ginmanauthor=S.+Karlstroemauthor=J.+Kihlstroemauthor=K.+Kolmodinauthor=J.+Lindstroemauthor=S.+von+Bergauthor=F.+von+Kieseritzkyauthor=C.+Slivoauthor=B.-M.+Swahnauthor=L.-L.+Olssonauthor=P.+Johanssonauthor=S.+Eketjaellauthor=J.+Faeltingauthor=F.+Jeppssonauthor=K.+Stroembergauthor=J.+Jansonauthor=F.+Rahm&title=New+aminoimidazoles+as+%CE%B2-Secretase+%28BACE-1%29+inhibitors+showing+amyloid-%CE%B2+%28A%CE%B2%29+lowering+in+brain&doi=10.1021%2Fjm300991n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300991n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300991n%26sid%3Dliteratum%253Aachs%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DKarlstroem%26aufirst%3DS.%26aulast%3DKihlstroem%26aufirst%3DJ.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DLindstroem%26aufirst%3DJ.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DEketjaell%26aufirst%3DS.%26aulast%3DFaelting%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DStroemberg%26aufirst%3DK.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DNew%2520aminoimidazoles%2520as%2520%25CE%25B2-Secretase%2520%2528BACE-1%2529%2520inhibitors%2520showing%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520lowering%2520in%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D21%26spage%3D9297%26epage%3D9311%26doi%3D10.1021%2Fjm300991n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hitchcock, S. A.</span></span> <span> </span><span class="NLM_article-title">Structural modifications that alter the P-Glycoprotein efflux properties of compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4877</span>– <span class="NLM_lpage">4895</span>, <span class="refDoi"> DOI: 10.1021/jm201136z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&issue=11&author=S.+A.+Hitchcock&title=Structural+modifications+that+alter+the+P-Glycoprotein+efflux+properties+of+compounds&doi=10.1021%2Fjm201136z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span></div><div class="casAuthors">Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4877-4895</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This perspective is focused on structural modifications and strategies that can be applied during compd. optimization in order to modulate the P-glycoprotein efflux properties of small mols. with a particular emphasis on implications for CNS penetration. The precise mol. interactions that confer P-glycoprotein efflux remain relatively poorly defined. The promiscuous nature of P-glycoprotein efflux renders the rational circumvention of efflux, while simultaneously optimizing compds. for eficacy, safety, and pharmacokinetic properties, an extremely challenging undertaking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_5RBtwgb-rVg90H21EOLACvtfcHk0liZjBYCXFmfhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFKlt7s%253D&md5=6c5dffbb11db6fa893ff3c50fe7778cc</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520modifications%2520that%2520alter%2520the%2520P-Glycoprotein%2520efflux%2520properties%2520of%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D11%26spage%3D4877%26epage%3D4895%26doi%3D10.1021%2Fjm201136z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann-Roder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, K.</span></span> <span> </span><span class="NLM_article-title">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1002%2Fcmdc.200700059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=17530727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1100-1115&issue=8&author=M.+Morgenthalerauthor=E.+Schweizerauthor=A.+Hoffmann-Roderauthor=F.+Beniniauthor=R.+E.+Martinauthor=G.+Jaeschkeauthor=B.+Wagnerauthor=H.+Fischerauthor=S.+Bendelsauthor=D.+Zimmerliauthor=J.+Schneiderauthor=F.+Diederichauthor=M.+Kansyauthor=K.+Muller&title=Predicting+and+tuning+physicochemical+properties+in+lead+optimization%3A+amine+basicities&doi=10.1002%2Fcmdc.200700059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span></div><div class="casAuthors">Morgenthaler, Martin; Schweizer, Eliane; Hoffmann-Roder, Anja; Benini, Fausta; Martin, Rainer E.; Jaeschke, Georg; Wagner, Bjorn; Fischer, Holger; Bendels, Stefanie; Zimmerli, Daniel; Schneider, Josef; Diederich, Francois; Kansy, Manfred; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1100-1115</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  This review describes simple and useful concepts for predicting and tuning the pKa values of basic amine centers, a crucial step in the optimization of phys. and ADME properties of many lead structures in drug-discovery research.  The article starts with a case study of tricyclic thrombin inhibitors featuring a tertiary amine center with pKa values that can be tuned over a wide range, from the usual value of around 10 to below 2 by (remote) neighboring functionalities commonly encountered in medicinal chem.  Next, the changes in pKa of acyclic and cyclic amines upon substitution by fluorine, oxygen, nitrogen, and sulfur functionalities, as well as carbonyl and carboxyl derivs. are systematically analyzed, leading to the derivation of simple rules for pKa prediction.  Electronic and stereoelectronic effects in cyclic amines are discussed, and the emerging computational methods for pKa predictions are briefly surveyed.  The rules for tuning amine basicities should not only be of interest in drug-discovery research, but also to the development of new crop-protection agents, new amine ligands for organometallic complexes, and in particular, to the growing field of amine-based organocatalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodsWRMtrxWPbVg90H21EOLACvtfcHk0liZjBYCXFmfhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D&md5=478b70744312c01d3a43cf435d9598de</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700059%26sid%3Dliteratum%253Aachs%26aulast%3DMorgenthaler%26aufirst%3DM.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DHoffmann-Roder%26aufirst%3DA.%26aulast%3DBenini%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DPredicting%2520and%2520tuning%2520physicochemical%2520properties%2520in%2520lead%2520optimization%253A%2520amine%2520basicities%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26issue%3D8%26spage%3D1100%26epage%3D1115%26doi%3D10.1002%2Fcmdc.200700059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ginman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viklund, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmstroem, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blid, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emond, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsblom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lake, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehgelmeble, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterky, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeppsson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faelting, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gravenfors, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahm, F.</span></span> <span> </span><span class="NLM_article-title">Core refinement toward permeable β-Secretase (BACE-1) inhibitors with low hERG activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4181</span>– <span class="NLM_lpage">4205</span>, <span class="refDoi"> DOI: 10.1021/jm3011349</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3011349" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4181-4205&issue=11&author=T.+Ginmanauthor=J.+Viklundauthor=J.+Malmstroemauthor=J.+Blidauthor=R.+Emondauthor=R.+Forsblomauthor=A.+Johanssonauthor=A.+Kersauthor=F.+Lakeauthor=F.+Sehgelmebleauthor=K.+J.+Sterkyauthor=M.+Berghauthor=A.+Lindgrenauthor=P.+Johanssonauthor=F.+Jeppssonauthor=J.+Faeltingauthor=Y.+Gravenforsauthor=F.+Rahm&title=Core+refinement+toward+permeable+%CE%B2-Secretase+%28BACE-1%29+inhibitors+with+low+hERG+activity&doi=10.1021%2Fjm3011349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm3011349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3011349%26sid%3Dliteratum%253Aachs%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DMalmstroem%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DEmond%26aufirst%3DR.%26aulast%3DForsblom%26aufirst%3DR.%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DLake%26aufirst%3DF.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSterky%26aufirst%3DK.%2BJ.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DLindgren%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DFaelting%26aufirst%3DJ.%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DCore%2520refinement%2520toward%2520permeable%2520%25CE%25B2-Secretase%2520%2528BACE-1%2529%2520inhibitors%2520with%2520low%2520hERG%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D11%26spage%3D4181%26epage%3D4205%26doi%3D10.1021%2Fjm3011349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanguinetti, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tristani-Firouzi, M.</span></span> <span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span>. <i>Nature (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>440</i></span> (<span class="NLM_issue">7083</span>),  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.1038/nature04710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&issue=7083&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia&doi=10.1038%2Fnature04710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0liJNzGbTbZtrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2006%26volume%3D440%26issue%3D7083%26spage%3D463%26epage%3D469%26doi%3D10.1038%2Fnature04710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hilpert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guba, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woltering, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wostl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauser, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayweg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers-Evans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krummenacher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muser, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozmen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergadano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochstrasser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David-Pierson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narquizian, R.</span></span> <span> </span><span class="NLM_article-title">β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s Disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3980</span>– <span class="NLM_lpage">3995</span>, <span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&issue=10&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+Disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D10%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brodney, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parris, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundesmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buzon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaChapelle, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Alsina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikochik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakya, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, B. T.</span></span> <span> </span><span class="NLM_article-title">Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">3223</span>– <span class="NLM_lpage">3252</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3223-3252&issue=7&author=M.+A.+Brodneyauthor=E.+M.+Beckauthor=C.+R.+Butlerauthor=G.+Barreiroauthor=E.+F.+Johnsonauthor=D.+Riddellauthor=K.+Parrisauthor=C.+E.+Nolanauthor=Y.+Fanauthor=K.+Atchisonauthor=C.+Gonzalesauthor=A.+E.+Robshawauthor=S.+D.+Doranauthor=M.+W.+Bundesmannauthor=L.+Buzonauthor=J.+Dutraauthor=K.+Henegarauthor=E.+LaChapelleauthor=X.+Houauthor=B.+N.+Rogersauthor=J.+Panditauthor=R.+Liraauthor=L.+Martinez-Alsinaauthor=P.+Mikochikauthor=J.+C.+Murrayauthor=K.+Ogilvieauthor=L.+Priceauthor=S.+M.+Sakyaauthor=A.+Yuauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Utilizing+structures+of+CYP2D6+and+BACE1+complexes+to+reduce+risk+of+drug-drug+interactions+with+a+novel+series+of+centrally+efficacious+BACE1+inhibitors&doi=10.1021%2Facs.jmedchem.5b00191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DBuzon%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DJ.%26aulast%3DHenegar%26aufirst%3DK.%26aulast%3DLaChapelle%26aufirst%3DE.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%26aulast%3DMikochik%26aufirst%3DP.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DPrice%26aufirst%3DL.%26aulast%3DSakya%26aufirst%3DS.%2BM.%26aulast%3DYu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DUtilizing%2520structures%2520of%2520CYP2D6%2520and%2520BACE1%2520complexes%2520to%2520reduce%2520risk%2520of%2520drug-drug%2520interactions%2520with%2520a%2520novel%2520series%2520of%2520centrally%2520efficacious%2520BACE1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D7%26spage%3D3223%26epage%3D3252%26doi%3D10.1021%2Facs.jmedchem.5b00191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">1,4-Oxazine β-Secretase 1 (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8216</span>– <span class="NLM_lpage">8235</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&issue=20&author=F.+J.+R.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Martinez-Lamencaauthor=M.+Van+Goolauthor=A.+Garcia-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-Secretase+1+%28BACE1%29+inhibitors%3A+from+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMartinez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarcia-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-Secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D20%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosez, L.</span></span> <span> </span><span class="NLM_article-title">α-Chloroenamines. New reagents for organic synthesis</span>. <i>Angew. Chem., Int. Ed. Engl.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">852</span>– <span class="NLM_lpage">853</span>, <span class="refDoi"> DOI: 10.1002/anie.197208522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1002%2Fanie.197208522" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1972&pages=852-853&issue=9&author=L.+Ghosez&title=%CE%B1-Chloroenamines.+New+reagents+for+organic+synthesis&doi=10.1002%2Fanie.197208522"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fanie.197208522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.197208522%26sid%3Dliteratum%253Aachs%26aulast%3DGhosez%26aufirst%3DL.%26atitle%3D%25CE%25B1-Chloroenamines.%2520New%2520reagents%2520for%2520organic%2520synthesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1972%26volume%3D11%26issue%3D9%26spage%3D852%26epage%3D853%26doi%3D10.1002%2Fanie.197208522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ufimtsev, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, T. J.</span></span> <span> </span><span class="NLM_article-title">Quantum chemistry on graphical processing units. 3. analytical energy gradients, geometry optimization, and first principles molecular dynamics</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2619</span>– <span class="NLM_lpage">2628</span>, <span class="refDoi"> DOI: 10.1021/ct9003004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct9003004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVelurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=2619-2628&issue=10&author=I.+S.+Ufimtsevauthor=T.+J.+Martinez&title=Quantum+chemistry+on+graphical+processing+units.+3.+analytical+energy+gradients%2C+geometry+optimization%2C+and+first+principles+molecular+dynamics&doi=10.1021%2Fct9003004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Quantum Chemistry on Graphical Processing Units. 3. Analytical Energy Gradients, Geometry Optimization, and First Principles Molecular Dynamics</span></div><div class="casAuthors">Ufimtsev, Ivan S.; Martinez, Todd J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2619-2628</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We demonstrate that a video gaming machine contg. two consumer graphical cards can outpace a state-of-the-art quad-core processor workstation by a factor of more than 180× in Hartree-Fock energy + gradient calcns.  Such performance makes it possible to run large scale Hartree-Fock and D. Functional Theory calcns., which typically require hundreds of traditional processor cores, on a single workstation.  Benchmark Born-Oppenheimer mol. dynamics simulations are performed on two mol. systems using the 3-21G basis set - a hydronium ion solvated by 30 waters (94 atoms, 405 basis functions) and an aspartic acid mol. solvated by 147 waters (457 atoms, 2014 basis functions).  Our GPU implementation can perform 27 ps/day and 0.7 ps/day of ab initio mol. dynamics simulation on a single desktop computer for these systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWznU7lqZh8LVg90H21EOLACvtfcHk0liJCaXsqELenA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVelurvJ&md5=f4e320ac3479e4b566a6b8bdb9e5add8</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fct9003004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct9003004%26sid%3Dliteratum%253Aachs%26aulast%3DUfimtsev%26aufirst%3DI.%2BS.%26aulast%3DMartinez%26aufirst%3DT.%2BJ.%26atitle%3DQuantum%2520chemistry%2520on%2520graphical%2520processing%2520units.%25203.%2520analytical%2520energy%2520gradients%252C%2520geometry%2520optimization%252C%2520and%2520first%2520principles%2520molecular%2520dynamics%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2009%26volume%3D5%26issue%3D10%26spage%3D2619%26epage%3D2628%26doi%3D10.1021%2Fct9003004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span> <i>MacroModel</i>, Schrödinger
Release 2017–4; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MacroModel%2C+Schr%C3%B6dinger%0ARelease+2017%E2%80%934%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMacroModel%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trapa, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyn, S. J.</span></span> <span> </span><span class="NLM_article-title">Insights from an integrated physiologically based pharmacokinetic model for brain penetration</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>105</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">971</span>, <span class="refDoi"> DOI: 10.1016/j.xphs.2015.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1016%2Fj.xphs.2015.12.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2016&pages=965-971&issue=2&author=P.+E.+Trapaauthor=E.+Belovaauthor=J.+L.+Lirasauthor=D.+O.+Scottauthor=S.+J.+Steyn&title=Insights+from+an+integrated+physiologically+based+pharmacokinetic+model+for+brain+penetration&doi=10.1016%2Fj.xphs.2015.12.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2015.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2015.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DTrapa%26aufirst%3DP.%2BE.%26aulast%3DBelova%26aufirst%3DE.%26aulast%3DLiras%26aufirst%3DJ.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26atitle%3DInsights%2520from%2520an%2520integrated%2520physiologically%2520based%2520pharmacokinetic%2520model%2520for%2520brain%2520penetration%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D105%26issue%3D2%26spage%3D965%26epage%3D971%26doi%3D10.1016%2Fj.xphs.2015.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Danilenko, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G. D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span> <span> </span><span class="NLM_article-title">In vitro skin models and their predictability in defining normal and disease biology, pharmacology, and toxicity</span>. <i>Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1177/0192623316632074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1177%2F0192623316632074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=26940714" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2qur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=555-563&issue=4&author=D.+M.+Danilenkoauthor=G.+D.+L.+Phillipsauthor=D.+Diaz&title=In+vitro+skin+models+and+their+predictability+in+defining+normal+and+disease+biology%2C+pharmacology%2C+and+toxicity&doi=10.1177%2F0192623316632074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro skin models and their predictability in defining normal and disease biology, pharmacology, and toxicity</span></div><div class="casAuthors">Danilenko, Dimitry M.; Phillips, Gail D. Lewis; Diaz, Dolores</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">555-563</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">In vitro skin model systems are increasingly being used both in the early evaluation of therapeutic drug candidates and in confirmatory mechanistic studies.  The most commonly used of these in vitro model systems are reconstituted human epidermis (RHE) models.  These RHE models consist solely of epidermal keratinocytes, which comes with some limitations but also with the advantage of focusing toxicol. and pharmacol. evaluation on keratinocytes alone.  RHE models can generally be implemented more quickly, easily, and reproducibly than in vivo models and can thus be used for high throughput compd. screening while potentially reducing the need for animal studies.  Histol. evaluation of RHE sections can be done quite easily, and the sections are very amenable to quantification via image anal., including automated anal.  RHE model systems can provide very valuable early indications of therapeutic candidate biol., pharmacol., and toxicity; and early results have demonstrated that RHE models have been quite predictive for in vivo pharmacol. and toxicol. effects on the skin, including clin. skin toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcv7KaXFHzyLVg90H21EOLACvtfcHk0liUaqKSDxdLBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2qur%252FP&md5=d92c01898512a6376621231d6dbc145e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1177%2F0192623316632074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623316632074%26sid%3Dliteratum%253Aachs%26aulast%3DDanilenko%26aufirst%3DD.%2BM.%26aulast%3DPhillips%26aufirst%3DG.%2BD.%2BL.%26aulast%3DDiaz%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520skin%2520models%2520and%2520their%2520predictability%2520in%2520defining%2520normal%2520and%2520disease%2520biology%252C%2520pharmacology%252C%2520and%2520toxicity%26jtitle%3DToxicol.%2520Pathol.%26date%3D2016%26volume%3D44%26issue%3D4%26spage%3D555%26epage%3D563%26doi%3D10.1177%2F0192623316632074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takekoshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osamura, R. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawana, S.</span></span> <span> </span><span class="NLM_article-title">Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model</span>. <i>J. Mol. Histol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1023/B:HIJO.0000023388.51625.6c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1023%2FB%3AHIJO.0000023388.51625.6c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=15328920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvFKrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2004&pages=157-165&issue=2&author=R.+Takeyamaauthor=S.+Takekoshiauthor=H.+Nagataauthor=R.+Y.+Osamuraauthor=S.+Kawana&title=Quercetin-induced+melanogenesis+in+a+reconstituted+three-dimensional+human+epidermal+model&doi=10.1023%2FB%3AHIJO.0000023388.51625.6c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model</span></div><div class="casAuthors">Takeyama, Reiko; Takekoshi, Susumu; Nagata, Hidetaka; Osamura, R. Yoshiyuki; Kawana, Seiji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Histology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-165</span>CODEN:
                <span class="NLM_cas:coden">JMHOAO</span>;
        ISSN:<span class="NLM_cas:issn">1567-2379</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">Quercetin (3,5,7,3',4'-pentahydroxyflavone) is one of the most abundant natural flavonoids.  It is present in various common vegetables and fruits.  In this report, we examd. the effect of quercetin on melanogenesis using a three-dimensional reconstituted human epidermal culture model, MelanoDerm, which is a new com.-available cultured human epidermis contg. functional melanocytes.  Treatment with 10 μM quercetin induced an increase of tyrosinase activity in cultured epidermis after 3-5 days in time-dependent manner.  In the quercetin-treated epidermis, furthermore, melanin content and tyrosinase expression were markedly increased, as shown by immunohistochem. after a 7-day culture period.  Ultrastructural studies clearly indicated an accumulation of mature melanosomes (stages III and IV) inside the basal layer of the cultured epidermis after the quercetin treatment.  In addn., the dendrites of melanocytes extended further towards the adjacent keratinocytes after quercetin treatment.  These results suggest that quercetin has an effect on maturation of melanosomes and that quercetin has the potential to induced melanogenesis in human epidermis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptdi8MRP_MsLVg90H21EOLACvtfcHk0liUaqKSDxdLBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvFKrtLw%253D&md5=d08dc43ed8e62309966870349005dd92</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1023%2FB%3AHIJO.0000023388.51625.6c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253AHIJO.0000023388.51625.6c%26sid%3Dliteratum%253Aachs%26aulast%3DTakeyama%26aufirst%3DR.%26aulast%3DTakekoshi%26aufirst%3DS.%26aulast%3DNagata%26aufirst%3DH.%26aulast%3DOsamura%26aufirst%3DR.%2BY.%26aulast%3DKawana%26aufirst%3DS.%26atitle%3DQuercetin-induced%2520melanogenesis%2520in%2520a%2520reconstituted%2520three-dimensional%2520human%2520epidermal%2520model%26jtitle%3DJ.%2520Mol.%2520Histol.%26date%3D2004%26volume%3D35%26issue%3D2%26spage%3D157%26epage%3D165%26doi%3D10.1023%2FB%3AHIJO.0000023388.51625.6c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwat, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batzer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smuda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolbe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hearing, V. J.</span></span> <span> </span><span class="NLM_article-title">The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>123</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">3102</span>– <span class="NLM_lpage">3111</span>, <span class="refDoi"> DOI: 10.1242/jcs.064774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1242%2Fjcs.064774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=20736300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlGls7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2010&pages=3102-3111&issue=18&author=W.+Choiauthor=R.+Wolberauthor=W.+Gerwatauthor=T.+Mannauthor=J.+Batzerauthor=C.+Smudaauthor=H.+Liuauthor=L.+Kolbeauthor=V.+J.+Hearing&title=The+fibroblast-derived+paracrine+factor+neuregulin-1+has+a+novel+role+in+regulating+the+constitutive+color+and+melanocyte+function+in+human+skin&doi=10.1242%2Fjcs.064774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin</span></div><div class="casAuthors">Choi, Wonseon; Wolber, Rainer; Gerwat, Wolfram; Mann, Tobias; Batzer, Jan; Smuda, Christoph; Liu, Hongfang; Kolbe, Ludger; Hearing, Vincent J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3102-3111</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Interactions between melanocytes and neighboring cells in the skin are important in regulating skin color in humans.  We recently demonstrated that the less pigmented and thicker skin on the palms and soles is regulated by underlying fibroblasts in those areas, specifically via a secreted factor (DKK1) that modulates Wnt signaling.  In this study, we tested the hypothesis that dermal fibroblasts regulate the constitutive skin color of individuals ranging from very light to very dark.  We used microarray anal. to compare gene expression patterns in fibroblasts derived from lighter skin types compared to darker skin types, with a focus on secreted proteins.  We identified a no. of genes that differ dramatically in expression and, among the expressed proteins, neuregulin-1, which is secreted by fibroblasts derived from dark skin, effectively increases the pigmentation of melanocytes in tissue culture and in an artificial skin model and regulates their growth, suggesting that it is one of the major factors detg. human skin color.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprH4CJ0OpTXbVg90H21EOLACvtfcHk0liUaqKSDxdLBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlGls7zE&md5=428d53c9baec75a30d1df7eed4ed45e2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1242%2Fjcs.064774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.064774%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DWolber%26aufirst%3DR.%26aulast%3DGerwat%26aufirst%3DW.%26aulast%3DMann%26aufirst%3DT.%26aulast%3DBatzer%26aufirst%3DJ.%26aulast%3DSmuda%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DKolbe%26aufirst%3DL.%26aulast%3DHearing%26aufirst%3DV.%2BJ.%26atitle%3DThe%2520fibroblast-derived%2520paracrine%2520factor%2520neuregulin-1%2520has%2520a%2520novel%2520role%2520in%2520regulating%2520the%2520constitutive%2520color%2520and%2520melanocyte%2520function%2520in%2520human%2520skin%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2010%26volume%3D123%26issue%3D18%26spage%3D3102%26epage%3D3111%26doi%3D10.1242%2Fjcs.064774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wills, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tankisheva, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckeridge, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span> <span> </span><span class="NLM_article-title">Saftey, tolerability, and pharmacokinetic and pharmacodynamic effects of PF-06751979, a potent and selective oral BACE1 inhibitor: results from phase1 single and multiple ascending dose studies in healthy young and older volunteers</span>. <i>Alzheimer’s Dementia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">P575</span>– <span class="NLM_lpage">P576</span>, <span class="refDoi"> DOI: 10.1016/j.jalz.2017.07.196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1016%2Fj.jalz.2017.07.196" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=P575-P576&issue=7&author=R.+Qiuauthor=R.+Liuauthor=P.+Heauthor=A.-M.+Willsauthor=E.+Tankishevaauthor=C.+Alveyauthor=C.+Buckeridgeauthor=M.+Bednarauthor=R.+C.+Alexanderauthor=D.+Chen&title=Saftey%2C+tolerability%2C+and+pharmacokinetic+and+pharmacodynamic+effects+of+PF-06751979%2C+a+potent+and+selective+oral+BACE1+inhibitor%3A+results+from+phase1+single+and+multiple+ascending+dose+studies+in+healthy+young+and+older+volunteers&doi=10.1016%2Fj.jalz.2017.07.196"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2017.07.196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2017.07.196%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DHe%26aufirst%3DP.%26aulast%3DWills%26aufirst%3DA.-M.%26aulast%3DTankisheva%26aufirst%3DE.%26aulast%3DAlvey%26aufirst%3DC.%26aulast%3DBuckeridge%26aufirst%3DC.%26aulast%3DBednar%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DChen%26aufirst%3DD.%26atitle%3DSaftey%252C%2520tolerability%252C%2520and%2520pharmacokinetic%2520and%2520pharmacodynamic%2520effects%2520of%2520PF-06751979%252C%2520a%2520potent%2520and%2520selective%2520oral%2520BACE1%2520inhibitor%253A%2520results%2520from%2520phase1%2520single%2520and%2520multiple%2520ascending%2520dose%2520studies%2520in%2520healthy%2520young%2520and%2520older%2520volunteers%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2017%26volume%3D13%26issue%3D7%26spage%3DP575%26epage%3DP576%26doi%3D10.1016%2Fj.jalz.2017.07.196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osmanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viana, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meghpara, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edward, D. P.</span></span> <span> </span><span class="NLM_article-title">Objective measurement of periocular pigmentation</span>. <i>Photodermatol., Photoimmunol. Photomed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1111/j.1600-0781.2008.00377.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1111%2Fj.1600-0781.2008.00377.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=19000184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A280%3ADC%252BD1cjjt1Sgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2008&pages=285-90&issue=6&author=J.+A.+Leeauthor=S.+Osmanovicauthor=M.+A.+Vianaauthor=R.+Kapurauthor=B.+Meghparaauthor=D.+P.+Edward&title=Objective+measurement+of+periocular+pigmentation&doi=10.1111%2Fj.1600-0781.2008.00377.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Objective measurement of periocular pigmentation</span></div><div class="casAuthors">Lee Janet Agnes; Osmanovic Smajo; Viana Marlos A G; Kapur Rashmi; Meghpara Beeran; Edward Deepak P</div><div class="citationInfo"><span class="NLM_cas:title">Photodermatology, photoimmunology & photomedicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">285-90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  To evaluate the Minolta CR-400 chromameter in objectively measuring periocular/facial pigmentation in subjects of different ethnicities.  METHODS:  The CR-400 was used to obtain skin color measurements from 75 African-American, Caucasian and Hispanic subjects in 16 facial and periocular locations.  Comparisons between ethnic and Fitzpatrick groups and instrument reliability were analyzed.  RESULTS:  Significant differences in L* were observed among all three ethnic groups, while values a* and b* were less sensitive to differences in pigmentation.  Comparison between Fitzpatrick groups again identified value L* as being the most sensitive, demonstrating significant differences between the more heavily pigmented groups.  The 16 facial locations measured were found to be statistically similar to each other, and the chromameter demonstrated excellent inter- and intra-instrument reliability.  CONCLUSIONS:  The Minolta CR-400 chromameter reliably measures facial pigmentation and can be useful for studies evaluating changes in skin pigmentation.  Value L* is the parameter that is most sensitive to differences between ethnic and Fitzpatrick groups.  Overlap between groups was observed, demonstrating that in future studies, each individual must serve as their own control when monitoring changes in pigmentation.  The similarity between all the locations tested demonstrates uniformity of facial pigmentation within an individual.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIBTA0A173CE2yPDyEFiigfW6udTcc2eZOMj0pAMi8aLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjjt1Sgtw%253D%253D&md5=e1a95a9bf9075660cc30fc56d6b3966e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0781.2008.00377.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0781.2008.00377.x%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DOsmanovic%26aufirst%3DS.%26aulast%3DViana%26aufirst%3DM.%2BA.%26aulast%3DKapur%26aufirst%3DR.%26aulast%3DMeghpara%26aufirst%3DB.%26aulast%3DEdward%26aufirst%3DD.%2BP.%26atitle%3DObjective%2520measurement%2520of%2520periocular%2520pigmentation%26jtitle%3DPhotodermatol.%252C%2520Photoimmunol.%2520Photomed.%26date%3D2008%26volume%3D24%26issue%3D6%26spage%3D285%26epage%3D90%26doi%3D10.1111%2Fj.1600-0781.2008.00377.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalvass, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollack, G. M.</span></span> <span> </span><span class="NLM_article-title">Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo P-glycoprotein efflux ratios</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">666</span>, <span class="refDoi"> DOI: 10.1124/dmd.106.012294</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1124%2Fdmd.106.012294" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=660-666&issue=4&author=J.+C.+Kalvassauthor=T.+S.+Maurerauthor=G.+M.+Pollack&title=Use+of+plasma+and+brain+unbound+fractions+to+assess+the+extent+of+brain+distribution+of+34+drugs%3A+comparison+of+unbound+concentration+ratios+to+in+vivo+P-glycoprotein+efflux+ratios&doi=10.1124%2Fdmd.106.012294"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.012294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.012294%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DPollack%26aufirst%3DG.%2BM.%26atitle%3DUse%2520of%2520plasma%2520and%2520brain%2520unbound%2520fractions%2520to%2520assess%2520the%2520extent%2520of%2520brain%2520distribution%2520of%252034%2520drugs%253A%2520comparison%2520of%2520unbound%2520concentration%2520ratios%2520to%2520in%2520vivo%2520P-glycoprotein%2520efflux%2520ratios%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26issue%3D4%26spage%3D660%26epage%3D666%26doi%3D10.1124%2Fdmd.106.012294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kutchinsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asmild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taboryski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vestergaard, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krzywkowski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljungstrom, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helix, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bech, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willumsen, N. J.</span></span> <span> </span><span class="NLM_article-title">Characterization of potassium channel modulators with QPatch automated patch-clamp technology: system characteristics and performance</span>. <i>Assay Drug Dev. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">685</span>– <span class="NLM_lpage">693</span>, <span class="refDoi"> DOI: 10.1089/154065803770381048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1089%2F154065803770381048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=685-693&issue=5&author=J.+Kutchinskyauthor=S.+Friisauthor=M.+Asmildauthor=R.+Taboryskiauthor=S.+Pedersenauthor=R.+K.+Vestergaardauthor=R.+B.+Jacobsenauthor=K.+Krzywkowskiauthor=R.+L.+Schroderauthor=T.+Ljungstromauthor=N.+Helixauthor=C.+B.+Sorensenauthor=M.+Bechauthor=N.+J.+Willumsen&title=Characterization+of+potassium+channel+modulators+with+QPatch+automated+patch-clamp+technology%3A+system+characteristics+and+performance&doi=10.1089%2F154065803770381048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1089%2F154065803770381048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252F154065803770381048%26sid%3Dliteratum%253Aachs%26aulast%3DKutchinsky%26aufirst%3DJ.%26aulast%3DFriis%26aufirst%3DS.%26aulast%3DAsmild%26aufirst%3DM.%26aulast%3DTaboryski%26aufirst%3DR.%26aulast%3DPedersen%26aufirst%3DS.%26aulast%3DVestergaard%26aufirst%3DR.%2BK.%26aulast%3DJacobsen%26aufirst%3DR.%2BB.%26aulast%3DKrzywkowski%26aufirst%3DK.%26aulast%3DSchroder%26aufirst%3DR.%2BL.%26aulast%3DLjungstrom%26aufirst%3DT.%26aulast%3DHelix%26aufirst%3DN.%26aulast%3DSorensen%26aufirst%3DC.%2BB.%26aulast%3DBech%26aufirst%3DM.%26aulast%3DWillumsen%26aufirst%3DN.%2BJ.%26atitle%3DCharacterization%2520of%2520potassium%2520channel%2520modulators%2520with%2520QPatch%2520automated%2520patch-clamp%2520technology%253A%2520system%2520characteristics%2520and%2520performance%26jtitle%3DAssay%2520Drug%2520Dev.%2520Technol.%26date%3D2003%26volume%3D1%26issue%3D5%26spage%3D685%26epage%3D693%26doi%3D10.1089%2F154065803770381048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawiec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21917</span>, <span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21917&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+L.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0lioOo9UyTyhOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BL.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21917%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CLM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5CLM','PDB','5CLM'); return false;">PDB: 5CLM</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i63"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00246">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26672"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00246">10.1021/acs.jmedchem.8b00246</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Effect of compound <b>64</b> on brain Aβ following 5 days of subchronic dosing; BACE2 inhibition causes accumulation of full length PMEL in primary human melanocytes; BACE1 and BACE2 binding curves; time course of fur regrowth in control C57Blk mice following depilation with Nair; dose response effect of <b>3</b> and <b>4</b> on pigmentation in C57Blk mice at 3 weeks post-depilation; projected <i>C</i><sub>avg</sub> concentration in mouse studies; mouse skin epithelial transmission electron microscopic images; 3D skin model delta L quantification for <b>61</b> and <b>65</b>; single crystal X-ray analysis of <b>64</b>-HCl (CCDC 1829109); representative <sup>1</sup>H NMR (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_001.pdf">jm8b00246_si_001.pdf (4.4 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00246/suppl_file/jm8b00246_si_002.csv">jm8b00246_si_002.csv (1.64 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00246&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-10%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00246%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00246" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679919b58e5c3d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
